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1 
CHAPTER I. 
 
INTRODUCTION 
 
1.1 Approaches to the Stereoselective Synthesis of 1,2-Diamines 
Many common structural motifs are found in nature among biologically active 
compounds. Among these common motifs are 1,2-diamines. The ability to make these 
compounds in a stereoselective fashion is important for making biologically active 
compounds (Figure 1) as well as asymmetric reagents for synthesis.  
Chiral 1,2-diamines are very important backbones of a vast array of asymmetric 
catalysts (Figure 2). Chiral diamines have been used as chiral ligands in combination with 
Figure 1. Biologically Active 1,2-Diamines 
  
Figure 2. 1,2-Diamines Used for Asymmetric Catalysis 
 
2 
metals and as metal-free chiral organocatalysts.
1,2,3,4,5,6
  
Stereochemically enriched 1,2-diamines can be obtained in many different ways. 
Perhaps the oldest method for this task is resolution using a stoichiometric amount of a 
chiral resolving agent. This procedure has many drawbacks including the lack of 
generality towards substrates, as they must be solids for recrystallization-based 
techniques, and the limited yields that can be obtained by resolution. 
Enantiomerically pure amino acids can be inexpensive starting materials for the 
synthesis of chiral 1,2-diamines. Reetz demonstrated the use of various L-amino acids to 
obtain both syn and anti-1,2-diamines (Scheme 1).
7
 This solution is ultimately limited by 
the availability of the amino acid starting material. 
Xu and Lin utilized aryl N-sulfinyl imines in a stereoselective samarium mediated 
                                                 
1
 Perron, Q.; Alexakis, A. Tetrahedron: Asymmetry 2007, 18, 2503-2506. 
2
 Trost, B. M.; Xie, J. J. Am. Chem. Soc. 2006, 128, 6044-6045. 
3
 Noyori, R.; Hashiguchi, S. Acc. Chem. Res. 1997, 30, 97-102. 
4
 Xu, X.; Furukawa, T.; Okino, T.; Miyabe, H.; Takemoto, Y. Chem. Eur. J. 2006, 12, 466-476. 
5
 Yoon, T. P.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2005, 44, 466-468.  
6
 Saito, B.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 6694-6695. 
7
 Reetz, M. T.; Jaeger, R.; Drewlies, R.; Hübel, M. Angew. Chem. Int. Ed. 1991, 30, 103-106. 
Scheme 1. Reetz' Synthesis of 1,2-Diamines from Amino Acids 
 
 
  
3 
homocoupling (eq 1).
8
 This chiral auxiliary approach resulted in the formation of a single 
stereoisomer which was then reduced to form 1,2-diamines. A cross-coupling reaction 
between nitrones and imines bearing a chiral auxiliary led to stereoisomerically enriched 
unsymmetrical 1,2-diamines (eq 2).
9
  
Enders demonstrated the use of diastereoselective Michael additions to 
nitroalkenes to form 1,2-diamines. A mannitol-derived chiral ammonia equivalent 1 was 
used as shown in Scheme 2.
10
 
Mioskowski also demonstrated the use of a diastereoselective Michael addition to 
nitroalkenes (eq 3). An oxazolidinone chiral auxiliary was employed to make 1,2-
diamines with high stereoselectivity. 
                                                 
8
 Zhong, Y.; Izumi, K.; Xu, M.; Lin, G. Org. Lett. 2004, 6, 4747-4750. 
9
 Lin, G.; Xu, M.; Zhong, Y.; Sun, X. Acc. Chem. Res. 2008, 41, 831-840. 
10
 Enders, D.; Wiedemann, J. Synthesis 1996, 1443-1450. 
  
Scheme 2. Enders‟ Diastereoselective Michael Addition to Nitroalkenes 
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 Stereoselective diamination of alkenes has been studied separately by Muniz and 
Shi. Muniz was able to diaminate alkenes using osmium and a titanium TADDOL 
catalyst 2 for absolute stereocontrol, up to 90% ee (eq 4).
11
 This method provided 
reasonable generality. The imide functionality is needed for this reaction to take place, 
but it can be easily converted to other functionalities like alcohols or carboxylic acids. 
The osmate imide is readily cleaved by hydride reduction. 
Shi was also able to diaminate alkenes stereoselectively.
12
 A palladium BINOL 
derived catalyst was employed to achieve high levels of enantioselectivity (eq 5). This 
chemistry is limited to the use of dienes as starting materials. The resulting cyclic urea 
                                                 
11
 Almodovar, I.; Hövelmann, C. H.; Streuff, J.; Nieger, M.; Muñiz, K. Eur. J. Org. Chem. 2006, 704-712. 
12
 Du, H.; Yuan, W.; Zhao, B.; Shi, Y. J. Am. Chem. Soc. 2007, 129, 11688-11689. 
  
 
 
 
5 
product 4 can be easily converted to a 1,2-diamine with a pendant vinyl group or to an 
1,2-diamino acid.  
Evans explored the asymmetric aziridination of olefins to accomplish the task of 
making 1,2-diamines in equation 6.
13
 A copper bis-oxazoline catalyst was used to affect 
stereoselectivity. Enantiomerically enriched aziridines could then be opened 
stereospecifically with a nitrogen nucleophile to yield anti-1,2-diamines. 
Wulff formed aziridines stereoselectively from N-dianisylmethylimines (eq 7).
14
 
The asymmetric catalyst used was a VANOL-borate system derived from triphenylborate 
and VANOL ligand 6.  
Shibasaki also used aziridines to arrive at 1,2-diamines.
15
 By desymmetrizing 
meso-aziridines, a variety of syn-1,2-diamines were synthesized (Scheme 3). This 
procedure was used to make Tamiflu (7) in 15 steps from a meso-aziridine.  
                                                 
13
 Evans, D. A.; Faul, M. M.; Bilodeau, M. T.; Anderson, B. A.; Barnes, D. M. J. Am. Chem. Soc. 1993, 
115, 5328-5329. 
14
 Lu, Z.; Zhang, Y.; Wulff, W. D. J. Am. Chem. Soc. 2007, 129, 7185-7194. 
15
 Fukuta, Y.; Mita, T.; Fukuda, N.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2006, 128, 6312-6313. 
  
 
 
6 
Chin and coworkers have extensively studied the stereospecific synthesis of C2-
symmetric diamines from the “mother diamine” through the diaza-Cope rearrangement 
(eq 8).
16
 Enantiopurity of the “mother diamine” is maintained as (R,R) diamine 8 
condenses with the aldehyde, undergoes rearrangement, and hydrolyzes to give the (S,S)-
“daughter diamine” 9. Electron-rich and electron-deficient aryl groups are tolerated and 
modest to good yields are seen. Still, this reaction relies on a stoichiometric chiral, non-
racemic substrate. 
 
                                                 
16
 Kim, H.; Nguyen, Y.; Yen, C. P.-H.; Chagal, L.; Lough, A. J.; Kim, B. M.; Chin, J. J. Am. Chem. Soc. 
2008, 130, 12184-12191. 
Scheme 3. Shibasaki's Desymmetrization of meso-Aziridines and Application to Tamiflu 
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 1.2 Asymmetric Aza-Henry Reaction 
The aza-Henry, or nitro-Mannich, reaction is a C-C bond forming reaction in 
which a nitroalkane (11) is added to an imine (10). This is typically with the aid of an 
acid or base catalyst. The α-nitro amine products (12) of this reaction can be readily 
transformed into useful products like 1,2-diamines, α-amino acids, or α-amino ketones 
(eq 10).  
The aza-Henry reaction can be traced back to the discovery of nitroalkane 
additions to aldehydes by Henry in 1896.
17,18
 At the same time, Henry outlined a reaction 
of a nitroalkane with two equivalents of a hemiaminal (eq 11). This reaction could be 
considered the first example of an aza-Henry reaction. This is simply a traditional 
Mannich reaction with a nitroalkane as the nucleophile and is also often referred to as a 
nitro-Mannich reaction. In 1937, Cerf extended the scope of the reaction.
19
 Cerf claimed 
that only two equivalents of 13 will react with nitromethane and only one equivalent of 
13 with react with any other nitroalkane. Subsequently, Senkus published work to the 
                                                 
17
 Henry, L. Bull. Acad. Roy. Belg. 1896, 32, 33. 
18
 Henry, L. Chem. Ber. 1905, 38, 2027. 
19
 Cerf de Mauney, C. d. Bull. Soc. Chim. France 1937, 4, 1451. 
 
 
 
8 
contrary in 1946 using primary amines and formaldehyde.
20
 At the same time, Johnson 
used secondary amines to form hemiaminal precursors.
21
 
Further developments were not made until the late 1950s when mechanistic 
studies were performed. Butler proposed that the hemiaminal formed the gem-diamine 
prior to attack from the nitroalkane (eq 12).
22
 Then, Fernandez proposed that the aci-
nitroalkane (14, eq 13), analogous to the enol tautomer of a ketone, was the active form 
involved in the transition state.
23,24
  
The traditional aza-Henry reaction using an imine (instead of a hemiaminal) and 
nitroalkane was not reported until 1950. Hurd and Strong performed a nitromethane 
addition to N-phenylbenzylimine to give the aza-Henry product in 65% yield (eq 14).
25
 A 
similar reaction was also performed with nitroethane in this report, but there was no 
mention of diastereoselectivity. 
                                                 
20
 Senkus, M. J. Am. Chem. Soc. 1946, 68, 10-12. 
21
 Johnson, H. G. J. Am. Chem. Soc. 1946, 68, 12-14. 
22
 Butler, G. B. J. Am. Chem. Soc. 1956, 78, 482-484. 
23
 Fernandez, J. E.; Fowler, J. S. J. Org. Chem. 1964, 29, 402-407. 
24
 Fernandez, J. E.; Fowler, J. S.; Glaros, S. J. J. Org. Chem. 1965, 30, 2787-2791. 
25
 Hurd, C. D.; Strong, J. S. J. Am. Chem. Soc. 1950, 72, 4813-4814. 
 
 
 
9 
In 1998, Anderson used the aza-Henry reaction as an approach to 1,2-diamines.
26
 
He added alkyl nitronate anions to para-methoxy benzylimines in the presence of a 
Brønsted acid and observed good diastereoselection in a few cases (eq 15). The aza-
Henry products were then reduced with SmI2 and deprotected with ceric ammonium 
nitrate to give free diamines. 
Just one year later, Shibasaki reported a catalytic enantioselective aza-Henry 
reaction (eq 16). A heterobimetallic complex consisting of Yb(O
i
Pr)3, KO
t
Bu, and (R)- 
binaphthol was used to achieve enantioselection up to 91% ee.
27
 This catalyst system 
however failed to catalyze the addition of nitroethane into the phosphonyl imine. An 
AlLi[(R)-binaphthoxide]2 complex was used to give as high as 83% ee and 7:1 dr with 
nitroethane additions.
28,29
 Shibasaki used this chemistry to synthesize two biologically 
active compounds, ICI-199441 and CP-99994 (Figure 3).
30
 Not only was this a good 
                                                 
26
 Adams, H.; Anderson, J. C.; Peace, S.; Pennell, A. M. K. J. Org. Chem. 1998, 63, 9932-9934. 
27
 Yamada, K.; Harwood, S. J.; Groger, H.; Shibasaki, M. Angew. Chem., Int. Ed. 1999, 38, 3504-3506. 
28
 Yamada, K.; Moll, G.; Shibasaki, M. Synlett 2001, 980-982. 
29
 Shibasaki, M.; Kanai, M. Chem. Pharm. Bull. 2001, 49, 511-524. 
30
 Tsuritani, N. Y., K.; Yoshikawa, N.; Shibasaki, M. Chem. Lett. 2002, 31, 276. 
 
 
Figure 3. Biologically Active 1,2-Diamines Synthesized by Shibasaki 
 
10 
demonstration of the generality of this catalyst system, but it also showed the advantage 
of using the asymmetric aza-Henry reaction as a synthetic method. Previously, these 
compounds were made by functional group transformations starting from an amino acid. 
The aza-Henry reaction provided a more straightforward route to these compounds. 
Shortly after Shibasaki‟s initial findings, others reported metal-catalyzed 
enantioselective aza-Henry reactions.
31
 In 2001, Jorgensen reported a Cu-Box catalyzed 
aza-Henry reaction of silyl nitronates to α-imino esters (eq 17).32 As high as 25:1 dr and 
95% ee was achieved with catalyst 15. Under different conditions, Jorgensen also added 
phenylnitromethane to an α-imino ester with low diastereoselection and modest 
enantioselection (eq 18).
33
 In 2005, Anderson also used Cu-Box catalyst 17 for 
                                                 
31
 A review on catalytic enantioselective aza-Henry reactions: Marqués-López, E.; Merino, P.; Tejero, T.; 
Herrera, R. P. Eur. J. Org. Chem. 2009, 2401-2420. 
32
 Knudsen, K. R.; Risgaard, T.; Nishiwaki, N.; Gothelf, K. V.; Jorgensen, K. A. J. Am. Chem. Soc. 2001, 
123, 5843-5844. 
33
 Nishiwaki, N.; Rahbek Knudsen, K.; Gothelf, K. V.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2001, 40, 
2992-2995. 
 
  
11 
enantioselective reactions using aryl and alkyl imines (eq 19).
34
 More recently, Trost used 
bimetallic zinc catalyst 18 to achieve good enantioselectivity albeit with low 
diastereocontrol (eq 20).
35
 
In 2004, Johnston reported organocatalyzed aza-Henry reactions using bisamidine 
catalyst 19 (eq 21). This work will be discussed in great detail in Chapter 2 of this 
document.  
Much progress has been made recently with metal-free organocatalyzed aza-
Henry reactions. In work published near the same time, Takemoto and Jacobsen 
demonstrated aza-Henry reactions promoted by similar thiourea catalysts, 20 and 21 
(Figure 4) respectively.
36,37
 Takemoto used this asymmetric aza-Henry reaction to make 
                                                 
34
 Anderson, J. C.; Howell, G. P.; Lawrence, R. M.; Wilson, C. S. J. Org. Chem. 2005, 70, 5665-5670. 
35
 Trost, B. M.; Lupton, D. W. Org. Lett. 2007, 9, 2023-2026. 
36
 Okino, T.; Nakamura, S.; Furukawa, T.; Takemoto, Y. Org. Lett. 2004, 6, 625-627. 
37
 Yoon, T. P.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2005, 44, 466-468. 
 
 
 
Figure 4. Takemoto and Jacobsen‟s Thiourea Catalysts 
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two biologically active piperidines. Takemoto proposes two different modes of activation 
that each involve a bifunctional catalyst (Scheme 4).
38
 The thiourea N-H protons are 
crucial for stereochemical induction while the tertiary amine is responsible for 
deprotonation of the nitroalkane.  
Rueping demonstrated the use of a chiral BINOL-based phosphoric acid catalyst 
to promote the asymmetric aza-Henry reaction (eq 22).
39
 The addition of aliphatic 
nitroalkanes to α-imino esters was accomplished with 7-13:1 dr, 84-92% ee and modest 
to good yield. One example of an aryl nitroalkane addition was given as compound 23 
                                                 
38
 Xu, X.; Furukawa, T.; Okino, T.; Miyabe, H.; Takemoto, Y. Chem. Eur. J. 2006, 12, 466-476. 
39
 Rueping, M.; Antonchick, A. P. Org. Lett. 2008, 10, 1731-1734. 
Scheme 4. Proposed Reaction Process of Thiourea Catalyzed Aza-Henry Reaction 
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was synthesized in 2:1 dr and 84% ee.  
A phase-transfer catalysis approach to the asymmetric aza-Henry reaction has 
been demonstrated by Palomo.
40
 A cinchona based phase transfer catalyst 24 in 
combination with exogenous base CsOH is used in equation 23. This reaction starts from 
the α-amido sulfone, forms the N-Boc imine in situ, and forms the aza-Henry adduct in 
one pot. This procedure circumvents some of the practical issues of using pre-formed N-
Boc imines that typically have a short bench lifetime. Aside from the obvious advantage 
of eliminating a discreet synthetic step, this allows for use of bench stable solids as 
starting materials.
41
 Also enolizable alkyl N-Boc imines are formed in situ and used in 
this reaction. Aryl and alkyl α-amido sulfones were used to produce adducts in 
consistently high ee and varying dr.  
                                                 
40
Gomez-Bengoa, E.; Linden, A.; Lopez, R.; Mugica-Mendiola, I.; Oiarbide, M.; Palomo, C. J. Am. Chem. 
Soc. 2008, 130, 7955-7966. 
41
 Petrini, M. Chem. Rev. 2005, 105, 3949-3977. 
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1.3 Asymmetric Brønsted Acid Catalysis 
Asymmetric Brønsted acid catalysis is a relatively new area of study by organic 
chemists. It is essential for chemists to seek ways to enhance reaction rates and make 
compounds in an efficient and inexpensive manner. Still, much of the driving force for 
this area is the desire to use “greener” organic materials that do not involve the use of 
toxic metal-based Lewis acids. Brønsted acid catalysts have been studied since the 
earliest days of organic chemistry, but asymmetric Brønsted acid catalysis has only been 
the focus of study recently. For the sake of brevity, the discussion will be focused on 
systems where the primary mode of asymmetric induction is binding noncovalently to a 
Brønsted acid (not the use of iminium ion or enamine catalysis). This section is organized 
by catalyst type. For the sake of chronology, a timeline of important accomplishments in 
asymmetric Brønsted acid catalysis is presented in Figure 5. 
Figure 5. Timeline of Asymmetric Brønsted Acid Catalysis 
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Duhamel‟s use of a chiral Brønsted acid 26 to enantioselectively protonate a 
lithium enolate 25 in equation 24 can be viewed as a starting point for asymmetric 
Brønsted acid catalysis.
42
 This is simply an asymmetric protonation which has been 
demonstrated numerous times.
43
  The use of hydrogen bonds to accelerate reactions and 
to perform reactions enantioselectively will be discussed.  
 It was ultimately Yamamoto that pioneered the concept of asymmetric Brønsted 
acid catalysis in the mid 1990s.  In earlier work, he used Brønsted acid assisted chiral 
Lewis acids (27).
44,45
 Although it is not a purely Brønsted acid catalyst, a Lewis acid 
assisted chiral Brønsted acid (28) is different from BLA. A BLA is presumed to both 
activate and direct a substrate using the chiral Lewis acid center, while the Brønsted acid 
acts as a secondary control element. In contrast, an LBA activates the substrate through 
the chiral Brønsted acid, while the Lewis acid serves only as a means by which the 
Brønsted acid is activated. 
                                                 
42
 Duhamel, L.; Plaquevent, J. C. J. Am. Chem. Soc. 1978, 100, 7415-7416. 
43
 Fehr, C. Angew. Chem. Int. Ed. 1996, 35, 2566-2587. 
44
 Ishihara, K.; Yamamoto, H. J. Am. Chem. Soc. 1994, 116, 1561-1562. 
45
 Ishihara, K.; Miyata, M.; Hattori, K.; Tada, T.; Yamamoto, H. J. Am. Chem. Soc. 1994, 116, 10520-
10524. 
Figure 6. Yamamoto‟s BLA and LBA Catalysts 
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Yamamoto used LBA in a groundbreaking report in 1999 to promote a 
biomimetic polyprenoid cyclization (eq 25).
46
 Using LBA as a chiral proton donor, a 
polycyclic terpenoid 29 was constructed in a single step stereoselectively. This was the 
first example of an enantioselective biomimetic cyclization of polyprenoids.  
Many examples of chiral alcohol Brønsted acids emerged beginning in 2003. In 
that year, Shaus demonstrated an enantioselective Morita-Baylis-Hillman reaction (eq 26) 
using a chiral Brønsted acid 27 (Figure 7).
47
 Schaus used a modified BINOL framework 
to achieve as high as 96% ee with aliphatic aldehydes. 
                                                 
46
 Ishihara, K.; Nakamura, S.; Yamamoto, H. J. Am. Chem. Soc. 1999, 121, 4906-4907.  
47
 McDougal, N. T.; Schaus, S. E. J. Am. Chem. Soc. 2003, 125, 12094-12095. 
 
Figure 7. Chiral Alcohol Catalysts 
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In a report published in Nature in 2003, Rawal used a TADDOL chiral diol 
catalyst 31 to promote hetero Diels-Alder reactions with excellent enantioselectivity (eq 
27).
48
 Interestingly, Rawal compares this type of catalysis to enzymes, suggesting that 
this is a more biomimetic form of traditional Lewis acid catalysis.  
Phosphoric acids based on the BINOL framework have become versatile catalysts 
capable of promoting a variety of reactions.
49
 Akiyama (eq 28) and Terada (eq 29) have 
each demonstrated the utility of these catalysts. Each demonstrated an asymmetric 
Mannich reaction with their respective catalysts.
50,51
  
                                                 
48
 Huang, Y.; Unni, A. K.; Thadani, A. N.; Rawal, V. H. Nature 2003, 424, 146. 
49
 Zamfir, A.; Schenker, S.; Freund, M.; Tsogoeva, S. B. Org. Biomol. Chem. 2010, 8, 5262-5276. 
50
 Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem., Int. Ed. 2004, 43, 1566-1568. 
51
 Uraguchi, D.; Terada, M. J. Am. Chem. Soc. 2004, 126, 5356-5357. 
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A myriad of reactions catalyzed by these chiral phosphoric acids have since been 
reported both by Akiyama and Terada. Akiyama was able to use chiral phosphoric acids 
to perform C-phosphonylation of imines (eq 30)
52
, hetero-Diels-Alder reactions (eq 31, 
32)
53,54
, and Friedel-Crafts alkylations (eq 33).
55
  
                                                 
52
 Akiyama, T.; Morita, H.; Itoh, J.; Fuchibe, K. Org. Lett. 2005, 7, 2583-2585. 
53
 Itoh, J.; Fuchibe, K.; Akiyama, T. Angew. Chem. Int. Ed. 2006, 45, 4796-4798. 
54
 Akiyama, T.; Morita, H.; Fuchibe, K. J. Am. Chem. Soc. 2006, 128, 13070-13071. 
55
 Itoh, J.; Fuchibe, K.; Akiyama, T. Angew. Chem., Int. Ed. 2008, 47, 4016-4018. 
Scheme 5. Chiral Phosphoric Acid Catalyzed Asymmetric Reactions Reported by Akiyama 
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 Similarly, Terada has used BINOL-derived phosphoric acids to promote 
asymmetric alkylations of α-diazoesters (eq 34)56, Friedel-Crafts reactions of furan (eq 
35)
57
, and aza-ene-type reactions (eq 36).
58
  
 A vast majority of the phosphoric acid-catalyzed reactions published involve 
additions to imines or Friedel-Crafts type additions. More recent reports have displayed 
work outside of these areas. Antilla has demonstrated the use of chiral phosphoric acids 
(Scheme 7) in the desymmetrization of meso-aziridines
59
 (eq 37) and the allylboration of 
aldehydes
60
 (eq 38).  
                                                 
56
 Uraguchi, D.; Sorimachi, K.; Terada, M. J. Am. Chem. Soc. 2005, 127, 9360-9361. 
57
 Uraguchi, D.; Sorimachi, K.; Terada, M. J. Am. Chem. Soc. 2004, 126, 11804-11805. 
58
 Terada, M.; Machioka, K.; Sorimachi, K. Angew. Chem. Int. Ed. 2006, 45, 2254-2257. 
59
 Rowland, E. B.; Rowland, G. B.; Rivera-Otero, E.; Antilla, J. C. J. Am. Chem. Soc. 2007, 129, 12084-+. 
60
 Jain, P.; Antilla, J. C. J. Am. Chem. Soc. 2010, 132, 11884-11886. 
Scheme 6. Chiral Phosphoric Acid Catalyzed Asymmetric Reactions Reported by Terada 
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 Akiyama has demonstrated chiral Brønsted acid-catalyzed Robinson annulations 
(eq 39).
61
 First, phosphoric acid catalyst 40 promotes the Michael addition to form 41. 
Then, a kinetic resolution takes place in the presence of catalyst 38 to preferentially 
convert one enantiomer of 41 to annulation product 42. Terada also used catalyst 38 to 
perform a direct aldol-type reaction of azlactones (eq 40).
62
 The vinyl ether is presumably 
protonated by the acid catalyst to form a hydrogen-bonded ion pair that serves to induce 
enantioselectivity. 
                                                 
61
 Akiyama, T.; Katoh, T.; Mori, K. Angew. Chem. Int. Ed. 2009, 48, 4226-4228. 
62
 Terada, M.; Tanaka, H.; Sorimachi, K. J. Am. Chem. Soc. 2009, 131, 3430-3431. 
Scheme 7. Examples of Chiral Phosphoric Acid-Catalyzed Reactions by Antillla 
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 Examples of chiral phosphoric acid-catalyzed rearrangements have recently 
surfaced. Reuping has developed a catalytic, enantioselective aza-Cope rearrangement 
using catalyst 43 to form homoallylic amine precursor 44 in good enantioselection (eq 
41).
63
 An enantioselective aza-Petasis-Ferrier rearrangement (eq 42) has been 
demonstrated by Terada.
64
 A Ni-catalyzed olefin isomerization, enantioselective 
rearrangement catalyzed by 45, and subsequent aldehyde reduction yielded amino alcohol 
46 with good enantio- and diasteroselectivity. 
                                                 
63
 Rueping, M.; Antonchick, A. P. Angew. Chem. Int. Ed. 2008, 47, 10090-10093. 
64
 Terada, M.; Toda, Y. J. Am. Chem. Soc. 2009, 131, 6354-6355. 
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 Multi-component and cascade reactions promoted by chiral phosphoric acids have 
allowed for the enantioselective synthesis of highly complex molecules in a single 
reaction. Gong has reported a multicomponent asymmetric catalytic three-component 
1,3-dipolar cycloaddition (eq 43).
65
 Products 48 containing up to two newly formed 
quaternary stereocenters are obtained in remarkably high regio- and stereoselectivity 
using catalyst 47. A Brønsted acid-catalyzed cyclization cascade of N-acyliminium ions 
was demonstrated by Dixon in equation 44.
66
 Phosphoric acids 37 and 38 promoted this 
reaction to give tetracyclic products 49 with good to excellent stereoselectivity and yield. 
                                                 
65
 Chen, X.-H.; Wei, Q.; Luo, S.-W.; Xiao, H.; Gong, L.-Z. J. Am. Chem. Soc. 2009, 131, 13819-13825. 
66
 Muratore, M. E.; Holloway, C. A.; Pilling, A. W.; Storer, R. I.; Trevitt, G.; Dixon, D. J. J. Am. Chem. 
Soc. 2009, 131, 10796-10797. 
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Toste has recently published a report in Nature describing asymmetric additions 
to unactivated alkenes catalyzed by a dithiophosphoric acid (Scheme 8).
67
 This 
intramolecular hydroamination of dienes catalyzed by 50 or 51 or proceeds with excellent 
enantioselectivity and E:Z selectivity in most cases. Apart from being a novel 
transformation, this reaction also is mechanistically distinct from simple hydrogen bond 
activation. Studies revealed that the phosphoric adds to the diene in an SN2‟ fashion then 
a subsequent SN2‟ displacement leads to the product.  
                                                 
67
 Shapiro, N. D.; Rauniyar, V.; Hamilton, G. L.; Wu, J.; Toste, F. D. Nature 2011, 470, 245-249. 
 
Scheme 8. Toste‟s Intramolecular Dithiophosphoric Acid-Catalyzed Hydroamination 
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Much success has also been achieved using protonated amines as chiral Brønsted 
acids. A very early example of this work was demonstrated by Inoue in 1981.
68
 He used a 
dipeptide catalyst 52 to promote an asymmetric hydrocyanation of benzaldehyde that 
gave >99% ee for some substrates. Still, the reaction suffered from racemization if 
allowed to go to full conversion.  
Lipton used a strikingly similar catalyst 53 to do asymmetric Strecker reactions 
(eq 45).
69
 This reaction gave products of high enantiopurity and high yields. This reaction 
did not prove to be general though. 
Corey and Jacobsen soon developed novel catalysts for use in the asymmetric 
Strecker reaction (54 and 55 respectively).
70,71,72
 Both catalysts gave the α-aminonitrile 
products in high yield and excellent enantioselectivities. 
 
                                                 
68
 Oku, J. I.; Inoue, S. J. Chem. Soc. Chem. Commun. 1981, 229-230. 
69
 Iyer, M. S.; Gigstad, K. M.; Namdev, N. D.; Lipton, M. J. Am. Chem. Soc. 1996, 118, 4910-4911. 
70
 Corey, E. J.; Grogan, M. J. Org. Lett. 1999, 1, 157-160. 
71
 Sigman, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 1998, 120, 4901-4902. 
72
 Sigman, M. S.; Vachal, P.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2000, 39, 1279-1281. 
Figure 8. Inoue and Lipton‟s Dipeptide Catalysts 
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Jacobsen soon expanded the utility of this thiourea type catalyst. With some slight 
modifications of catalyst 55, the ability to promote a plethora of asymmetric reactions  
Figure 9. Corey‟s Guanidine and Jacobsen‟s Thiourea Catalysts 
 
Scheme 9. Asymmetric Reactions Catalyzed by Jacobsen‟s Thiourea Derivatives 
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was exhibited. Nitro-Mannich reactions
73
, hydrophosphonylations
74
, acyl Pictet-Spengler 
reactions
75
, Mannich
76
 and acyl-Mannich reactions
77
, conjugate additions of ketones and 
α,α-disubstituted aldehydes to nitroalkenes78,79, cyanosilylations of ketones80, aza-Baylis-
Hillman reactions
81
, and Claisen reaarrangements
82
 have all been demonstrated and 
shown in Scheme 9. 
An impressive amount of progress has been made in a very short amount of time 
by Jacobsen. These thiourea catalysts are shown to be very versatile and useful tools for 
the synthesis of complex stereoenriched products. This is exemplified in their use in the 
asymmetric Povarov reaction (Scheme 10).
83
 Urea catalyst 63 promotes the formation of 
two new carbon-carbon bonds and up to three stereocenters (compound 64) with high 
stereoselectivity.  
Scheme 10. Chiral Urea Catalyzed Povarov Reaction 
 
                                                 
73
 Yoon, T. P.; Jacobsen, E. N. Angew. Chem., Int. Ed. 2005, 44, 466-468. 
74
 Joly, G. D.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 4102-4103. 
75
 Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 10558-10559. 
76
 Wenzel, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 12964-12965. 
77
 Taylor, M. S.; Tokunaga, N.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2005, 44, 6700-6704. 
78
 Huang, H.; Jacobsen, E. N. J. Am. Chem. Soc. 2006, 128, 7170-7171. 
79
 Lalonde, M. P.; Chen, Y.; Jacobsen, E. N. Angew. Chem. Int. Ed. 2006, 45, 6366-6370. 
80
 Fuerst, D. E.; Jacobsen, E. N. J. Am. Chem. Soc. 2005, 127, 8964-8965. 
81
 Raheem, I. T.; Jacobsen, E. N. Adv. Synth. Catal. 2005, 347, 1701-1708. 
82
 Uyeda, C.; Jacobsen, E. N. J. Am. Chem. Soc. 2008, 130, 9228-9229. 
83
 Xu, H.; Zuend, S. J.; Woll, M. G.; Tao, Y.; Jacobsen, E. N. Science 2010, 327, 986-990. 
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 Another catalyst motif that has found much use in asymmetric Brønsted acid 
catalysis not discussed thus far is the cinchona alkaloids. The pioneering work in this 
field was done by Wynberg in 1981.
84
 He screened a number of cinchona and ephedra 
alkaloids containing a hydroxyl group and developed enantioselective 1,2- and 1,4- 
conjugate additions to enones (eq 46). The free hydroxyl group was found to be crucial 
for high levels of enantioselection. Wynberg‟s work seemed to be well ahead of its time 
as unfortunately further advances with cinchona alkaloid based asymmetric catalysts 
were not made until many years later. 
 In 2002, Deng published work using an unnatural biscinchona alkaloid 66 to do 
1,4-additions with thiols that paralled the work of Wynberg.
85
 The mechanism of 
induction here was shown to be different from that of the natural cinchona alkaloids used 
by Wynberg. A free hydroxyl was not necessary for enantioselection, and the bisalkaloid 
derived from the same enantiomer of natural alkaloid gave the opposite enantioselection 
as the natural alkaloid.  
                                                 
84
 Hiemstra, H.; Wynberg, H. J. Am. Chem. Soc. 1981, 103, 417-430. 
85
 McDaid, P.; Chen, Y.; Deng, L. Angew. Chem. Int. Ed. 2002, 41, 338-340. 
 
29 
 In work published in 2005, Deng used a different cinchona alkaloid to perform 
conjugate additions to vinyl sulfones (Scheme 8).
86
 The 9‟ –OH group of catalyst 50 was 
replaced with an aryl ether and a hydroxyl group was added to the quinoline ring to give 
a catalyst that led to high levels of stereoselection.  
Deng also used cinchona alkaloids to perform other asymmetric reactions 
(Scheme 11). Enone conjugate additions similar to those demonstrated by Wynberg but 
again with an unnatural alkaloid were performed.
87
 Also, Friedel-Crafts reactions 
between imines and indoles were demonstrated with a cinchona derived-thiourea 
catalyst.
88
 Unnatural alkaloid 70 was used to promote the Diels-Alder reaction between 
pyrones and α,β-unsaturated esters with good enantio- and diastereoselectivity.89 
                                                 
86
 Li, H.; Song, J.; Liu, X.; Deng, L. J. Am. Chem. Soc. 2005, 127, 8948-8949. 
87
 Wu, F.; Li, H.; Hong, R.; Deng, L. Angew. Chem. Int. Ed. 2006, 45, 947-950. 
88
 Wang, Y.-Q.; Song, J.; Hong, R.; Li, H.; Deng, L. J. Am. Chem. Soc. 2006, 128, 8156-8157. 
89
 Wang, Y.; Li, H.; Wang, Y.-Q.; Liu, Y.; Foxman, B. M.; Deng, L. J. Am. Chem. Soc. 2007, 129, 6364-
6365. 
Figure 10. Cinchona Alkaloid Comparison 
 
30 
 
Scheme 11. Asymmetric Reactions Catalyzed by Cinchona Alkaloids by Deng 
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A catalytic asymmetric electrophilic halogenation has been accomplished with a 
cinchona alkaloid catalyst. Borhan has recently described an organocatalytic asymmetric 
chlorolactonization using (DHQD)2PHAL (71) (eq 47).
90
 It seems likely that the 
protonated chiral amine is promoting enantioselection through hydrogen bonding, but it is 
also possible that the amine is affecting enantioselection through the covalent formation 
of a chiral chlorenium source. Nevertheless, this represents a powerful new mode of 
activation potentially achieved through chiral Brønsted acid catalysis. 
The work described thus far has been focused around three general catalytic 
motifs: BINOL, chiral urea/thiourea, and cinchona alkaloid. The catalyst discussed 
henceforth is different from these three motifs, but shares some similar characteristics. 
                                                 
90
 Whitehead, D. C.; Yousefi, R.; Jaganathan, A.; Borhan, B. J. Am. Chem. Soc. 2010, 132, 3298-3300. 
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CHAPTER II 
 
CHIRAL PROTON CATALYSIS 
 
2.1 Background 
Hydrogen bonding has been heavily exploited by organic chemists over the last 
several years as seen in the numerous aforementioned reactions. Hydrogen bonds can be 
characterized as polar covalent or polar ionic (Figure 11). The source of asymmetry in 
polar covalent hydrogen bond catalysis is the chiral anion. Polar ionic hydrogen bonds on 
the otherhand contain a neutral chiral ligand for the proton.  At the time of the birth of 
chiral proton catalysis, all of the pre-existing asymmetric hydrogen bond catalysts used 
polar, covalent hydrogen bonds. One potential advantage to polar ionic hydrogen bond 
catalysis is the ease with which electrophilicity might be modulated by counterion choice. 
 
Figure 11. Comparison of Polar Covalent and Polar Ionic Hydrogen Bond Solvation 
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2.2 Previous Development 
Initially, silyl nitronate additions to imines were performed to gather information 
about this reaction. The use of silyl nitronate nucleophiles removed the deprotonation 
step. It also simplified the bifunctional catalyst to just a Lewis acid catalyst that solely 
activated the electrophile. 
Catalysts of the general structure 73 were envisioned to be chiral Brønsted acids 
for asymmetric synthesis. Central to this plan was the idea that the acidic proton of the 
chiral catalyst complex would be an electrophilic “chiral proton”. This came to be the 
case as catalyst 73 was able to promote asymmetric aza-Henry reactions with good to 
excellent diastereo- and enantioselectivity. Through much work of optimization of 
catalyst structure, certain aspects of the catalyst structure were identified as key control 
elements. Substitution of the pyridine ring directly affects the stereoselection observed 
Figure 12. BisAMidine Structure 
 
Table 1. Effect of Stereoelectronics of BAM Ligand 
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(Table 1). A substituent-free pyridine led to racemic product, as did the catalyst bearing a 
methyl at the 3- position. However, methyl substitution at the 5- or 6- positions leads to 
high levels of diastereo- and enantioselection. This led to the use of quinoline in catalyst 
74·HOTf, which gave optimal stereoselection. It is important to note that 4-methyl 
quinoline or lepidine (75·HOTf) exhibited reactivity and stereoselectivity 
indistinguishable from quinoline (H,QuinBAM·HOTf) shown in Scheme 12. This 
indicates that substitution by a methyl at the 4- position has little steric or electronic 
impact on stereoselection.  
Scheme 12. Effect of Stereoelectronics of BAM Ligand 
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The effect of variation of the electrophile is explored in Table 2. It was important 
to use an imine with a sufficiently Brønsted basic nitrogen for binding to the chiral 
proton. Still, the R2 group must be of correct electronics to provide a sufficiently 
electrophilic azomethine. Of all R2 groups used, only the triphenylmethyl exhibited no 
reactivity. The more electron rich imines (R2= 
2
pyridyl, DPM, OMePh) in entries 1-3 and 
11-14 exhibited higher reactivity than the carbamate imines (entries 7-11). Although 
some enantioselectivity was seen with the 
2
pyridyl and DPM imines as shown in entry 2 
and 3, the Cbz and Boc imines performed best in terms of enantioselectivity. In entries 8 
and 10, the Boc and Cbz gave product in 54% ee and 48% ee respectively. In terms of 
utility, Boc and Cbz groups are favorable as they are easily removed to yield the free 
amines for further manipulation. The Boc and Cbz adducts are also not prone to the retro 
aza-Henry process like the adducts of more electron rich R2 groups like DPM. 
Table 2. Effect of Electrophile Variation on Stereoselection in the Aza-Henry Reaction 
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Another important aspect of this catalyst is the role of the counterion. To utilize a 
polar ionic hydrogen bond, the BAM catalyst must be protonated to make an acid salt. It 
is presumed that the chiral neutral ligand is responsible for asymmetry, so the counterion 
should not be involved in this process. It is this logic that suggests that the most loosely 
associating counterions should be best. H,QuinBAM was protonated with various acids to 
make different BAM acid salt complexes as shown in Table 3. The weakly associating 
triflate counterion seems to be best for highest levels of enantioselection. Comparing this 
to the results given by more strongly associating counterions like acetate leads to the 
thought that more loosely associating counterions are optimal for this catalyst and 
reaction.  
Table 3. Effect of Counterion on Stereoselection 
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H,QuinBAM was able to promote the asymmetric aza-Henry reaction and give 
good enantio- and diastereoselection in most cases. A wide range of aryl N-Boc imines in 
terms of sterics and electronics were tolerated with good generality (Table 4). Reactivity 
however was poor. It was necessary to run the reactions with the nucleophile as the 
solvent (56 equivalents) with reaction times of several days.  
At the time my work began, we were confident that the catalyst was activating the 
electrophile as a chiral Brønsted acid, due to the observations in the silyl nitronate 
addition reactions, and activating the nitroalkane by deprotonation. The latter role, 
however, seemed to affect stereoselection very little since similar diastereo- and 
enantioselection was observed in both the silyl nitronate and nitroalkane additions. Our 
hypothesis for this dual activation is depicted in Figure 13. This model uses a single 
catalyst to bind the azomethine and deprotonate the nitroalkane. Many details of this 
reaction remained unknown. A series of subsequent experiments revealed crucial 
information about the mechanism of this reaction. 
Table 4. Direct Aza-Henry Reaction Catalyzed by H,QuinBAM·HOTf 
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The structure activity relationship studies using silyl nitronate additions were the 
basis for design of a proposed stereochemical model shown in Figure 14. It is suggested 
that the proton coordinates to the ligand in a bidentate fashion. With the imine associated 
with the catalyst in this fashion, the importance of substitution at the 6-position of 
pyridine is demonstrated. It is the steric blocking at the 6-position that shields the Re face 
from attack. 
The results shown in equation 48 are very similar to that of the parallel reaction of 
entry 11, Table 4 of 20:1 dr, 88% ee for the direct aza-Henry reaction. Activation in the 
silyl nitronate addition can only occur through azomethine binding. Therefore, 
stereocontrol must be achieved through the catalysts‟ function as a chiral Brønsted/Lewis 
acid.  
Figure 13. Mechanistic Picture of Aza-Henry Reaction 
 
Figure 14. Proposed Catalyst Substrate Complex for the Enantioselective Aza-Henry Reaction 
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More mechanistic information was gleaned from the use of a different 
nitroalkane. α-Nitroesters are significantly more acidic than simple nitroalkanes. These 
were used in the H,QuinBAM catalyzed aza-Henry reaction, and the results are shown in 
equation 49. With a simple change to a more acidic nucleophile, the reactivity of this 
system increased dramatically. This allowed for the use of stoichiometric α-nitroester 
with a shorter reaction time than previously needed with simple nitroalkanes. It is 
important to consider the simple acid-base equilibrium that exists between catalyst and 
nitroalkane (eq 50). This result certainly suggests that the more acidic nitroester results in 
a greater concentration of the nitronate nucleophile, which translates to an enhancement 
of reaction time. As a result of these findings, we hypothesized that a more Brønsted 
basic catalyst might increase the reaction rate (Figure 15). This was a somewhat 
counterintuitive approach to reaction improvement since we had found stereoinduction to 
be determined by the catalyst‟s ability to bind the azomethine as a chiral Lewis acid. So 
an increase in the basicity of the quinoline nitrogen would cause a decrease in the 
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Brønsted acidity of the conjugate acid of that nitrogen. It would seem that that could be 
detrimental to the stereoselectivity of the catalyst.  
2.3 Catalyst Redesign and Results 
Of the numerous positions an additional electron donating group could be placed 
on the quinoline ring, the 4- position was determined to be optimal. The pKa 
measurements of various substituted quinolines have shown that substitution at the 4- 
position by far has the greatest effect on the pKa of the quinoline nitrogen. Numerous 
nitrogen-based electron-donating groups could be installed at the 4-position. Pyrrolidine 
was chosen owing to its excellent nucleophilicity which should aid in the synthesis of the 
catalyst. Also, pyrroldine should be an excellent electron donating group based on the 
enhanced reactivity seen with pyrollidine-based enamines and 4-pyrrolidine substituted 
pyridines as acylation catalysts.
91
 pKa measurements of 4-substituted pyridines also show 
4-pyrrolidinyl pyridine to be the most basic of this series.
92
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Figure 15. Effect of Catalyst Change on Brønsted Acidity and Basicity 
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Initially, PBAM (Figure 16, synthetic details in Chapter 5) was used alongside 
H,QuinBAM to compare reactivity and stereoselectivity (Table 5). Using 10 mol% 
catalyst with nitroethane as solvent, a dramatic increase in reactivity was seen with 
PBAM.
93
 Both the free base and the triflic acid salt provided much higher levels of 
conversion than H,QuinBAM·HOTf. The stereoselection exhibited was slightly lower 
than what was seen in previous work with H,QuinBAM·HOTf (18:1 dr, 82% ee), but the 
overall result was still encouraging. Some enantioselection was also seen with the 
unprotonated catalyst, but was lower than the triflic acid salt. This behavior was 
unexpected as previous results using the H,QuinBAM free base under the same 
conditions with nitromethane as the nucleophile lead to little to no enantioselection.  
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Table 5. Comparison of the Reactivity of PBAM vs. H,QuinBAM 
 
Figure 16. Structure of PBAM 
 
42 
The performance of the H,QuinBAM free base turns out to be quite different 
when using nitroethane rather than nitromethane. Initially (Table 6, entry 1), 
H,QuinBAM free base provided the aza-Henry product 77 with modest diastereoselection  
and enantioselection (5:1 dr and 73% ee). To ascertain that this is not an effect of any 
acidic impurities or stabilizing compounds in the nitroethane, the solvent was distilled 
over CaH2 and the same reactions were performed using the distilled nitroethane. It 
appears that the use of distilled nitroethane had some effect on the reaction as 
enantioselection dropped from entries 1 and 2 to entries 3 and 4. Still, it is clear that 
H,QuinBAM free base provides the nitroethane aza-Henry product with significant 
enantioselection and that the free base of PBAM is not unique among the BAM catalysts 
with its enantioselectivity in the aza-Henry reaction. 
Table 6. H,QuinBAM and H,QuinBAM·HOTf with Distilled and Undistilled Nitroethane 
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This significant increase in reactivity with the 4-pyrrolidine catalysts led us to 
attempt this reaction with a stoichiometric amount of nitroethane in solvent. Toluene and 
1,2-dichloroethane are solvents that have provided optimal results previously with BAM 
catalysts, so these solvents were used as shown in Table 7. High levels of conversion 
were seen in only 2.5 hours with two equivalents of nitroethane at -20 °C. To our delight, 
the enantioselection exhibited with PBAM in solvent was significantly higher than that 
provided by H,QuinBAM neat in nitroalkane. Diastereoselection was good but did not 
exceed the diastereoselection provided by H,QuinBAM. 
Interestingly, the reaction proved to be faster with stoichiometric amounts of 
nitroethane in solvent than it was neat in nitroethane (56 equivalents). It did not appear to 
be an issue of solubility as the PBAM catalysts and the N-Boc imine dissolve more easily 
in nitroethane than toluene. This seems counterintuitive as any increase in concentration 
of either of the reactants should cause an increase in the rate of the reaction regardless of 
Table 7. PBAM Catalyzed Aza-Henry Optimization 
 
Figure 17. Effect of Reactant Concentration on Rate 
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the order with respect to either of the reactants. A simplistic picture of the reaction rate is 
displayed in Figure 17. Performing the reaction neat in nitroethane should significantly 
increase the concentration of nitronate thus increasing the rate of the reaction. This does 
not seem to be the case so it is likely something more complex is going on that explains 
the significant decrease in reaction time seen in solvent with stoichiometric nitroalkane. 
Although it was previously established that PBAM was a more reactive catalyst 
than H,QuinBAM when used with neat nitroethane, the levels of reactivity seen in Table 
5 could be attributed to some combination of optimal solvent, amount of nucleophile, and 
optimal catalyst. The results in Table 8 specifically show that the reactivity increase with 
the 4-pyrollidine catalysts plays an crucial role in the success of these optimal reaction 
conditions. Reactions catalyzed by H,QuinBAM and H,QuinBAM·HOTf (entries 3 and 4, 
Table 8) were 1% and 2% conversion respectively after 23 hours. 
A graphical representation of the reactivity differences of the two catalysts are 
displayed in Figure 18. Conversion was measured by gas chromatography with the aid of 
an external standard. This graph clearly shows the increased reactivity of the 4-
pyrrolidine catalysts over H,QuinBAM and H,QuinBAM·HOTf. PBAM and the 
associated salts promoted the reaction to full conversion at 8 hours, as only 1% and 2% 
Table 8. PBAM/H,QuinBAM Comparison in Toluene 
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conversion was observed with H,QuinBAM and H,QuinBAM·HOTf, respectively. This 
figure offers a clear comparison of the reactivity of the three protonation states of PBAM. 
PBAM·HOTf is the most reactive catalyst, reaching nearly full conversion at 4 hours. 
PBAM2HOTf3 is slightly less reactive, reaching full conversion at about 7 hours. The free 
base of PBAM is the least reactive of the three under these conditions as 8 hours is 
needed to reach full conversion. 
These clear results display the interesting trend of the more Brønsted basic 
Brønsted acid catalyst PBAM·HOTf providing higher enantioselectivity and 
diastereoselectivity than H,QuinBAM·HOTf. Although there have been few studies on 
the effect of catalyst acidity upon the rate and stereoselectivity of an enantioselective 
Figure 18. Reactivity Comparsion of H,QuinBAM, PBAM, and their Triflic Acid Salts  
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reaction, Sigman has recently published a detailed report on the variation of catalyst pKa 
on a hetero-Diels-Alder reaction.
94
  
Sigman used a catalyst structure (78) whose acidity was easily modulated to 
provide catalysts with a broad range of pKa values (Table 9) without substantial steric 
consequence. Through thorough kinetic measurements obtained by in situ IR, many 
details were ascertained about this reaction.
95
 This reaction was found to be first order 
with respect to catalyst, saturation in aldehyde, and first order with respect to diene. The 
aldehyde is activated by hydrogen bonding with the catalyst to form a catalyst:aldehyde 
complex, which then reacts with diene. Furthermore, the electronic nature of the aldehyde 
had a major effect on the saturation kinetics on the catalyst aldehyde complex. This 
suggested that a stronger hydrogen bond existed between the stronger Brønsted base 
(more electron-rich aldehyde) and the Brønsted acid (catalyst). Inversely, it was found 
that the most Brønsted acidic catalyst was the most enantioselective and reactive catalyst. 
Using the known pKa  values of the corresponding carboxylic acids as an estimate of the 
pKa  of the catalyst, these values were plotted against log(rate) and log(er) as shown in 
Figure 19. Both plots showed a linear relationship between pKa  of the catalyst and the 
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Table 9. Sigman‟s Oxazoline-Amide Catalyzed Hetero Diels-Alder Reaction 
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rate and enantioselection of the reaction. Simply put, the closer in pKa the Brønsted acid 
catalyst and Brønsted basic substrate, the stronger the hydrogen bond between the two, 
the more rigid the transition state, and the more enantioselective and faster the reaction.  
Sigman‟s system contrasts starkly with our reaction. Kinetic studies of the 
PBAM-catalyzed aza-Henry were attempted but were inconclusive. Nevertheless, it is 
clear that our system behaves in the opposite way as the more Brønsted basic catalyst is 
the most reactive and enantioselective. If our mechanism was the same as Sigman‟s, our 
results would make little sense as one would expect the more acidic catalyst to form a 
stronger hydrogen bond with the imine. This would lead to a faster reaction and higher 
enantioselectivity assuming there is no steric consequence of the pyrrolidines on the 
binding pocket. 
It seems more likely that the bifunctionality of our catalyst presents a more 
complicated scenario. The dramatic increase in reactivity of PBAM·HOTf suggests that 
the catalyst might also bind to the nitroalkane independently before the bond-forming 
event occurs. Since the catalyst and nitroalkane are closer in pKa, this binding should be 
stronger with the more basic catalyst. A visual aid for this rationale is given in Figure 20. 
This strengthening of the hydrogen bonding with the nitroalkane might atone for the 
Figure 19. Plots of pKa vs. Rate and pKa vs. Enantioselection in Sigman‟s Enantioselective Hetero-Diels-Alder 
Reaction 
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weakening of the hydrogen bonding with imine. Furthermore, the observation of a faster 
reaction with stoichiometric nitroalkane than with neat nitroalkane suggests a possible 
saturation of the catalyst with nitroalkane. 
Detailed kinetic studies should be performed in the future to give more evidence 
of the mechanism of this interesting reaction. We have been unable to use in situ IR to 
perform these studies due to precipitation of the product at the concentrations needed to 
monitor the reaction. Some attempts using gas chromatography to monitor the reaction 
have been promising, but the data was inconclusive. This method could probably work 
given a considerable effort. The mechanistic details that can be obtained through kinetic 
studies is likely to yield very useful information for the future application of this catalyst. 
 
Figure 20. Rationale for Increased Stereoselection and Reactivity with More Brønsted Basic Catalysts 
 
Table 10. Secondary Nitroalkane Additions 
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Despite the lack of understanding of mechanism of this reaction, the increased 
reactivity was evident and applicable to a broader range of substrates. The reactivity of 
this system was such that a secondary nitroalkane, 2-nitropropane, could be used 
successfully as the pronucleophile (Table 10). At room temperature for 20 hours, full 
conversion and enantioselection at the 76% level was measured. Using differing 
protonation states of PBAM led to interesting results. As has been seen previously in this 
group, the free base gave lower enantioselection (52% ee). The 1:1 PBAM triflic acid salt 
gave 76% ee. Curiously, the 2:1 PBAM triflic acid salt gave the same enantioselection as 
the 1:1 salt. Since the active catalyst in the PBAM free base reactions is the nitronate salt, 
it is possible that in the case of PBAM2(HOTf)1 the concentration of PBAM·HOTf is 
much greater than that of the PBAM nitronate salt in situ. This would also explain the 
enantioselection of PBAM2(HOTf)1 being equal to that of PBAM·HOTf. Regardless, it 
did suggest that further study of protonation state and catalyst performance was 
warranted.  
Figure 21. Relationship of Catalyst Protonation State and Enantioselection with 2-Nitropropane to 
Azomethine 
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An array of catalysts was prepared by varying the ratio of ligand to triflic acid., 
and each was screened in the aza-Henry reaction (Table 11). Again to our delight, a better 
catalyst emerged. PBAM2(HOTf)3 gave the same enantioselection as PBAM·HOTf, but 
the diastereoselection improved from 7:1 to 18:1.  Overall, the diastereoselection values 
increased as the protonation state of the catalyst increased, while enantioselection 
plateaued at an earlier point. This increase in diastereoselection was at the cost of some 
reactivity, but this was manageable since the overall reaction times were reasonably 
short. PBAM1(HOTf)2 still provided product with high enantio- and diastereoselection. 
This was unexpected as it was previously observed that the use H,QuinBAM1(HOTf)2 led 
to hydrolysis of the imine and no aza-Henry product. It should be stated that use of 
PBAM1(HOTf)3 also led to hydrolysis of the imine and no aza-Henry product. 
Table 11. PBAM Catalyst Protonation State Study 
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To ascertain the generality of this trend, the same experiments were performed 
with different imines. The results in Table 12 exhibit the same trend seen previously. 
Compounds 77c and 77d were formed with increasing diastereoselectivity as the relative 
amount of triflic acid to catalyst increased. Enantioselectivity plateaued in each case at 
the 1:1 triflic acid to ligand ratio. 
It seemed possible that post-reaction epimerization was affecting the 
diastereoselectivity observed. A simple experiment was performed to probe this as shown 
in Table 13. After 7 and 25 hours, essentially the same diastereoselection was seen with 
both PBAM·HOTf and PBAM2(HOTf)3. These results indicate that no significant post-
reaction epimerization was occuring under these reaction conditions.  
Table 12. PBAM Catalyst Protonation State Study, Part 2 
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This behavior of PBAM across protonation states is significantly different than 
the activity exhibited by H,QuinBAM (Figure 22). The free base of PBAM is much more 
reactive and more selective than the free base of H,QuinBAM. The silyl nitronate 
additions indicated that the acidity of the catalyst-triflic acid complex was responsible for 
Figure 22. Comparison of BAM Catalyst Performance in the Aza-Henry Reaction 
 
Table 13. Post Reaction Epimerization Study 
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stereoinduction. We therefore suspect that the nitroalkane forms a nitronate salt with  
PBAM thereby becoming the active catalyst (Figure 23). This nitronate salt of PBAM 
behaves differently than that of H,QuinBAM. A plausible explanation for this is the 
crucial role counterion plays in enantioselection with this reaction. More loosely 
associated counterions have led to higher levels of enantioselection with H,QuinBAM. It 
could be the case that the nitronate counterion is more loosely associated with the more 
basic PBAM catalyst than with the less basic H,QuinBAM catalyst.  
The 1:1 triflic acid salt of PBAM is more reactive than and similarly selective as 
the H,QuinBAM 1:1 triflic acid salt. With the obtained data, it is impossible to determine 
that the 1:1 triflic acid salt of PBAM is more diastereo- or enantioselective than that of H, 
QuinBAM. What has been observed thus far is an increase in stereoselection as the 
reaction was run with stoichiometric nitroalkane and toluene as solvent. The much 
increased reactivity of PBAM has allowed for these conditions to be used and the 
increased stereoselection that comes with these optimal conditions. Despite the electronic 
differences of the catalysts, it is very likely that PBAM·HOTf and H,QuinBAM·HOTf 
are similarly stereoselective in this aza-Henry reaction. 
 PBAM1(HOTf)2 leads to aza-Henry product enantio- and diastereoselectively 
while H,QuinBAM1(HOTf)2 leads to hydrolysis of imine. It is possible that 
Figure 23. PBAM-Acid Complexes 
 
Figure 24. Mechanism of Hydrolysis 
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H,QuinBAM1(HOTf)2 exceeds the threshhold of Brønsted acidity to access a hydrolysis 
pathway as shown in Figure 24. A less Brønsted acidic PBAM1(HOTf)2 may not exceed 
that threshold. The decreased but still significant reactivity seen suggests there still might 
exist a strong enough Brønsted basic nitrogen with PBAM1(HOTf)2 to deprotonate the 
nitroalkane. It is also possible that enough PBAM·HOTf is present to promote the 
reaction based on the equilibrium displayed in equation 51. This necessary basicity  
needed to generate the nitronate nucleophile in great enough concentration to compete 
with hydrolysis might not exist with H,QuinBAM1(HOTf)2 .  
It seems almost certain that the active Brønsted acid catalyst is different in 
reactions performed with PBAM1(HOTf)2 than those performed with PBAM·HOTf. This 
is suggested by observed diastereoselection values and the sheer fact that the catalyst 
composition is different. It is plausible that PBAM1(HOTf)2 is equally enantioselective 
and more diastereoselective than PBAM·HOTf when activating an imine in the aza-
Henry reaction. This is strange as the binding cavity PBAM1(HOTf)2 should be 
substantially different from that of PBAM·HOTf due to the lack of a bidentate hydrogen 
bond in PBAM1(HOTf)2 . The similarities in behavior for catalysis by H,QuinBAM and 
PBAM (dr, ee, same absolute configuration) suggest that a common mechanism for 
stereoinduction is involved. While this is merely an assumption, there is value in using a 
single catalyst substrate model to rationalize these observations.  
We have formulated a hypothesis for anti-selectivity observed in these reactions 
(Figure 25). In terms of steric consequence of the nitroalkane nucleophile, it seems the 
alkyl group must be the largest group. The hydrogen must be the smallest group, and the 
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nitro group fits nicely in between the two. It would seem logical to place the large alkyl 
group between the aryl group and hydrogen of the imine. The small hydrogen could then 
be best placed in the area between the bulky ligand and aryl group. This would leave the 
nitro to sit between the hydrogen and the Boc group. This arrangement, however, would 
lead to syn-diastereoselection which is not observed. If the argument is made for a 
hydrogen bonding interaction between the nitro group and the chiral proton, anti-
diastereoselection can be explained through the favorable arrangement of atoms of the 
Newman projection on the left. 
The increased reactivity provided by the 4-pyrrolidine catalysts signficantly 
extended the scope of the aza-Henry reaction both in terms of imine and nitroalkane used. 
This reaction is very general across a wide variety of aryl imines with the addition of 
nitroethane (Table 14). Furyl and thiophenyl imines were tolerated. Different 
functionalities of a methyl ester (entry 9) and an allyloxy group (entry 14) were 
successfully employed. Diastereoselectivity was exceptionally high (>12:1) in all cases, 
except for aryl imines substituted at the ortho position (11:1 and 8:1 dr, entries 6 and 7).  
Figure 25. Explanation for Diastereoselectivity 
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The ability to use stoichiometric amounts of nitroalkane allowed us to easily 
demonstrate the use of different nitroalkanes. Nitroalkanes can be synthesized from the 
corresponding alkyl bromides and sodium nitrite as reported by Kornblum.
96
 Nitromethyl 
cyclohexane (80) was prepared according to this procedure (31% yield) in equation 52. 
This reaction exhibited generality with different nitroalkanes (Table 15). 
Although diastereoselectivity was lessened to 7-13:1 dr when using branched 
nitroalkanes (entries 3 and 4), enantioselectivity was good and consistent across the 
scope. 
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Table 14. Aryl Imine Scope Expansion 
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It was not until the conclusion of the study of the addition of aliphatic 
nitroalkanes that a library of substituted PBAM catalysts were made. To this point, a 
broader screen of catalysts was not applied to this reaction. One new PBAM derivative, 
7
MeOPBAM·HOTf (76b·HOTf), was used in the nitroethane addition (eq 53) similar to 
the reaction in Table 14 with the exception that 5 mol% catalyst was used. 77 was 
produced with slightly higher enantioselectivity (93% ee vs 91% ee - Table 14, entry 1) 
than PBAM2(HOTf)3. It seems possible that the use of the different PBAM derivatives 
discussed later in the document could result in higher enantioselectivities in the aza-
Henry addition of simple nitroalkanes. 
Table 15. Nitroalkane Scope Expansion 
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The ability to use aliphatic imines as substrates would drastically broaden the 
scope and applicability of the BAM-catalyzed aza-Henry reaction. To this point, aliphatic 
imines have been unstable to our reaction conditions. PBAM has given us the reactivity 
to approach this challenge. Some success has been achieved using aliphatic N-tosyl 
imines as electrophiles using PBAM as a catalyst. Fair enantio- and diastereoselection 
was exhibited as the best result obtained was 6:1 dr and 68% ee (eq 54).  
2.4 Synthesis of Aryl Nitroalkanes 
1,2-Diaryl-1,2-diamines are a very useful class of compounds that can be 
approached by the addition of aryl nitromethanes to aryl imines and subsequent 
reduction. Phenylnitromethane 82 can be made from benzyl bromide and sodium nitrite 
as initially described by Nathan Kornblum of Purdue University (eq 55).
97
 Our other 
attempts to make this compound from various oxidations of benzaldoxime were 
unsuccessful.
98
  
Benzyl halides are good starting materials since many are commercially available. 
A few of these compounds were synthesized in one step (Scheme 13). The p-chloro and 
p-nitro benzyl bromides were made by free-radical halogenation from the corresponding 
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toluene compounds. p-Methoxy benzyl bromide was made from the treatment of the 
benzyl alcohol with PBr3. 
As it is with the synthesis of other nitroalkanes with the corresponding alkyl 
bromide and metal nitrites, formation of the alkyl nitrite is a competitive process. In this 
case, benzyl nitrite formation not only lowers the yield directly, but it can also react 
further with the desired phenylnitromethane as noted by Kornblum. Furthermore, we 
have found that benzyl nitrite converts to benzaldehyde on silica during column 
chromatography. Adding to the problem, benzaldehyde and phenylnitromethane are 
difficult to separate using flash chromatography. In this reaction, phloroglucinol is used 
to convert benzyl nitrite to benzyl alcohol to avoid the destructive pathway and ease 
purification. The yield is quite low as the reaction did not go to completion and has not 
been optimized. Still, a high yield of this reaction cannot be expected as 
phenylnitromethane is formed in a 60:40 ratio to benzyl nitrite. Even though nitro 
formation is generally favored slightly, this nitrite nitrogen versus oxygen nucleophilicity 
issue is an inherent problem in making nitroalkanes in this way. In the over 50 years 
since Kornblum‟s studies, no solution to this problem of O versus N nucleophilicity has 
been reported.  It seems most effective way to make phenylnitromethane specifically is 
through nitrite addition, even though there have been other methods reported.
99,100
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Scheme 13. Synthesis of Subsituted Benzyl Bromides 
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The importance of phloroglucinol as an alkyl nitrite scavenger was confirmed 
with our attempt to synthesize p-methoxy phenylnitromethane (eq 56). After 3 hours, the 
reaction was quenched and found to be a mixture of desired product, alkyl nitrite, and 
alcohol (2.6 : 1 : 2.2). An attempt to isolate the nitro compound by column 
chromatography failed as p-methoxybenzaldehyde coeluted with the desired compound. 
This formation of aldehyde is a result of decomposition of the alkyl nitrite on the column. 
When phloroglucinol is in the reaction mixture, it reacts with the alkyl nitrite to form the 
benzyl alcohol which is easily separated from the nitro compound by column 
chromatography. Nevertheless, 520 mg was isolated after two columns and an additional 
500 mg was isolated after vacuum distillation followed by column chromatography to 
give the desired product in 12% yield. Undoubtedly, some desired material was not 
isolated as indicated by the crude NMR. 
This method was found to be useful in making several different aryl nitroalkanes 
from the corresponding benzyl bromides (Scheme 14). We erred on the side of stopping 
the reactions somewhat early, as allowing the reaction to continue past full conversion 
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Scheme 14. Arylnitroalkane Syntheses from Corresponding Benzyl Bromide 
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results in the destruction of product. All reactions were performed at -20 °C for 4 to 6 
hours. All aryl nitroalkanes were purified by column chromatography. The yields shown 
are low mainly because of the formation of alcohol and other compounds resulting from 
attack through the oxygen of the nitrite. To a lesser extent, low yields are due to reactions 
not being run to full completion and the inability to completely isolate the nitroalkane 
formed. The latter problems could easily be addressed with some optimization, but the 
amounts of product isolated were sufficient for exploratory work. Halogenated benzyl 
bromides proved to be good substrates for this reaction. The o-
dichlorophenylnitromethane 82b was formed in relatively excellent yield of 57%. The o-
Br (82c) and m-Br (82d) nitroalkanes were formed in 30% and 29% yield respectively. p-
Chlorobenzyl bromide was smoothly nitrated to give 82f in 37% yield. 2-
Nitromethylnaphthalene (82e) was also formed from the corresponding bromide in lower 
yield (19%). 
Other procedures had to be employed for certain substrates. The reaction of 
sodium nitrite with p-nitrobenzyl bromide in the absence of phloroglucinol proceeds in a 
similar fashion to other benzyl bromides. After column chromatography, the desired 
nitroalkane (82g) was unable to be separated from unidentified byproducts presumably 
from the decomposition of alkyl nitrite 84 on silica. Unfortunately, the employment of 
phloroglucinol to convert the alkyl nitrite 84 to alcohol 83 was not successful as analysis 
of the crude reaction showed a 10:1 ratio of alcohol to nitro (eq 58). In retrospect, this 
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product distribution might have more to do with decomposition of product owing to the 
unduly long reaction time of 16 hours. 
Nevertheless, we sought to use better conditions for this particular reaction. 
Kornblum also used silver nitrite to nitrate alkyl and benzyl halides.
101
 Although we were 
unable to reproduce the yield reported by Kornblum (75%), we were able to isolate 82g 
in 60% yield after column chromatography (eq 59) which was sufficient.  
More recent work by Gelbard indicated a better way to make aryl nitroalkanes.
102
 
He used a nitrite resin to nitrate aryl and alkyl halides. This resin is made by simply 
washing commercially available Amberlite IRA-900(Cl
-
) resin with aqueous NaNO2 
solution. This reaction has the obvious advantage of the use of polymer-supported 
reagents, which is simple workup. The resin can be filtered off and presumably retreated 
and reused. Gelbard reacted the corresponding bromides with the resin in benzene at 25-
50 °C (Scheme 15). Less valuable nitroalkanes 1-nitropropane and 2-nitropropane were 
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Scheme 15. Gelbard‟s Nitrating Resin 
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formed in low yield (47% and 29% respectively). A β-nitro ester was formed in 
reportedly quantitative yield. Phenylnitromethane was formed from benzyl bromide in 
excellent isolated yield of 87%. Intrigued by this result, work was done in this lab by 
Anand Singh to reproduce this exceptional result for this valuable compound.
103
  
Under the exact conditions described by Gelbard, full conversion was not 
achieved. Also, a considerable amount of the alkyl nitrite and a small amount of 
benzaldehyde was seen by crude NMR (eq 60). Ultimately, results more akin to 
Gelbard‟s result were achieved by change of solvent to toluene, the change of 
temperature to 0 °C, and the addition of phloroglucinol to the reaction. The optimal result 
of 72% isolated yield is displayed in equation 61. The O vs. N selectivity seen from 
reaction to reaction with this system is prone to significant amount of variability, but 
overall better N selectivity is seen using this resin than with sodium nitrite. 
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As p-chloro phenylnitromethane became a very important substrate for us, our 
desire to obtain a higher yielding procedure to make it increased. Some time was spent 
using the IRA-900-ONO resin to improve the yield of 82f. Despite screening a variety of 
conditions and solvents, we could never reach the yield of 72% achieved with 
phenylnitromethane for compound 82f. Essentially no increase in yield of nitroalkane 
over the Kornblum conditions is seen. 82f can be obtained in 46% isolated yield using the 
IRA-900-ONO resin (eq 63). Our best result with the Kornblum conditions was 46% 
yield on a relatively large scale of 170 mmol (13.1 grams isolated, eq 62). With either 
reaction (resin or NaNO2 as the nitrite source), the benzyl alcohol is the major product 
and could be recovered, converted to the corresponding benzyl bromide, and resubmitted 
to the nitration conditions.  
Perhaps the most direct route imaginable for the synthesis of aryl nitroalkanes is 
the C-H activation of the corresponding toluene leading directly to the nitro compound 
without the intermediacy of a benzyl halide. In work once again originating from the 
undoubted (former) capital of nitro chemistry, Purdue University, Henry Feuer reported 
the nitration of alkyl substituted heterocyclic compounds in 1972.
104
 Sodium or 
potassium amide was used to deprotonate a variety of heterocyclic compounds before 
quenching with n-propyl nitrate to form the desired nitro compounds. A representative 
reaction is shown in equation 64. 4-Picoline was converted to 4-nitromethylpyridine 82h 
in 66% yield. Most yields for this reaction are between 50 and 70%, and some substrates 
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fail to form the desired nitroalkane at all. Nevertheless, this is a great way to make 
heteroaryl nitromethane compounds. 
 We emulated the Feuer work in the design of the reaction in equation 65. LDA 
was used as a substitute for NaNH2, and isopropyl nitrate was used in place of n-propyl 
nitrate simply due to its commercial availability. In unoptimized results, 82h was formed 
in appreciable yield of 40% using LDA in THF at -78 °C. This method has the promise of 
being a quick way to access heteroaryl nitroalkanes from robust starting materials. 
2.5 BAM Catalyzed Additions of Aryl Nitroalkanes to Azomethine 
The use of arylnitroalkanes as substrates for the asymmetric aza-Henry reaction is 
rare. Only two examples exist in the literature (Scheme 16). Jorgensen produced adduct 
85 in 1.2:1 dr and 74/77% ee (major/minor).
33
 Reuping performed a similar addition to an 
α-imino ester with 2:1 dr and 84% ee.39 Aryl nitroalkanes are a relevant substrate, as this 
reaction produces precursors to valuable chiral, non-racemic substituted 1,2-diamines. 
The scarcity of aryl nitroalkane additions reported in the literature could be an indication 
of the poor performance of this substrate in the aza-Henry reaction with other catalyst 
systems.  
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In comparison to a simple alkyl nitroalkane like nitroethane (pKa = 16.7 in 
DMSO)
105
, phenylnitromethane is considerably more acidic (pKa = 12.2 in DMSO).
106
 
Since phenylnitromethane is more easily deprotonated than other nitroalkanes, it should 
be expected that the aza-Henry reaction should be faster with phenylnitromethane.  
Performing the reaction under similar conditions as previously used with aliphatic 
nitroalkane additions, we indeed found that the addition of phenylnitromethane was much 
faster than those of simple aliphatic nitroalkanes. With PBAM catalysts of three different 
protonation states, full conversion was achieved after just 2.5 hours (Table 16). Each 
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Scheme 16. Examples of Aryl Nitroalkane aza-Henry Additions 
 
Table 16. Phenylnitromethane Additions at -20 °C 
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catalyst gave aza-Henry product 86 in greater than 20:1 dr. By comparison, a full day was 
needed to achieve full conversion with nitroethane under these conditions. 
With such a reactive system in hand, the reaction was performed at -78 °C. The 
results are displayed in Table 17. Even at -78 °C, reactions performed with all three 
catalysts were complete after only 2.5 hours. The most remarkable result of this series of 
reactions is the fact that unprotonated PBAM was equally enantioselective as its 
protonated counterparts. Never before in the use of BAM catalysts in any reaction has the 
free base provided enantioselection equal to that of the protonated catalysts. 
Enantioselection in these reactions was high but not at the level seen with aliphatic 
nitroalkanes as displayed previously. 
Unexpectedly, a notable increase in enantioselection was observed when the 
reaction was run under more dilute conditions (eq 66). Of course, this was at the expense 
of longer reaction time, but time to completion remained reasonable at less than one day. 
This time with just 5 mol% catalyst aza-Henry product 86 was obtained in greater than 
Table 17. Phenylnitromethane Additions at -78 °C 
 
 
 
68 
20:1 and 89% ee with 80% yield. We speculate that solubility issues contribute to the 
slight drop in ee at higher concentrations. 
The ability of unprotonated PBAM to promote the aza-Henry reaction of 
phenylnitromethane with high enantio- and diastereoselectivity gave us the confidence to 
try the elimination of the α-amido sulfone to the imine and subsequent aza-Henry 
reaction in one pot. As discussed previously with the work of Palomo in Chapter 1, there 
are many advantages to doing these two reactions in one pot. Initial attempts using just 
catalytic amounts of PBAM did not go to completion as shown in Table 18. Still, this was 
encouraging as significant conversion to aza-Henry product was observed with high 
diastereoselectivity and moderate enantioselectivity. The conversion of these reactions  
consistently correlated with the catalyst loadings. For example a catalyst loading of 20 
mol% would cause the reaction to occur, but conversion would reach 40% and go no 
further as shown in entry 1, Table 18. We speculated that was due to catalyst 
diprotonation during the reaction, rendering it inactive as it is no longer sufficiently basic 
to promote the elimination of sulfinic acid.  
Table 18. One-Pot Elimination/Aza-Henry with PBAM 
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This suggested that an exogenous stoichiometric base should be employed to aid 
in the elimination. Initially, a wide range of stoichiometric organic bases were used to aid 
in the process as shown in Table 19. Four organic amine bases of varying pKa values 
were chosen, but none of these bases led to a notable increase in conversion to imine.  
Although, the addition of a stoichiometric organic base did not appear to promote 
the one pot elimination/aza-Henry, potassium carbonate remained a candidate for the 
one-pot process, as it is the base used to perform the elimination of the α-amido sulfones 
to make the imines. When potassium carbonate was used in conjunction with PBAM in 
the one-pot reaction, a remarkably fast conversion was observed by comparison to the 
reaction times needed for the carbonate elimination of sulfones to imines. Oddly, the 
K2CO3 elimination, when performed separately, is quite sluggish at room temperature as 
several days are typically needed to reach full conversion. The slow step in this process 
has to be the elimination based on the previously displayed work. This large increase in 
the rate of elimination in this system indicates that the 
PBAM/K2CO3/phenylnitromethane reagent combination is much more efficient at 
promoting the elimination than K2CO3 alone. This is something that Palomo also 
observed when using CsOH in combination with cinchona alkaloids and nitroalkanes to 
perform aza-Henry reactions starting from the α-amido sulfones. The diastereoselection 
Table 19. One-Pot Elimination/Aza-Henry with PBAM 
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was low presumably due to the high temperature of this reaction and the possibility of 
post-reaction epimerization at this temperature. Enantioselection was good for this 
temperature. There seems to be little influence of the heterogeneous base (K2CO3) on 
enantioselection of this reaction. 
A proposed mechanism of this one-pot reaction is given in Scheme 17. The 
basicity of the combination of PBAM and phenylnitromethane is responsible for the 
elimination step. The elimination is much slower using PBAM and K2CO3 without 
phenylnitromethane. Therefore, the most active base species is likely the in situ formed 
nitronate of phenylnitromethane. The organic base must be recycled to get full 
conversion of the sulfone to imine, so K2CO3 deprotonates the conjugate acid of the base 
species. The reformed PBAM·phenylnitromethane is then able to eliminate more sulfone 
to imine. The K2CO3 does not participate in the aza-Henry reaction, and 
Scheme 17. Proposed Mechanism of One-Pot Elimination Addition 
 
71 
PBAM·phenylnitromethane is responsible for forming aza-Henry product 
stereoselectively.  
This one-pot elimination of sulfones and subsequent addition has been utilized in 
a 1,4-addition to indoles.
107
 Good enantioselection with low diastereoselection was 
observed in preliminary studies shown in equation 67. This is a good example of the 
utility of this one-pot reaction as the vinylogous imine intermediate to this point has 
proven to be difficult to isolate, yet the addition product to the vinylogous imine (formed 
in situ) has been isolated in excellent yield (90%). 
These α-amido sulfones are made via a simple process from the corresponding 
aldehyde, phenylsulfinic acid sodium salt, tert-butyl carbamate, and formic acid in a 
water/methanol mixture (eq 68). The resulting sulfones are simply filtered and are 
sufficiently pure without further manipulation. The formic acid and sulfinate salt 
presumably react to make phenylsulfiinic acid in situ, so this reaction takes place by 
merely stirring the sulfinic acid, aldehyde, and carbamate.  
It seemed possible that this three step process from aldehyde, to sulfone, to imine, 
and finally to aza-Henry product could be accomplished in one reaction. Sulfinic acid 
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was made prior to the reaction for the purpose of simplification. Remarkably, the reaction 
resulted in 69% yield still with significant enantioselection (eq 69). Possibly due to post-
reaction epimerization, 2:1 dr favoring the syn diastereomer was observed. 
This result also placed focus on the mechanism of α-amido sulfone synthesis. The 
most likely scenario is outlined in Scheme 18. If the imine or iminium is being formed 
and subsequently trapped by the sulfinate, it would seem possible that that imine or 
iminium could be trapped by a different nucleophile. The use of stoichiometric amounts 
of sulfinic acid may not be necessary. 
A series of reactions was performed that affirmed some necessary aspects of this 
sulfone formation (Scheme 19). Using a catalytic amount of sulfinic acid and combining 
all reagents at once resulted in no reaction.  The same result occurred when using no 
sulfinic acid and when combining the rest of the reagents at once. At this point, it seemed 
that an equivalent of acid was needed to promote iminium formation. Combining 
carbamate, aldehyde, and an equivalent of tosic acid led to no reaction. Finally, a 
catalytic amount of PBAM·HOTf was used with aldehyde, carbamate, and 
phenylnitromethane. Since PBAM·HOTf can act as both an acid and a base, it was 
 
 
Scheme 18. Proposed Mechanism of Sulfone Formation 
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thought that its acidity could help promote imine formation. The basicity of the catalyst 
could help form the nitronate, and imine could be trapped by the nitronate in a 
stereoselective fashion. This strategy also resulted in no reaction. All of the reactions in 
Scheme 19 resulted in only recovered starting materials.  
Nevertheless, we had a remarkable process in hand that went through two isolable 
intermediates to form a product with two stereocenters with good stereoselection. 
Enantioselection and diastereoselection were still short of the levels previously exhibited 
with nitroalkane additions to imines. It seemed the lowering of the reaction temperature 
could help us achieve these higher levels. The sulfone formation and elimination to imine 
could be performed at room temperature. The third step of the process could then be done 
at -20 °C or -78 °C to favor higher enantio- and diastereoselection. After the imine was 
formed, the reaction could be cooled before the addition of phenylnitromethane. This did 
not turn out to be successful as the elimination to the imine was very sluggish in the 
absence of phenylnitromethane.  
Scheme 19. Probing the Mechanism of Sulfone Formation 
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In equation 70, the elimination and aza-Henry reaction occurred to the level of 
90% conversion in 2 hours at room temperature. The product 86 was formed in 1:1 dr, 
74% ee anti and 53% ee syn. In contrast, the reaction in equation 71 was allowed to stir 
for 8 hours at room temperature.  Still, this longer time did not allow for full conversion 
of the sulfone to imine. This suggests that phenylnitromethane plays a role in the 
elimination step. It seems phenylnitromethane is essential for rapid sulfone elimination to 
imine, so optimal reaction conditions must involve the imine formation and aza-Henry 
reaction occurring simultaneously. 
 
 
 
 
Table 20. One-Pot Elimination/Aza-Henry Reaction at -78 °C 
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 The elimination and addition steps of this process were isolated to examine the 
viability of performing these steps at -78 °C as shown in Table 20. Significant levels of 
conversion were seen after 17 hours further highlighting the enhanced ability this system 
has of eliminating the sulfone to imine. Concentrating the reaction and increasing the  
equivalents of K2CO3 appeared to have some positive effect on the conversion of this 
reaction; while this favored higher conversion, stereoselection is lowered slightly (vide 
supra). The product 86 of entry 3 was isolated (48% yield) and found to be 79% ee. 
Diastereoselection was found to be >20:1 with all reactions. 
This was performed with different aldehydes to show the scope of the reaction 
(Table 21). A 48 hour reaction time and a concentration of 0.2 M were chosen as optimal 
conditions for reactivity. The results were disappointing in that all reactions did not go to 
full conversion despite the longer reaction times. It was encouraging that similar levels of 
enantio- and diastereoselection were observed with different aldehydes. Since full 
conversion has not been achieved at -78 °C, it seemed like the reaction would need to be 
run at a warmer temperature. It also seemed likely that decreasing the concentration of 
these reactions would be beneficial as the reaction mixtures were always very thick and it 
was difficult to achieve sufficient stirring throughout the reaction. 
Table 21. Aldehyde Scope of One-Pot Elimination/Aza-Henry Reaction at -78 °C 
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Table 22 displays the results of varying base and catalyst equivalents at a more 
dilute concentration of 0.09 M and warmer temperature of -20 °C. Entry 2 represents a 
good result of 72% yield after 15 hours reaction time and a lower base and catalyst 
loading. Diastereoselection was still exceptional under these conditions, but 
enantioselection was only at the level of 74% ee. 
Further experiments in Table 23 indicate the equivalents of K2CO3 can be lowered 
without the loss of reactivity. All three reactions were performed at different 
temperatures and catalyst loading to find an optimal reaction protocol. It seems that -20 
°C is the temperature needed to obtain high reactivity and yields without the sacrifice of 
diastereoselection observed at room temperature. Still, enantioselectivity is only 
moderate at 73% ee. The 83% yield in entry 2 is the best yield we have obtained in this 
reaction and notable considering the complexity of the process.  
Table 22. Further Optimization of One-Pot Reaction 
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Although it was clear that diastereoselection was excellent in this process, the 
absolute configuration of the products had to be determined. A series of recrystallizations 
was performed to stereochemically enrich the previously synthesized aza-Henry products 
(Table 24). Entries 3 through 6 all exhibited enrichment in the crystals obtained. 
Crystalline material of exceptionally high ee and dr were obtained for the substrate in 
entry 4 (86g). An X-ray crystal structure was obtained from this material.
108
 The anti 
stereochemistry assigned to all N-Boc imine phenylnitromethane addition products in this 
document is by analogy to this experimental assignment. This enrichment by 
recrystallization was reproducible as shown in entry 5. 
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Table 23. Further Optimization of One-Pot Reaction 
 
Table 24. Recrystallization of Phenylnitromethane Addition Products 
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The diastereomer obtained in these reactions is the anti diasteromer. The syn 
diastereomer is more often employed in applications of asymmetric catalysis. The syn 
diastereomer could easily be converted to the syn-1,2-diaryl-1,2-diamine by reduction 
and deprotection (Scheme 21) That diamine could be used as the chiral backbone for 
many asymmetric catalysts like Noyori‟s ligand (87) and Trost‟s ligand (88).  
Fortunately, the diastereomer obtained from these aza-Henry reactions is the 
kinetic diastereomer. Allowing these reactions to warm up and stir with either PBAM or 
an achiral base can lead to epimerization. We experimentally determined that at 
equilibrium a 1.2:1 mixture of diastereomers favoring the syn diastereomer is obtained 
(Scheme 20).  
Scheme 20. Epimerization of Aza-Henry Products 
 
Scheme 21. 1,2-Diaryl-1,2-Diamine Anti and Syn diastereomers 
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Another potential approach to epimerization as a means to generate high syn β-
amino-nitroalkane would be to diastereoselectively protonate one face of the nitronate 
under kinetic conditions (excess acid, low temperature). A model for this kinetic 
protonation of the nitronate is shown in Figure 26. A Felkin-Anh type model could 
suggest that 89 represents a lower energy transition state than 90 due to steric interactions 
of the -Ar and -Ph groups in 90. Protonation from the right side of 89 would lead to syn 
product. In equation 72, the aza-Henry adduct was deprotonated with lithium 
diisopropylamide to form the lithium nitronate salt. The nitronate salt was then 
protonated with acetic acid. Unfortunately, the selectivity exhibited was for the face of 
the nitronate leading to the anti product.  
A final approach to the syn diastereomer that was investigated was the search of 
our catalyst collection for one that might provide kinetic syn-selectivity. Table 24 shows 
the effect of variation at the 4-position of the quinoline has on stereoselection in the one-
pot phenylnitromethane addition reaction. For simplicity this reaction was performed at 
room temperature. At room temperature diastereoselection is uniformly low across all 
catalysts, and only anti-selectivity is observed. Less Brønsted basic catalysts in entries 1 
Figure 26. Model for Kinetic Protonation of Phenylnitromethane Addition Products 
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and 2 performed poorly in terms of enantioselection. Increasing the Brønsted basicity in 
entries 3 through 5 had a positive effect on enantioselection. It is likely that the less 
reactive, less Brønsted basic catalysts did not promote the reaction to the extent to 
compete with a probable background rate.  
Despite the lack of syn-selectivity observed in all reactions in Table 25, other 
useful information could be gathered from these results. A variety of different electron-
rich amines were coupled to make the catalysts in entries 6 through 15. The cyclic 
secondary amines (morpholine, piperidine, N-methylpiperazine, and homopiperidine) 
should be similar electronically to pyrrolidine based on nucleophilicity measurements.
109
  
Interestingly, the pyrrolidine based catalyst remained the best catalyst in terms of 
enantioselection by far. It seems unlikely that the slight steric differences with the 
different amines plays a factor in this as these changes are relatively far away from the 
binding pocket. Although we do not have the pKa measurements to definitely suggest 
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Table 25. One-Pot Aza-Henry BAM Catalyst Screen 
 
81 
this, it seems that the pyrollidine catalyst is likely the most basic catalyst as the only 
noticeable trend seen in this table is that the enantioselectivity of this transformation 
increases with the Brønsted basicity of the catalyst. Of the non-pyrollidine catalysts, the 
catalyst derived from N-methylaniline in entry 9 provided the highest enantioselectivity. 
The results in Table 25 seem to follow a trend of increased Brønsted basicity of 
the quinoline nitrogen leading to increased enantioselection. Specifically, the highest 
enantioselectivity with the 4-pyrrolidine substituted catalyst should be expected based on 
the increased electon donating ability of the pyrrolidine in this system. To this point, all 
our evidence points to this increased Brønsted basicity of the quinoline nitrogen being the 
reason for this increase in enantioselection. An explanation for the observed decrease in 
enantioselectivity seen with other 4-amino substituted catalysts is given in Figure 27. The 
excellent electron-donating abilities of pyrrolidine increases the basicity of the quinoline 
nitrogen ensuring that the imine associates with a proton bound to the quinoline nitrogen. 
The introduction of less electron-donating amines at the 4-position opens up the 
possibility of an undesired protonation site becoming competitive with the quinoline 
nitrogen. If the imine is activated by a proton bound to the 4-amino nitrogen, a less 
enantioselective pathway could be accessed leading to lower enantioselection. 
Figure 27. Rationale for Decreased Enantioselectivity with other Amines at the 4-position 
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A series of catalysts were screened to ascertain the optimal ligand for the 
phenylnitromethane addition to the preformed N-Boc imine. The results are shown in 
Table 26. The use of less Brønsted basic catalyst 93 resulted in essentially the same 
enantioselection as PBAM. Substitution at the 7- and 8- positions of the quinoline in the 
catalyst 95 resulted in no enantioselection but still high diastereoselection. This seems to 
suggest that steric bulk in the 8-position of the catalyst completely disallows the typical 
binding leading to no facial bias. Unsymmetrical catalyst 96, used previously in this 
group in the addition of α-nitro esters to aryl imines to provide product with generally 
higher diastereo- and enantioselection than H,QuinBAM·HOTf (74·HOTf), resulted in 
similar enantioselection and diastereoselection values as PBAM. As seen in previous 
work in this group with nitroalkane additions, the triflic acid salt of unsymmetrical 
catalyst 97 led to exceptional diastereoselection. Enantioselection of the opposite 
enantiomer but of similar magnitude to PBAM was exhibited with this catalyst. 
Unprotonated 97 gave essentially no enantioselection but still high diastereoselection. 
This was strange as it was the first time with phenylnitromethane additions that a 
significant difference in enantioselection was observed between the triflic acid salt and 
free base of a particular catalyst. 
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The stereoselectivity provided by catalysts 96 and 97 (Table 26) as well as the 
success of the use of unsymmetrical catalysts in nitroacetate additions
110,111
 led us to 
explore more Brønsted basic derivatives of these catalysts (Table 27). It was hoped that 
these catalysts would provide the increased reactivity observed with the 
4
pyrrolidine 
catalysts and the increased stereoselectivity observed with catalysts such as 96. The 
synthesis of these compounds is explained in Chapter 5. These catalysts were used with 
the optimized conditions for phenylnitromethane additions. Catalysts 98 and 99 did 
appear to offer similar but slightly reduced reactivity compared to PBAM as 49-70% 
conversion was observed after 20-44 hours (entries 2-5, Table 27). Enantioselection was 
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Table 26. Phenylnitromethane Aza-Henry Catalyst Screen 
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signficantly lower while diastereoselection was equally high with this series of catalysts. 
As seen with PBAM, the triflic acid salts generally provided similar enantioselection 
values to the free bases. 98 and structurally similar 99 provided comparable 
stereoselection values (>20:1 dr, 63-77% ee). The 
2
quin
3
quin catalyst (99 and 99·HOTf) 
provided the lowest enantioselection of the series (27% and 32% ee respectively). 
Throughout the broad screen of catalysts, it was interesting to find that catalyst 
92c performed significantly better than 92 (Table 28). A clear trend has already been 
established in that stereoselectivity increases as Brønsted basicity of the catalyst 
increases. Methyl substitution at the 5- and 7- positions seemingly had a positive effect 
on stereoselection. This could be an electronic effect, a steric effect, or a combination of 
the two. It seemed logical to extend this design to the 4-pyrrolidine catalysts seeking a 
similar increase in stereoselection.  
Table 27. Performance of non-C2-symmetric PBAM Catalysts 
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Table 29 exhibited the reactivity of 4-pyrrolidine catalysts with substitution at the 
5-,6-, and 7- positions. Catalyst 76c substituted at the 5- and 7- positions exhibited lower 
enantioselectivity than PBAM. This was somewhat expected as any substitution at the 5- 
position would force the pyrrolidine ring to twist out of the plane of the quinoline 
rendering it unable to donate into the quinoline system. Catalysts 76d and 76b 
preliminarily appeared to be more enantioselective than PBAM. Extending this study to 
the one-pot elimination addition reaction, a similar result was seen. Again, the PBAM 
catalysts with substitution at the 6- and 7- positions gave significantly higher 
Table 28. Phenylnitromethane Aza-Henry Catalyst Screen of 
4
Cl BAM Catalysts 
 
Table 29. Phenylnitromethane Aza-Henry Catalyst Screen of 
4
Pyrrolidine Catalysts 
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enantioselection for the anti diastereomer. These results are shown in Table 30. 
Diastereoselection was low as usual at ambient temperature. 
Using optimal conditions for the one-pot elimination addition reaction these 
substituted 
4
pyrrolidine catalysts were not found to perform as well as PBAM (Table 31). 
At -20 °C, catalyst 76d provided product 86 with 11:1 dr and 74% ee. Catalyst 76b was 
also similar to PBAM in that it provided product in 7:1 dr and 71% ee. Unfortunately it 
appears that enantioselection of the anti diastereomer for all 
4
pyrrolidine catalysts 
decreases at lower temperatures in the one-pot elimination/addition procedure.  
These catalysts were also employed in the direct addition of phenylnitromethane 
to imines under optimum conditions for stereoselection in Table 32. Almost identical 
enantioselection and diastereoselection to PBAM was exhibited by catalysts 76d and 76b. 
Table 30. Phenylnitromethane Aza-Henry Catalyst Screen of 
4
Pyrrolidine Catalysts in One-Pot Reaction 
 
Table 31. Phenylnitromethane Aza-Henry Catalyst Screen of 
4
Pyrrolidine Catalysts in One-Pot Reaction 
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To this point, it seems inconclusive that substitution of 
4
pyrrolidine catalysts at the 6- and 
7- positions positively affects stereoselection.  
With optimal conditions established for the enantioselective aza-Henry addition 
of phenylnitromethane to azomethine, the substrate scope for this reaction was explored. 
This reaction was found to be very general as tolerance of a broad range of aryl N-Boc 
Table 32. Phenylnitromethane Aza-Henry Catalyst Screen of 
4
Pyrrolidine Catalysts at -78 °C 
 
Table 33. Aryl Imine Variation in Aryl Nitroalkane Addition Reaction 
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imines was shown. Diastereoselection (13:1 dr or greater) and yields (78-99%) were 
unanimously high across all substrates and with all 
4
pyrrolidine bisamidine catalysts 
used. Some less reactive imines required warming to -20 °C to reach full conversion and 
high yield. For most of the twenty entries in Table 33, multiple catalysts were screened to 
find the optimal catalyst for enantioselection. In all cases where multiple catalysts were 
used, the 
8
MeOPBAM (76f) or 
6,7
(MeO)2PBAM (76e) catalysts were found to be the 
most enantioselective. Both electron-rich aryl imines (entries 6, 13, 15, 18, and 19) and 
electron-poor aryl imines (entries 1, 5, 9, 12, and 20) were tolerated.  
Good results were obtained with imines having substitution at the ortho, meta, and 
para positions. Ortho substituted imines (entries 4 and 5) performed well, with lower 
enantioselection of 77% ee seen with the o-CF3 imine. Good enantioselection was also 
seen with the examples of meta substituted imines (entries 8, 19) while only modest 
enantioselection was seen with the m-Cl imine (entry 20, 74% ee). The use of vast array 
of para-substituted imines led to good enantioselection (entries 1, 6, 7, 9, 13-16, and 18). 
Varying levels of enantioselection were seen when using heteroaromatic N-Boc 
imines. The best example was 21:1 dr and 87% ee with the 2-thiophene imine (entry 2). 
The 3-thiophene imine (entry 11) led to lower, but still good enantioselection (82% ee). 
Other examples suffered from lower enantioselection. The 3-pyridyl (entry 10, 60% ee) 
and 2-furyl imines (entry 12, 68% ee) unfortunately gave only modest enantioselection 
despite being screened with a number of chiral proton catalysts. 
Some functionality was tolerated as halogens and an alkene were brought in as a 
part of the aryl N-Boc imine. An aryl fluoride, chloride, and bromide were all tolerated 
(entries 1, 3, 9, and 20) with mostly good enantioselection. An alkene was also 
89 
incorporated successfully as the p-Oallyl imine (entry 6) gave good enantioselection of 
84% ee. 
With the imine scope thoroughly explored, we sought to also use different aryl 
nitroalkanes to further demonstrate the generality of this transformation. The results are 
shown in Table 34. Once again, excellent yields were seen with most cases. Tolerance of 
substitution at the ortho, meta, and para positions was demonstrated. Substitution at the 
ortho position was problematic as lower enantio- and diastereoselection (4:1 dr, 76% ee) 
was seen with the o-Br phenylnitromethane (entry 1). The m-Br nucleophile (entry 2) 
fared much better leading to 13:1 dr and 91% ee. The previously displayed results using 
the p-Cl phenylnitromethane (entry 8) demonstrate good diastereoselection and excellent 
enantioselection with a para- substituted nucleophile. Both electron-poor (entry 4) and 
electron-rich (entry 5) phenylnitromethanes were employed. The p-NO2 nucleophile gave 
low dr (2:1) but modest ee (76%). The low diastereoselection was not unexpected for this 
substrate as post-reaction epimerization is more likely due to the increased acidity of this 
Table 34. Aryl Nitroalkane Variation in Enantioselective Addition 
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product. The electron-rich p-methoxy phenylnitromethane gave excellent 
diastereoselection (17:1 dr) and good enantioselection (86% ee).  
A heteroaromatic substrate, 4-nitromethylpyridine (entry 7), was also successfully 
used in this reaction, although with essentially no diastereoselection and only modest 
enantioselection (71% and 67% ee) and yield (57%). Once again, the low 
diastereoselection could be expected as the inherent basicity of that aza-Henry product 
could promote post-reaction epimerization, a process that must be controlled with this 
reaction. This 4-nitromethylpyridine (82h, eq 73) substrate is a challenging nucleophile 
for this reaction in that itself is appreciably Brønsted basic and could potentially form an 
appreciably Brønsted acidic nitronate salt in situ. A 
1
H NMR spectrum of 4-
nitromethylpyrdine in DMSO-d6 actually shows that an equilibrium exists in solution 
between the neutral species and the zwitterionic pyridinium nitronate species. This 
tautomer could act as a non-selective catalyst promoting formation of racemic product. 
The modest enantioselectivity here at least indicates that our enantioselective catalyst is 
outcompeting any aforementioned unselective Brønsted acid species that could be formed 
with this substrate. This furthers the case for this system offering broad applicability. 
Despite the plethora of examples of enantioselective aza-Henry reactions in the 
literature, only two examples of the addition of aryl nitroalkanes currently exist as 
discussed earlier (Scheme 16). The absence of aryl nitroalkane examples in the literature 
could be due to the lack of commercial availability of these compounds, the fact that 
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these compounds perform poorly with the reported system, or simply because the 
substrate was not considered for whatever reason. In order to compare the performance of 
our catalysts to others in the field, we used two other common catalysts with our 
conditions for the aryl nitroalkane aza-Henry reaction (Scheme 22).  
The thioureas popularized by Takemoto and Deng did promote the aza-Henry 
reaction to form product 86. The reaction temperature of -20 °C was chosen to ensure 
sufficient conversion to product. 10 mol% of the Takemoto thiourea promoted this 
reaction to yield 86 in 4:1 dr and 57% ee in our optimal solvent for this reaction, toluene. 
This catalyst was also used with Takemoto‟s optimal solvent, CH2Cl2, to give 86 in 
higher diastereo- and enantioselection (11:1 dr, 67% ee). The Deng thiourea offered 
lower enantioselection as 31% ee of the opposite enantiomer was yielded in toluene. 
Essentially no enantioselection was observed in CH2Cl2 (61% ee, -8% ee). Under the 
same conditions, 5 mol% 
6,7
(MeO)2PBAM (76e) gave 10:1 dr and 80% ee. Although it is 
unfair to make the assumption that thiourea-based catalysts are inferior catalysts for this 
Scheme 22. Catalyst Comparison with Aryl Nitroalkane Additions 
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transformation, this data suggests that the use of aryl nitroalkanes as nucleophiles in this 
reaction cannot be viewed as a simple substrate change. A catalyst proven to promote the 
aza-Henry reaction with aryl N-Boc imines and simple alkyl nitroalkanes with 
exceptional stereoselectivity (4-14:1 dr, 92-99% ee) fails to do the same under similar 
conditions with aryl nitroalkanes. 
 
2.6 Michael Additions to Nitroalkenes 
 With the unique reactivity that PBAM exhibits, it seems likely that this catalyst 
could be applicable to a broader range of reactions dependent on pronucleophile 
deprotonation. To explore the utility of PBAM beyond additions to imines, the Michael 
addition of nitroalkanes was attempted using PBAM as a catalyst. This was inspired by 
the work of Wulff in this area using a similar increased Brønsted basic catalyst.
112
  
Wulff initially screened less Brønsted basic catalyst 102 in this reaction and found 
that reaction to proceed very sluggishly (Scheme 23). Using catalyst 103, nitroalkanes 
were added to nitroalkenes to give addition products with good dr and excellent ee. The 
yields were generally modest and an excess of nitroalkane was necessary to prevent 
polymerization. 
                                                 
112
 Rabalakos, C.; Wulff, W. D. J. Am. Chem. Soc. 2008, 130, 13524-13525. 
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 This catalyst 103 is very similar to PBAM on one side with a thiourea moiety on 
the other side. It is reasonable that the thiourea participates in hydrogen bonding with the 
nitroalkene while the amidine serves to deprotonate and bind to the nitroalkane (Figure 
28). These two interactions can also be envisioned with the triflic acid salt of PBAM. The 
necessary increased Brønsted basicity is present with PBAM, and the protonated amidine 
could serve to hydrogen bond with the nitroalkene nucleophile. 
 
Scheme 23. Wulff‟s Michael Addition of Nitroalkanes to Nitroalkenes 
 
Figure 28. Dual Activation by Wulff‟s Catalyst and PBAM 
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In a brief study, PBAM and PBAM·HOTf were found to catalyze this Michael 
addition to nitroalkenes (Scheme 24). We also found that the use of excess nitroalkane 
was necessary to avoid undesired polymerization and obtain high yields. Ultimately, 
excellent yields were obtained when using 30 equivalents of nitropropane with both 
catalysts. Unfortunately, this was at the expense of enantioselectivity as ee values 
decreased. PBAM·HOTf was able to produce 104 with a promising level of 
stereoselection (4:1 dr, 66% ee) when using 5 equivalents of nitroalkane. 
This reaction could perhaps be optimized to get higher enantioselection and more 
favorable nucleophile stoichiometry in the future. Nevertheless, this presented an 
example of PBAM promoting an enantioselective reaction without the use of an imine 
electrophile. There are likely many more prochiral substrates capable of interacting with 
PBAM to undergo reaction and yield useful chiral, non-racemic products. 
  
Scheme 24. PBAM Catalyzed Nitroalkane Michael Additions 
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CHAPTER III 
 
ASYMMETRIC SYNTHESIS OF A GLYT1 INHIBITOR 
 
3.1 Background 
 Schizophrenia is a disease characterized by the symptoms of delusions and 
hallucinations. Apart from the mental health symptoms, patients diagnosed with 
schizophrenia die 12-15 years earlier than the average population. The lifetime 
prevalence and incidence are 0.30-0.66%.
113
 
 Typical treatment of schizophrenia is the administration of antipsychotic drugs 
that act as dopamine D2 and serotonin 5-HT2a receptor antagonists. These drugs are 
effective in the management of the positive symptoms such as delusions and 
hallucinations, but they have a minimal effect on the negative symptoms (lack of 
motivation, social withdrawal, etc.). Additionally, many of undesired side effects 
accompany the use of these drugs due to the promiscuous pharmacology exhibited by 
these medicines.
114
 
 There exists the need for better therapeutics for the treatment of schizophrenia 
than the aforementioned antipsychotic drugs. In the last several years, a large amount of 
evidence has surfaced that reduced function of glutamatergic N-methyl-D-aspartate 
(NMDA) receptors may play an important role in the pathophysiology of schizophrenia. 
                                                 
113
 van Os, J.; Kapur, S. The Lancet 2009, 374, 635-645. 
114
Pinard, E.; Alanine, A.; Alberati, D.; Bender, M.; Borroni, E.; Bourdeaux, P.; Brom, V.; Burner, S.; 
Fischer, H.; Hainzl, D.; Halm, R.; Hauser, N.; Jolidon, S.; Lengyel, J.; Marty, H.-P.; Meyer, T.; Moreau, J.-
L.; Mory, R.; Narquizian, R.; Nettekoven, M.; Norcross, R. D.; Puellmann, B.; Schmid, P.; Schmitt, S.; 
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Enhancing the function of NMDA receptors is being explored as a potential therapy for 
schizophrenia. Glycine has been found to potentiate the NMDA response
115
 and is a 
coagonist for NMDA activation.
116
 Increasing the concentration of glycine in the brain 
without exogenous administration of glycine is a strategy being explored to increase 
NMDA function. One way to do this is to inhibit glycine uptake by small molecule 
inhibition of the glycine transporter I receptor (GlyT1). 
 Sarcosine (N-methylglycine), a protypical weak GlyT1 inhibitor, was found to 
improve positive, negative, and cognitive symptoms in schizophrenia patients. 
Unfortunately, this compound suffers from a poor pharmacological profile. Better 
therapeutic agents than sarcosine would be needed to adequately treat schizophrenia. 
Many modifications of sarcosine‟s structure were made in an attempt to find better GlyT1 
inhibitors but ultimately failed due to the cause of undesirable effects. 
 Pharmaceutical companies are actively pursuing and developing non-sarcosine 
based GlyT1 inhibitors. Hoffmann-La Roche is developing a molecule RG1678 (105) and 
has recently (2010) reported positive Phase II clinical results for this compound.  
  
  
                                                 
115
 Johnson, J. W.; Ascher, P. Nature 1987, 325, 529-531. 
116
 Kleckner, N.; Dingledine, R. Science 1988, 241, 835-837. 
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3.2 PBAM Catalyzed Asymmetric Synthesis of a GlyT1 Inhibitor
117
 
 Similar efforts are being made here at Vanderbilt. Compound 106 has been found 
to be a potent GlyT1 inhibitor by the Lindsley group.
118
 Furthermore, one enantiomer of 
106, whose absolute configuration has yet to be assigned, was found to be 10
4
 times more 
reactive than its antipode.  
The racemic synthesis of 106 is outlined in the patent. A Grignard addition to a 
Boc-protected 3-cyanoazetidine and subsequent hydrolysis led to the corresponding 
ketone in 15% yield over two steps. Reductive amination followed by acylation provided 
                                                 
117
 Davis, T. A.; Danneman, M. W.; Johnston, J. N. unpublished results. 
118
 Lindsley, C. W.; Conn, P. J.; Williams, R.; Jones, C. K.; Sheffler, D. J. US Patent 7572792 
Scheme 25. Retrosynthetic Analysis of GlyT1 Inhibitor 
 
Scheme 26. Lindsley Patent Medicinal Chemistry Route to GlyT1 Inhibitor 106 
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the corresponding Boc-protected azetidine in 69% yield over three steps. This compound 
was converted to racemic 106 (56% over two steps) after deprotection and acylation. 
 Our desire to use our chiral proton catalysis technology to facilitate the 
development therapeutics led us to envision an approach to this molecule using an 
asymmetric aza-Henry reaction between imine 107 and nitroazetidine 108 (Scheme 25). 
Subsequent denitration of the resulting tertiary nitroalkane 109 could give compound 
106. In the process, absolute stereochemistry of 106 could be assigned by analogy. 
 The most direct and convergent route to GlyT1 inhibitor 106 would involve 
addition of nitroazetidine 108 to benzoyl imine 107 (eq 74). Attempts to 
enantioselectively add to benzoyl imines have been unfruitful in our studies as they have 
led to products with no enantioselection. For example, Scheme 27 shows the BAM 
catalyzed addition of 2-nitropropane to benzoyl imine 110. Essentially no 
enantioselection is observed with PBAM and its triflic acid salt. Alternatively, 
enantioselective additions of nitroalkanes to aryl N-Boc imines have been performed with 
a high level of enantioselectivity as shown previously in this document.  
 
 
Scheme 27. Enantioselective 2-Nitropropane Additions 
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 Early attempts to make sulfonyl nitroazetidine 108 were unsuccessful. A –Cbz 
protected nitroazetidine seemed to be a better substrate for the BAM catalyzed aza-Henry 
reaction since it would presumably have more desirable solubility and would not contain 
any Brønsted basic atoms that might self-catalyze the aza-Henry reaction resulting in a 
competitive, nonselective pathway. It seemed more logical to protect the nitrogen of 3-
hydroxyazetidine 111, then deprotect and acylate at a later stage. 3-Hydroxyazetidine was 
a good starting point as it is a relatively, cheap commercially available substance.
119
 This 
reaction proceeded smoothly to give a nearly quantitative yield of protected 
hydroxyazetidine 112 (eq 75).  
 Attempts to directly halogenate 112 were unsuccessful (Scheme 29). Treating 112 
with triphenylphosphine and carbon tetrabromide in benzene or CH2Cl2 failed to produce 
                                                 
119
 Krishna Reddy, V. V. R. M.; Udaykiran, D.; Chintamani, U. S.; Mahesh Reddy, E.; Kameswararao, C.; 
Madhusudhan, G. Org. Process Res. Dev. 2011, 15, 462-466. 
 
Scheme 28. Synthesis of and Reactions involving 3-MsO Azetidine 
 
Scheme 29. Attempts at Direct Halogenation of 3-Hydroxyazetidine 
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bromo-azetidine 113, resulting in an intractable mixture of compounds. Similarly, 
treating 112 with triphenylphosphine, iodine, and imidazole failed to produce the desired 
iodo-azetidine 114. Instead, it seemed necessary to activate the alcohol and isolate it in a 
discreet synthetic step. Unfortunately, attempts to go through the mesylate failed. The 
mesylate 115 was easily formed but failed to halogenate or nitrate under all conditions 
tried. Ultimately, nitroazetidine 116 was constructed in four steps from commercially 
available 3-hydroxyazetidine HCl salt (111, Scheme 30). The protected azetidine 112 was 
triflated and underwent displacement with sodium iodide to give 3-iodoazetidine 114 in 
89% overall yield. A final displacement with sodium nitrite gave the desired aza-Henry 
substrate 116 in 40% yield.  
 With the desired nitroalkane in hand, we followed conditions previously 
developed for the aza-Henry addition of secondary nitroalkanes with PBAM·HOTf in 
Scheme 31. We were delighted to see good enantioselection of 78% ee of aza-Henry 
product 117 using PBAM·HOTf as a catalyst at room temperature. This reaction was 
surprisingly fast at this temperature as full conversion was achieved after only 70 
minutes. This is in contrast to the addition of 2-nitropropane to aryl N-Boc imines for 
which reaction times of ~24 hours are required to achieve full conversion. With such a 
relatively reactive system in hand, the reaction temperature was lowered in an attempt to 
increase the observed enantioselection. Lowering the temperature to 0 °C led to a 
Scheme 30. Synthesis of 3-Nitroazetidine from 3-Hydroxyazetidine 
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noticeable increase in enantioselection while reactivity was still good as only a four hour 
reaction time was necessary. 
 Ultimately, the optimal conditions for stereoselection were found to be -20 °C 
with a one day reaction time. A brief screen of BAM catalysts was performed to find the 
best catalyst for this reaction (Table 35). PBAM·HOTf was found to once again provide 
measurably higher enantioselection than at warmer temperatures as 86% ee was 
observed. The 7- substituted PBAM catalysts 
7
MeOPBAM·HOTf (76b·HOTf) and 
7t
BuPBAM·HOTf (76q·HOTf) each led to appreciably higher enantioselection of 92% 
and 90% ee, respectively. Excellent yields were seen with all catalysts screened. 
With enantiomerically enriched aza-Henry product 117 in hand, a tin-mediated 
denitration was attempted (Scheme 32).
120,121
 This reaction proceeded smoothly to 
furnish denitrated product 118 with a yield of 69%. Compound 118 provides a scalemic 
                                                 
120
 Ono, N.; Miyake, H.; Tamura, R.; Kaji, A. Tet. Lett. 1981, 22, 1705-1708. 
121
 Tanner, D. D.; Blackburn, E. V.; Diaz, G. E. J. Am. Chem. Soc. 1981, 103, 1557-1559. 
Scheme 31. Aza-Henry Addition of Nitroazetidine Catalyzed by PBAM·HOTf 
 
Table 35. BAM Catalyzed Addition of Nitroazetidine 
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scaffold that can be used to access GlyT1 inhibitor 106 or any number of derivatives 
through employment of different acyl groups. 
Scalemic scaffold 118 has been converted to GlyT1 inbibitor 106 (Scheme 33) by 
Michael Danneman. The –Cbz group of 118 was removed by hydrogenlysis before 
acylation with sulfonyl chloride 120 to provide 121 (56% yield over two steps). Acid-
promoted –Boc deprotection and subsequent acylation provided the GlyT1 inhibitor 106 
in 27% yield over two steps. 
Scheme 32. Completion of Scalemic Scaffold for GlyT1 Inhibitor 106 
 
Scheme 33. Completion of GlyT1 Inbibitor 106 
 
103 
Apart from the achievement of synthesizing 106 using our chemistry, the 
demonstration of a method utilizing an important heterocycle is noteworthy. The 4-
membered nitrogen-containing heterocycle azetidine is a functional group often seen in 
bioactive molecules and therapeutics. Furthermore, the synthesis of azetidines and their 
incorporation into larger molecules is a topic of focus among synthetic organic 
chemists.
122
 The ability to incorporate this functional group into more complex structures 
while controlling stereochemistry could potentially have many medicinal chemistry 
applications. 
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 Brandi, A.; Cicchi, S.; Cordero, F. M. Chem. Rev. 2008, 108, 3988-4035. 
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CHAPTER IV 
 
 ENANTIOSELECTIVE SYNTHESIS OF THE ANTI-CANCER 
COMPOUND NUTLIN-3 
 
4.1 Background 
The tumor-suppressor protein p53 is a very important and well-studied gene and 
protein. This protein is a transcription factor that plays a major role in cell cycle 
regulation, particularly programmed cell death (apoptosis). p53 became the object of 
intense study after Hollstein and co-workers made the discovery that about half of human 
cancer cell lines contain mutations in the p53 gene.
123
 Furthermore, it was found to be the 
most frequently inactivated protein in human cancer. 
MDM2 is a protein involved in the regulation of p53. MDM2 is subsequently 
found to be amplified or overexpressed in many malignancies. This p53-MDM2 protein-
protein interaction has been characterized by the crystal structure of MDM2 bound to a 
peptide from the transcriptional domain of p53. It was found that MDM2 possesses a 
deep hydrophobic pocket filled by three side chains from the helical region of the p53 
peptide. This led to the idea that a small molecule could inhibit this MDM2/p53 
interaction. 
Vassilev and co-workers identified a series of cis-imidazoline compounds that 
effectively displaced p53 from MDM2 at low concentrations.
124
 The compounds were 
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made as racemic mixtures and separated by chiral chromatography. The Nutlins (short for 
Nutley inhibitors) are displayed in Figure 29. All three feature similar structural elements. 
Each has two identical aryl rings substituted with a halogen at the para-position. Some 
subtle changes in the piperazine ring ultimately led to the optimal inhibitor, (-)-Nutlin-3 
(124). The levorotatory enantiomer (also referred to as enantiomer-a) was found to be 
nearly 150 times more potent as an inhibitor than the other (enantiomer-b). 
Nutlin-3 is currently being developed by Hoffmann-La Roche and others as a 
therapeutic. Despite its potential to be a drug in the future, Nutlin-3 has been extensively 
used by the scientific community as a biological tool. This is evidenced by the avalanche 
of literature involving the compound since its disclosure to the public in 2004. A simple 
Scifinder search on the keyword “Nutlin-3” retrieves over 1000 research articles. 
If Nutlin-3‟s only mechanism of action is the inhibition of the MDM2-p53 
interaction, then it should only trigger apoptosis in the half of human cancer cell lines in 
which p53 is wild-type. Recent research has suggested that the mechanism of action of 
Nutlin-3 might not be that simple, as Nutlin-3 has been found to induce cell death in the 
absence of wild-type p53.
125
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Figure 29. Nutlins: cis-Imidazoline MDM2-p53 Inhibitors 
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 p73 shares significant sequence homology to p53, but less is known about its 
function. In contrast to p53, p73 is rarely mutated or absent in cancers. Irwin and co-
workers showed that Nutlin-3 induces apoptosis in p53-mutant and p53-deficient cells 
through the activation of p73.
125
 There are other published examples of this p73 
activation by Nutlin-3 in different types of cancer cells.
126,127
 This suggests that Nutlin-3 
could potentially be used to treat tumors that do not contain wild-type p53. 
Several other non-p53 dependent pathways have been demonstrated as targets of 
Nutlin-3. VanderBorght showed that Nutlin-3 induces p21 expression and G1 cell cycle 
arrest in p53-deficient lung carcinoma cells.
128
 It inhibits the binding of MDM2 to E2F-1 
which causes an induction of apoptosis downstream in cells lacking functional p53.
129
 
The molecule can prevent the association of HDM2 (human MDM2) and HIF1-α 
(hypoxia-inducible factor 1α) which subsequently decreases VEGF (vascular endothelial 
growth factor) levels.
 130
 This reduction is seen as a potential therapy for certain types of 
cancers. Yoon, and co-workers recently published results demonstrating Nutlin‟s ability 
to bind to the anti-apoptotic Bcl family of proteins triggering apoptosis at the 
mitochondria.
131
 
The significance and importance of Nutlin-3 is unquestionable. Unfortunately, no 
synthetic research on Nutlin-3 has been reported to date outside of the limited patent 
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details provided by Hoffmann-La Roche. Nutlin-3 is available in enantiopure and racemic 
form from various sources. Racemic Nutlin-3 is available from major, domestic supplier 
Sigma-Aldrich ($52/mg).
132
 The necessity to separate the desired enantiomer by chiral 
column chromatography adds to the cost and inconvenience. The more potent enantiomer 
is also available domestically from Cayman Chemical for a price of $80/mg (5 mg) or 
$62/mg (25 mg).
133
 This quantity may be practical for cell-based studies involving 
Nutlin-3 but is cost-prohibitive for most types of animal studies. Recently, we gave 500 
mg of (-)-Nutlin-3 to the research group of Jennifer Pietenpol here at Vanderbilt for 
mouse studies. This amount of the compound would cost $31,160 based on the Cayman 
25 mg quote. A bulk quote would likely be significantly lower, still, any price in this 
range would be prohibitively high for academic researchers. 
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Scheme 34. Hoffmann-La Roche Patent Synthesis of Nutlin-3 
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The synthesis of (-)-Nutlin-3 by Hoffmann-La Roche is outlined in a series of 
patents (Scheme 34). The synthesis starts as a diaza-Cope rearrangement between benzil 
(125) and salicylaldehyde (126) to provide 1,2-diamide 127 in 76% yield. The diamide 
was then acylated and hydrolyzed to unmask the free meso-1,2 diamine 128. Another 
condensation with 2 equivalents of p-chlorobenzaldehyde and subsequent diaza-Cope 
rearrangement and hydrolysis provided meso-1,2-diamine 129 in 55% yield over 2 steps. 
The other component for the convergent condensation step was synthesized starting from 
4-methoxysalicylaldehyde 130. The aldehyde was converted to a nitrile by an interesting 
reaction with NaOAc and nitroethane in refluxing acetic acid. The free hydroxyl group of 
this nitrile was then appropriately alkylated to provide nitrile 131 in 57% yield over two 
steps. Nitrile 131 was then reacted with HCl gas in EtOH to give imidate 132 in an 
exceptional yield of 99%. This imidate was then condensed with meso-diamine 129 in 
refluxing ethanol to give meso-imidazoline 133 in good yield.  
Imidazoline 133 was then converted to racemic Nutlin-3 by reaction with 
phosgene and oxo-piperazine 134 forming the necessary urea (Scheme 35). Chiral 
supercritical fluid chromatography was then used to separate (-)-Nutlin-3 (124) from the 
undesired enantiomer. 
Scheme 35. Hoffmann-La Roche Synthesis of Nutlin-3 
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Overall, Hoffman-La Roche presents a highly convergent racemic synthesis of 
Nutlin-3. The yields are mostly good with the exception of the sequence to make meso-
diamine 128 from protected diamide 127. 128 is available commercially from 
GLSyntech, LLC for $2988 for 5 grams.
134
 It seems likely this price is so high due to the 
inefficiency of this synthetic sequence. 
The fact that this is a racemic synthesis presents the obvious drawback in that 
50% of the material produced in the last step will not be used, resulting in a waste of raw 
material used for the synthesis and material that will have to be disposed of in the end. 
Asymmetric synthesis is commonly used to avoid these downfalls in scenarios where a 
chiral, non-racemic reagent or asymmetric catalyst can easily be applied. Unfortunately 
in this case, that opportunity does not exist as the synthesis goes through achiral 
intermediates. A new route would have to be designed without the use of achiral 
intermediates to render the synthesis of (-)-Nutlin-3 enantioselective. 
A better route would greatly benefit the scientific community as the need for 
larger amounts of the compound undoubtedly grows. Particularly, a published route that 
is enantioselective would allow scientists without access or expertise with chiral SFC to 
synthesize the active enantiomer of Nutlin-3. This would greatly reduce the cost of 
research involving Nutlin-3 and perhaps open doors for additional research and 
development. Additionally, access to the synthesis of new derivatives of Nutlin-3 could 
be facilitated by a convergent, enantioselective route. 
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4.2 PBAM-Catalyzed Asymmetric Synthesis of Nutlin-3 
With the development of the phenylnitromethane aza-Henry addition chemistry, 
Nutlin-3 seemed to offer an excellent application for this asymmetric transformation. It 
was very obvious that compound 101 could be easily made in high diastereo- and 
enantioselection. A retrosynthetic analysis of Nutlin-3 (Scheme 36) led to a simple, 
straightforward deconstruction of the molecule featuring chiral, nonracemic, orthogonally 
protected, 1,2-diaryl diamine 101. Care has to be taken in this synthetic approach to avoid 
meso intermediates that would erase the established stereochemistry. Urea 135 is at the 
correct oxidation state to form Nutlin-3 through a dehydrative cyclization. This urea 
could be formed from simple functionalization of the masked cis-stilbene diamine 101. A 
BAM-catalyzed aza-Henry reaction between the corresponding N-Boc imine and 
arylnitroalkane 82f could provide masked diamine 101 with high stereoselectivity.  
Scheme 36. Retrosynthesis of Nutlin-3 
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The optimal conditions for arylnitroalkane additions to aryl N-Boc imines 
previously described in this document were used to produce masked cis-stilbene diamine 
101. Initial results were good as the desired addition product was formed in good 
diastereo- and enantioselection with excellent yield (entry 1, Table 36). Once again the 
use of the triflic acid salts of PBAM did not improve stereoselection (entries 2 and 3). 
With the reactivity of the 4-pyrrolidine catalysts seemingly not necessary for this 
relatively more reactive system, it seemed logical to broaden the scope of catalysts used 
Table 36. Effect of Protonation State on Aryl Nitroalkane aza-Henry Addition 
 
Table 37. Broad Screen of BisAMidine Catalysts for Nutlin-3 Precursor 101 
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for this particular aza-Henry reaction (Table 37). Less reactive catalyst H,QuinBAM (74) 
and its triflic acid salt performed similarly, leading to modest enantioselection but good 
diastereoselection. Unsymmetrical protonated catalyst 96 gave higher enantioselection 
(80% ee) but lower diastereoselection. The free base of catalyst 96 gave slightly lower 
enantioselection but similar diastereoselection. Both the salt and free base form of the 
6
Me pyridine BAM catalyst (73c) performed similarly (5:1 dr, 58% ee and 6:1 dr, 63% 
ee, respectively). All of the less Brønsted basic catalysts (entries 1-6) failed to provide the 
levels of stereoselection that the 4-pyrrolidine catalysts provided.   
Figure 30. Catalyst Screen for Aryl Nitroalkane Aza-Henry Addition 
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The only noticeable trend seen with this addition thus far was that more Brønsted 
basic catalysts led to higher enantioselection. In that regard, PBAM catalysts with 
additional electron donating groups were desired. Through the development of a robust 
synthetic route, a plethora of substituted 4-pyrrolidine bisamidine catalysts were created 
with various steric and electronic variations. This allowed for a large number of 
bisamidine catalysts to be screened for an addition reaction directly relevant to Nutlin-3 
(Figure 30). Fortunately, this synthetic effort was not in vain as catalysts with noticeably 
higher stereoselectivity for this reaction were identified. 
6
MeOPBAM (76g) offered 
essentially the same enantioselection but higher diastereoselection than PBAM. 
6
MePBAM (76h) gave significantly higher enantioselection but slightly lower 
enantioselection. The addition of a methoxy group at the 7-position increased 
enantioselection slightly and diastereoselection significantly. 
6,7
(MeO)2PBAM (76e) 
proved to be a superior catalyst providing 101 in 13:1 dr and 91% ee. 
8
MeOPBAM (76f) 
gave the highest enantioselection of all catalysts while diastereoselection was only 
moderate. This result was somewhat surprising considering a previous result (Table 26, 
entries 3 and 4) that suggested substitution at the 8-position completely shut down any 
enantioselectivity. Overall, the installation of EDG at the 6-, 7- and 8- positions were 
somewhat beneficial. The steric bulk of these groups appear to have no ill effect on the 
stereoselectivity. Catalysts with EDG at the 5-position were not made due to the 
interference substitution at that position has on the pyrrolidine‟s ability to donate electron 
density to the quinoline. 
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The development of this reaction at warmer reaction temperatures would be 
beneficial as the ability to perform reactions at -78 °C is not practical or even possible for 
some laboratories, especially on large scale. Warmer reaction temperatures would also 
likely result in shortening the reaction times from a day to a period of hours. For these 
reasons, the reaction was run at -20 °C with a variety of catalysts (Table 38). As 
expected, a decrease in stereoselectivity was seen at this warmer temperature. All PBAM 
catalysts (entries 1-7) gave modest diastereoselection (4-11:1 dr) and good 
enantioselection at this temperature. Encouragingly, the most selective catalyst at -78 °C, 
8
MeOPBAM (76f), still provided a high level of enantioselection of 89% ee at -20 °C. 
BAM catalysts with N-methylaniline (MANBAM, 94d) and dimethylamine 
(
4
Me2NBAM, 94i) coupled at the 4- position were screened (entries 8 and 9). MANBAM 
provided 101 in good diastereoselection and comparable enantioselection (8:1 dr, 81% 
ee), while catalyst 94i provided 101 in substantially lower enantio- and diastereoselection 
(2:1 dr, 52% ee) than the PBAM derivatives. 
Table 38. Catalyst Screen for Aryl Nitroalkane Aza-Henry Reaction 
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A quirk of this reaction is that the product is not very soluble in cold toluene and 
precipitates out of solution as it is formed. This turned out to be very useful as the 
reaction could simply be filtered and the solid washed as the reaction was scaled up. This 
filtered and washed solid was sufficiently pure and was routinely carried through without 
further purification. Additionally, this solid is consistently diastereomerically pure 
(≥100:1 by HPLC) as the minor diastereomer is significantly more soluble in toluene than 
the major diastereomer. A reaction with such a simple purification protocol allowed for a 
rapid screening and optimization of catalysts and conditions. Therefore, the high dr 
numbers displayed in the figures below may not reflect the true diastereoselection but do 
reflect the purity of the material isolated. 
This aza-Henry reaction suffered from some variability in enantioselection which 
was thought to be a consequence in varying purities of the imine substrates. Although 
elimination of the α-amido sulfones to the corresponding N-Boc imines is 
straightforward, it can be difficult to stop the reaction at the proper time. If the reaction is 
stopped too early, some sulfone will remain. If the reaction is stopped too late, there will 
be some decomposition of the formed imine which includes aldehyde and carbamate. 
Due to the instability of the N-Boc imine, any purification of the material beyond 
filtration and evaporation of the solvent is not possible. For this reason, these imines 
often contain a small amount (1-2%) of sulfone. It has already been established that 
PBAM is capable acting as a general base for these α-amido sulfones and promoting the 
elimination to the imine. It was thought that if the reaction was performed with imine that 
contained sulfone that PBAM might promote the elimination of that small amount of 
sulfone and form the PBAM-sulfinic acid salt. The acid salts of PBAM have been shown 
116 
to behave quite differently from the free base in this reaction. Even though the amount of 
this PBAM-sulfinic acid salt formed would have to be quite low owing to the small 
amount of sulfone present, it is possible that it could have an effect on the reaction due to 
low catalyst loadings. Therefore, a series of reactions were set up to examine this theory. 
 First, a series of catalysts were screened in conjunction with the use of one 
equivalent of a heterogeneous base, K2CO3 and the same batch of imine (found to be 1% 
sulfone and 2% aldehyde by 
1
H NMR) in Table 39. K2CO3 could potentially act as an 
acid scavenger to quench any sulfinic acid liberated from the elimination of trace 
amounts of sulfone associated with the imine. No significant change in enantioselection 
was seen with entries 1-3 and 7. Interestingly, catalysts with alkyl substitution at the 8-
position (entries 4-6) suffered from low reactivity under these conditions. 
Stereoselectivity exhibited by these catalysts was also low, likely due to a non-selective 
alternate reaction pathway. This apparent significant reactivity difference observed with 
8
alkyl substituted PBAM catalysts will be discussed later.  
 
Table 39. Effect of Heterogenous Base on Aryl Nitroalkane Aza-Henry Reaction 
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A set of reactions was also performed with imine that contained no detectable α-
amido sulfone by 
1
H NMR (Table 40). Once again, no real trend is seen. Enantioselection 
did not change much from catalyst to catalyst. Catalysts (76, 76f, 76 j, and 76 m) which 
previously yielded good enantioselection in this reaction gave similar enantioselection 
values. Once again, PBAM catalysts with alkyl substitution at the 8- position gave lower 
yields presumably due to their lower reactivities. It is interesting but difficult to 
rationalize why these 
8
alkyl PBAM catalysts (entries 4-6, 8) uniformly provided higher 
enantioselection than the corresponding reactions under the conditions in Table 39. 
Catalyst 76m gave the highest enantioselection (88% ee) under these conditions, but still 
not to a level that is significantly superior to the other catalysts. These results do not shed 
any light on the reasoning of some reaction to reaction variance in observed 
stereoselection. 
Table 40. Aryl Nitroalkane Aza-Henry Additions in the Complete Absence of Sulfone 
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One important finding from the reactions of Table 39 and Table 40 is that low 
catalyst loadings are possible for this reaction. Loadings of 1 mol % led to essentially the 
same enantio- and diastereoselection as reactions using 5 mol %.  
This led us to do a catalyst loading study on this reaction. PBAM and 
6,8
(MeO)2PBAM were both used with a range of catalyst loadings. A pronounced trend 
was seen in both cases. With PBAM (Table 41), poor enantioselection was observed 
when 20 mol% catalyst loading was employed. The yields were also noticeably lower 
with entries 1 and 2. This is presumably due to lower diastereoselection stemming from 
low kinetic diastereoselection or post-reaction epimerization. As the catalyst loading 
decreased, the enantioselection significantly increased. The smallest loading of 1 mol% 
(entry 5) produced 101 in the highest level of optical purity (74%). The results of entry 6 
appear to indicate that the slow addition of the electrophile might also be beneficial for 
enantioselection. 
Lower catalyst loadings also led to higher enantioselection with the 
6,8
(MeO)2PBAM catalyst (Table 42). The highest catalyst loading of 15.4 mol% only 
Table 41. Catalyst Loading Effect Study of PBAM 
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provided 101 in 62% ee (entry 1). Enantioselection increased until loadings below 1 
mol% (entries 5-7) provided equally high enantioselection of 86-87% ee. Incredibly, 
reactivity was still sufficient with only 0.15 mol% catalyst under these more ambient 
conditions (-20 °C vs. -78 °C).  
The ability to use low catalyst loadings was quite useful for the scale-up of this 
reaction. Using 
8
MeOPBAM as the catalyst, the reaction was found to be quite amenable 
to relatively large scale. For practical purposes, -20 °C was chosen as the reaction 
temperature. Table 43 represents the efforts put forth in scaling up this reaction to 
ultimately a 6 mmol scale (2.2 g 101). Catalyst loadings were reduced down to 0.5 mol % 
without a detectable change in enantioselection. Even at such low loadings, reactivity was 
sufficient for reaction times to be less than one day. The reaction was also run under 
more concentrated conditions without a loss in yield or stereoselection. 
Table 42. Catalyst Loading Effect Study of 
6,8
(MeO)2PBAM 
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Having fully established 
8
MeOPBAM to the optimal catalyst for this reaction, we 
then used its triflic acid salt as a catalyst (Figure 31). Previously in similar reactions, the 
triflic acid salt of PBAM led to the same or slightly lower levels of stereoselection than 
the free base of PBAM. Expecting similar results, we were surprised to see that this triflic 
acid salt led to much lower stereoselection than the free base of 
8
MeOPBAM. This 
reaction was performed at -20 °C to produce the adduct 101 in 37% ee. Although it is 
obvious that this 8-methoxy substituted catalyst functions somewhat differently than 
PBAM, this drop from 91% ee (entry 2, Table 43) to 37% ee suggests the mechanisms of 
these two catalysts might be quite different. For comparison, the triflic acid salt of 
4
Me2NBAM was also used. This catalyst led to slightly higher enantioselection (64% ee) 
than its free base (52% ee). Still, this enantioselection was much lower than that given by 
PBAM (and derivatives) offering another example of how critical the pyrrolidine is in the 
performance of this catalyst. 
Table 43. Scale-up and Optimization of Nutlin-3 Aza-Henry Reaction 
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Even with a reaction capable of producing a large amount of aza-Henry product 
with a simple purification, the desire to increase the enantiopurity of the product existed. 
Fortunately compound 101 was easily recrystallized from toluene (Scheme 37) to 
produce material of exceptionally high enantiopurity (99% ee) without any epimerization. 
This circumvented the need for chiral preparatory chromatography to separate the 
enantiomers of Nutlin-3 as was needed in the Hoffmann-La Roche patent synthesis of the 
compound. This proved to be a robust method for producing orthogonally protected 
diamine scaffold 101. 
The most logical next step in the synthesis would be to reduce the nitro group to 
the free amine as deprotection of the Boc group at this stage would most likely lead to the 
retro aza-Henry reaction. Four attempts are shown in Scheme 38. The first reduction 
Figure 31. Enantioselectivity Provided by BAM Triflic Acid Salts 
 
Scheme 37. Optimal Aza-Henry Reaction and Recrystallization 
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conditions tried were conditions applied by this research group to similar reactions 
utilizing CoCl2 and NaBH4. The result of this initial reaction was a promising 61% yield. 
Another previously successful nitro reducing reagent used in this group (Zn/HCl) also 
proved to be moderately successful in an initial reaction producing 136 in 60% yield. 
Metal based hydrogenolysis conditions of both Raney Ni and Pd/C did not result in the 
formation of any amine product.  
The carboxylic acid needed for the upcoming amide formation step was 
synthesized in two steps from commercially available 4-methoxysalicylic acid 130. The 
acid 130 was dialkylated in the presence of K2CO3 and isopropyl bromide in refluxing 
DMF to give ester 137 in 70% yield.
135
 Saponification of that ester provided the desired 
carboxylic acid 138 in excellent yield (89%). 
                                                 
135
 Hattori, T.; Shimazumi, Y.; Goto, H.; Yamabe, O.; Morohashi, N.; Kawai, W.; Miyano, S. J. Org. 
Chem. 2003, 68, 2099-2108. 
Scheme 38. Exploration of Reduction Conditions 
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Amine 136 was then subjected to typical amide bond formation conditions. When 
amine 136 and carboxylic acid 138 were reacted with DCC and catalytic DMAP in 
CH2Cl2 (eq 77), amide 139 was formed in 35% yield (with some amide isolated in mixed 
fractions with DCC). With DCC co-eluting with the desired product, EDC was chosen as 
the coupling reagent to ease purification. This strategy proved fruitful as this reaction 
yielded amide 139 in 80% yield (eq 78). Purification proved to be much easier as a 
simple CH2Cl2 and hexanes wash yielded sufficiently pure product. 
Amide 139 was then converted to amine 140 in a straightforward Boc 
deprotection protocol using trifluoroacetic acid in CH2Cl2 at room temperature (eq 79). 
This led to clean conversion of the carbamate to amine 140 in 90% yield. 
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2-Oxopiperazine 134 was prepared according to a patent procedure. Ethyl 2-
chloroacetate and ethylene diamine were condensed in the presence of sodium ethoxide 
in ethanol to give 2-oxopiperazine 134 in 71% yield (eq 80). 
This set the stage to install the desired urea to access the dehydrative cyclization 
substrate 135 (eq 81). 1,1-Carbonyldiimidazole (CDI) was chosen as the coupling reagent 
as a phosgene equivalent. An initial attempt to form urea 135 by treating 2-oxopiperazine 
with CDI then adding amine 140 failed as the amine failed to attack the intermediate urea 
or isocyanate even after heating. Reversing the order of reagents proved fruitful as urea 
135 was formed under mild reaction conditions allowed by formation of the isocyanate in 
situ.  
A dehydrative cyclization of compound 135 where a urea cyclizes onto an amide 
would appear to be an unprecedented reaction. We were encouraged by similar 
 
Scheme 39. Dehydrative Cyclizations using Hendrickson‟s Reagent 
 
 
125 
cyclizations in the literature (Scheme 39). Kelly and co-workers successfully 
demonstrated a sulfonamide cyclization to an amide using a combination of 
triphenylphosphine oxide and triflic anhydride (Hendrickson‟s reagent136) as a 
dehydrating reagent.
137
 Later, Almquist and co-workers used a very similar procedure to 
cyclize a carbamate onto an amide.
138
 This led us to try similar conditions to that above to 
attempt this intramolecular cyclization. 
Urea 135 was reacted with a mixture of Ph3PO (4 equiv.) and Tf2O (2 equiv.) at 0 
°C to give a single product in 88% yield (eq 82). Without an authentic sample in hand 
and with only a reported mass as the available characterization data in the literature, we 
sought out to fully characterize and definitively assign the structure of our synthetic 
Nutlin-3. The correct mass was assigned by high resolution mass spectrometry. Proton 
NMR strongly indicated that a cyclized product had formed, but the alternate, undesired 
regioisomer 141 (Figure 32) from the cyclization could not be ruled out.  
                                                 
136
 Hendrickson, J. B.; Schwartzman, S. M. Tetrahedron Lett. 1975, 16, 277-280. 
137
 You, S.-L.; Kelly, J. W. Org. Lett. 2004, 6, 1681-1683. 
138
 Pemberton, N.; Pinkner, J. S.; Edvinsson, S.; Hultgren, S. J.; Almqvist, F. Tetrahedron 2008, 64, 9368-
9376. 
 
 
126 
An HMBC experiment provided evidence that the urea did cyclize onto the amide 
to give (-)-Nutlin-3 (Figure 32). C26 (155 ppm) was clearly defined by the correlations to 
H27/H27` and H30/H30‟. A correlation was also seen from C26 to one of the imidazole 
methines at C1 (but not H8). The amidine carbon C15 (160 ppm) was clearly defined by 
its correlation to H25 and also showed correlations to both of the imidazoline methines 
(H1 and H8).  
The optical rotation of this Nutlin-3 derived from the aza-Henry product catalyzed 
by the (R,R)-configuration of bisamidine catalysts was found to be levorotatory. Using a 
correlation to aza-Henry product 86g for which a crystal structure has been solved, the 
absolute configuration of (-)-Nutlin-3 can be confirmed to be (4S,5R) by analogy. 
Stereochemical integrity was maintained throughout the synthesis as confirmed 
qualitatively through optical rotation measurement and quantitatively by comparison to 
known chiral HPLC retention times.
139
  
The biological activity was also assessed. A collaboration with the research group 
of Dr. Jennifer Pietenpol here at Vanderbilt resulted in the use of this (-)-Nutlin-3 in 
biological assays reported by Hoffmann-La Roche. The material was found to exhibit the 
same activity as that has been published previously in the literature. 
                                                 
139
 Wang, Z.; Jonca, M.; Lambros, T.; Ferguson, S.; Goodnow, R. J. Pharm. Biomed. Anal. 2007, 45, 720-
729. 
Figure 32. HMBC Evidence of Formation of Desired Cyclization Regioisomer 
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(-)-Nutlin-3 has been synthesized asymmetrically in 11 overall steps (8 steps 
longest linear sequence).
140
 The overall synthesis is displayed in Scheme 40. The yields 
and results given are the results from the largest scale reactions attempted thus far. aza-
Henry product 101 can be produced on a reasonably large scale (2.2 grams) with very 
low catalyst loading (0.5 mol%). A unique dehydrative cyclization is employed in the 
final step to produce the cis-imidazoline. Over 380 mg of (-)-Nutlin-3 has been 
synthesized in one batch. All the reactions gave similar results to those of smaller scale. 
Column chromatography is only necessary after the final step of this sequence as simple 
workups yield acceptably pure products for the rest of the steps. 
 Another advantage of this method is the ease with which different aryl groups can 
be incorporated on the 1,2-diamine backbone. This would be very difficult with the 
Hoffmann-La Roche patent synthesis as a mixture of three products would result from the 
diaza-cope with two different aldehydes. As shown earlier in this document, derivatives 
                                                 
140
 Davis, T. A.; Johnston, J. N. Chem. Sci. 2011, 2, 1076-1079. 
Scheme 40. Overall Asymmetric Synthesis of Nutlin-3 
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of compound 101 can be made by the addition of an imine and aryl nitroalkane 
containing different aryl groups. This highlights a major advantage of this asymmetric 
synthesis in terms of a medicinal chemistry approach. 
4.3 Efforts Towards Derivatives of Nutlin-3 
 In collaboration with Dr. Kip Guy from St. Jude Research Hospital, a plan has 
been made to approach new derivatives of Nutlin-3. Interestingly, five of the six 
structures featured different aryl groups at the 4- and 5- positions of the imidazoline. 
These structures with different aryl groups give us the opportunity to use one of the 
inherent advantages of our enantioselective route. 
 The retrosynthesis of these compounds also reveals options for starting materials. 
All six of the desired derivatives contain at least one heteroaryl group at the 4- or 5- 
position of the imidazoline. Unfortunately, none of the necessary heterocycles can be 
easily obtained through purchase or straightforward synthesis. The retrosynthesis of 
Figure 33. Outline and Diversity Points of Nutlin-3 Synthesis 
 
Figure 34. Retrosynthesis of Nutlin Derivative 142 
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perhaps the most easily accessible derivative, 142, is shown in Figure 34. This molecule 
could be synthesized from the aza-Henry product coming from the addition of 86f to 143 
or the addition of 144 to 145, allowing for a choice depending on availability of starting 
materials, product yields, or stereoselectivity. 
  
 Scheme 41 explains the ability to use either nitroalkane/imine combination to 
produce derivative 142. Using our current route, Nutlin derivative 142 would have to 
come from an aza-Henry reaction between 86f and 143. Assuming the straightforward 
changes of forming the urea, deprotecting, then forming the amide are possible, 143 
could also be formed from the aza-Henry reaction of 144 and 145. This would form the 
(R,S) product when using (R,R)-PBAM catalyst, but the more active (S,R) product could 
still be formed using the (S,S)-PBAM catalyst. 
Scheme 41. Nutlin-3 Change in Order of Operations 
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 Separate attempts at the synthesis of both nitroalkane 144 and imine 143 were 
made from commercially available chloropyridine 146. Several methods were attempted 
to install a one-carbon unit (Scheme 42). No desired methylated product 147 resulted 
from the treatment of 146 with AlMe3 and Pd(PPh3)4 (eq 83). Addition of 
diethylmalonate and subsequent attempted decarboxylation (eq 84,85) resulted in 
mixtures from which the desired product could not be isolated.
141
 A similar addition of 
ethyl nitroacetate in the presence of sodium tert-butoxide (eq 86) only resulted in the 
isolation of t-butoxide adduct to the pyridine. A direct nitromethylation of 146 to form 
144 (eq 87) using doubly-deprotonated nitromethane did not result in the formation of 
                                                 
141
 Huestis, M. P.; Fagnou, K. Org. Lett. 2009, 11, 1357-1360. 
Scheme 42. Attempts Toward the Synthesis of Nitroalkane 144 
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detectable product. Also, the palladium-catalyzed nitromethylation protocol of Buchwald 
produced an intractable mixture (eq 88).
142
 
 
Luckily, attempts to make the imine 143 were more fruitful. 146 was smoothly 
converted to bromopyridine 150 using TMSBr. Hydroformylation of this substrate was 
achieved through transmetallation and subsequent treatment with DMF. The volatility of 
the aldehyde 151 prevented successful isolation. Instead, p-toluenesulfinic acid and t-
butyl carbamate were added to the crude extract to form the desired sulfones 152 in one 
pot (eq 90). This strategy was successful albeit with only modest yield over two steps. 
Additionally, the sulfone recovered contained a significant amount of carbamate and 
sulfinic acid after washing the obtained solid with ether. Nevertheless, this material was 
sufficient to take forward as purification should be possible at a later stage. 
 The attempted elimination of sulfones 152 resulted in the isolation of very impure 
imine, more than likely the result of the impure sulfone. We previously determined that 
performing the aza-Henry reaction with the preformed imine is desired as better yields 
and stereoselectivities result versus the one-pot elimination/addition reaction from the 
sulfone. Since it did not appear to be easy to obtain the imine, the sulfone was subjected 
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to a one-pot elimination/addition reaction that has been moderately successful with other 
substrates as explained earlier.  
 This one-pot reaction was run at room temperature as attempts at -20 °C resulted 
in no conversion. The results using three different catalysts are shown in Table 44. No 
diastereoselection is observed, likely due to post-reaction epimerization occurring at 
warmer than optimal reaction conditions. Enantioselection is low as somewhat expected 
with the less enantioselective one pot reaction. The yield is also low probably stemming 
from the low purity of the sulfone.  
Still, Nutlin-3 derivative precursor 153 was made with significant 
enantioinduction. This synthesis highlights the advantage our method possesses as two 
different aryl groups are incorporated into the 1,2-diamine backbone. It is likely that the 
synthesis of 153 can be improved by the development of a better method to synthesize 
the aldehyde, especially in terms of purity. Pure aldehyde 151 should dramatically 
improve the chances of obtaining pure sulfone 152 and imine 153. Performing the aza-
Henry reaction directly with the imine should allow us to run the reaction at colder 
temperatures, increasing the enantioselection and preventing the erosion of 
Table 44. One-Pot Reaction Towards Nutlin-3 Derivative 142 
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diastereoselection through post-reaction epimerization. Nutlin-3 derivative 142 should be 
obtained from 153 by application of the final five steps of the synthesis. 
 
4.4 Dehydrative Cyclization Reaction 
The final reaction of the Nutlin-3 synthesis is an intramolecular dehydrative 
cyclization to form the imidazoline using Hendrickson‟s reagent (eq 91). This is a 
powerful transformation that reacts two relatively unreactive functional groups in an 
amide and a urea. This reaction consistently produces Nutlin-3 in very good yields after 
column chromatography (80-90%). 
 It is noteworthy that an excess of PPh3O and Tf2O (at least 3 and 1.5 equivalents 
respectively) is necessary for the successful employment of this reagent
137,138
 in the 
literature. This leads to interesting questions about the mechanism of this reaction.  
 The overall stoichiometry of the reaction is shown in Scheme 43. The two 
hydrogen atoms and one oxygen atom from the molecule of water lost from the starting 
materials are incorporated into two molecules of triflic acid as the byproduct. Each 
 
Scheme 43. Molecular Accounting for the Hendrickson Dehydrative Cyclization Reaction 
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molecule of triflic anhydride is converted to two molecules of triflic acid explaining the 
necessity for a stoichiometric amount of triflic anhydride. On the other hand, 
triphenylphosphine oxide is not consumed in this reaction. Therefore, it should be 
possible to use a catalytic amount of Ph3PO in this reaction. This is obviously desirable 
from an economic standpoint, but it also would ease the purification as column 
chromatography is necessary, primarily to separate Nutlin-3 from the excess Ph3PO. 
 Several attempts to reduce the equivalents of Ph3PO used in this cyclization were 
made (Table 45). Departure from the optimal stoichiometry (4 equivalents Ph3PO, 2 
equivalents Tf2O) of the two reagents resulted in only partial conversion to product at 
best. The reaction did proceed in the presence of Tf2O without Ph3PO but only to 36% 
conversion. Increasing the equivalents of Tf2O to six did not improve the conversion. 
Interestingly, even less conversion (9%) was observed when one equivalent of Ph3PO 
was used in conjunction with two equivalents of Tf2O. 
Table 45. Effect of Stoichiometry Changes and Base Addition on the Dehydrative Cyclization 
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 With the confirmation of the requisite excess Ph3PO for this reaction, Tf2O was 
used with various bases. These bases could serve to react with Tf2O to form a more 
reactive acylating species or sequester the TfOH formed as a byproduct of the reaction. 
The addition of pyridine or triethylamine resulted in no conversion to product. However, 
sodium carbonate and 2,6-di-tert-butyl-4-methylpyridine led to slightly higher conversion 
(40% and 52% conversion, respectively) to Nutlin-3 than Tf2O alone. Still, no conditions 
were found that allowed for full conversion to the desired product. 
 Additionally, thionyl chloride and POCl3 were used as substitutes for 
Hendrickson‟s reagent both individually and in combination with other reagents. These 
reagents are cheaper than Tf2O/Ph3PO and would produce water-soluble byproducts, 
easing purification. Unfortunately, SOCl2 and POCl3 generally produced messier crude 
reaction mixtures than those observed with Tf2O. SOCl2 was used as solvent alone and in 
combination with differing amounts of Ph3PO, pyridine, and DMF. In most cases, 
consumption of the starting material was observed by NMR but traces, if any, of the 
desired product were seen. POCl3 and pyridine in toluene at 50 °C led to 33% conversion 
but small amounts of unknown byproducts were also observed in the crude NMR. All 
other reactions with POCl3 led to consumption of starting material with no significant 
amount of product observed. 
 This combination of triflic anhydride and triphenylphosphine leads to an 
equilibrium of at least three different possible species, each possibly a strong electrophile 
and acylating reagent (Scheme 44). Based on the experiment described above and their 
outcomes, we hypothesize that species B or C could be the most reactive activating agent 
136 
formed in solution.
143
 It has been found by 
31
P NMR studies that this equilibrium heavily 
favors the phosphonium anhydride (POP) species C in the presence of excess Tf2O 
(species B is not observed).
144
 This seems to suggest that the POP species is significantly 
lower in energy (2-3 kcal/mol) than species B. Although the equilibrium appears to favor 
C, it is not clear whether B or C is the more reactive. 
 A testable hypothesis is that the necessary equivalents of the reagents are crucial 
for forming a sufficient concentration of the active acylating species. Specifically, the 
employment of excess Ph3PO could lead to the formation of species C, which could be 
the active acylating reagent (Scheme 45). Alteration of the phosphine oxide could have 
an effect on this equilibrium to favor the formation of species B.  
This could be accomplished through the use of more sterically demanding 
phosphine oxides (Scheme 46). The steric strain between the groups of the two phosphine 
oxides of the POP species could raise the energy of the POP species and shift this 
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Scheme 44. Equilibrium of Hendrickson‟s Reagent 
 
Scheme 45. Potential Pathways for Activation by Hendrickson‟s Reagent 
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equilibrium to the left. Also, electronic changes to the phosphine oxide could affect this 
equilibrium as well as alter the reactivity of the two species. The creation of a more 
reactive system through this approach could remove the necessity for excess phosphine 
oxide in this reaction and find use in many other applications. 
  
 
  
Scheme 46. Potential Changes to Phosphine Oxides for the Dehydrative Cyclization 
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CHAPTER V 
 
SYNTHESIS OF BAM LIGANDS 
5.1 Recent Applications of PBAM in Asymmetric Synthesis 
 We did not anticipate the success and broad applicability of PBAM as an 
asymmetric organocatalyst at the genesis of this chemistry. The counterintuitive approach 
of having a more Brønsted basic catalyst perform as a better chiral Brønsted acid is a 
design principle under continuing investigation. Furthermore, in each of the following 
cases, PBAM is the most stereoselective catalyst from the library of BisAMidine 
catalysts screened.  
 PBAM has been found to promote the alkylation of indoles of type 154 with high 
enantioselectivity (eq 92, Scheme 47).
107
 This reaction appears to proceed through 
indolenine intermediate 155 to produce indoles 156. An in situ formed PBAM acid salt 
may be responsible for the enantioselectivity observed in this reaction through hydrogen 
bonding with the indolenine intermediate. As observed with the addition of aryl 
nitroalkanes to aryl N-Boc imines, PBAM was found to be a superior catalyst to 
H,QuinBAM and other less Brønsted basic catalysts. 
139 
 PBAM has also been found to promote the aza-Henry addition of 
bromonitromethane to aryl N-Boc imines in very high enantioselectivity to give product 
157 (eq 93). This arylglycine equivalent can then be coupled to the N-terminus of an 
amino acid or peptide through umpolung amide synthesis (UmAS) to produce peptides 
(such as 158) as a single diastereomer.
145
  
 Similarly, bromonitromethane can be added to silyl imines in a highly 
enantioselective fashion in the presence of catalytic PBAM (eq 94).
146
 This adduct is then 
converted in the same pot to various N-protected adducts of general structure 159. These 
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Scheme 47. Recent Applications of PBAM in Asymmetric Synthesis 
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adducts can be used in UmAS, thereby broadening the utility of this process. In all cases 
in Scheme 47, PBAM was found to be the optimal ligand for enantioselectivity and 
reactivity. 
  
5.2 Synthesis of PBAM and a Library of other C2-Symmetric, 4-
Pyrrolidine Substituted BAM Ligands 
 
Of the numerous positions an additional electron donating group could be placed 
on the quinoline ring, the 4-position was determined to be optimal. The pKa 
measurements of various substituted quinolines have shown that substitution at the 4-
position has the greatest effect on the pKa of the protonated quinoline nitrogen (Figure 
35).
147
  Synthetically this seemed to play into our hands as 2,4-dichloroquinoline can be 
employed as the starting quinoline (Scheme 48). This substance can easily be prepared. 
The major challenge would be obtaining regioselectivity at the 2-position with the first 
nucleophilic aromatic substitution of the dihaloquinoline.  
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Figure 35. Resulting pKa of Amino-Substituted Quinoline 
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The Buchwald-Hartwig amination proceeded smoothly between (R,R)-
diaminocyclohexane and 2,4-dichloroquinoline 160 with a modest yield of 54% (eq 95). 
Initially, it was envisioned to use another Buchwald-Hartwig coupling to aminate at the 
4-position of 92. This reaction did successfully produce the mono-aminated product, but 
was unsuccessful at installing the second amine.
148
 This did turn out to be valuable as this 
mono-aminated product is an interesting non-C2-symmetric ligand possessing 
electronically different quinoline rings. This strategy produced only mono-aminated 
product with no detectable doubly-aminated product, even after variation of the 
phosphine ligand and base. In some cases, H,QuinBAM was produced as a result of 
reduction of both chlorides. 
 Fortunately, heating compound 92 with an excess of pyrrolidine under 
microwave conditions led to the desired catalyst 76 (simplified to „PBAM‟) in excellent 
yield (92%). PBAM can be purified by column chromatography. The free base of PBAM 
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Scheme 48. Retrosynthesis of 4-Substituted Catalysts 
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binds strongly to silica and copious amounts of solvent are required to fully elute the 
compound. The addition of a small amount of acetic acid (0.5%) to the solvent system (5-
10% MeOH/CH2Cl2) allows for the smooth elution of the acetate salt of PBAM. 
Treatment of this acetate salt with aqueous NaOH produces the PBAM free base. Both 
the free base (unprotonated catalyst) and corresponding triflic acid salts are bench stable 
solids that are indefinitely stable at room temperature. PBAM has been recovered after 
use, repurified by column chromatography, and reused successfully without a decrease in 
reactivity or stereoselectivity. 
As PBAM‟s utility as a catalyst became apparent, we decided to explore 
derivatives to further increase reactivity and/or stereoselectivity. The same three steps 
used to synthesize PBAM (starting from malonic acid and aniline) could be used to make 
derivatives of PBAM by simply starting with different anilines. Anilines are particularly 
good starting materials as they are readily commercially available and cheap.  
 Although 2,4-dichloroquinoline (160) is commercially available, it is quite 
expensive.
149
 This led us to make it ourselves by reacting malonic acid with aniline in 
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Scheme 49. 2,4-Dichloroquinoline Synthesis 
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refluxing phosphorus oxychloride (POCl3). This reaction is a one-pot, two-step reaction 
where the two reagents initially condense to form the intermediate 4-hydroxyquinolinone 
and then react with POCl3 to produce the 2,4-dichloroquinoline as shown in Scheme 49. 
 A large number of anilines were ultimately subjected to this reaction with the 
desire of synthesizing sterically and electronically different BAM catalysts. As 
experience with this reaction increased, several improvements were made to the reaction 
conditions and work-up procedure. Initially, column chromatography was used to isolate 
the quinoline after aqueous work-up. This aqueous work-up featured a dichloromethane 
extraction of the aqueous mixture that often resulted in emulsions and subsequently the 
use of large amounts of dichloromethane. It was found that after quenching the reaction 
by pouring onto ice and adjusting the pH of the solution with conc. aq. NaOH, a filterable 
crude solid resulted that contained the desired quinoline. Soxhlet extraction with hexanes 
was eventually implemented to isolate the quinoline from this crude solid without 
chromatography.
150
  In most cases, this soxhlet extract was sufficiently pure to carry on to 
the next step. The vast majority of these reactions were performed only once, so the 
yields shown are unoptimized, and modest to low yields were observed. Regardless, this 
is a convenient reaction as isolation of the intermediate hydroxyquinolinone is 
unnecessary. Inexpensive and robust starting materials are used, allowing these reactions 
to be run on relatively large scale. Thus, the material produced from each reaction was 
always more than enough to carry on to the next step of the catalyst synthesis. 
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 The results for the synthesis of 15 different 2,4-dichloroquinoline derivatives are 
shown in Table 46. All these reactions were on a reasonable scale and produced a 
considerable amount of product even with the lower yielding reactions. The best results 
came with electron-rich anilines (entries 1-7, 10, and 12). Anilines containing alkoxy 
substituents at the ortho-position fared particularly poorly. Electron-poor anilines (entries 
13-15) also failed to produce the corresponding quinolines in high yield. 
Table 46. 2,4-Dichloroquinoline Library Synthesis 
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 Another consideration must be made for entries 10 and 12 (Table 46) where two 
regioisomeric products are possible. In these cases, complete selectivity was observed for 
the desired 6,7-isomers as none of the 5,6-isomers were observed by NMR. Two other 
anilines did not offer this selectivity as a mixture of two quinolines was obtained. 3,4-
Dimethylaniline and 3-methoxyaniline each produced a mixture of regioisomers (Scheme 
50) but with relatively good yield (54%).
151
 Although some separation of the 
regioisomers occurred with column chromatography, recrystallization was ultimately 
necessary to isolate the desired 6,7- (160d) and 7- (160b) isomers.  
 With hydroxyquinolinone 164 in hand as it was previously synthesized in the 
group, this 2,4-dichloroquinoline 160i was made in one step in 55% yield. 
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Scheme 50. Regioisomeric Distribution Observed with Anilines Lacking a Plane of Symmetry 
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 These 2,4-dichloroquinolines proved to be uniformly good substrates for the 
Buchwald-Hartwig amination reaction.
152
 The success of this reaction relies upon the 
selectivity for reaction at the 2-position of the quinoline and subsequent inertness of the 
product to further reaction. If amination occurs at the 4-position of the quinoline, 
undesired compound 165 would be formed. Furthermore, compound 166 could be formed 
if the desired product undergoes reaction to aminate another molecule of quinoline. 
Production of this triarylated product was observed by Buchwald when he used 
diaminocyclohexane as a substrate.
153
 If either of the pathways is operational, this 
synthetic strategy may not be useful because of low yields or purification problems. 
Luckily, neither of these pathways appear to be prevalent as no significant byproducts 
like 165 or 166 are observed. 
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Scheme 51. Reactivity Control in Buchwald-Hartwig Amination of 2,4-Dichloroquinoline 
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Table 47. Synthesis of 
4
Cl-BisAMidines 
 
148 
  A variety of different thermal conditions were used in the development of this 4-
Cl BisAMidine library, but very similar catalyst and reagent conditions were used across 
the scope. Some reactions were heated conventionally in an oil bath (60-90 °C) with 
toluene as the solvent while others were heated in a microwave (100-120 °C) with 
trifluorotoluene as the solvent. Both methods produced generally good yields for the 
reaction. The microwave protocol offers the advantage of very short reaction times (10-
20 min vs. 1-6 h for conventional). Eventually, the conventional heating method was used 
simply for uniformity. Pd(dba)2 was used as the palladium source, BINAP was used as 
the phosphine ligand, and NaO
t
Bu was the base chosen. Once again, the vast majority of 
these reactions were performed once, therefore they are likely not under optimal 
conditions. The results of these reactions are shown in Table 47.  
 This reaction was shown to be remarkably general with relatively good yields 
with most substrates. Electron-rich (entries 2-14) and electron-deficient quinolines 
(entries 15-16) were tolerated, and the presence of steric bulk at carbons 5-8 did not 
adversely affect yields. In most cases, simple column chromatography was sufficient to 
purify the product. In some cases, a simple solvent rinse of the crude product provided 
sufficiently pure product. Sixteen different 
4
Cl BisAMidines were ultimately synthesized. 
It is noteworthy that the employment of a single Pd source (Pd(dba)2) and phosphine 
ligand (BINAP) was sufficient for each of these reactions. Variations in these two 
reagents are oftentimes necessary for the success of these reactions, but we did not have 
to optimize this aspect of the reaction.
152
 
 The last reaction to arrive at the 
4
Pyrrolidine BisAMidine catalysts is a simple 
nucleophilic aromatic substitution of the aryl chloride by pyrrolidine. This was achieved 
149 
using microwave conditions by heating the 
4
Cl substrate in the presence of excess 
pyrrolidine. This proved to be an easy, robust method to make these catalysts. 
 The results of this reaction using sixteen different 
4
Cl precursors are displayed in 
Table 48. Heating the substrates to 180-230 °C with excess pyrrolidine in trifluorotoluene 
led to a range of yields (unoptimized). The reaction tolerated a variety of sterically and 
electronically different 
4
ClBAM substrates. All of the products were purified by column 
chromatography, then washed with aqueous base to remove any residual acid from the 
catalyst. One obvious optimization of this process that could be implemented is a non-
chromatographic purification. These compounds are quite polar, and a solvent system of 
2-10% methanol in dichloromethane with 0.5% acetic acid must be employed. The 
addition of acetic acid seems to help alleviate the streaking that occurs as these 
compounds elute. It is very difficult to get many of these compounds to completely elute 
from the column. It is likely that this is a major source of product loss in this process, as 
oftentimes the crude NMR spectra look quite clean. The possibility of recrystallization is 
discussed in the next section. 
150 
 The reaction yielding highly stereoselective catalysts 76f and 76m did suffer from 
the production of one major identifiable byproduct. After column chromatography, some 
of the fractions containing the desired product contained another compound. The loss of 
C2 symmetry and absence of a methyl singlet (
1
H NMR) combined with a mass spectrum 
indicating a M+H of 553 (
8
MeOPBAM, 76f = 567) verified 167 as the byproduct. This 
demethylation (compound 168) was also observed (
1
H NMR and mass spec confirmed) in 
the synthesis of 76m.  
Table 48. Synthesis of 
4
Pyrrolidine BisAMidine Catalyst Library 
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This is obviously a source of product loss with this reaction and could potentially 
be detrimental to the synthesis of other methoxy substituted catalysts. Mechanistically, 
this demethylation of the desired product could be the result of chloride ion attack on the 
methoxide (Scheme 52). Hydrochloric acid is produced as a byproduct of this reaction 
and forms a salt with pyrrolidine (used in excess). This source of chloride ion could serve 
to promote an SN2 attack of the methyl group leaving the corresponding phenol. The use 
of silver to scavenge free chloride ions could be an effective strategy to shut down this 
undesired reaction.  
Conversely, conditions for this demethylation could be optimized to produce 
8
HydroxyPBAM (169), which is potentially useful as a catalyst or a precursor to other 
interesting BAM compounds. Williamson ether synthesis of 169 could provide 
macrocyclic catalysts of general structure 170 (eq 99). Catalysts of this type would 
provide useful information about the role of conformational freedom and its relationship 
to enantioselection in PBAM catalyzed reactions.  
Scheme 52. Potential Mechanism for Demethylation of 
8
MeOPBAM 
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These microwave conditions also permitted other amines to be smoothly coupled 
to 
4
ClBAM to make the corresponding 4-amino catalysts. These results are displayed in 
Table 49. Various amines were used in excess at 200-240 °C for 10 to 60 minutes to give 
good to modest yields. 
5.3 Development of an Organic Syntheses Preparation of PBAM 
 The success of PBAM as a catalyst in many different reactions described in 
previous parts of this document made clear the need to provide a reliable, convenient 
synthesis protocol to the scientific community. We already had a fairly robust process in 
place, but we needed to scale-up the reactions and simplify the work-up. 
 
Table 49. Synthesis of 4-Amino BAM Catalysts 
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 Although 2,4-dichloroquinoline is commercially available, its cost is too high to 
use as a starting material,
149
 so we chose to make it ourselves. There are many procedures 
available in the literature to make this compound from aniline, malonic acid, and 
phosphorus oxychloride. Our procedure most resembles the protocol of Jones
154
 and has 
evolved over time to facilitate our growing need for this compound.  
 Some care has to be taken with the use of POCl3 as a reagent in this reaction, as it 
reacts violently with water. Also, this reagent produces HCl gas upon reaction so an HCl 
trap must be connected to the system to trap the HCl gas liberated. On two occasions, 
difficulties were encountered. In one incident, a condenser cracked in the middle of the 
reaction pouring water into the hot POCl3, resulting in an eruption. In another incident, 
water was siphoned into the reaction from the attached HCl trap due to reduced pressure 
formation in the system. The first mishap was quite unavoidable. The second was easily 
avoided in future reactions as continual positive pressure (nitrogen) was placed on the 
system. 
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 A general depiction of our 2,4-dichloroquinoline set-up is shown in Figure 36. 
Initially, malonic acid is dispensed into a 3-neck round bottom flask with a stir bar. 
POCl3 is added to the flask and the suspension is chilled to 0 °C. The apparatus is fully 
constructed and a slight flow of nitrogen is placed into the system. Aniline is added to the 
stirring suspension via syringe (usually over 5-10 minutes). After addition, the reaction 
mixture was heated to ~110 °C and stirring continued for 4-8 hours. 
 Initially, our workup consisted of pouring the cooled reaction mixture onto 
crushed ice, adjusting the pH to basic, then extracting with dichloromethane. 
Unavoidable emulsions usually resulted from this. Eventually, we bypassed this 
extraction and simply poured the reaction mixture onto ice, adjusting the pH to basic with 
aqueous sodium hydroxide, and filtering the resulting suspension. We originally purified 
the crude solid by column chromatography before we came to the realization that a solid-
liquid extraction was possible. Ultimately, this filtered red solid was soxhlet extracted 
Figure 36. Schematic of 2,4-Dichloroquinoline Set-up 
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with hexanes to obtain a sufficiently pure product without the necessity of column 
chromatography. 
 One major issue of scale-up with this reaction is the large volume of ice/water 
needed to quench the large volumes of POCl3 used. This caused us to run the reaction 
under as concentrated conditions as possible to reduce these volumes and lessen the 
inconvenience of dealing with such volumes. The concentration was increased from 1.3 
M to 2.5 M for these large scale reactions without a drop in yield or addition of other 
complications. The reaction mixture was significantly more viscous which necessitated a 
pouring of the reaction mixture onto ice (carefully) while it was still warm. If it was 
allowed to cool, it would congeal and require copious amounts of water and solvent to 
transfer from the reaction flask for quenching. 
 The results of four large scale syntheses of 2,4-dichloroquinoline (160) are shown 
in Table 50. Although the yields are low, we were able to make up to 44.6 g of 
sufficiently pure quinoline without column chromatography in one batch. With the 
increased concentration, only 300 mL of POCl3 was used in the 750 mmol reaction 
resulting in less than 1.5 L of aqueous solution created in workup. The use of aqueous 
NaOH to adjust the pH to basic was also beneficial in reducing workup volume. 
Table 50. Large Scale Syntheses of 2,4-Dichloroquinoline 
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 The crude material obtained from soxhlet extraction with hexanes was very pure 
by 
1
H NMR and was acceptably pure for the next step of the synthesis. For additional 
purity, the compound was recrystallized from toluene/hexanes or ether/hexanes. Only a 
small difference in melting points was observed between crude material (62-63 °C), 
recrystallized material (63.5-64.0 °C), and chromatographed material (64.0-64.5 °C). 
 The yields are quite low but match what is seen in the literature with similar 
reactions. The process can be viewed as two reactions in one pot as discussed earlier. 
Furthermore, the reaction uses very cheap starting materials. Aniline can be purchased for 
$22 per kg. Malonic acid is available for $153 per kg, and POCl3 is available for $70 per 
kg.
155
 The cost of reagents for this reaction is approximately $16 dollars on the 250 mmol 
scale. Increasing the concentration to 2.5 M effectively cut this cost in half. Despite the 
low yields, we still find this to be the easiest and cheapest way to make this compound. 
This reliable route to our starting material quinoline allowed us to scale up the next 
reaction of the sequence. 
As the Buchwald-Hartwig amination was repeatedly performed on increasing 
larger scales over the last four years, the work-up procedures were gradually optimized. 
Initially, 
4
ClBAM was purified by column chromatography. This became more difficult 
as the scale of the reaction was increased. The main problem was the difficulty of 
dissolving the crude product with dichloromethane to load onto the column. At some 
point, the sparingly soluble ashy white solid from the crude product was analyzed by 
1
H 
NMR. This solid was found to be sufficiently pure. This washed solid was taken through 
and no difference was observed from the column purified 
4
ClBAM. Shortly after this 
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observation, washing the crude solid with small amounts of solvent (CH2Cl2 was found to 
be a sufficient solvent) supplanted column chromatography as the purification method. 
 With this knowledge, an Organic Syntheses preparation in terms of style and scale 
seemed appropriate. The two major challenges for this reaction would be obtaining 
equitable results on multi-gram scale and the development of a reliable, non-
chromatographic work-up. There were no major problems encountered when running this 
reaction on a scale to produce over 4 grams of 
4
ClBAM. No changes needed to be made 
in terms of relative amounts of reagents and reaction conditions. There was some 
optimization of reaction concentration. It seemed likely that the product could precipitate 
out of the reaction mixture owing to its general insolubility. This would be beneficial as 
our work-up could be simplified to a simple filtration and washings of the obtained solid 
on the filter.  
The first generation of the 
4
ClBAM synthesis was run under dilute conditions 
(0.08 M in toluene) to produce 1.8 grams (54%) on a 7.6 mmol scale after column 
chromatography. With our initial attempts at 14.3 mmol scale, the concentration was 
increased to 0.41 M in toluene.
156
 This turned out to be just right as the product did 
indeed precipitate. After five or ten minutes of heating and stirring (stir bar) at 80 °C, the 
reaction mixture became unstirrable. Manual swirling of the flask by hand broke up this 
solid, and stirring was able to continue for the duration of the reaction. 
 After 1.5 hours of heating at 80 °C, little to no starting material was observed by 
thin layer chromatography. The reaction mixture was allowed to cool to room 
temperature. A mild aqueous acid (NH4Cl) was added to the flask to quench any 
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remaining sodium tert-butoxide. The resulting suspension was then chilled in an ice bath 
to influence any additional product to precipitate. 
 A simple filtration through a Buchner funnel left a considerable amount of a light 
yellow solid which was washed on the filter with water (50 mL) and then hexanes (150 
mL). This solid, found to be sufficiently pure by 
1
H NMR, amounted to 4.18 grams 
(68%) on the first attempt. Satisfied with this result, we repeated this exact procedure 
several times with multiple sets of hands.
157
 The results of these trials are shown in Table 
51. Three chemists executed the procedure to give 4.10-4.77 grams of desired compound 
92 in 65-76% yield. With good yields and reproducibility established, we moved on to 
the scale-up and optimization of the final step of the synthesis. 
 The microwave-assisted nucleophilic aromatic substitution was found to be a 
simple, high-yielding reaction without any optimization. These conditions (20 equiv. 
pyrrolidine in PhCF3 at 200 °C for 3.5 h) produced 635 mg of 76 (92%) on a 1.37 mmol 
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Table 51. Reproducibility of the Organic Synthesis Procedure for 
4
Cl BAM 
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scale. Even though the reaction was very high yielding, the chromatographic purification 
of PBAM was very inconvenient. PBAM is a quite polar compound, and it binds strongly 
to silica gel. What results is a very “streaky” column where copious amounts of solvent 
(methanol and dichloromethane) must be used to flush the desired compound off the 
column. The addition of a small amount of acetic acid to the eluent did somewhat lessen 
this problem, but this was still a major issue in terms of developing a robust procedure on 
an appreciable scale. 
 Initially, adjustments had to be made in consideration of the capacity of our 
microwave system. We were limited to the volume we could fit into one 10-20 mL vial, 
the maximum vessel size for our microwave system. The equivalents of pyrrolidine were 
reduced from 20 to 4. The amount of solvent was also reduced resulting in a very 
concentrated reaction (1.5 M). This concentration allowed us to run the reaction in one 
microwave batch. Fortunately, equitable results were obtained under these conditions. 
With the first trial, 4.51 g (94%) of crude product was observed on a 9.6 mmol scale. A 
simple base wash (aqueous NaOH) followed by water washes yielded material that was 
acceptably pure by 
1
H NMR. This process was quite reproducible in terms of yield, but a 
consistent, true melting point could not be found. This indicated the need for a better 
method for purification.  
160 
 Despite the inability to obtain a melting point, other issues existed. It was quite 
difficult to remove solvent completely from the compound. Although the amounts varied 
from run to run, a significant amount of triflourotoluene and sometimes pyrrolidine was 
still seen after subjection to high vacuum.  The results of seven different trials are shown 
in Table 52. The inability to completely remove solvent was seen with the solvent 
inflated yields of trials 4 through 7. In each case, the only noticeable impurities seen by 
crude NMR were trifluorotoluene, pyrrolidine and to a lesser extent, dichloromethane. It 
appeared that the only reproducibility issue was the removal of these volatile impurities. 
The use of a drying pistol (refluxing toluene) to thoroughly remove this residual solvent 
was fairly successful, but a trace of these impurities could still be seen by 
1
H NMR after 
rigorous drying for a few days. Furthermore, the increased purity of the compound from 
the drying did not result in a consistent melting point.  
 Shortly after the initial synthesis of PBAM (76), single crystals of the catalyst 
were grown. Two crystal structures of the free base were obtained from crystals grown 
Table 52. Reproducibility Study of PBAM Synthesis 
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from acetone and nitromethane. Each crystal structure had a molecule of the 
corresponding solvent in the crystal lattice. This served as a hint that acetone might be a 
good choice for a recrystallization solvent. Indeed, the catalyst did recrystallize from 
acetone. A myriad of other solvents and solvent combinations of ethyl acetate, diethyl 
ether, dichloromethane, ethanol, acetonitrile, hexanes, and toluene among others failed to 
produce crystals. 
 Although PBAM did recrystallize from acetone, it was difficult to reproduce 
consistently. The main problem was that the compound was quite insoluble in acetone. 
Oftentimes so much acetone was required to dissolve the material that the solution was 
too dilute to produce crystals upon cooling. Even when crystals were formed, the 
recovery was quite low. Through these recrystallization attempts and other experiences 
handling the compound, toluene was found to be the best solvent for dissolving PBAM 
by far. This led to the use of an acetone/toluene mixture for recrystallization as acetone 
would provide the proper medium for crystal growth and toluene could help solvate the 
compound. A 90:10 mixture of acetone/toluene was ultimately found to be the best 
solvent. 
 The resulting crystals were washed with cold acetone and placed under high 
vacuum to remove the solvent. The crystalline material was found to be exceptionally 
pure by 
1
H NMR with the exception of the presence of about one equivalent of acetone. 
Drying in a drying pistol was found to be necessary to remove the acetone. Furthermore, 
it was deemed necessary to pulverize the solid after partial drying to aid the complete 
evaporation of the residual solvent. Upon evaporation of the acetone, the solid changed 
from a light bronze color to nearly white. A consistent melting point of 242.5-244.0 °C 
162 
was observed. It appeared some decomposition occurred as the material turned to a light 
brown when heated above 200 °C. Still, a discreet melting happened at 242.5-244.0 °C. 
Additionally, the material was found to be exceptionally pure by elemental analysis.  
  Very similar results for this last optimized step of the PBAM synthesis were 
obtained by two chemists demonstrating reproducibility. Amounts of 3.12 and 3.35 grams 
were produced in two experiments, corresponding to 63% and 67% yield respectively. In 
each case, identical melting points were obtained. Also, it was demonstrated that the 
mother liquor could be concentrated and resubjected to the recrystallization procedure to 
give an additional 800 mg of product raising the overall yield of the step to 81-85%. 
 We have developed a practical, reproducible, large-scale protocol for the 
synthesis of PBAM in 3 steps. This protocol is most likely translatable to other 
derivatives of PBAM as well. This procedure has been submitted for review to Organic 
Syntheses and will provide the scientific community the means to synthesize this 
compound.
158
 This should help others to use the reactions developed in this group for 
various applications as well as encourage the development of new methodologies using 
PBAM. 
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5.4 Synthesis of Non-C2-Symmetric BAM Ligands 
 
 The synthesis of non-C2-symmetric BAM ligands is more difficult than that of C2-
symmetric BAM ligands. The structures 100, 98, and 99 in Figure 37 are more Brønsted 
basic versions of effective catalyst motifs. The most straightforward route to the 
compounds is a Buchwald-Hartwig type amination with two different aryl halide 
coupling components. 
 This direct route was attempted in the synthesis of 171 from cyclohexane 
diamine, 2,4-dichloroquinoline (160), and 3-bromoquinoline (eq 100). 160 was added 
first until consumption of that quinoline, then 3-bromoquinoline was added. The desired 
compound (171) was isolated after column chromatography, but the yield was low and 
the material was not appreciably pure. An effort to isolate the monoarylated diamine also 
failed. Although 3-bromoquinoline is commercially available, the precursor aryl 
bromides to make 98 and 99 are not. A more robust route to this class of catalysts was 
needed.  
Figure 37. Desired Non-C2-Symmetric BAM Ligands 
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 The use of a mono-protected cyclohexane diamine is a strategy that has been 
successfully used previously in this group. Despite the increase in the number of steps 
needed to access the desired catalysts, this route has the advantages of associated with a 
common intermediate. Cyclohexane diamine is treated with phthalic anhydride in the 
presence of tosic acid to yield the protected acid salt (eq 101). This salt is then treated 
with base to liberate the free protected diamine 172 in good yield. It is convenient to 
leave this stored as the tosic acid salt until ready to use.  
 Next, singly protected diamine 172 was subjected to a Buchwald-Hartwig 
amination reaction with 2,4-dichloroquinoline 160 (eq 102). Several initial attempts at 
this reaction failed. This reaction was sluggish as compared to the amination reactions 
involving the unprotected diamine. Also, sodium tert-butoxide competitively added to the 
quinoline to give 174 as a byproduct. Changing the palladium source from Pd(dba)2 to 
Pd(OAc)2 did not improve the reaction. JohnPhos was used in place of BINAP as a 
phosphine ligand but also did not improve this reaction. Although changing the base to 
K3PO4 was futile, reducing the equivalents of NaO
t
Bu from 3 to 1 while using a slight 
 
 
165 
excess of amine 172 (1.2 equivalents) did effectively limit the formation 174. After a 
reaction time of 43 hours at 90 °C, nearly a gram of 173 was produced in 57% yield. 
 173 was then deprotected cleanly by treatment with hydrazine hydrate in 
refluxing ethanol for one hour (eq 103). This produced free amine 175, a common 
intermediate towards all three desired non-C2-symmetric catalysts, in 80% yield. 
Reaction of this free amine 175 with 3-bromoquinoline under Buchwald-Hartwig 
amination produced aryl chloride 171, albeit in low yield (eq 171). This material was then 
heated with pyrrolidine in the microwave to produce 50 mg of catalyst 100 in 65% yield. 
 The other two targets 98 and 99 required preparation of the halopyridine substrate 
for the amination reaction. A Suzuki coupling would be used to make both of these 
halopyridines. 
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 Following a route previously developed in this group, boronic acid 177 was made 
from anthracene in two steps (eq 105). 9-Bromoanthracene 176 is made from an 
electrophilic aromatic substitution of anthracene with N-bromosuccinimide in good yield. 
Metallation of 176 followed by a quench with trimethylborate gives boronic acid 177 
upon aqueous acid workup. Anthracene is produced as a major byproduct of this reaction, 
and its reproducibility was generally troublesome. Ultimately, Mark Dobish found that 
concentration of the crude material in the presence of acid led to the decomposition of the 
boronic acid to anthracene. He has reported consistently higher yields with this reaction 
now using a recrystallization-purification protocol. 
  A Suzuki coupling between 2,6-dibromopyridine and boronic acid 177 was used 
to produce bromopyridine 178 (eq 106). This suffered from competitive formation of 
anthracene as well. Diarylated pyridine 179 and 9-hydroxypyridine were major undesired 
products from the reaction. After column chromatography, the desired compound was 
isolated as a nearly 1:1 mixture with starting material dibromopyridine. Recrystallization 
provided pure desired bromopyridine 178 in 16% yield with significant material left in 
the mother liquor.  
 
167 
 Similarly, commercially available bromomesitylene was converted to the 
corresponding boronic acid en route to catalyst 99 (eq 107). Following a modified 
procedure
159
, 2-bromomesitylene was metallated and then treated with trimethylborate to 
produce 1.4 g of boronic acid 180 in 21% yield following washing with EtOAc and 
hexanes. The majority of the mass balance was the diarylboronic acid (181) which was 
produced in a 57:43 ratio to the desired product. Adding an excess of trimethylborate 
quickly (instead of dropwise) had no effect on product distribution.  
 Again, 2,6-dibromopyridine was coupled to boronic acid 180 (eq 108). This 
reaction was attempted twice as the first reaction suffered from the formation of phenol 
184. In the first reaction, a satisfactory ratio of desired product 182 to diarylated product 
183 of 5:1 was observed. The second attempt incorporated freeze-pump-thaw cycles to 
ensure no oxygen was in the system.
160
 This strategy did somewhat minimize the 
formation of the undesired phenol as the ratio of the product to the phenol increased from 
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 Morgan, J.; Pinhey, J. T. J. Chem. Soc. Perkin Trans. I 1990, 715-720. 
160
 Zhang, H.; Tse, M. K.; Chan, K. S. Synth. Comm. 2001, 31, 1129 - 1139. 
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nearly 2:1 to 3:1. Still, the formation of the diarylated product was prevalent and only a 
26% yield of 182 resulted. 
 The Buchwald-Hartwig reaction smoothly produced 
4
Cl bisamidine 185 (eq 109). 
This compound was reacted with pyrrolidine under microwave conditions to produce 301 
mg of the desired catalyst (98) in 75% yield in over two steps.  
 The same sequence was used to make catalyst 99 (eq 110). The Buchwald-
Hartwig coupling between bromopyridine 182 and amine 175 produced 
4
Cl bisamidine 
186 in fair yield (45%). Aromatic substitution of 186 with pyrrolidine produced 106 mg 
of desired catalyst 99 in excellent yield (99%). 
 Overall, sufficient material was produced to test these catalysts performance 
despite the low yield observed for their preparation. Despite the increased difficulty in 
synthesis, the ability to make non-C2-symmetric catalysts allows access to a larger library 
of structural motifs. These catalysts may allow for better reactivity and selectivity than 
C2-symmetric ligands in future investigations. 
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CHAPTER VI 
 
NEW MECHANISTIC INSIGHT 
 
 Much of the information available about the mechanism of the BAM-catalyzed 
aza-Henry reaction was obtained at the very beginning of the chiral proton catalysis 
program. Most of this work involved the establishment of key structural elements of the 
BAM catalyst for the aza-Henry reaction of aliphatic nitroalkanes and silyl nitronates. 
These elements have been incorporated in the structure of PBAM, a highly 
enantioselective catalyst that has promoted a broader range of reactions. Although there 
are likely mechanistic similarities between the BAM-catalyzed addition of aliphatic 
nitroalkanes and aryl nitroalkanes, important differences exist with the addition of the 
latter species. These unique aspects warrant individual mechanistic consideration for this 
reaction. 
170 
 The free base of PBAM is more enantioselective than its triflic acid salt in nearly 
all cases in the phenynitromethane addition reaction. Conversely, the free base is 
substantially less enantioselective in the aliphatic nitroalkane additions. It is likely that 
the in situ formed nitronate salt of the catalyst is functioning as a chiral Brønsted acid in 
this reaction. This presents interesting mechanistic scenarios. 
There lies the possibility that two molecules of catalyst are involved in the 
transition state. A non-linear effect study was performed on the p-chloro 
phenylnitromethane addition to p-chloro aryl N-Boc imine to address this possibility. If 
two molecules of catalyst are involved in the transition state, a positive or negative non-
linear effect could result from differences in energies of the diastereomeric transition 
Figure 38. Non-linear Effect Study 
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states.
161
 Six different batches of PBAM with varying optical purity were used and the 
results are shown in Figure 38. No significant deviation from linearity was observed with 
this reaction. Although it is still possible for multiple catalyst molecules to be involved in 
the transition state, this study failed to provide evidence for that scenario. 
 As discussed briefly earlier, a stereochemical model (shown again in Figure 39) 
has been developed to explain the stereochemical outcome of these BAM catalyzed 
reactions. This model has not been disclosed in a publication to this point due to fact that 
it is constructed from many circumstantial trends and observations. Nevertheless, this 
model does incorporate many key findings made in early catalyst development. 1) It 
explains the increase in stereoselectivity observed with a larger quinoline system versus 
the smaller pyridine system. 2) It incorporates the bidenticity that is suggested by the 
necessity of the catalyst possessing two quinoline rings. 3) It allows for hydrogen 
bonding of the cyclohexyl N-H with the carbonyl of the imine electrophile which 
explains the importance of the presence of the cyclohexyl N-H. 
  Another piece of evidence that supports this model is the performance of 
H,
2
(
7,8
benzoQuin)-BAM (95) in the phenylnitromethane addition reaction. This catalyst 
bears resemblance to the helical chiral amidine catalyst used by Takenaka to promote 
                                                 
161
 Satyanarayana, T.; Abraham, S.; Kagan, H. B. Angew. Chem. Int. Ed. 2009, 48, 456-494. 
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enantioselective additions of 4,7-dihydroindoles to nitroalkenes.
162
 This catalyst 
promoted the formation of completely racemic product, seemingly an indication that the 
usual binding pocket was completely disrupted and a totally different, non-selective 
pathway was being accessed. This is in agreement with the model in Figure 39 as steric 
bulk near the 8-position of the quinoline would occupy the docking area of the imine. 
 Although this model is consistent with many of the observed trends, there are 
other possibilities that have not yet been disproven. The only bidentate hydrogen bonding 
that has been suggested by crystallographic evidence is an intramolecular hydrogen bond 
between the quinoline nitrogen and the N-H of the opposite cyclohexylamine. Even 
though a solid state structure has limited direct applicability to the transition state 
complex, this crystal structure can at least suggest a low energy conformation that might 
also exist in solution. This intramolecular hydrogen bond has been observed in multiple 
crystal structures of different BAM catalysts.  
 Two different X-ray crystal structures of PBAM were obtained from single 
crystals grown in nitromethane and acetone. The two structures are displayed in Figure 
40. Both structures are overall remarkably similar. Each features an intramolecular 
                                                 
162
 Takenaka, N.; Chen, J.; Captain, B.; Sarangthem, R. S.; Chandrakumar, A. J. Am. Chem. Soc. 2010, 132, 
4536-4537. 
Figure 39. Previous Model for Stereoselectivity in BAM Catalyzed aza-Henry Reaction 
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hydrogen bond between the N-H of the cyclohexyl diamine and the opposing quinoline 
N. The N-H---N distances of 2.134 Å and 1.963 Å for the nitromethane and acetone 
crystal respectively suggest a medium-strong H-bond.
163
,
164
 
 These structures are similar to the crystal structure obtained for 
H,QuinBAM·HOTf (Figure 41). This triflic acid salt (as opposed to the structures of the 
free base of PBAM) possesses a comparable hydrogen bond between the cyclohexyl N-H 
and the opposing quinoline as the N-H---N distance is 1.818 Å. The protonated quinoline 
ring is swung out and is hydrogen bonded to the triflate counterion. Although the 
conformation in solution cannot be inferred from a solid state structure, the crystal 
                                                 
163
 Steiner, T. Angew. Chem. Int. Ed. 2002, 41, 48-76. 
164
 Jeffrey, G. A. An Introduction to Hydrogen Bonding; Oxford University Press: Oxford, 1997. 
Figure 40. X-ray Crystal Structure of PBAM with Nitromethane and Acetone 
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structures obtained for different BAM catalysts provide an alternative intramolecular 
hydrogen-bonded catalyst for consideration relative to that illustrated in Figure 39. 
  
 Despite the data (eq 111) that suggested substitution at the 8-position of the BAM 
catalysts detrimentally changes the transition state, this position was still considered a 
location where beneficial changes could be made owing to its distance to the binding site. 
To this point, a series of 8-substituted PBAM catalysts were synthesized to explore 
potential differences in reactivity and stereoselectivity. In contrast to H,
2
(
7,8
benzoQuin)-
BAM, these catalysts offered similar and sometimes better enantioselectivity than PBAM 
in the phenylnitromethane aza-Henry reaction (Tables 33, 38-40, Figure 30).  
These results offer strong evidence that the model in Figure 39 is not operational 
for this reaction. The Chem3D figure shows the imine docked perpendicularly to the 
quinoline ring to which it is associating through hydrogen bonding. Bonding in this space 
would be impossible with the 8-alkoxy substituted PBAM catalysts which have proven to 
be the most enantioselective for this reaction. It is likely that PBAM and the 8-alkoxy 
substituted PBAM catalysts are operating through a similar mechanism, one that is not 
similar to Figure 39. Furthermore, a bidentate hydrogen bond between the two quinolines 
Figure 41. X-ray Crystal Structure of H,QuinBAM·HOTf 
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would be highly sterically disfavored with the 8-substituted PBAM catalysts. On the 
basis of these trends, the stereochemical model akin to Figure 41 is advance as an 
alternative to that in Figure 39. 
 A study was performed to measure the relative reactivity of PBAM and PBAM 
derivatives in the phenylnitromethane addition reaction. This was inspired by the yields 
in Table 39 and Table 40 which suggest that 8-alkyl substituted catalysts are significantly 
less reactive then other PBAM derivatives. The key discovery of two addition products 
that were appreciably stable to gas chromatography conditions (all other products 
screened decomposed mainly due to the retro-aza-Henry reaction) allowed for the 
Figure 42. Catalyst Reactivity Study, Phenylnitromethane Addition Reaction 
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reaction to be conveniently monitored by comparison of the starting material imine to an 
internal standard. The addition products of the most electron-deficient imines (
o
CF3, 86l 
and 
p
CF3, 86q) both produced only a small amount of retro product (2-5%) under GC 
conditions. The 
o
CF3 product was chosen to ensure homogeneity in the reaction as this 
compound was relatively soluble in toluene. Furthermore, the ortho- substitution renders 
this imine relatively less reactive which should accentuate reactivity differences of the 
catalysts.  
 The results of this study are plotted in Figure 43. PBAM was found to be the most 
reactive catalyst under these conditions. The more electron-rich and presumably more 
Brønsted basic 
6,7
(MeO)2PBAM was found to be less reactive than PBAM. This was 
somewhat unexpected as the increased reactivity of PBAM appeared to be due to its 
increased Brønsted basicity. 
8
EtOPBAM was only marginally less reactive than 
6,7
(MeO)2PBAM, which was also surprising due to the increased steric bulk near the 
binding site.  
Figure 43. Plot of Imine Concentration vs. Time, Phenylnitromethane Addition Reaction 
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 Remarkably, 
8
EtPBAM was drastically less reactive than the other three catalysts. 
Five days of reaction were required to achieve 50% conversion compared to 
approximately 1 and 2 hours respectively for PBAM and the alkoxy-substituted PBAM 
catalysts.
165
 This decreased reactivity for 
8
EtPBAM could easily be explained by the 
presence of steric bulk in the vicinity of the binding site of the catalyst, but the similarly 
sterically encumbered 
8
EtOPBAM does not exhibit this low reactivity. It is possible that 
the oxygen atom is sufficiently small compared to the methylene to not substantially 
hinder substrate binding. A comparison of the A-values
166
 of an ethoxy group versus an 
ethyl group (0.89 versus 2.09 kcal/mol, respectively
167
) suggests that these groups may be 
effectively different in terms of sterics. The observed reactivity trend, particularly the 
lower reactivity of 
6,7
(MeO)2PBAM relative to PBAM, might also suggest a beneficial 
local electronic effect of the oxygen of 
8
EtOPBAM.  
 Products from the reactions monitored by GC were isolated by column 
chromatography and analyzed by chiral HPLC. Similar diastereo- and enantioselectivities 
(16-22:1 dr and 58-66% ee) were observed (Figure 42) for PBAM, 
6,7
(MeO)2PBAM, and  
8
EtOPBAM. Substantially lower enantioselection (20% ee) was observed with 
8
EtPBAM.  
The absence of a background rate suggests that a less enantioselective pathway is being 
accessed. It is likely that the imine is binding in a different way to the catalyst because 
the typical PBAM transition state is too crowded due to the bulky imine. This less 
enantioselective pathway is not accessed with the more reactive catalysts.  
                                                 
165
 No detectable background (non-PBAM catalyzed) reaction occurred under these conditions. A reaction 
without catalyst yielded no product (GC) after 10 days. 
166
 Hirsch, J. A. In Topics in Stereochemistry; John Wiley & Sons, Inc.: 2007, p 199-222. 
167
 Noyce, D. S.; Dolby, L. J. J. Org. Chem. 1961, 26, 3619-3626. 
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 In another reaction involving a less sterically hindered imine, PBAM and its 8-
alkoxy and 8-alkyl derivatives provided similar stereoselectivities (Table 38, Table 40). 
These common stereochemical outcomes offer strong evidence that each catalyst is 
utilizing a similar transition state. Although the reaction rate is severely retarded with 
8
EtPBAM, the steric nature of this catalyst does not seem to prevent a common transition 
state from being accessed with this less sterically hindered imine. 
 The most likely affected mechanistic step is imine binding. The sterics imparted 
by the ethyl group at the 8-position crowd the binding site which likely discourages imine 
binding. However, once imine is bound to the chiral proton, the reaction could proceed 
through the same transition state as less sterically hindered catalysts. 
8
EtOPBAM should 
have similar crowding near the imine binding site, but hydrogen bonding between the 
oxygen and the chiral proton could serve to orient the alkyl chain away from the binding 
site. This should lessen the entropic burden of that chain and render the chiral proton 
more available to bind to the imine. 
 Another possible advantage of the alkoxy group at the 8- position is the 
participation of that oxygen in an intramolecular hydrogen bond (Figure 44) with the 
cyclohexyl N-H. As shown in the displayed crystal structures (Figure 40 and Figure 41), 
a hydrogen bond exists between the quinoline and the opposing cyclohexyl N-H. The low 
Figure 44. Binding Considerations of 
8
EtOPBAM and 
8
EtPBAM Catalysts 
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energy conformation implied by the crystal structures places the oxygen of 
8
EtOPBAM 
close enough to the opposing N-H for hydrogen bonding. This additional hydrogen 
bonding may rigidify the catalyst structure and increase the concentration of catalyst in a 
reactive conformation. 
 The use of a PBAM derivative with a hydroxy group at the 8-position could 
provide evidence supporting this hypothesis. The presumed reactivity consequence of 
substitution at the 8-position of the catalyst should be greatly diminished. The ability for 
that oxygen to hydrogen bond with the opposing cyclohexyl N-H should be increased due 
to decreased steric strain. Compounds 167 and 168 (eq 98) have been synthesized but not 
completely isolated as a byproduct in the synthesis of corresponding PBAM catalysts. It 
is possible that these catalysts could exhibit even higher reactivity than PBAM. Further 
demethylation of 167 could produce 
8
(OH)PBAM, which might also be a more reactive 
catalyst. 
 At this point, there is not enough data to generate a new stereochemical model for 
this reaction. Still, recently obtained information has increased our understanding of the 
mechanism of this reaction. The interesting trends observed may not be fully explained 
currently, but their discovery will likely lead to more fruitful experiments. The 
development of a monitorable reaction by GC could allow for a complete kinetic study 
which could reveal the molecularity of this reaction. Further elucidation of the 
mechanism should inspire future catalyst design and aid the discovery of new 
enantioselective reactions with BAM catalysts. 
  
  
180 
CHAPTER VII 
 
EXPERIMENTAL 
 
All reagents and solvents were commercial grade and purified prior to use when 
necessary. The following reagents were used as supplied by Sigma-Aldrich without 
further purification: nitroethane, 1-nitropropane, 2-nitropropane, and 1-nitrobutane. 2-
methyl-1-nitropropane and (nitromethyl)cyclohexane were prepared using the Kornblum 
procedure.
168
 Aldimines were prepared as reported in the literature.
169
 Toluene was dried 
by passage through a column of activated alumina as described by Grubbs
170
. Thin layer 
chromatography (TLC) was performed using glass-backed silica gel (250 μm) plates and 
flash chromatography utilized 230–400 mesh silica gel from Sorbent Technologies. UV 
light, and/or the use of potassium iodoplatinate and potassium permanganate solutions 
were used to visualize products. 
Nuclear magnetic resonance spectra (NMR) were acquired on a Bruker DRX-500 
(500 MHz), Bruker AV-400 (400 MHz) or Bruker AV II-600 (600 MHz) instrument. 
Chemical shifts are measured relative to residual solvent peaks as an internal standard set 
to δ 7.26 and δ 77.0 (CDCl3). IR spectra were recorded on a Thermo Nicolet IR100 
spectrophotometer and are reported in wavenumbers (cm
-1
). Compounds were analyzed 
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as neat films on a NaCl plate (transmission). Mass spectra were recorded on a Waters 
LCT spectrometer by use of the ionization method noted.  
Gas Chromatography (GC) was performed on a Varian CP-3800 gas 
chromatograph equipped with flame ionization detectors. The column used was a WCOT 
fused silica column with CP-Sil 5 CB stationary phase (15 m x 0.25 mm). The following 
settings were used: flow = 2.0 mL/min, oven = 1 min at 60 °C, to 220 °C at 10°C/min, 2 
min at 220 °C; detector =  300 °C, injector = 200 °C. 
Absolute and relative configurations of 77, 77b-77r, 79, and 117 were assigned 
by analogy to a chemically correlated product.
171
 Absolute and relative configurations of 
86-86f, 86h-86v and 101-101g were assigned by analogy to the crystal structure obtained 
for 86g. 
 
H,
6
Me-BAM (73c). Pd(dba)2
 
(10.1 mg, 17.5 μmol), rac-BINAP (21.8 mg, 35.0 μmol), 
and sodium tert-butoxide (286.4 mg, 2.98 mmol) were loaded into a round bottom flask 
in a glove box. Toluene (10 mL, 0.10M) was added to the mixture, followed by (R,R)-
diaminocyclohexane (100.0 mg, 876.0 μmol). 2-Bromo-6-methylpyridine (301.5 mg, 
1.75 mmol) was added as a solution in toluene. The reaction was allowed to stir at 80 °C 
and monitored by TLC. The reaction was then cooled to room temperature, concentrated, 
and purified by flash column chromatography on silica gel (5% triethylamine, 10% ethyl 
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acetate in hexanes) affording a white solid (200 mg, 77%). [α] 20
D
 +110 (c 0.10, CHCl3); 
mp 126-128 °C; Rf = 0.17 (5% Et3N, 10% EtOAc/hexanes); IR (neat) 3256, 3051, 2927, 
2855, 1559 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.19 (dd, J = 8.0, 8.0 Hz, 2H), 6.35 (d, J 
= 7.2 Hz, 2H), 6.11 (d, J = 8.4 Hz, 2H), 5.16 (br s, 2H), 3.73-3.64 (m, 2H), 2.37 (s, 6H), 
2.27-2.18 (m, 2H), 1.78-1.65 (m, 2H), 1.50-1.28 (m, 4H); 
13
C NMR (100 MHz, CDCl3) 
ppm 158.2, 156.5, 137.3, 111.3, 104.2, 55.0, 32.1, 24.4, 24.3; HRMS (EI) Exact mass 
calcd for C18H24N4
 
[M]
+
 296.2001, found 296.1994. 
 
PBAM (76).
172
  A 10-20 mL microwave vial was charged with the corresponding 
4
ClQuinBAM (600 mg, 1.37 mmol), pyrrolidine (2.24 mL, 27.3 mmol), and 
trifluoromethylbenzene (9 mL). This suspension was heated at 200 °C and stirred in the 
microwave for 3.5 h. The reaction was then concentrated and purified by column 
chromatography (5-10-20% methanol in dichloromethane) to provide a light brown solid. 
This material was dissolved in dichloromethane and then washed with 3M NaOH. The 
combined organic layers were dried over sodium sulfate and concentrated. The material 
was then triturated with hexanes to afford a light brown powder (635 mg, 92%); mp 
243.0-245.0; [α] 20D  +406 (c 1.2, CHCl3); Rf = 0.38 (10% MeOH/CH2Cl2 with 0.5% acetic 
acid); IR (film) 3259, 3056, 2927, 2855, 2935, 1591, 1529 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.87 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.40 (dd, J = 7.2, 7.2 Hz, 
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2H), 7.01 (dd, J = 7.2, 7.2 Hz, 2H), 5.70 (br s, 2H), 5.28 (s, 2H), 4.09 (br s, 2H), 3.35-
3.22 (m, 4H), 3.16-3.05 (m, 4H), 2.37-2.23 (m, 2H), 1.90-1.75 (m, 10H), 1.58-1.37 (m, 
4H); 
13
C NMR (100 MHz, CDCl3) ppm 158.4, 153.2, 149.9, 128.3, 126.4, 124.7, 119.1, 
118.7, 93.0, 56.3, 51.5, 33.4, 25.5, 25.1; HRMS (ESI): Exact mass calcd for 
C32H39N6[M+H]
+
 507.3236, found 507.3250. Anal. calcd for C32H38N6: C, 75.85; H, 
7.56; N, 16.59. Found: C, 75.80; H, 7.72; N, 16.45. PBAM purified by column 
chromatography has been stable upon storage in a screw cap vial on the benchtop for 
several years without sign of decomposition. 
 
PBAM·HOTf (76·HOTf). To a flame-dried vial with stir bar was added 
H,
4
PyrrolidineQuin-BAM (286.3 mg, 565.1 μmol) and dichloromethane (2 mL). 
Trifluoromethanesulfonic acid (50.0 μL, 565 μmol) was added dropwise to the stirring 
solution at room temperature. The reaction mixture was allowed to stir an additional 10 
minutes before concentration to a light brown solid that was used without further 
purification. Other catalyst acid salts were made in a similar fashion. 
 
7
MeOPBAM (76b). A 2-5 mL microwave vial was charged with the corresponding 
4
ClBAM (200 mg, 402 μmol), pyrrolidine (660 μL, 8.041 mmol), and 
trifluoromethylbenzene (2 mL). This suspension was heated at 220 °C and stirred in the 
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microwave for 20 min. The reaction was then concentrated and purified by column 
chromatography (5-10% methanol in dichloromethane) to provide a light brown solid. 
This material was dissolved in dichloromethane and then washed with 3 M aq NaOH. 
The combined organic layers were dried over MgSO4 and concentrated to afford a light 
brown powder (123.5 mg, 54%); [α] 20
D
 +480 (c 0.13, CHCl3); Rf = 0.39 (10% 
MeOH/CH2Cl2); IR (film) 3253, 2930, 2855, 1616, 1589, 1526 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) δ 7.76 (d, J = 9.0 Hz, 2H), 7.09 (s, 2H), 6.65 (dd, J = 9.5, 2.5 Hz, 2H), 5.77 
(br s, 2H), 5.23 (s, 2H), 4.04 (br s, 2H), 3.88 (s, 6H), 3.35-3.25 (m, 4H), 3.20-3.10 (m, 
4H), 2.33-2.25 (m, 2H), 1.90-1.78 (m, 10H), 1.55-1.35 (m, 4H); 
13
C NMR (125 MHz, 
CDCl3) ppm 159.9, 158.6, 153.2, 151.5, 125.9, 112.7, 110.4, 105.8, 90.7, 56.3, 55.2, 
51.5, 33.3, 25.6, 25.0; HRMS (ESI): Exact mass calcd for C34H43N6O2 [M+H]
+
 567.3447, 
found 567.3467. 
 
5,7
(Me)2PBAM (76c). A 2-5 mL microwave vial was charged with the corresponding 
4
ClBAM (150.0 mg, 304.0 μmol), pyrrolidine (500 μL, 6.08 mmol), and 
trifluoromethylbenzene (2 mL). This suspension was heated at 200 °C and stirred in the 
microwave for 3.5 h. The reaction was then concentrated and purified by column 
chromatography (2-8% methanol in dichloromethane w/ 0.5% AcOH) to afford a light 
brown powder (158.7 mg, 93%). mp 126.0-128.0 °C; [α] 20D  +423 (c 1.04, CHCl3); Rf = 
 
185 
0.31 (10% MeOH/0.5% AcOH/CH2Cl2); IR (film) 3249, 2930, 2856, 1598, 1539 cm
-1
;
 1
H 
NMR (400 MHz, CDCl3, 325 K) δ 7.33 (s, 2H), 6.73 (s, 2H), 5.82 (br s, 2H), 5.66 (s, 
2H), 4.10-3.98 (m, 2H), 3.00-2.76 (br m, 4H), 2.76-2.55 (br m, 4H), 2.66 (s, 6H), 2.38 (s, 
6H), 2.36-2.26 (m, 2H), 1.90-1.70 (m, 10H), 1.55-1.35 (m, 4H); 
13
C NMR (150 MHz, 
CDCl3) ppm 157.5, 155.8, 150.5, 137.7, 134.3, 126.2, 123.6, 117.7, 97.6, 56.3, 51.8, 
33.2, 25.0, 23.4, 21.1, 20.7; HRMS (ESI): Exact mass calcd for C36H47N6 [M+H]
+
 
563.3862, found 563.3868. 
 
6,7
(MeO)2PBAM (76e). A 2-5 mL microwave vial was charged with the corresponding 
4
ClBAM (1.000 g, 1.794 mmol) and pyrrolidine (2.9 mL, 36 mmol). This suspension was 
heated at 180 °C and stirred in the microwave for 40 min. The reaction was then 
concentrated and purified by column chromatography (2-5-10% methanol in 
dichloromethane with 1% AcOH) to provide a light brown solid. This material was 
dissolved in dichloromethane and then washed with 3 M aq NaOH. The combined 
organic layers were dried over MgSO4 and concentrated. The material was then triturated 
with hexanes to afford a light brown viscous foam (351.1 mg, 31%); [α] 20
D
 +340 (c 0.11, 
CHCl3);  Rf = 0.22 (10% MeOH/1% AcOH/CH2Cl2); IR (film) 3391, 2931, 2855, 1593 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.24 (s, 2H), 7.10 (s, 2H), 5.51 (br s, 2H), 5.37 (s, 
2H), 3.99 (br s, 2H), 3.99 (s, 6H), 3.89 (s, 6H), 3.37-3.26 (m, 4H), 3.23-3.13 (m, 4H), 
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2.35-2.25 (m, 2H), 1.91-1.79 (m, 10H), 1.52-1.38 (m, 4H); 
13
C NMR (100 MHz, CDCl3) 
ppm 157.6, 152.8, 150.7, 146.0, 143.5, 111.7, 106.5, 105.2, 91.9, 56.3, 55.8, 55.5, 51.2, 
33.3, 25.3, 25.0; HRMS (CI): Exact mass calcd for C36H47N6O4 [M+H]
+
 627.3653, found 
627.3658. 
 
8
MeOPBAM (76f). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (200.0 mg, 402.1 μmol), pyrrolidine (132 μL, 1.61 mmol), and 
trifluoromethylbenzene (1.2 mL). This suspension was heated at 180 °C and stirred in the 
microwave for 30 min. The reaction mixture was purified by column chromatography (2-
5% methanol in dichloromethane with 0.5% AcOH) to provide a light brown solid. This 
material was dissolved in dichloromethane and then washed with 3 M aq NaOH. The 
combined organic layers were dried over MgSO4 and concentrated. The resulting solid 
was dissolved in EtOAc and washed with water, dried over MgSO4, filtered, and 
concentrated to a light brown solid (108.4 mg, 48%). [α] 20D  +320 (c 0.14, CHCl3); Rf = 
0.24 (10% MeOH/CH2Cl2); IR (film) 3244, 2933, 2857, 1637, 1593 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.49 (d, J = 8.4 Hz, 2H), 6.93 (dd, J = 7.6, 7.6 Hz, 2H), 6.88 (d, J = 7.2 
Hz, 2H), 5.78 (br s, 2H), 5.52 (br s, 2H), 4.10-4.00 (m, 2H), 4.00 (s, 6H), 3.41-3.29 (m, 
4H), 3.28-3.15 (m, 4H), 2.40-2.27 (m, 2H), 1.90-1.73 (m, 8H), 1.73-1.65 (m, 2H), 1.60-
1.40 (m, 4H); 
13
C NMR (150 MHz, CDCl3, 325 K) ppm 157.5, 153.8, 153.7, 141.6, 
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119.5, 118.5, 117.3, 109.0, 93.3, 56.5, 56.3, 51.7, 33.1, 25.4, 24.9; HRMS (ESI): Exact 
mass calcd for C34H43N6O2 [M+H]
+
 567.3448, found 567.3431. 
 
6
MeOPBAM (76g). A 2-5 mL microwave vial was charged with the corresponding 
4
ClBAM (200 mg, 402 μmol), pyrrolidine (660 μL, 8.041 mmol), and 
trifluoromethylbenzene (2 mL). This suspension was heated at 220 °C and stirred in the 
microwave for 20 min. The reaction was then concentrated and purified by column 
chromatography (5-10% methanol in dichloromethane) to provide a light brown solid. 
This material was dissolved in dichloromethane and then washed with 3 M aq NaOH. 
The combined organic layers were dried over MgSO4 and concentrated to afford a light 
brown powder (174.4 mg, 77%); [α] 20
D
 +350 (c 0.14, CHCl3); Rf = 0.29 (10% 
MeOH/CH2Cl2); IR (film) 3261, 2930, 2856, 1595, 1531 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.61 (d, J = 9.2 Hz, 2H), 7.27 (d, J = 2.8 Hz, 2H), 7.11 (dd, J = 8.8, 2.8 Hz, 
2H), 5.57 (br s, 2H), 5.35 (s, 2H), 4.03 (br s, 2H), 3.82 (s, 6H), 3.32-3.20 (m, 4H), 3.15-
3.05 (m, 4H), 2.32-2.25 (m, 2H), 1.90-1.75 (m, 10H), 1.50-1.30 (m, 4H); 
13
C NMR (100 
MHz, CDCl3) ppm 157.3, 153.0, 152.8, 144.8, 127.5, 118.9, 118.4, 106.0, 94.0, 56.4, 
55.6, 51.4, 33.4, 25.4, 25.1; HRMS (ESI): Exact mass calcd for C34H43N6O2 [M+H]
+
 
567.3448, found 567.3442. 
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6
MePBAM (76h). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (300.0 mg, 644.6 μmol), pyrrolidine (212 μL, 2.58 mmol), and 
trifluoromethylbenzene (1.3 mL). This suspension was heated at 200 °C and stirred in the 
microwave for 2.5 h. The reaction mixture was purified by column chromatography (2-
5% methanol in dichloromethane with 0.5% AcOH) to provide a light brown solid. This 
material was dissolved in dichloromethane and then washed with 3 M aq NaOH. The 
combined organic layers were dried over MgSO4 and concentrated. The resulting solid 
was dissolved in EtOAc and washed with water, dried over MgSO4, filtered, and 
concentrated to a light brown solid (158.3 mg, 46%). [α] 20D  +370 (c 0.13, CHCl3); Rf = 
0.35 (10% MeOH/CH2Cl2); IR (film) 3253, 2927, 2857, 1591, 1531 cm
-1
;
 1
H NMR (600 
MHz, CDCl3) δ 7.64 (s, 2H), 7.56 (d, J = 8.4 Hz, 2H), 7.24 (dd, J = 8.4, 1.6 Hz, 2H), 5.56 
(br s, 2H), 5.28 (s, 2H), 4.11-4.01 (m, 2H), 3.31-3.21 (m, 4H), 3.12-3.02 (m, 4H), 2.39 (s, 
6H), 2.33-2.23 (m, 2H), 1.90-1.75 (m, 10H), 1.55-1.35 (m, 4H); 
13
C NMR (150 MHz, 
CDCl3) ppm  158.0, 153.1, 148.0, 130.0, 128.3, 126.2, 124.1, 118.6, 93.5, 56.3, 51.5, 
33.4, 25.4, 25.1, 21.5; HRMS (ESI): Exact mass calcd for C34H43N6 [M+H]
+
 535.3549, 
found 535.3538. 
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8
MePBAM (76i). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (400.0 mg, 859.4 μmol), pyrrolidine (420 μL, 5.2 mmol), and 
trifluoromethylbenzene (1.3 mL). This suspension was heated at 200 °C and stirred in the 
microwave for 60 min. The reaction mixture was purified by column chromatography (3-
10% methanol in dichloromethane with 0.5% AcOH) to provide a light brown solid. This 
material was dissolved in dichloromethane and then washed with 3 M aq NaOH. The 
combined organic layers were dried over MgSO4 and concentrated. The resulting solid 
was dissolved in EtOAc and washed with water, dried over MgSO4, filtered, and 
concentrated to a light brown solid (249.8 mg, 54%). [α] 20D  +340 (c 0.10, CHCl3); Rf = 
0.42 (10% MeOH/CH2Cl2); IR (film) 3263, 2926, 2856, 1592, 1531 cm
-1
;
 1
H NMR (600 
MHz, CDCl3) δ 7.76 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 6.6 Hz, 2H), 6.94 (dd, J = 7.8, 7.2 
Hz, 2H), 5.79 (br s, 2H), 5.42 (s, 2H), 4.15-4.05 (m, 2H), 3.38-3.28 (m, 4H), 3.25-3.15 
(m, 4H), 2.70 (s, 6H), 2.46-2.36 (m, 2H), 1.92-1.70 (m, 10H), 1.55-1.45 (m, 2H), 1.45-
1.35 (m, 2H); 
13
C NMR (150 MHz, CDCl3) ppm 157.4, 154.0, 148.5, 133.7, 128.7, 122.6, 
118.6, 118.2, 92.8, 56.9, 51.7, 33.4, 25.5, 25.3, 18.9; HRMS (ESI): Exact mass calcd for 
C34H43N6 [M+H]
+
 535.3549, found 535.3529. 
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8
EtOPBAM (76j). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (350.0 mg, 666.1 μmol), pyrrolidine (330 μL, 3.996 mmol), and 
trifluoromethylbenzene (650 μL). This suspension was heated at 180 °C and stirred in the 
microwave for 10 min. The reaction was then concentrated and purified by column 
chromatography (0-4% methanol in dichloromethane w/ 0.5% AcOH). This material was 
dissolved in dichloromethane and then washed with 3 M aq NaOH. The combined 
organic layers were dried over MgSO4 and concentrated to afford a light brown powder 
(306.6 mg, 77%). mp 120.0-122.0 °C; [α] 20D  +354 (c 1.02, CHCl3); Rf = 0.17 (10% 
MeOH/0.5% AcOH/CH2Cl2); IR (film) 3237, 3062, 2973, 2929, 2867, 1593, 1540 cm
-1
;
 
1
H NMR (400 MHz, CDCl3) δ 7.49 (dd, J = 4.8,4.8 Hz, 2H), 6.93-6.87 (m, 4H), 6.17 (br 
s, 2H), 5.54 (s, 2H), 4.32-4.14 (m, 4H), 4.12-3.98 (m, 2H), 3.40-3.25 (m, 4H), 3.25-3.12 
(m, 4H), 2.43-2.30 (m, 2H), 1.90-1.75 (m, 10 H), 1.54 (t, J = 7.2 Hz, 6H), 1.50-1.35 (m, 
4H); 
13
C NMR (100 MHz, CDCl3) ppm 157.3, 153.5, 152.8, 141.6, 119.4, 118.4, 117.5, 
110.8, 93.1, 64.9, 56.5, 51.6, 33.2, 25.4, 25.0, 15.0; HRMS (CI): Exact mass calcd for 
C36H47N6O2 [M+H]
+
 595.3755, found 595.3760. 
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8
EtPBAM (76k). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (200.0 mg, 405.3 μmol), pyrrolidine (333 μL, 4.05 mmol), and 
trifluoromethylbenzene (300 μL). This suspension was heated at 200 °C and stirred in the 
microwave for 40 min. The reaction was then concentrated and purified by column 
chromatography (0-5% methanol in dichloromethane w/ 0.5% AcOH). This material was 
dissolved in dichloromethane and then washed with 3 M aq NaOH. The combined 
organic layers were dried over MgSO4 and concentrated to afford a light brown powder 
(165.6 mg, 73%). mp 83.0-85.0 °C; [α] 20D  +417 (c 1.00, CHCl3); Rf = 0.21 (10% 
MeOH/0.5% AcOH/CH2Cl2); IR (film) 3265, 2928, 2866, 1592, 1528 cm
-1
;
 1
H NMR 
(400 MHz, CDCl3) δ 7.76 (dd, J = 8.4, 1.2 Hz, 2H), 7.33 (d, J = 6.8 Hz, 2H), 6.99 (dd, J 
= 8.4, 7.2 Hz, 2H), 5.64 (br s, 2H), 5.45 (s, 2H), 4.15-4.05 (m, 2H), 3.35-3.18 (m, 10H), 
3.12 (dq, J = 14.4, 7.2 Hz, 2H), 2.47-2.37 (m, 2H), 1.92-1.80 (m, 10 H), 1.54-1.46 (m, 
2H), 1.46-1.35 (m, 2H), 1.40 (t, J = 7.6 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 
157.3, 154.1, 147.9, 139.6, 127.1, 122.6, 118.8, 118.4, 92.9, 56.8, 51.8, 33.6, 25.5, 25.4, 
25.3, 14.8; HRMS (CI): Exact mass calcd for C36H47N6 [M+H]
+
 563.3857, found 
563.3865. 
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7,8
(Me)2PBAM (76l). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (200.0 mg, 405.3 μmol), pyrrolidine (333 μL, 4.05 mmol), and 
trifluoromethylbenzene (500 μL). This suspension was heated at 200 °C and stirred in the 
microwave for 40 min. The reaction was then concentrated and purified by column 
chromatography (0-5% methanol in dichloromethane w/ 0.5% AcOH). This material was 
dissolved in dichloromethane and then washed with 3 M aq NaOH. The combined 
organic layers were dried over MgSO4 and concentrated to afford a light brown solid 
(164.4 mg, 72%). Mp 115.5-117.5 °C; [α] 20D  +403 (c 1.18, CHCl3); Rf = 0.21 (10% 
MeOH/0.5% AcOH/CH2Cl2); IR (film) 3257, 2927, 2858, 1595, 1530 cm
-1
;
 1
H NMR 
(400 MHz, CDCl3) δ 7.65 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.4 Hz, 2H), 5.80 (br s, 2H), 
5.38 (s, 2H), 4.15-4.04 (m, 2H), 3.36-3.26 (m, 4H), 3.24-3.14 (m, 4H), 2.68 (s, 6H), 2.50-
2.40 (m, 2H), 2.42 (s, 6H), 1.92-1.78 (m, 10H), 1.55-1.46 (m, 2H), 1.46-1.35 (m, 2H); 
13
C NMR (100 MHz, CDCl3) ppm 157.4, 154.0, 148.3, 135.9, 131.1, 121.6, 121.5, 116.6, 
92.1, 56.9, 51.7, 33.5, 25.5, 25.3, 20.5, 13.8; HRMS (ESI): Exact mass calcd for 
C36H47N6 [M+H]
+
 563.3862, found 563.3839. 
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6,8
(MeO)2PBAM (76m). A 0.5-2.0 mL microwave vial was charged with the 
corresponding 
4
ClBAM (125.0 mg, 224.2 μmol), pyrrolidine (200 μL, 2.44 mmol), and 
trifluoromethylbenzene (600 μL). This suspension was heated at 180 °C and stirred in the 
microwave for 10 min. The reaction was then concentrated and purified by column 
chromatography (0-10% methanol in dichloromethane) to provide a light brown solid. 
This material was dissolved in dichloromethane and then washed with 3 M aq NaOH. 
The combined organic layers were dried over MgSO4 and concentrated to afford a 
brown/red powder (100.9 mg, 72%). mp 112.0-114.0 °C; [α] 20D  +274 (c 1.03, CHCl3); Rf 
= 0.14 (10% MeOH/0.5% AcOH/CH2Cl2); IR (film) 3257, 2930, 2858, 1607, 1538 cm
-1
;
 
1
H NMR (400 MHz, CDCl3) δ 6.83 (d, J = 2.4 Hz, 2H), 6.58 (d, J = 2.4 Hz, 2H), 5.71 (br 
s, 2H), 5.60 (s, 2H), 4.05-3.92 (m, 2H), 3.97 (s, 2H), 3.82 (s, 6H), 3.34-3.23 (m, 2H), 
3.23-3.12 (m, 4H), 2.35-2.24 (m, 2H), 1.93-1.82 (m, 8H), 1.82-1.74 (m, 2H), 1.55-1.35 
(m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 156.5, 154.4, 153.6, 152.6, 136.7, 119.0, 
100.2, 96.8, 94.4, 56.3, 56.2, 55.3, 51.6, 33.1, 25.4, 24.9; HRMS (CI): Exact mass calcd 
for C36H46N6O4 [M]
+
 626.3575, found 626.3550. 
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6,8
(Me)2PBAM (76n). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (200.0 mg, 405.3 μmol), pyrrolidine (300 μL, 3.63 mmol), and 
trifluoromethylbenzene (600 μL). This suspension was heated at 180 °C and stirred in the 
microwave for 30 min. The reaction was then concentrated and purified by column 
chromatography (0-5% methanol in dichloromethane). This material was dissolved in 
dichloromethane and then washed with 3 M aq NaOH. The combined organic layers were 
dried over MgSO4 and concentrated to afford a light brown powder (119.3 mg, 52%). mp 
122.5-124.5 °C; [α] 20D  +304 (c 1.06, CHCl3); Rf = 0.20 (10% MeOH/0.5% 
AcOH/CH2Cl2); IR (film) 3263, 2925, 2859, 1591, 1527 cm
-1
;
 1
H NMR (600 MHz, 
CDCl3) δ 7.53 (s, 2H), 7.18 (s, 2H), 5.76 (br s, 2H), 5.43 (s, 2H), 4.14-4.02 (m, 2H), 3.36-
3.26 (m, 4H), 3.25-3.14 (m, 4H), 2.67 (s, 6H), 2.45-2.35 (m, 2H), 2.38 (s, 6H), 1.92-1.80 
(m, 10 H), 1.55-1.35 (m, 4H); 
13
C NMR (150 MHz, CDCl3) ppm 156.9, 153.8, 146.5, 
133.4, 130.6, 127.6, 121.9, 118.1, 93.2, 56.9, 51.7, 33.3, 25.4, 25.2, 21.5, 18.7; HRMS 
(CI): Exact mass calcd for C36H47N6 [M+H]
+
 563.3857, found 563.3845. 
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6
CF3PBAM (76o). A 0.2-0.5 mL microwave vial was charged with the corresponding 
4
ClBAM (150.0 mg, 261.6 μmol), pyrrolidine (122 μL, 1.49 mmol), and 
trifluoromethylbenzene (122 μL). This suspension was heated at 200 °C and stirred in the 
microwave for 10 min. The reaction was then concentrated and purified by column 
chromatography (0-5% methanol in dichloromethane w/ 0.5% AcOH). This material was 
dissolved in dichloromethane and then washed with 3 M aq NaOH. The combined 
organic layers were dried over MgSO4 and concentrated to afford a yellow/brown solid 
(145.6 mg, 87%). mp 229.0-231.0 °C; [α] 20D  +278 (c 1.01, CHCl3); Rf = 0.44 (10% 
MeOH/0.5% AcOH/CH2Cl2); IR (film) 3222, 2933, 2856, 1586 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 8.16 (s, 2H), 7.67 (d, J = 8.8 Hz, 2H), 7.57 (d, J = 8.8 Hz, 2H), 5.57 (br s, 
2H), 5.19 (s, 2H), 4.20-4.05 (m, 2H), 3.40-3.20 (m, 4H), 3.15-3.00 (m, 4H), 2.32-2.20 
(m, 2H), 1.95-1.80 (m, 10H), 1.55-1.35 (m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 
159.5, 153.0, 151.8, 126.8, 124.9 (q, 
1
JCF = 270 Hz), 124.4, 122.7, 120.5 (q, 
2
JCF = 32.0 
Hz), 117.5, 92.8, 56.3, 51.6, 33.2, 25.6, 25.1;
 19
F NMR (282 MHz, CDCl3) ppm -59.3; 
HRMS (CI): Exact mass calcd for C34H37F6N6 [M+H]
+
 643.2978, found 643.2976. 
 
General Procedure for the Synthesis of Adducts 77-77r, 79. To a flame-dried vial with 
stir bar was added imine (100 μmol), PBAM2(HOTf)3 (7.3 mg, 10 μmol), toluene (100 
μL). The reaction mixture was then cooled to -20 °C before nitroalkane (150 μmol) was 
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added, and then stirred at -20 °C for 24 h. The solution was then filtered while cold 
through a pad of silica gel using CH2Cl2 and EtOAc.  
 
 
 
tert-Butyl (1R,2S)-2-nitro-1-ortho-tolylpropylcarbamate (77b). The imine (21.9 mg, 
100 µmol) was treated with nitroethane according to the general procedure. The reaction 
was stirred for 24 h and concentrated to a colorless solid determined to be 11:1 dr by GC 
(major diastereomer: tr = 12.60 min, minor diastereomer: tr = 12.24 min).  Flash column 
chromatography (SiO2, 8-25% ethyl acetate in hexanes) yielded the addition product as a 
colorless solid (19.4 mg, 66%); the major diastereomer was determined to be 90% ee by 
chiral HPLC analysis (Chiralcel IA, 3% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) = 15.2 
min, tr(anti, minor) = 12.5 min, tr(syn, major) = 14.4 min, tr(syn, minor) = 19.2 min); mp 
80.0-82.0 °C; Rf = 0.41 (20% EtOAc/hexanes); IR (film) 3339, 2978, 2918, 1702, 1553 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.25-7.15 (m, 4H), 5.57 (br s, 1H), 4.98 (br s, 1H), 
4.89 (br s, 1H), 2.45 (s, 3H), 1.61 (d, J = 6.8 Hz, 3H), 1.42 (s, 9H); 
13
C NMR (100 MHz, 
CDCl3) ppm 154.9, 136.3, 135.7, 131.2, 128.4, 126.6, 124.9, 85.1, 80.5, 53.0, 28.2, 19.4, 
15.5; HRMS (ESI): Exact mass calcd for C15H22N2NaO4 [M+Na]
+
 317.1477, found 
317.1481. 
tert-Butyl (1R,2S)-1-(3,4-dimethoxyphenyl)-2-nitropropylcarbamate (77d). The imine 
(26.5 mg, 100 µmol) was treated with nitroethane according to the general procedure. 
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The reaction was stirred for 23 h and concentrated to a colorless solid determined to be 
20:1 dr by GC (major diastereomer: tr = 15.49 min, minor diastereomer: tr = 15.22 min).  
Flash column chromatography (SiO2, 20-30% ethyl acetate in hexanes) yielded the 
addition product as a colorless solid (27.7 mg, 80%); the major diastereomer was 
determined to be 90% ee by chiral HPLC analysis (Chiralcel IA, 10% 
i
PrOH/hexanes, 1 
mL/min, tr(anti, major) = 14.0 min, tr(anti, minor) = 17.2 min, tr(syn, major) = 15.0 min, 
tr(syn, minor) = 26.1 min); mp 142.0-143.0 °C; [α]
20
D  -25.0 (c 1.6, CHCl3); Rf = 0.24 
(30% EtOAc/hexanes); IR (film) 3361, 2977, 2936, 1694, 1551, 1516 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 6.81-6.72 (m, 3H), 5.35 (br s, 1H), 5.09 (m, 1H), 4.89 (br s, 1H), 
3.82 (s, 6H), 1.51 (d, J = 6.8 Hz, 3H), 1.40 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 
154.9, 149.1 (2C), 128.9, 118.4, 111.2, 110.1, 85.8, 80.3, 57.2, 55.83, 55.75, 28.1, 15.4; 
HRMS (ESI): Exact mass calcd for C16H24N2NaO6 [M+Na]
+
 363.1532, found 363.1514. 
tert-Butyl (1R,2S)-1-(naphthalen-1-yl)-2-nitropropylcarbamate (77e). The imine (25.5 
mg, 100 µmol) was treated with nitroethane according to the general procedure. The 
reaction was stirred for 23 h and concentrated to a colorless oil determined to be 8:1 dr by 
GC (major diastereomer: tr = 15.85 min, minor diastereomer: tr = 16.18 min). Flash 
column chromatography (SiO2, 8-20% ethyl acetate in hexanes) yielded the addition 
product as a colorless solid (31.9 mg, 97%); the major diastereomer was determined to be 
87% ee by chiral HPLC analysis (Chiralcel IA, 5% 
i
PrOH/hexanes, 1 mL/min, tr(anti, 
major) = 15.0 min, tr(anti, minor) = 13.4 min, tr(syn, major) = 17.1 min, tr(syn, minor) = 
19.0 min); Rf = 0.73 (40% EtOAc/hexanes); IR (film) 3347, 3052, 2979, 2933, 1701 cm
-
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1
; 
1
H NMR (400 MHz, CDCl3) δ 8.26 (d, J = 8.4 Hz, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.84 
(d, J = 8.8 Hz, 1H), 7.64 (dd, J = 7.2, 7.2 Hz, 1H), 7.55 (dd, J = 7.6, 7.3 Hz, 1H), 7.48-
7.40 (m, 2H), 6.31 (dd, J = 8.8, 6.0 Hz, 1H), 5.24 (br s, 1H), 5.15 (br s, 1H), 1.57 (d, J = 
6.0 Hz, 3H), 1.43 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 155.0, 134.0, 133.2, 130.5, 
129.3, 129.1, 127.2, 126.2, 125.1, 123.0, 122.5, 84.4, 80.6, 52.8, 28.2, 14.5; HRMS 
(ESI): Exact mass calcd for C18H22N2O4 [M]
+
 330.1580, found 330.1571. 
 
 
tert-Butyl (1R,2S)-1-(4-fluorophenyl)-2-nitropropylcarbamate (77h). The imine (22.3 
mg, 100 µmol) was treated with nitroethane according to the general procedure. The 
reaction was stirred for 23 h and concentrated to a colorless solid determined to be 26:1 
dr by GC (major diastereomer: tr = 11.88 min, minor diastereomer: tr = 11.58 min). Flash 
column chromatography (SiO2, 8-20% ethyl acetate in hexanes) yielded the addition 
product as a colorless solid (19.6 mg, 66%); the major diastereomer was determined to be 
93% ee by chiral HPLC analysis (Chiralcel IA, 5% 
i
PrOH:hexanes, 1 mL/min, 230 nm, 
tr(anti, major) = 12.6 min, tr(anti, minor) = 12.1 min, tr(syn, major) = 15.6 min, tr(syn, 
minor) = 16.1 min); mp 129.5-130.5 °C; [α] 20D  -18.5 (c 1.3, CHCl3);  Rf = 0.31 (20% 
EtOAc/hexanes); IR (film) 3334, 2980, 2929, 1700, 1553, 1511 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 7.26-7.21 (m, 2H), 7.04 (dd, J = 8.8, 8.4 Hz, 2H), 5.40 (br s, 1H), 5.15 
(dd, J = 8.8, 6.0 Hz, 1H), 4.90 (br s, 1H), 1.53 (d, J = 6.8 Hz, 3H), 1.42 (s, 9H); 
13
C NMR 
(100 MHz, CDCl3) ppm 163.6 (d, 
1
JCF = 246.0 Hz), 154.8, 132.3, 128.6 (d, 
3
JCF = 8.0 
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Hz), 115.9 (d, 
2
JCF = 21.0 Hz), 85.7, 80.7, 56.8, 28.2, 15.3; HRMS (ESI): Exact mass 
calcd for C14H18FN2O4 [M-H]
-
 297.1251, found 297.1250. 
 
 
 
 
Methyl 4-((1R,2S)-1-(tert-butoxycarbonylamino)-2-nitropropyl)benzoate (77i). The 
imine (26.3 mg, 100 µmol) was treated with nitroethane according to the general 
procedure. The reaction was stirred for 23 h and concentrated to a colorless solid 
determined to be 12:1 dr by GC (major diastereomer: tr = 15.69 min, minor diastereomer: 
tr = 15.45 min). Flash column chromatography (SiO2, 8-20% ethyl acetate in hexanes) 
yielded the addition product as a colorless solid (21.2 mg, 63%); the major diastereomer 
was determined to be 91% ee by chiral HPLC analysis (Chiralcel IA, 5% 
i
PrOH:hexanes, 
1 mL/min, 230 nm, tr(anti, major) = 25.5 min, tr(anti, minor) = 30.0 min, tr(syn, major) = 
32.9 min, tr(syn, minor) = 38.2 min); mp 121.0-123.0 °C; Rf = 0.57 (40% 
EtOAc/hexanes); IR (film) 3362, 2980, 1718 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.01 
(d, J = 8.4 Hz, 2H), 7.33 (d, J = 7.6 Hz, 2H), 5.48 (br s, 1H), 5.25 (dd, J = 8.8, 5.6 Hz, 
1H), 4.92 (br s, 1H), 3.90 (s, 3H), 1.52 (d, J = 6.8 Hz, 3H), 1.41 (s, 9H); 
13
C NMR (100 
MHz, CDCl3) ppm 166.4, 154.8, 141.4, 130.4, 130.2, 126.9, 85.4, 80.8, 57.1, 52.2, 28.2, 
15.1; HRMS (ESI): Exact mass calcd for C16H23N2O4 [M+H]
+
 339.1556, found 339.1544. 
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tert-Butyl (1S,2S)-2-nitro-1-(thiophen-2-yl)propylcarbamate (77k). The imine (21.1 
mg, 100 μmol) was treated with nitroethane according to the general procedure. The 
reaction was stirred for 24 h and concentrated to a colorless solid determined to be 20:1 
dr by GC (major diastereomer: tr = 12.06 min, minor diastereomer: tr = 11.66 min). Flash 
column chromatography (SiO2, 8-20% ethyl acetate in hexanes) yielded the addition 
product as a colorless solid (28.6 mg, 100%); the major diastereomer was determined to 
be 95% ee by chiral HPLC analysis (Chiralcel IA, 5%
 
EtOH/hexanes, 1 mL/min, 210 nm, 
tr(anti, major) = 12.7 min, tr(anti, minor) = 12.2 min, tr(syn, major) = 14.2 min, tr(syn, 
minor) = 21.1 min); mp 124.0-127.0 °C; [α] 20D  -38.4 (c 1.2, CHCl3); Rf = 0.32 (20% 
EtOAc/hexanes); IR (film) 3374, 2977, 1689, 1547, 1520 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.26 (m, 1H), 6.96 (m, 2H), 5.48 (dd, J = 9.2, 5.6 Hz, 1H), 5.31 (d, J = 9.2 Hz, 
1H), 4.93 (m, 1H) , 1.58 (d, J = 6.8 Hz, 3H), 1.44 (s, 9H); 
13
C NMR (100 MHz, CDCl3) 
ppm 154.7, 139.1, 127.1, 126.0, 125.6, 85.8, 80.8, 53.3, 28.2, 15.5; HRMS (ESI): Exact 
mass calcd for C12H18N2NaO4S [M+Na]
+
 309.0885, found 309.0903.
 
 
 
 
tert-Butyl (1R,2S)-2-nitro-1-(thiophen-3-yl)propylcarbamate (77l). The imine (21.1 
mg, 100 μmol) was treated with nitroethane according to the general procedure. The 
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reaction was stirred for 24 h and concentrated to a colorless solid determined to be 35:1 
dr by GC (major diastereomer: tr = 12.09 min, minor diastereomer: tr = 11.83 min). Flash 
column chromatography (SiO2, 8-20% ethyl acetate in hexanes) yielded the addition 
product as a colorless solid (26.3 mg, 92%); the major diastereomer was determined to be 
91% ee by chiral HPLC analysis (Chiralcel IA, 5%
 i
PrOH/hexanes, 1 mL/min, 210 nm, 
tr(anti, major) = 12.7 min, tr(anti, minor) = 12.2 min, tr(syn, major) = 14.2 min, tr(syn, 
minor) = 21.1 min); mp 145.5-147.0 °C; [α] 20D  -38.4 (c 1.9, CHCl3); Rf = 0.29 (20% 
EtOAc/hexanes); IR (film) 3376, 3094, 3009, 2978, 2935, 1682, 1545,1524 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.32 (dd, J = 4.8, 2.8 Hz, 1H), 7.19 (br s, 1H), 6.98 (d, J = 4.4 
Hz, 1H), 5.31 (br s, 2H), 4.91 (br s, 1H), 1.52 (d, J = 6.8 Hz, 3H), 1.44 (s, 9H);
 13
C NMR 
(100 MHz, CDCl3) ppm 154.9, 136.9, 126.9, 125.8, 123.0, 85.4, 80.5, 53.5, 28.2, 15.3; 
HRMS (ESI): Exact mass calcd for C12H18N2NaO4S [M+Na]
+
 309.0885, found 309.0893. 
 
 
 
tert-Butyl (1R,2S)-2-nitro-1-(4-(phenylthio)phenyl)propylcarbamate (77m). The 
imine (31.3 mg, 100 µmol) was treated with nitroethane according to the general 
procedure. The reaction was stirred for 24 h and concentrated to a colorless solid (20:1 
dr, 
1
H NMR).  Flash column chromatography (SiO2, 8-20% ethyl acetate in hexanes) 
yielded the addition product as a colorless solid (30.9 mg, 80%); the major diastereomer 
was determined to be 89% ee by chiral HPLC analysis (Chiralcel IA, 5% 
i
PrOH/hexanes, 
1 mL/min, 230 nm, tr(anti, major) = 17.8 min, tr(anti, minor) = 19.3 min, tr(syn, major) = 
22.5 min, tr(syn, minor) = 26.2 min); mp 163.0-165.0 °C; [α]
20
D  -35.0 (c 1.8, CHCl3);  Rf = 
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0.23 (20% EtOAc/hexanes); IR (film) 3376, 2980, 2928, 1680, 1545, 1517 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.42-7.28 (m, 5H), 7.24 (d, J = 7.6 Hz, 2H), 7.14 (d, J = 8.0 
Hz, 2H), 5.31 (br s, 1H), 5.15 (dd, J = 8.8, 6.0 Hz, 1H), 4.89 (br s, 1H), 1.52 (d, J = 6.4 
Hz, 3H), 1.42 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.8, 137.5, 134.6, 134.1, 
132.2, 130.1, 129.4, 127.8, 127.6, 85.6, 80.6, 57.0, 28.2, 15.3; HRMS (ESI): Exact mass 
calcd for C20H24N2NaO4S [M+Na]
+
 411.1354, found 411.1338. 
 
 
 
tert-Butyl (1R,2S)-1-(4-(allyloxy)phenyl)-2-nitropropylcarbamate (77n). The imine 
(26.1 mg, 100 µmol) was treated with nitroethane according to the general procedure. 
The reaction was stirred for 24 h and concentrated to a colorless solid determined to be 
28:1 dr by GC (major diastereomer: tr = 15.49 min, minor diastereomer: tr = 15.27 min). 
Flash column chromatography (SiO2, 8-20% ethyl acetate in hexanes) yielded the 
addition product as a colorless solid (30.6 mg, 91%); the major diastereomer was 
determined to be 89% ee by chiral HPLC analysis (Chiralcel IA, 5% 
i
PrOH/hexanes, 1 
mL/min, 230 nm, tr(anti, major) = 15.8 min, tr(anti, minor) = 17.0 min, tr(syn, major) = 
21.4 min, tr(syn, minor) = 17.8 min); mp 109.0-111.0 °C; [α]
20
D  -30.9 (c 1.1, CHCl3); Rf = 
0.30 (20% EtOAc/hexanes); IR (film) 3376, 2981, 2926, 1681, 1548, 1516 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.14 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 6.03 (dddd, 
J = 17.2, 10.6, 5.3, 5.3 Hz, 1H), 5.39 (dd, J = 17.2, 1.2 Hz, 1H), 5.29 (br s, 1H), 5.28 (dd, 
J = 10.4, 0.8 Hz, 1H), 5.10 (dd, J = 8.4, 6 Hz, 1H), 4.89 (br s, 1H), 4.51 (d, J = 5.2 Hz, 
2H), 1.52 (d, J = 6.8 Hz, 3H), 1.42 (s, 9H); 
13
C NMR (150 MHz, CDCl3) ppm 158.6, 
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154.9, 132.9, 128.5, 128.0, 117.8, 115.0, 85.9, 80.3, 68.7, 56.9, 28.2, 15.4; HRMS (ESI): 
Exact mass calcd for C17H24N2NaO5 [M+Na]
+
 359.1583, found 359.1579. 
 
 
 
tert-Butyl (1R,2S)-1-(4-chlorophenyl)-2-nitrobutylcarbamate (77o). The imine (24.0 
mg, 100 µmol) was treated with 1-nitropropane according to the general procedure but 
using PBAM·HOTf as the catalyst. The reaction was stirred for 21 h and concentrated to 
a colorless solid. Flash column chromatography (SiO2, 20% ethyl acetate in hexanes) 
yielded the addition product as a colorless solid (28.3 mg, 86%) that was determined to 
be 20:1 dr, 91% ee (major diastereomer) by chiral HPLC analysis (Chiralcel AD, 5% 
EtOH/hexanes, 1 mL/min, tr(anti, major) = 9.4 min, tr(anti, minor) = 13.2 min, tr(syn, 
major) = 12.1 min, tr(syn, minor) = 17.0 min); mp 155.5-157.5 °C; [α]
20
D  -35.6 (c 1.4, 
CHCl3); Rf = 0.33 (20% EtOAc/hexanes); IR (film) 3375, 2981, 1677, 1547, 1519, 1495 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 
5.17 (br s, 1H), 5.11 (br s, 1H), 4.71 (br s, 1H), 2.03 (m, 1H), 1.87 (m, 1H), 1.42 (s, 9H), 
0.98 (dd, J = 7.2, 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 154.8, 135.2, 134.6, 
129.1, 128.2, 92.7, 80.8, 56.2, 28.2, 23.5, 10.4; HRMS (ESI): Exact mass calcd for 
C15H20ClN2O4 [M-H]
-
 327.1112, found 327.1118. 
tert-Butyl (1R,2S)-1-(4-chlorophenyl)-2-nitropentylcarbamate (77p). The imine (24.0 
mg, 100 µmol) was treated with 1-nitrobutane according to the general procedure but 
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using PBAM ·HOTf as the catalyst. The reaction was stirred for 21 h and concentrated to 
a colorless solid. Flash column chromatography (SiO2, 20% ethyl acetate in hexanes) 
yielded the addition product as a colorless solid (28.3 mg, 86%) that was determined to 
be 23:1 dr, 91% ee (major diastereomer) by chiral HPLC analysis (Chiralcel AD, 5% 
EtOH/hexanes, 1 mL/min, tr(anti, major) = 9.4 min, tr(anti, minor) = 13.2 min, tr(syn, 
major) = 12.1 min, tr(syn, minor) = 17.0 min); mp 154.0-155.5 °C; [α]
20
D  -31.8 (c 1.1, 
CHCl3); Rf = 0.42 (20% EtOAc/hexanes); IR (film) 3378, 2961, 2929, 1680, 1548, 1520 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 
5.17 (br s, 1H), 5.11 (br s, 1H), 4.71 (br s, 1H), 2.03 (m, 1H), 1.87 (m, 1H), 1.42 (s, 9H). 
1.40-1.25 (m, 2H), 0.98 (dd, J = 7.2, 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 
154.8, 135.2, 134.6, 129.1, 128.2, 92.7, 80.8, 56.2, 28.2, 23.5, 10.4; HRMS (ESI): Exact 
mass calcd for C16H22ClN2O4 [M-H]
-
 341.1268, found 341.1269. 
tert-Butyl (1R,2S)-1-(4-chlorophenyl)-3-methyl-2-nitrobutylcarbamate (77q). The 
imine (24.0 mg, 100 µmol) was treated with 2-methyl-1-nitropropane according to the 
general procedure but using PBAM ·HOTf as the catalyst. The reaction was stirred for 19 
h and concentrated to a colorless solid (7:1 dr, 
1
H NMR). Flash column chromatography 
(SiO2, 4-20% ethyl acetate in hexanes) yielded the addition product as a colorless solid 
(20.8 mg, 61%); the major diastereomer was determined to be 88% ee by chiral HPLC 
analysis (Chiralcel AD, 2% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) = 26.9 min, tr(anti, 
minor) = 30.4 min, tr(syn, major) = 20.6 min, tr(syn, minor) = 18.1 min); mp 149.0-151.0 
°C; Rf = 0.23 (10% EtOAc/hexanes); IR (film) 3351, 2975, 1699, 1550, 1494 cm
-1
; 
1
H 
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NMR (400 MHz, CDCl3) δ 7.31 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 5.23 (br s, 
1H), 4.97 (br s, 1H), 4.72 (br s, 1H), 2.29 (br s, 1H), 1.42 (s, 9H), 1.13 (d, J = 6.8 Hz, 
3H), 1.07 (d, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 154.6, 135.8, 134.6, 
129.1, 128.4, 96.1, 80.8, 53.8, 29.7, 28.7, 28.3, 19.8; HRMS (ESI): Exact mass calcd for 
C16H22ClN2O4 [M-H]
-
 341.1268, found 341.1274. 
tert-Butyl (1R,2S)-1-(4-chlorophenyl)-2-nitropentylcarbamate (77r). The imine (24.0 
mg, 100 µmol) was treated with (nitromethyl)cyclohexane according to the general 
procedure but using PBAM·HOTf as the catalyst. The reaction was stirred for 43 h and 
concentrated to a colorless solid (13:1 dr, 
1
H NMR). Flash column chromatography 
(SiO2, 4-20% ethyl acetate in hexanes) yielded the addition product as a colorless solid 
(27.7 mg, 72%); the major diastereomer was determined to be 89% ee by chiral HPLC 
analysis (Chiralcel AD, 5% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) = 25.8 min, tr(anti, 
minor) = 15.7 min, tr(syn, major) = 11.5 min, tr(syn, minor) = 20.4 min); mp 165.0-167.0 
°C; [α] 20D  -58.3 (c 1.2, CHCl3); Rf = 0.43 (20% EtOAc/hexanes); IR (film) 2932, 2855, 
1683, 1549 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.4 
Hz, 2H), 5.28 (br s, 1H), 4.98 (br s, 1H), 4.71 (br s, 1H), 2.00-1.60 (m, 6H), 1.42 (s, 9H), 
1.35-1.00 (m, 5H); 
13
C NMR (100 MHz, CDCl3) ppm 154.6, 135.7, 134.5, 129.1, 128.4, 
95.8, 80.7, 53.0, 38.0, 30.3, 28.2, 26.2, 25.8; HRMS (ESI): Exact mass calcd for 
C19H27ClNaN2O4 [M+Na]
+
 405.1557, found 405.1540. 
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(R)-tert-Butyl 1-(4-chlorophenyl)-2-methyl-2-nitropropylcarbamate (79). The imine 
(24.0 mg, 100 µmol) was treated with 2-nitropropane according to the general procedure 
with the exception that the reaction was carried out at room temperature with 
PBAM·HOTf as the catalyst. The reaction was stirred for 20 h and concentrated to a 
colorless solid.  Flash column chromatography (SiO2, 8-25% ethyl acetate in hexanes) 
yielded the addition product as a colorless solid (22.1 mg, 67%); the major product was 
determined to be 71% ee by chiral HPLC analysis (Chiralcel AD, 5% 
i
PrOH/hexanes, 1 
mL/min, tr(major) = 12.2 min, tr(minor) = 11.2 min; mp 162.0-164.0 °C; [α]
20
D  -34.0 (c 
1.0, CHCl3); Rf = 0.31 (20% EtOAc/hexanes); IR (film) 3338, 2980, 2929, 1699, 1543, 
1494 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.4 Hz, 2H), 7.11 (d, J = 8.4 Hz, 
2H), 5.84 (d, J = 10.0 Hz, 1H), 5.00 (d, J = 9.6 Hz, 1H), 1.69 (s, 3H), 1.52 (s, 3H), 1.41 
(s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 155.0, 135.2, 134.4, 129.1, 128.8, 90.3, 80.5, 
60.4, 28.2, 25.1, 23.2; HRMS (ESI): Exact mass calcd for C15H20ClN2O4 [M-H]
-
 
327.1112, found 327.1118. 
 
 
tert-butyl 2-methyl-2-nitro-1-(2-(trifluoromethyl)phenyl)propylcarbamate (79b). The 
imine (273.3 mg, 1.000 mmol) was dissolved in toluene (1.0 mL). Then DMAP (122.0 
mg, 1.000 mmol) and 2-nitropropane (449 μL, 5.00 mmol) were added to the reaction 
 
 
 
207 
mixture. The reaction was heated to 65 °C and stirred for 3 hours. The reaction mixture 
was then purified by column chromatography (SiO2, 7-20% EtOAc/hexanes) to yield a 
white solid (286.4 mg, 79%). mp 130.5-131.5 °C; Rf = 0.32 (20% EtOAc/hexanes); IR 
(film) 3267, 3148, 2983, 1698, 1546 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 325 K) δ 7.69 (d, 
J = 8.0 Hz, 1H), 7.51 (dd, J = 7.2, 7.2 Hz, 1H), 7.42 (dd, J = 7.6, 7.6 Hz, 1H), 7.30 (br s, 
1H), 5.88 (br s, 1H), 5.65 (d, J = 9.2 Hz, 1H), 1.70 (s, 3H), 1.49 (s, 3H), 1.43 (s, 9H); 
13
C 
NMR (100 MHz, CDCl3, 325 K)  ppm 154.7, 136.2, 132.5, 129.0 (q, 
2
JCF = 30.0 Hz) 
128.5, 127.6, 126.7 (q, 
3
JCF = 6.0 Hz), 124.1 (q, 
1
JCF = 273 Hz), 91.2, 80.6, 55.8, 28.2, 
25.9, 22.9; HRMS (ESI): Exact mass calcd for C16H22F3N2O4 [M+H]
+
 363.1526, found 
363.1519. 
 
(Nitromethyl)cyclohexane (80). NaNO2 (1.4 g, 20 mmol) and phloroglucinol (1.6 g, 12 
mmol) were dispensed into a 100 mL round-bottomed flask with stir bar. DMSO (57 mL) 
was added and the mixture was stirred at room temperature until homogenous. Bromide 
(2.0 g, 11 mmol) was added and the reaction mixture was stirred for 25 hours. The 
mixture was poured into ice water and extracted with diethyl ether. The combined 
organic layers were dried over MgSO4, filtered and concentrated. Purification by column 
chromatography (4-8% EtOAc/hexanes) provided a clear oil (500 mg, 31%). Rf = 0.10 
(10% EtOAc/hexanes); IR (film) 2930, 2856, 1550 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
4.20 (d, J = 7.2 Hz, 2H), 2.13 (m, 1H), 1.79-1.61 (m, 5H), 1.35-1.21 (m, 2H), 1.21-1.12 
(m, 1H), 1.09-0.96 (m, 2H); 
13
C NMR (100 MHz, CDCl3) ppm 81.7, 36.8, 30.0, 25.7, 
25.2; HRMS (CI): Exact mass calcd for C7H14NO2 [M+H]
+
 144.1025, found 144.1014. 
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1-Bromo-2-(nitromethyl)benzene (82c). NaNO2 (621.0 mg, 9.000 mmol), urea (721.2 
mg, 12.00 mmol), and phloroglucinol (832.3 mg, 6.600 mmol) were dispensed into a 15 
mL round bottom flask with a stir bar. DMF (9.1 mL) was added and the reaction mixture 
was stirred for 20 min at room temperature. The mixture was chilled to -20 °C before the 
addition of bromide (1.4996 g, 6.0000 mmol). The mixture was stirred for 5 h. The 
mixture was poured onto ice water and extracted with ether. The combined organic layers 
were washed with water, dried over MgSO4, filtered, and concentrated. The residue was 
purified by column chromatography (0-10% EtOAc/hexanes) to provide a slightly golden 
oil (391.8 mg, 30%). Rf = 0.28 (5% EtOAc/hexanes); IR (film) 3061, 3014, 2964, 2915, 
1557 cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 7.67 (dd, J =  8.4, 1.2 Hz, 1H), 7.44 (dd, J = 
7.8, 1.8 Hz, 1H), 7.40 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H), 7.33 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 
5.61 (s, 2H) ; 
13
C NMR (150 MHz, CDCl3) ppm 133.3, 132.7, 131.7, 129.4, 128.0, 125.8, 
79.0; HRMS (CI): Exact mass calcd for C7H10BrN2O2 [M+NH4]
+
 232.9920, found 
232.9921. 
1-Bromo-3-(nitromethyl)benzene (82d). NaNO2 (414.0 mg, 6.000 mmol), urea (721.2 
mg, 12.00 mmol), and phloroglucinol (756.7 mg, 6.000 mmol) were stirred with DMF 
(9.1 mL) at room temperature until homogenous. The reaction mixture was chilled to -20 
°C before the addition of bromide (1.4996 g, 6.000 mmol). The mixture was stirred at -20 
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°C for 5.5 h before pouring into ice water. The mixture was extracted with ether. The 
combined organic extracts were washed with water, dried over MgSO4, filtered, and 
concentrated. Column chromatography (0-10% EtOAc/hexanes) provided a clear, slightly 
green oil (379.9 mg, 29%). Rf = 0.23 (10% EtOAc/hexanes); IR (film) 3064, 2914, 1553 
cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 7.64-7.61 (m, 1H), 7.59 (d, J = 8.4 Hz, 1H), 7.40 (d, 
J = 7.8 Hz, 1H), 7.32 (dd, J = 7.8, 7.8 Hz), 5.40 (s, 2H); 
13
C NMR (150 MHz, CDCl3) 
ppm 133.2, 133.0, 131.4, 130.6, 128.6, 122.9, 79.1; HRMS (CI): Exact mass calcd for 
C7H6BrNO2 [M]
+
 214.9576, found 214.9575. 
2-(Nitromethyl)naphthalene (82e). NaNO2 (1.035 g, 15.00 mmol), urea (1.202 g, 20.00 
mmol), phloroglucinol (1.261 g, 10.00 mmol), and bromide (2.211 g, 10.00 mmol) were 
reacted according to the aforementioned procedure but with a reaction time of 5 h. 
Column chromatography (0-3% EtOAc/hexanes) provided a yellow solid (358.4 mg, 
19%). Mp 81.5-82.5 °C. Rf = 0.30 (10% EtOAc/hexanes); IR (film) 3060, 2910, 1550 cm
-
1
;
 1
H NMR (600 MHz, CDCl3) δ 7.94-7.85 (m, 4H), 7.59-7.52 (m, 3H), 5.60 (s, 2H); 
13
C 
NMR (150 MHz, CDCl3) ppm 133.6, 133.0, 130.0, 129.0, 128.2, 127.8, 127.2, 127.0, 
126.8, 126.4, 80.2; HRMS (CI): Exact mass calcd for C11H9NO2 [M]
+
 187.0628, found 
187.0634. 
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1-Chloro-4-(nitromethyl)benzene (82f). NaNO2 (7.600 g, 109.5 mmol), urea (8.800 g, 
146.0 mmol), and phloroglucinol (10.100 g, 80.30 mmol) were stirred with DMF (111 
mL) at room temperature until homogenous. The reaction mixture was chilled to -20 °C 
before the addition of bromide (15.0 g, 73.0 mmol). The mixture was stirred at -20 °C for 
3.25 h before pouring into ice water. The mixture was extracted with ether. The 
combined organic extracts were washed with water, dried over MgSO4, filtered, and 
concentrated. Column chromatography (0-4% EtOAc/hexanes) provided a clear oil that 
froze/solidified to a slightly yellow crystalline solid upon storage in a freezer (13.1 g, 
45%). Mp 28.0-29.0 °C; Rf = 0.45 (20% EtOAc/hexanes); IR (film) 3095, 3036, 2916, 
1555 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.45-7.35 (m, 4H), 5.41 (s, 2H); 
13
C NMR (100 
MHz, CDCl3) ppm 136.3, 131.4, 129.4, 128.0, 79.1; HRMS (CI): Exact mass calcd for 
C7H7ClNO2 [M+H]
+
 172.0160, found 172.0157.  
 
General Procedure for the Synthesis of Adducts 86-86v, 101-101g. Imine (100 μmol) 
and catalyst (5.0 μmol) were dispensed into a vial with a stir bar. Toluene (1.0 mL) was 
added, and the reaction was stirred at room temperature until homogenous. The reaction 
mixture was chilled to -78 °C before nitroalkane (110 μmol) was added. The reaction 
mixture was stirred for 18-26 h. The chilled mixture was diluted with CH2Cl2 and quickly 
filtered through a pad of silica. The silica pad was flushed with EtOAc. The filtrate was 
concentrated and purified by column chromatography. 
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tert-Butyl (1R,2S)-1-(4-chlorophenyl)-2-nitro-2-phenylethylcarbamate (86). 
According to the general procedure, purification by column chromatography (7-20% 
ethyl acetate in hexanes) afforded a white solid (36.5 mg, 97%) that was found to be 91% 
ee and 13:1 dr by chiral HPLC; (Chiralcel IA, 5% 
i
PrOH/hexanes, 1 mL/min, 230 nm, 
tr(anti, major) = 20.4 min, tr(anti, minor) = 27.7 min, tr(syn, major) = 24.3 min, tr(syn, 
minor) = 46.1 min); mp 177.5-178.5 °C; [α] 20
D
 -28.2 (c 0.11, CHCl3); Rf = 0.29 (20% 
EtOAc/hexanes); IR (film) 3386, 2984, 2924, 1683, 1549, 1520 cm
-1
; 
1
H NMR (600 
MHz, CDCl3) δ 7.54 (d, J = 6.6 Hz, 2H), 7.42 (m, 1H), 7.42 (d, J = 6.6 Hz, 2H), 7.34 (d, 
J = 9.0 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 5.76 (br s, 1H), 5.62 (br s, 1H), 4.84 (br s, 1H), 
1.26 (s, 9H); 
13
C NMR (150 MHz, CDCl3) ppm 154.2, 130.4, 129.2, 128.9, 128.6, 128.6, 
94.0, 80.6, 56.1, 28.2. HRMS (ESI): Exact mass calcd for C19H21ClN2NaO4 [M+Na]
+
 
399.1088, found 399.1070. 
 
tert-Butyl (1R,2S)-1-(naphthalen-2-yl)-2-nitro-2-phenylethylcarbamate (86c). 
Product was made according to the general procedure with the exception that 120 μmol 
of imine and 100 μmol of nitroalkane were used. Column chromatography (7-20% ethyl 
acetate in hexanes) afforded a white solid (38.9 mg, 99%) that was found to be 91% ee 
and 25:1 dr by chiral HPLC; (Chiralcel IA, 12% 
i
PrOH/hexanes, 1 mL/min, tr(anti, 
major) 10.6 min, tr(anti, minor) = 13.2 min, tr(syn, major) = 9.2 min, tr(syn, minor) = 17.5 
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min); Mp 183.0-184.5 °C; [α] 20
D
 -39 (c 0.11, CHCl3); Rf = 0.29 (20% EtOAc/hexanes); IR 
(film) 3403, 2977, 1688, 1547, 1519 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.89-7.80 (m, 
4H), 7.65-7.58 (m, 2H), 7.54-7.48 (m, 2H), 7.48-7.40 (m, 4H), 5.97-5.80 (m, 2H), 4.90 
(d, J = 8.4 Hz, 1H), 1.25 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 134.8, 133.23, 
133.16, 131.5, 130.2, 129.1, 128.9, 128.8, 128.1, 127.7, 126.7, 126.6 (2C), 124.4, 94.2, 
80.3, 56.7, 28.0; HRMS (ESI): Exact mass calcd for C23H24N2NaO4 [M+Na]
+
 415.1634, 
found 415.1635.  
tert-Butyl (1S,2S)-2-nitro-2-phenyl-1-(thiophen-2-yl)ethylcarbamate (86d). 
According to the general procedure, purification by column chromatography (7-25% 
ethyl acetate in hexanes) afforded a white solid (31.2 mg, 90%) that was found to be 87% 
ee and 21:1 dr by chiral HPLC; (Chiralcel IA, 5% 
i
PrOH/hexanes, 1 mL/min, tr(anti, 
major) 33.5 min, tr(anti, minor) = 23.0 min, tr(syn, major) = 22.0 min, tr(syn, minor) = 
43.1 min); Mp 169.0-171.0 °C; [α] 20
D
  -33 (c 0.10, CHCl3); Rf = 0.34 (20% 
EtOAc/hexanes); IR (film) 3385, 2979, 1688, 1546, 1515 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.55 (dd, J = 7.6, 1.6 Hz, 1H), 7.46-7.35 (m, 3H), 7.27 (dd, J = 5.2, 1.2 Hz, 
1H), 7.05 (br d, 1H), 6.95 (dd, J = 8.8, 3.6 Hz, 1H), 6.00-5.90 (m, 1H), 5.90-5.80 (m, 
1H), 4.98-4.85 (m, 1H), 1.28 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.1, 140.4, 
131.4, 130.2, 128.8, 128.6, 127.0, 126.3, 125.7, 94.5, 80.6, 52.5, 28.0; HRMS (ESI): 
Exact mass calcd for C17H20N2NaO4S [M+Na]
+
 371.1041, found 371.1026. 
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tert-butyl (1R,2S)-2-nitro-2-phenyl-1-(thiophen-3-yl)ethylcarbamate (86e). According 
to the general procedure, purification by column chromatography (7-20% ethyl acetate in 
hexanes) afforded a white solid (29.6 mg, 85%) that was found to be 82% ee and 30:1 dr 
by chiral HPLC; (Chiralcel AD-H, 12% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) 19.8 
min, tr(anti, minor) = 16.3 min, tr(syn, major) = 15.0 min, tr(syn, minor) = 28.1 min); Mp 
174.0-176.0 °C; [α] 20
D
 -35 (c 0.11, CHCl3); Rf = 0.34 (20% EtOAc/hexanes); IR (film) 
3385, 2977, 2927, 1678, 1547, 1519 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.56-7.50 (m, 
2H), 7.44-7.36 (m, 3H), 7.32 (dd, J = 5.2, 2.8 Hz, 1H), 7.28-7.24 (m, 1H), 7.07 (dd, 4.8, 
1.2 Hz, 1H), 5.90-5.70 (m, 2H), 4.88 (br s, 1H), 1.27 (s, 9H); 
13
C NMR (100 MHz, 
CDCl3) ppm 154.3, 138.1, 131.5, 130.1, 128.8, 128.7, 126.8, 126.1, 123.3, 94.0, 80.4, 
52.6, 28.0; HRMS (ESI): Exact mass calcd for C17H20N2NaO4S [M+Na]
+
 371.1041, 
found 371.1032. 
 
tert-Butyl (1R,2S)-1-(3-bromo-4-methoxyphenyl)-2-nitro-2-phenylethylcarbamate 
(86g). This was prepared according to the general procedure with the exception that the 
scale was 58 μmol (imine) and the reaction was warmed to -20 °C and stirred for one 
hour before workup. Purification by column chromatography (0-20% ethyl acetate in 
hexanes) afforded a white solid (20.4 mg, 78%) that was found to be 75% ee and 21:1 dr 
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by chiral HPLC; (Chiralcel IA, 5% iPrOH/hexanes, 1 mL/min, tr(anti, major) = 61.8 min, 
tr(anti, minor) = 29.2 min, tr(syn, major) = 26.8 min, tr(syn, minor) = 49.6 min); Mp 
157.0-159.0 °C; Rf = 0.19 (20% EtOAc/hexanes); IR (film) 3387, 2979, 1685, 1553 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.55 (dd, J = 7.2, 2.0 Hz, 2H), 7.53 (d, J = 2.0 Hz, 1H), 
7.46-7.38 (m, 3H), 7.30-7.25 (dd, J = 8.4, 2.0Hz, 1H), 6.86 (d, J = 8.4 Hz, 1H), 5.72 (d, J 
= 10.0 Hz, 1H), 5.58 (dd, J = 9.2, 9.2 Hz, 1H), 4.77 (d, J = 8.8 Hz, 1H), 3.89 (s, 3H), 1.26 
(s, 9H); 
13
C NMR (150 MHz, CDCl3) ppm 156.1, 154.1, 131.9, 131.3, 131.1, 130.3, 
128.9 (2C), 128.7 (2C), 127.7, 112.1, 112.0, 94.1, 80.5, 56.2, 55.8, 28.0; HRMS (ESI): 
Exact mass calcd for C20H23BrN2NaO5 [M+Na]
+
 473.0688, found 473.0711. 
 
Figure 45. Crystal Structure of Phenylnitromethane Aza-Henry Adduct 86g 
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tert-Butyl (1R,2S)-2-nitro-2-phenyl-1-o-tolylethylcarbamate (86h). Product was 
prepared according to the general procedure with the exception that the reaction was 
warmed to -20 °C and stirred for one hour before workup. Purification by column 
chromatography (7-25% ethyl acetate in hexanes) afforded a white solid (31.2 mg, 88%) 
that was found to be 87% ee and 50:1 dr by chiral HPLC; (Chiralcel AD-H, 5% 
EtOH/hexanes, 0.7 mL/min, tr(anti, major) 27.2 min, tr(anti, minor) = 14.5 min, tr(syn, 
major) = 17.0 min, tr(syn, minor) = 15.8 min); Mp 135.0-137.0 °C; [α]
20
D  -82 (c 0.11, 
CHCl3); Rf = 0.44 (20% EtOAc/hexanes); IR (film) ~3300 (broad), 2978, 2932, 1703, 
1555 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.65-7.58 (m, 2H), 7.46-7.36 (m, 3H), 7.33-
7.26 (m, 1H), 7.25-7.18 (m, 3H), 6.12-5.90 (m, 1H), 5.90-5.80 (m, 1H), 4.85-4.60 (m, 
1H), 2.53 (s, 3H), 1.23 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 136.9, 136.1, 
131.7, 131.2, 130.1, 128.8, 128.7, 128.5, 126.7, 124.9, 93.4, 80.2, 52.0, 27.9, 19.4; 
HRMS (ESI): Exact mass calcd for C20H24N2NaO4 [M+Na]
+
 379.1634, found 379.1633. 
tert-butyl (1R,2S)-2-nitro-2-phenyl-1-(2-(trifluoromethyl)phenyl)ethylcarbamate 
(86i). According to the general procedure, column chromatography (7-25% ethyl acetate 
in hexanes) afforded a white solid (35.6 mg, 87%) that was found to be 77% ee and 20:1 
dr by chiral HPLC; (Chiralcel IA, 10% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) 39.7 
min, tr(anti, minor) = 30.6 min, tr(syn, major) = 13.4 min, tr(syn, minor) = 27.8 min); [α]
20
D   -51.2 (c 1.11, CHCl3) of 62% ee material by HPLC; Rf = 0.25 (20% EtOAc/hexanes); 
IR (film) 3256, 3137, 2981, 2932, 1700, 1557 cm
-1
;
 1
H NMR (600 MHz, CDCl3, 322 K) δ 
7.73 (d, J = 7.8 Hz, 1H), 7.70-7.50 (m, 4H), 7.48-7.38 (m, 4H), 6.26 (br s, 1H), 5.99 (br s, 
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1H), 4.91 (br s, 1H), 1.27 (s, 9H) ; 
13
C NMR (150 MHz, CDCl3, 322 K) ppm 153.9, 
136.0, 132.4, 131.5, 130.2, 128.9 (2C), 128.8 (2C), 128.6 (q, 
2
JCF = 30 Hz), 127.0 (q, 
3
JCF 
= 6.0 Hz), 124.2 (q, 
1
JCF = 272 Hz), 91.9, 80.6, 53.6, 28.0; 
19
F NMR (282 MHz, CDCl3) 
ppm -56.4; HRMS (ESI): Exact mass calcd for C20H21F3N2NaO4 [M+Na]
+
 433.1351, 
found 433.1365. 
 
tert-Butyl (1R,2S)-1-(4-(allyloxy)phenyl)-2-nitro-2-phenylethylcarbamate (86j). 
Product was prepared according to the general procedure with the exception that the 
reaction was warmed to -20 °C and stirred for one hour before workup. Column 
chromatography (7-25% ethyl acetate in hexanes) afforded a white solid (28.0 mg, 79%) 
that was found to be 87% ee and 131:1 dr by chiral HPLC; (Chiralcel IA, 12% 
EtOH/hexanes, 0.5 mL/min, tr(anti, major) 14.9  min, tr(anti, minor) = 13.1 min, tr(syn, 
major) = 13.8 min, tr(syn, minor) = 22.3 min); Mp 174.5-176.0 °C; [α]
20
D
 -42 (c 0.16, 
CHCl3); Rf = 0.21 (20% EtOAc/hexanes); IR (film) 3394, 2981, 2930, 1683, 1549, 1514 
cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 7.57 (d, J = 7.8 Hz, 2H), 7.45-7.37 (m, 3H), 7.26 (d, 
J = 8.4 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H), 6.04 (dddd, J = 16.8, 10.2, 4.8, 4.8 Hz, 1H), 
5.74 (br s, 1H), 5.61 (br s, 1H), 5.41 (dd, J = 17.4, 1.2 Hz, 1H), 5.29 (dd, J = 10.2, 1.2 
Hz, 1H), 4.80 (d, J = 7.8 Hz, 1H), 4.52 (d, J = 4.8 Hz, 2H) 1.25 (s, 9H); 
13
C NMR (150 
MHz, CDCl3) ppm 158.8, 154.2, 133.0, 131.6, 130.1, 129.7, 128.8 (2C), 128.4, 117.8, 
115.1, 94.4, 80.3, 68.8, 56.1, 28.0; HRMS (ESI): Exact mass calcd for C22H26N2NaO5 
[M+Na]
+
 421.1739, found 421.1730. 
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tert-Butyl (1R,2S)-2-nitro-2-phenyl-1-p-tolylethylcarbamate (86k).  Product was made 
according to the general procedure with the exception that 120 μmol of imine and 100 
μmol of nitroalkane were used. Column chromatography (7-20% ethyl acetate in 
hexanes) afforded a white solid (33.0 mg, 93%) that was found to be 91% ee and 38:1 dr 
by chiral HPLC; (Chiralcel IA, 12% 
i
PrOH/hexanes, 0.7 mL/min, tr(anti, major) 12.1 
min, tr(anti, minor) = 13.1 min, tr(syn, major) = 11.2 min, tr(syn, minor) = 20.7 min); Mp 
181.0-183.0 °C; [α] 20
D
 -46 (c 0.11, CHCl3); Rf = 0.36 (20% EtOAc/hexanes); IR (film) 
3393, 2979, 1685, 1549, 1517 cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 7.58 (d, J = 7.2 Hz, 
2H), 7.45-7.37 (m, 3H), 7.24 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 7.8 Hz, 2H), 5.75 (br s, 
1H), 5.64 (br s, 1H), 4.78 (d, J = 9.0 Hz, 1H), 2.34 (s, 3H), 1.24 (s, 9H); 
13
C NMR (150 
MHz, CDCl3) ppm 154.2, 138.6, 134.5, 131.6, 130.1, 129.7, 128.78, 128.76, 127.0, 94.4, 
80.2, 56.3, 28.0, 21.1; HRMS (ESI): Exact mass calcd for C20H24N2NaO4 [M+Na]
+
 
379.1634, found 379.1626. 
 
tert-butyl (1R,2S)-2-nitro-2-phenyl-1-m-tolylethylcarbamate (86l). Product was 
prepared according to the general procedure with the exception that the reaction was 
warmed to -20 °C and stirred for one hour before workup. Column chromatography (7-
20% ethyl acetate in hexanes) afforded a white solid (32.2 mg, 90%) that was found to be 
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81% ee and 28:1 dr by chiral HPLC; (Chiralcel IA, 12% 
i
PrOH/hexanes, 1 mL/min, 
tr(anti, major) 8.2 min, tr(anti, minor) = 9.3 min, tr(syn, major) = 6.4 min, tr(syn, minor) = 
13.1 min); Mp 175.0-177.0 °C; [α] 20
D
  -18 (c 0.15, CHCl3); Rf = 0.35 (20% 
EtOAc/hexanes); IR (film) 3393, 2975, 2922, 1684 cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 
7.58 (d, J = 7.2 Hz, 2H), 7.46-7.37 (m, 3H), 7.24 (d, J = 7.2 Hz, 1H), 7.17-7.12 (m, 3H), 
5.75 (br s, 1H), 5.66 (br s, 1H), 4.82 (br s, 1H), 2.35 (s, 3H), 1.25 (s, 9H); 
13
C NMR (150 
MHz, CDCl3) ppm 154.2, 138.8, 137.4, 131.6, 130.1, 129.5, 128.9, 128.78, 128.75, 
127.9, 124.0, 94.4, 80.3, 56.4, 28.0, 21.4; HRMS (ESI): Exact mass calcd for 
C20H24N2NaO4 [M+Na]
+
 379.1634, found 379.1630. 
tert-Butyl (1R,2S)-1-(4-fluorophenyl)-2-nitro-2-phenylethylcarbamate (86m). Product 
was made according to the general procedure with the exception that 120 μmol of imine 
and 100 μmol of nitroalkane were used. Column chromatography (7-25% ethyl acetate in 
hexanes) afforded a white solid (35.0 mg, 97%) that was found to be 87% ee and 15:1 dr 
by chiral HPLC; (Chiralcel IA, 5% EtOH/hexanes, 0.5 mL/min, tr(anti, major) 19.1 min, 
tr(anti, minor) = 20.5 min, tr(syn, major) = 22.8 min, tr(syn, minor) = 39.9 min); Mp 
178.5-180.0 °C; [α] 20
D
 -18 (c 0.15, CHCl3); Rf = 0.34 (20% EtOAc/hexanes); IR (film) 
3391, 2986, 2925, 1683 cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 7.56 (dd, J = 7.2, 1.2 Hz, 
2H), 7.46-7.39 (m, 3H), 7.34 (dd, J = 8.4, 4.8 Hz, 2H), 7.05 (dd, J = 8.4, 8.4 Hz, 2H), 
5.75 (br s, 1H), 5.64 (br s, 1H), 4.81 (d, J = 9.0 Hz, 1H), 1.26 (s, 9H); 
13
C NMR (150 
MHz, CDCl3) ppm 162.7 (d, 
1
JCF = 246 Hz), 154.2, 133.4, 131.3, 130.3, 129.0 (d, 
3
JCF = 
9.0 Hz), 128.9, 128.7, 116.0 (d, 
2
JCF = 23 Hz), 94.2, 80.6, 56.2, 28.0; 
19
F NMR (376 
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MHz, CDCl3) ppm -112.7; HRMS (ESI): Exact mass calcd for C19H21FN2NaO4 [M+Na]
+
 
383.1383, found 383.1392. 
 
tert-butyl (1R,2S)-2-nitro-2-phenyl-1-(pyridin-3-yl)ethylcarbamate (86n). Product 
was made according to the general procedure with the exception that 120 μmol of imine 
and 100 μmol of nitroalkane were used. Column chromatography (20-40% ethyl acetate 
in hexanes) afforded a white solid (28.0 mg, 82%) that was found to be 60% ee and 28:1 
dr by chiral HPLC; (Chiralcel IA, 12% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) 14.7 
min, tr(anti, minor) = 8.6 min, tr(syn, major) = 11.6 min, tr(syn, minor) = 20.0 min); Mp 
166.0-168.0 °C; [α] 20
D
 -15 (c 0.13, CHCl3); Rf = 0.05 (20% EtOAc/hexanes); IR (film) 
3390, 2982, 2927, 1683, 1550, 1519 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 8.62 (d, J = 2.0 
Hz, 1H), 8.58 (dd, J = 4.8, 2.0 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.56-7.51 (m, 2H), 7.48-
7.38 (m, 3H), 7.30 (dd, J = 7.2, 4.8 Hz, 1H), 5.95-5.80 (m, 1H), 5.70-5.55 (m, 1H), 5.20-
5.00 (m, 1H), 1.27 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 150.0, 149.0, 135.0, 
133.3, 131.1, 130.5, 129.1, 128.5, 123.7, 93.5, 80.8, 55.0, 28.0; HRMS (ESI): Exact mass 
calcd for C18H22N3O4 [M+H]
+
 344.1610, found 344.1594. 
tert-butyl (1S,2S)-1-(furan-2-yl)-2-nitro-2-phenylethylcarbamate (86o). Product was 
made according to the general procedure with the exception that 120 μmol of imine and 
100 μmol of nitroalkane were used. Column chromatography (7-20% ethyl acetate in 
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hexanes) afforded a white solid (28.1 mg, 85%) that was found to be 68% ee and 18:1 dr 
by chiral HPLC; (Chiralcel IA, 5% EtOH/hexanes, 1 mL/min, tr(anti, major) 10.4 min, 
tr(anti, minor) = 8.0 min, tr(syn, major) = 9.2 min, tr(syn, minor) = 19.0 min); Mp 156.0-
158.0 °C; [α] 20
D
 -54 (c 0.15, CHCl3); Rf = 0.40 (20% EtOAc/hexanes); IR (film) 3392, 
2980, 2933, 1689, 1549, 1517 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.56-7.50 (m, 2H), 
7.45-7.36 (m, 4H), 6.35-6.30 (m, 2H), 5.90-5.75 (m, 2H), 5.00-4.80 (m, 1H), 1.26 (s, 
9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.1, 149.6, 142.8, 131.1, 130.1, 128.73, 
128.70, 110.6, 108.7, 92.4, 80.5, 50.4, 28.0; HRMS (ESI): Exact mass calcd for 
C17H20N2NaO5 [M+Na]
+
 355.1270, found 355.1257.  
 
tert-Butyl (1R,2S)-1-(4-methoxyphenyl)-2-nitro-2-phenylethylcarbamate (86p). 
Product was made according to the general procedure with the exception that reaction 
warmed to -20 °C and stirred for 1h before filtration. Column chromatography (7-20% 
ethyl acetate in hexanes) afforded a white solid (31.0 mg, 83%) that was found to be 85% 
ee and 81:1 dr by chiral HPLC; (Chiralcel IA, 12% 
i
PrOH/hexanes, 0.5 mL/min, tr(anti, 
major) 21.3 min, tr(anti, minor) = 23.6 min, tr(syn, major) = 19.8 min, tr(syn, minor) = 
37.0 min); Mp 161.0-162.5 °C; [α] 20
D
 -43 (c 0.14, CHCl3); Rf = 0.18 (20% 
EtOAc/hexanes); IR (film) 3390, 2980, 1683, 1548, 1515 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.60-7.53 (m, 2H), 7.44-7.37 (m, 3H), 7.27 (d, J = 8.8 Hz, 2H), 6.88 (d, J = 8.8 
Hz, 2H), 5.75 (d, J = 10.0 Hz, 1H), 5.61 (dd, J = 9.2, 9.2 Hz, 1H), 4.80 (d, J = 8.8 Hz, 
1H), 3.80 (s, 3H), 1.25 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 159.7, 154.2, 131.6, 
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130.1, 129.5, 128.8 (2C), 128.4, 114.3, 94.4, 80.3, 56.2, 55.3, 28.0; HRMS (ESI): Exact 
mass calcd for C20H24N2NaO4 [M+Na]
+
 395.1583, found 395.1567. 
tert-Butyl (1R,2S)-2-nitro-2-phenyl-1-(4-(trifluoromethyl)phenyl)ethylcarbamate 
(86q). Product was made according to the general procedure with the exception that 120 
μmol of imine and 100 μmol of nitroalkane were used. Column chromatography (7-20% 
ethyl acetate in hexanes) afforded a white solid (40.8 mg, 99%) that was found to be 84% 
ee and 14:1 dr by chiral HPLC; (Chiralcel IA, 8% 
i
PrOH/hexanes, 1 mL/min, tr(anti, 
major) 9.2 min, tr(anti, minor) = 13.9 min, tr(syn, major) = 12.6 min, tr(syn, minor) = 20.0 
min); Mp 193.5-194.5 °C; [α] 20
D
 -21 (c 0.14, CHCl3); Rf = 0.33 (20% EtOAc/hexanes); IR 
(film) 3390, 2985, 1683, 1548, 1521 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.0 
Hz, 2H), 7.58-7.53 (m, 2H), 7.49 (d, J = 8.4 Hz, 2H), 7.43-7.40 (m, 3H), 5.80 (br s, 1H), 
5.71 (br s, 1H), 4.89 (br s, 1H), 1.26 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 
141.5, 131.0, 130.9 (q, 
2
JCF = 32 Hz), 130.5, 129.0, 128.6, 127.7, 126.0 (q, 
3
JCF = 4.0 Hz), 
123.8 (q, 
1
JCF = 271 Hz), 93.7, 80.8, 56.3, 28.0;
 19
F NMR (282 MHz, CDCl3) ppm -61.1; 
HRMS (ESI): Exact mass calcd for C20H21F3N2NaO4 [M+Na]
+
 433.1351, found 
433.1364. 
tert-butyl (1R,2S)-2-nitro-1-(4-phenoxyphenyl)-2-phenylethylcarbamate (86r). 
According to the general procedure, column chromatography (7-20% ethyl acetate in 
hexanes) afforded a white solid (42.1 mg, 97%) that was found to be 83% ee and 25:1 dr 
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by chiral HPLC; (Chiralcel AD-H, 6% EtOH/hexanes, 1 mL/min, tr(anti, major) 21.3 
min, tr(anti, minor) = 23.0 min, tr(syn, major) = 26.1 min, tr(syn, minor) = 35.1 min); Mp 
184.0-185.0 °C; [α] 20
D
 -41 (c 0.11, CHCl3); Rf = 0.31 (20% EtOAc/hexanes); IR (film) 
3391, 2980, 1682, 1550, 1509 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.60-7.55 (m, 2H), 
7.45-7.39 (m, 3H), 7.38-7.33 (m, 2H), 7.33-7.28 (m, 2H), 7.16-7.10 (m, 1H), 7.04-7.00 
(m, 2H), 7.00-6.95 (m, 2H), 5.76 (d, J = 10.0 Hz, 1H), 5.70-5.60 (m, 1H), 4.78 (d, J = 9.2 
Hz, 1H), 1.26 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 157.8, 156.5, 154.2, 132.0, 
131.5, 130.2, 129.9, 128.84, 128.75, 128.7, 123.8, 119.4, 118.8, 94.3, 80.4, 56.3, 28.1; 
HRMS (ESI): Exact mass calcd for C25H26N2NaO5 [M+Na]
+
 457.1739, found 457.1730. 
tert-Butyl (1R,2S)-1-(biphenyl-4-yl)-2-nitro-2-phenylethylcarbamate (86s). Product 
was made according to the general procedure with the exception that 120 μmol of imine 
and 100 μmol of nitroalkane were used. Column chromatography (7-20% ethyl acetate in 
hexanes) afforded a white solid (41.5 mg, 99%) that was found to be 93% ee and 44:1 dr 
by chiral HPLC; (Chiralcel AD-H, 10% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) 32.6 
min, tr(anti, minor) = 23.9 min, tr(syn, major) = 26.1 min, tr(syn, minor) = 28.7 min); Mp 
194.0-196.0 °C; [α] 20
D
 -56 (c 0.15, CHCl3); Rf = 0.29 (20% EtOAc/hexanes); IR (film) 
3398, 2978, 2922, 1686, 1548, 1520 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.63-7.55 (m, 
6H), 7.47-7.40 (m, 7H), 7.39-7.33 (m, 1H), 5.82 (br s, 1H), 5.73 (br s, 1H), 4.90 (br s, 
1H), 1.27 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 141.6, 140.3, 136.4, 131.5, 
130.2, 128.83, 128.80, 128.76, 127.7, 127.59, 127.56, 127.1, 94.2, 80.4, 56.5, 28.0; 
HRMS (ESI): Exact mass calcd for C25H26N2NaO4 [M+Na]
+
 441.1790, found 471.1776. 
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tert-butyl (1R,2S)-1-(4-(methylthio)phenyl)-2-nitro-2-phenylethylcarbamate (86t). 
Product was made according to the general procedure with the exception that reaction 
warmed to -20 °C and stirred for 1h before filtration. Column chromatography (7-25% 
ethyl acetate in hexanes) afforded a white solid (36.6 mg, 94%) that was found to be 93% 
ee and 69:1 dr by chiral HPLC; (Chiralcel IA, 18% 
i
PrOH/hexanes, 0.6 mL/min, tr(anti, 
major) 13.0 min, tr(anti, minor) = 15.6 min, tr(syn, major) = 14.2 min, tr(syn, minor) = 
21.0 min); Mp 185.0-186.0 °C; [α] 20
D
 -54 (c 0.13, CHCl3); Rf = 0.23 (20% 
EtOAc/hexanes); IR (film) 3390, 2978, 2922, 1680, 1549, 1518 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.59-7.53 (m, 2H), 7.46-7.39 (m, 3H), 7.27 (d, J = 8.4 Hz, 2H), 7.22 (d, J 
= 8.8 Hz, 2H), 5.84-5.69 (m, 1H), 5.62 (br s, 1H), 4.88 (br s, 1H), 2.47 (s, 3H), 1.25 (s, 
9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 139.4, 134.1, 131.4, 130.2, 128.8, 128.7, 
127.6, 126.7, 94.1, 80.4, 56.4, 28.0, 15.5; HRMS (ESI): Exact mass calcd for 
C20H24N2NaO4S [M+Na]
+
 411.1354, found 411.1350. 
tert-butyl (1R,2S)-1-(3-methoxyphenyl)-2-nitro-2-phenylethylcarbamate (86u). 
Product was made according to the general procedure with the exception that reaction 
warmed to -20 °C and stirred for 1h before filtration. Column chromatography (7-25% 
ethyl acetate in hexanes) afforded a white solid (32.8 mg, 88%) that was found to be 89% 
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ee and 38:1 dr by chiral HPLC; (Chiralcel IA, 12% 
i
PrOH/hexanes, 1 mL/min, tr(anti, 
major) 48.8 min, tr(anti, minor) = 11.9 min, tr(syn, major) = 14.5 min, tr(syn, minor) = 
20.2 min); Mp 181.0-182.0 °C; [α] 20
D
 -44 (c 0.12, CHCl3); Rf = 0.22 (20% 
EtOAc/hexanes); IR (film) 3388, 2978, 2932, 1683, 1549, 1519 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.60-7.54 (m, 2H), 7.45-7.37 (m, 3H), 7.28 (dd, J = 8.4, 7.6 Hz, 1H), 
6.93 (br d, J = 7.6 Hz, 1H), 6.90-6.84 (m, 2H), 5.76 (br d, J = 9.6 Hz, 1H), 5.66 (br s, 
1H), 4.83 (br s, 1H), 3.80 (s, 3H), 1.25 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 159.9, 
154.2, 139.1, 131.5, 130.2, 130.1, 128.8 (2C), 119.1, 114.1, 113.1, 94.2, 80.4, 56.5, 55.3, 
28.0; HRMS (ESI): Exact mass calcd for C20H24N2NaO5 [M+Na]
+
 395.1583, found 
395.1568. 
tert-butyl (1R,2S)-1-(3-chlorophenyl)-2-nitro-2-phenylethylcarbamate (86v). Product 
was made according to the general procedure with the exception that reaction warmed to 
-20 °C and stirred for 1h before filtration. Column chromatography (7-25% ethyl acetate 
in hexanes) afforded a white solid (29.8 mg, 79%) that was found to be 74% ee and 17:1 
dr by chiral HPLC; (Chiralcel AD-H, 15% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) 10.8 
min, tr(anti, minor) = 9.2 min, tr(syn, major) = 8.1 min, tr(syn, minor) = 12.4 min); Mp 
174.0-176.0 °C; [α] 20
D
 -26 (c 0.13, CHCl3); Rf = 0.28 (20% EtOAc/hexanes); IR (film) 
3393, 2975, 1683, 1544, 1520 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.58-7.53 (m, 2H), 
7.47-7.39 (m, 3H), 7.35 (br s, 1H), 7.34-7.23 (m, 3H), 5.75 (br d, J = 10.0 Hz, 1H), 5.64 
(br s, 1H), 4.85 (br s, 1H), 1.26 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 139.6, 
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134.9, 131.2, 130.4, 130.3, 130.0 (2C), 128.6, 127.4, 125.5, 93.9, 80.7, 56.3, 28.0; HRMS 
(ESI): Exact mass calcd for C19H21ClN2NaO4 [M+Na]
+
 399.1088, found 399.1087. 
4
ClQuinBAM (92).
173
 A flame-dried flask was charged with Pd(dba)2 (217 mg, 378 
μmol), rac-BINAP (235 mg, 378 μmol), sodium tert-butoxide (2.180 g, 22.68 mmol), 
(R,R)-diaminocyclohexane (865 mg, 7.57 mmol), and 2,4-dichloroquinoline (3.000 g, 
15.22 mmol), and the reaction vessel was placed under an argon atomosphere.
174
 Toluene 
(90 mL) was added, and the resulting red-brown solution was heated at 85 °C. The 
reaction was monitored by TLC; after 3 h, nearly complete conversion was observed. The 
reaction was cooled to 25 °C, diluted with EtOAc, and washed with satd aq NH4Cl. The 
organic layer was dried (Na2SO4) and concentrated. Column chromatography (SiO2, 10% 
ethyl acetate in hexanes) of the residue provided the title compound (1.8 g, 54%) as a 
yellow powder. Mp 236.0-237.0; [α]
20
D  +508 (c 1.0, DMSO); Rf = 0.23 (20% 
EtOAc/hexanes); IR (film) 3220, 2930, 1601 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6) δ 
7.82 (d, J = 8.0 Hz, 2H), 7.62-7.53 (m, 4H), 7.29-7.20 (m, 4H), 6.84 (s, 2H), 4.05 (br s, 
2H), 2.28-2.16 (m, 2H), 1.83-1.67 (m, 2H), 1.50-1.28 (m, 4H); 
13
C NMR (100 MHz, 
DMSO-d6) ppm 156.5, 148.5, 140.2, 130.4, 126.0, 123.4, 122.1, 120.3, 112.6, 53.6, 31.7, 
24.3; HRMS (CI): Exact mass calcd for C24H23Cl2N4 [M+H]
+
 437.1300, found 437.1294. 
                                                 
173
 See Appendix for larger scale Organic Syntheses manuscript procedure. 
174
 Adapted from Wagaw, S.; Rennels, R.; Buchwald, S. J Am. Chem. Soc. 1997, 119, 8451-8458. 
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4
Cl
7
MeOQuinBAM (92b). A 2-5 mL μW vial was charged with (R,R)-
diaminocyclohexane (125.2 mg, 1.096 mmol), 2,4-dichloro-7-methoxyquinoline (500 
mg, 2.190 mmol), Pd(dba)2 (12.6 mg, 22.0 μmol), rac-BINAP (13.6 mg, 22.0 μmol), and 
sodium tert-butoxide (316.2 mg, 3.290 mmol).
176
 Trifluoromethylbenzene (3.8 mL) was 
added and the resulting suspension was heated at 100 °C and stirred in the microwave for 
10 min. The reaction mixture was diluted with CH2Cl2 and filtered through Celite. The 
filtrate was concentrated and washed with CH2Cl2 then hexanes to provide a light brown 
powder (412.9 mg, 76%) that was pure by 
1H NMR; [α] 20
D
 +580 (c 0.19, CHCl3); Rf = 
0.25 (50% EtOAc/hexanes); IR (film) 3220, 2933, 1610, 1510 cm
-1
;
 1
H NMR (500 MHz, 
CDCl3, 325 K) δ 7.82 (d, J = 9.0 Hz, 2H), 7.08 (s, 2H), 6.91 (dd, J = 9.0, 2.5 Hz, 2H), 
6.31 (br s, 2H), 5.64 (br s, 2H), 4.09 (br s, 2H), 3.94 (s, 6H), 2.41-2.32 (m, 2H), 1.90-1.80 
(m, 2H), 1.55-1.38 (m, 4H); 
13
C NMR (100 MHz, CDCl3, 325 K) ppm 162.0, 157.3, 
150.5, 142.3, 125.3, 116.3, 114.4, 109.5, 106.0, 56.1, 55.5, 32.9, 24.9; HRMS (ESI): 
Exact mass calcd for C26H27Cl2N4O2 [M+H]
+
 497.1511, found 497.1501. 
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4
Cl
5,7
(Me)2BAM (92c). A 25 mL round bottom flask was charged with Pd(dba)2 (15.9 
mg, 27.7 μmol), rac-BINAP (34.6 mg, 55.4 μmol), sodium tert-butoxide (362.0 mg, 3.76 
mmol), (R,R)-diaminocyclohexane (126.2 mg, 1.106 mmol), and the quinoline (500 mg, 
2.21 mmol). Toluene (8 mL) was added, and the reaction mixture was heated at 50 °C 
and stirred. The reaction mixture was monitored by TLC; after 6 h, complete conversion 
was observed. The reaction was cooled to room temperature, quenched with sat. aq. 
NH4Cl, and extracted with EtOAc. The extract was dried (MgSO4), filtered, and 
concentrated. Column chromatography (10-25% ethyl acetate in hexanes) provided a 
yellow solid (265.1 mg, 49%). mp 235.0-237.0 °C; [α] 20D  +356 (c 1.14, CHCl3); Rf = 0.36 
(25% EtOAc/hexanes); IR (film) 3225, 2967, 2938, 1595 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.38 (s, 2H), 6.84 (s, 2H), 6.29 (s, 2H), 5.65 (br s, 2H), 4.10-3.90 (m, 2H), 3.08-
2.85 (m, 2H), 2.84 (s, 6H), 2.40 (s, 6H), 2.38-2.25 (m, 2H), 1.90-1.70 (m, 2H), 1.55-1.35 
(m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 155.9, 150.6, 142.3, 139.7, 134.9, 128.5, 
125.0, 118.4, 112.9, 55.9, 32.8, 24.9, 21.3 (2C); HRMS (ESI): Exact mass calcd for 
C28H31Cl2N4 [M+H]
+
 493.1926, found 493.1927. 
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4
Cl
6,7
(Me)2BAM (92d). A 2-5 mL μW vial was charged with Pd(dba)2 (17.8 mg, 31.0 
μmol), rac-BINAP (19.3 mg, 31.0 μmol), sodium tert-butoxide (446.3 mg, 4.644 mmol), 
(R,R)-diaminocyclohexane (176.8 mg, 1.548 mmol), and the quinoline (700.0 mg, 3.096 
mmol). Trifluorotoluene (5 mL) was added, and the reaction mixture was heated at 100 
°C and stirred for 20 min. Complete conversion was observed by TLC. The reaction was 
cooled to room temperature, diluted with CH2Cl2, and filtered through celite. The filtrate 
was concentrated to a crude solid that was rinsed with ether to provide a light yellow 
solid (180.2 mg, 24%). mp >260 °C; [α] 20D  +228 (c 1.12, CHCl3); Rf = 0.30 (25% 
EtOAc/hexanes); IR (film) 3219, 2937, 2859, 1601 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 
7.65 (s, 2H), 7.50 (s, 2H), 6.37 (s, 2H), 5.69 (br s, 2H), 4.12-3.96 (m, 2H), 2.41 (s, 6H), 
2.38 (s, 6H), 2.37-2.29 (m, 2H), 1.89-1.80 (m, 2H), 1.55-1.35 (m, 4H); 
13
C NMR (100 
MHz, CDCl3) ppm 156.2, 147.3, 141.5, 140.4, 131.9, 126.1, 123.6, 119.7, 111.2, 56.0, 
32.8, 24.8, 20.2, 19.7; HRMS (ESI): Exact mass calcd for C28H31Cl2N4 [M+H]
+
 
493.1926, found 493.1949. 
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4
Cl
6,7
(MeO)2QuinBAM (92e). A 10-20 mL μW vial was charged with (R,R)-
diaminocyclohexane (442.4 mg, 3.874 mmol), 2,4-dichloro-6,7-dimethoxyquinoline 
(2.000 g, 7.749 mmol), Pd(dba)2 (44.5 mg, 77.48 μmol), rac-BINAP (48.2 mg, 77.48 
μmol), and sodium tert-butoxide (1.117 g, 11.62 mmol).176 Trifluoromethylbenzene (13.4 
mL) was added and the resulting suspension was heated at 100 °C and stirred in the 
microwave for 10 min. The reaction mixture was filtered through celite with CH2Cl2 and 
concentrated. The residue was triturated with ethyl acetate and hexanes to provide a light 
brown powder (1.4612 g, 68%) that was sufficiently pure by 
1H NMR; [α] 20
D
 +410 (c 
0.10, CHCl3); Rf = 0.15 (50% EtOAc/hexanes); IR (film) 3223, 2930, 1600 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3, 330 K) δ 7.24 (s, 2H), 7.09 (s, 2H), 6.32 (br s, 2H), 5.50 (br s, 
2H), 4.02 (s, 6H), 4.00 (br s, 2H), 3.97 (s, 6H), 2.38-2.28 (m, 2H), 1.90-1.80 (m, 2H), 
1.55-1.35 (m, 4H); 
13
C NMR (100 MHz, CDCl3, 330 K) ppm 156.2, 153.2, 147.1, 145.3, 
141.0, 115.7, 109.2, 106.6, 103.6, 56.2 (2C), 56.1, 33.0, 24.9; HRMS (CI): Exact mass 
calcd for C28H31Cl2N4O4 [M+H]
+
 557.1717, found 557.1717. 
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4
Cl
8
MeOQuinBAM (92f). A 100 mL round bottom flask was charged with Pd(dba)2 
(25.2 mg, 43.8 μmol), rac-BINAP (27.3 mg, 43.8 μmol), sodium tert-butoxide (632.0 
mg, 6.576 mmol), (R,R)-diaminocyclohexane (250.3 mg, 2.192 mmol), and the quinoline 
(1.0000 g, 4.385 mmol).
175
 Toluene (22 mL) was added, and the reaction mixture was 
heated at 70 °C and stirred for 3.5 h. The reaction was cooled to room temperature, 
diluted with CH2Cl2, and filtered through celite. The filtrate was concentrated and 
purified by column chromatography (25-50% ethyl acetate in hexanes) to provide a 
yellow solid (642.6 mg, 62%). [α] 20D  +530 (c 0.16, CHCl3); Rf = 0.31 (50% 
EtOAc/hexanes); IR (film) 3240, 2933, 1607, 1545 cm
-1
;
 1
H NMR  (400 MHz, CDCl3) δ 
7.54 (dd, J = 8.4, 0.8 Hz, 2H), 7.17 (dd, J = 7.6, 0.8 Hz, 2H), 7.01 (dd, J = 7.6, 0.8 Hz, 
2H), 6.59 (s, 2H), 6.38 (br s, 2H), 4.15-3.95 (m, 2H), 4.04 (s, 6H), 2.45-2.30 (m, 2H), 
1.85-1.70 (m, 2H), 1.50-1.30 (m, 4H); 
13
C NMR (150 MHz, CDCl3) ppm 155.9, 153.2, 
142.1, 140.0, 122.2, 121.9, 116.2, 112.7, 109.8, 56.6, 56.2, 32.5, 24.7; HRMS (ESI): 
Exact mass calcd for C26H27Cl2N4O2 [M+H]
+
 497.1511, found 497.1521. 
  
                                                 
175
 Adapted from Wagaw, S.; Rennels, R.; Buchwald, S. J Am. Chem. Soc. 1997, 119, 8451-8458. 
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4
Cl
6
MeOQuinBAM (92g). A 2-5 mL μW vial was charged with (R,R)-
diaminocyclohexane (125.2 mg, 1.096 mmol), 2,4-dichloro-6-methoxyquinoline (500 
mg, 2.190 mmol), Pd(dba)2 (12.6 mg, 22.0 μmol), rac-BINAP (13.6 mg, 22.0 μmol), and 
sodium tert-butoxide (316.2 mg, 3.290 mmol).
176
 Trifluoromethylbenzene (3.8 mL) was 
added and the resulting suspension was heated at 120 °C and stirred in the microwave for 
10 min. The reaction mixture was triturated with CH2Cl2 and filtered. The filtrate was 
concentrated and purified by column chromatography (10-20% ethyl acetate in hexanes) 
to provide a yellow solid (420.3 mg, 77%) that was pure by 
1H NMR; [α] 20
D
 +610 (c 0.18, 
CHCl3); Rf = 0.18 (20% EtOAc/hexanes); IR (film) 3218, 2925, 1605, 1495 cm
-1
;
 1
H 
NMR (600 MHz, CDCl3, 325 K) δ 7.64 (d, J = 9.0 Hz, 2H), 7.30 (d, J = 3.0 Hz, 2H), 7.25 
(dd, J = 9.0, 3.0 Hz, 2H), 6.38 (br s, 2H), 5.72 (br s, 2H), 4.05-3.90 (m, 2H), 3.91 (s, 6H), 
2.39-2.25 (m, 2H), 1.90-1.80 (m, 2H), 1.55-1.35 (m, 4H); 
13
C NMR (150 MHz, CDCl3, 
325 K) ppm 155.5, 155.4, 144.0, 141.4, 127.6, 121.9, 121.8, 111.8, 103.7, 56.1, 55.6, 
33.0, 24.9; HRMS (ESI): Exact mass calcd for C26H27Cl2N4O2 [M+H]
+
 497.1511, found 
497.1500. 
                                                 
176
 Adapted from Wagaw, S.; Rennels, R.; Buchwald, S. J Am. Chem. Soc. 1997, 119, 8451-8458. 
 
 
232 
 
4
Cl
6
MeQuinBAM (92h). A 100 mL round bottom flask was charged with Pd(dba)2 (27.1 
mg, 47.2 μmol), rac-BINAP (29.4 mg, 47.2 μmol), sodium tert-butoxide (679.8 mg, 
7.074 mmol), (R,R)-diaminocyclohexane (269.2 mg, 2.358 mmol), and the quinoline 
(1.0000 g, 4.715 mmol).
177
 Toluene (27 mL) was added, and the reaction mixture was 
heated at 80 °C and stirred for 3 h. The reaction was cooled to room temperature, diluted 
with CH2Cl2, and filtered through celite. The filtrate was concentrated and the resulting 
solid was washed with CH2Cl2 and hexanes to provide a brown powder (802.2 mg, 73%). 
[α] 20D  +310 (c 0.11, CHCl3); Rf = 0.16 (5% EtOAc/hexanes); IR (film) 3226, 2929, 2857, 
1603 cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 7.72 (s, 2H), 7.62 (d, J = 7.8 Hz, 2H), 7.43 (dd, 
J = 8.4, 1.8 Hz, 2H), 6.42 (br s, 2H), 5.77 (br s, 2H), 4.08 (br s, 2H), 2.49 (s, 6H), 2.41-
2.35 (m, 2H), 1.90-1.80 (m, 2H), 1.55-1.38 (m, 4H); 
13
C NMR (150 MHz, CDCl3) ppm 
156.1, 146.8, 141.7, 132.4, 132.1, 126.0, 123.2, 121.3, 112.1, 56.1, 32.8, 24.8, 21.3; 
HRMS (ESI): Exact mass calcd for C26H27Cl2N4 [M+H]
+
 465.1613, found 465.1602. 
  
                                                 
177
 Adapted from Wagaw, S.; Rennels, R.; Buchwald, S. J Am. Chem. Soc. 1997, 119, 8451-8458. 
 
 
233 
4
Cl
8
MeQuinBAM (92i). A 50 mL round bottom flask was charged with Pd(dba)2 (29.8 
mg, 51.9 μmol), rac-BINAP (32.3 mg, 51.9 μmol), sodium tert-butoxide (747.6 mg, 
7.779 mmol), (R,R)-diaminocyclohexane (296.1 mg, 2.593 mmol), and the quinoline 
(1.1000 g, 5.187 mmol).
178
 Toluene (24 mL) was added, and the reaction mixture was 
heated at 80 °C and stirred. The reaction mixture was monitored by TLC; after 75 min, 
complete conversion was observed. The reaction was cooled to room temperature, diluted 
with CH2Cl2, and filtered through celite. The filtrate was concentrated and purified by 
column chromatography (2-5% ethyl acetate in hexanes) to provide a yellow solid (989.7 
mg, 82%). [α] 20D  +600 (c 0.14, CHCl3); Rf = 0.34 (10% EtOAc/hexanes); IR (film) 3414, 
3279, 2932, 2856, 1604, 1525 cm
-1
;
 1
H NMR (600 MHz, CDCl3) δ 7.83 (d, J = 8.4 Hz, 
2H), 7.48 (d, J = 7.2 Hz, 2H), 7.18 (dd, J = 7.8, 7.8 Hz, 2H), 6.45 (s, 2H), 5.88 (br s, 2H), 
4.15-4.05 (m, 2H), 2.71 (s, 6H), 2.48-2.38 (m, 2H), 1.92-1.82 (m, 2H), 1.55-1.45 (m, 
2H), 1.45-1.35 (m, 2H) ; 
13
C NMR (150 MHz, CDCl3) ppm 155.5, 147.2, 142.6, 133.9, 
130.7, 122.0, 121.9, 121.1, 111.5, 56.9, 32.8, 25.0, 18.2; HRMS (ESI): Exact mass calcd 
for C26H27Cl2N4 [M+H]
+
 465.1613, found 465.1606. 
  
                                                 
178
 Adapted from Wagaw, S.; Rennels, R.; Buchwald, S. J Am. Chem. Soc. 1997, 119, 8451-8458. 
 
 
234 
4
Cl
8
OEtQuinBAM (92j). A 50 mL round bottom flask was charged with Pd(dba)2 (23.7 
mg, 41.3 μmol), rac-BINAP (25.7 mg, 41.3 μmol), sodium tert-butoxide (595.3 mg, 
6.195 mmol), (R,R)-diaminocyclohexane (235.8 mg, 2.065 mmol), and the quinoline 
(1.000 g, 4.131 mmol). Toluene (14 mL) was added, and the reaction mixture was heated 
at 80 °C and stirred. The reaction mixture was monitored by TLC; after 2.5 h, complete 
conversion was observed. The reaction was cooled to room temperature, diluted with 
CH2Cl2, and filtered through celite. The filtrate was concentrated and purified by column 
chromatography (0-20% ethyl acetate in hexanes) to provide a yellow solid (779.2 mg, 
72%). mp 102.0-104.0 °C; [α] 20D  +590 (c 1.27, CHCl3); Rf = 0.38 (25% EtOAc/hexanes); 
IR (film) 3238, 3069, 2980, 2931, 2859, 1608, 1545 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 
7.55 (dd, J = 8.0, 0.8 Hz, 2H), 7.15 (dd, J = 8.0, 0.8 Hz, 2H), 7.04 (br d, J = 7.2 Hz, 2H), 
6.59 (s, 2H), 6.57 (s, 2H), 4.27 (qd, J = 6.8, 2.0 Hz, 4H), 4.08-3.97 (m, 2H), 2.46-2.35 
(m, 2H), 1.86-1.75 (m, 2H), 1.56 (t, J = 6.8 Hz, 6H), 1.49-1.31 (m, 4H); 
13
C NMR (100 
MHz, CDCl3) ppm 155.7, 152.5, 142.0, 140.3, 122.3, 121.9, 116.3, 112.6, 111.8, 64.9, 
56.9, 32.6, 24.8, 14.9; HRMS (ESI): Exact mass calcd for C28H31Cl2N4O2 [M+H]
+
 
525.1824, found 525.1813. 
  
 
235 
 
4
Cl
8
EtQuinBAM (92k). A 50 mL round bottom flask was charged with Pd(dba)2 (25.4 
mg, 44.2 μmol), rac-BINAP (27.5 mg, 44.2 μmol), sodium tert-butoxide (637.4 mg, 
6.633 mmol), (R,R)-diaminocyclohexane (252.5 mg, 2.211 mmol), and the quinoline 
(1.000 g, 4.423 mmol).
179
 Toluene (15 mL) was added, and the reaction mixture was 
heated at 80 °C and stirred. The reaction mixture was monitored by TLC; after 2.5 h, 
complete conversion was observed. The reaction was cooled to room temperature, diluted 
with CH2Cl2, and filtered through celite. The filtrate was concentrated and purified by 
column chromatography (0-2% ethyl acetate in hexanes) to provide a light yellow solid 
(660.6 mg, 61%). mp 74.0-76.0 °C; [α] 20D  +611 (c 1.08, CHCl3); Rf = 0.53 (10% 
EtOAc/hexanes); IR (film) 3414, 3282, 2931, 2858, 1606, 1524 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.85 (dd, J = 8.0, 1.2 Hz, 2H), 7.49 (d, J = 6.4 Hz, 2H), 7.23 (dd, J = 8.0, 
7.2 Hz, 2H), 6.47 (s, 2H), 5.76 (br s, 2H), 4.16-4.04 (m, 2H), 3.29 (dq, J = 14.8, 7.6 Hz, 
2H), 3.11 (dq, J = 14.8, 7.2 Hz, 2H), 2.52-2.40 (m, 2H), 1.95-1.83 (m, 2H), 1.55-1.46 (m, 
2H), 1.46-1.36 (m, 2H), 1.41 (t, J = 7.6 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 
155.5, 146.7, 142.7, 139.7, 129.1, 122.2, 121.9, 121.3, 111.6, 56.8, 33.1, 25.01, 24.97, 
14.7; HRMS (ESI): Exact mass calcd for C28H31Cl2N4 [M+H]
+
 493.1926, found 
493.1947. 
                                                 
179
 Adapted from Wagaw, S.; Rennels, R.; Buchwald, S. J Am. Chem. Soc. 1997, 119, 8451-8458. 
 
236 
4
Cl
7,8
(Me)2QuinBAM (92l). A 50 mL round bottom flask was charged with Pd(dba)2 
(25.4 mg, 44.2 μmol), rac-BINAP (27.5 mg, 44.2 μmol), sodium tert-butoxide (637.4 
mg, 6.663 mmol), (R,R)-diaminocyclohexane (252.5 mg, 2.211 mmol), and the quinoline 
(1.000 g, 4.423 mmol). Toluene (15 mL) was added, and the reaction mixture was heated 
at 80 °C and stirred. The reaction mixture was monitored by TLC; after 2.5 h, complete 
conversion was observed. The reaction was cooled to room temperature, diluted with 
CH2Cl2, and filtered through silica gel. The filtrate was concentrated and the crude solid 
was rinsed with EtOAc/hexanes to provide a light yellow solid (723.8 mg, 66%). mp 
>260 °C;  [α] 20D  +702 (c 1.18, CHCl3); Rf = 0.49 (10% EtOAc/hexanes); IR (film) 3413, 
3279, 2931, 2857, 1607, 1527 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.4 Hz, 
2H), 7.10 (d, J = 8.4 Hz, 2H), 6.38 (s, 2H), 5.81 (br s, 2H), 4.17-4.03 (m, 2H), 2.66 (s, 
6H), 2.50-2.39 (m, 2H), 2.47 (s, 6H), 1.95-1.80 (m, 2H), 1.55-1.46 (m, 2H), 1.46-1.35 
(m, 2H); 
13
C NMR (100 MHz, CDCl3) ppm 155.6, 147.1, 142.5, 138.4, 131.3, 125.0, 
120.8, 119.5, 110.6, 56.9, 32.9, 25.1, 20.8, 13.5; HRMS (ESI): Exact mass calcd for 
C28H31Cl2N4 [M+H]
+
 493.1926, found 493.1942. 
  
 
237 
4
Cl
6,8
(MeO)2QuinBAM (92m). A 25 mL round bottom flask was charged with Pd(dba)2 
(22.3 mg, 38.7 μmol), rac-BINAP (24.1 mg, 38.7 μmol), sodium tert-butoxide (558.4 
mg, 5.811 mmol), (R,R)-diaminocyclohexane (221.2 mg, 1.937 mmol), and the quinoline 
(1.000 g, 3.874 mmol). Toluene (13 mL) was added, and the reaction mixture was heated 
at 85 °C and stirred. The reaction mixture was monitored by TLC; after 65 min, complete 
conversion was observed. The reaction was cooled to room temperature, diluted with 
CH2Cl2, and filtered through celite. The filtrate was concentrated and purified by column 
chromatography (25-30% ethyl acetate in hexanes) to provide a yellow/orange solid 
(775.7 mg, 72%). mp 120.0-122.0 °C; [α] 20D  +434 (c 1.28, CHCl3); Rf = 0.09 (25% 
EtOAc/hexanes); IR (film) 3245, 2934, 2856, 1606, 1545 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 6.86 (d, J = 2.4 Hz, 2H), 6.68 (d, J = 2.4 Hz, 2H), 6.57 (s, 2H), 6.09 (s, 2H), 
4.01 (s, 6H), 3.98-3.90 (m, 2H), 3.88 (m, 6H), 2.42-2.28 (m, 2H), 1.86-1.70 (m, 2H), 
1.52-1.35 (m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 155.0, 154.7, 154.2, 141.2, 136.0, 
122.1, 112.6, 102.2, 94.7, 56.6, 56.2, 55.4, 32.5, 24.7; HRMS (ESI): Exact mass calcd for 
C28H31Cl2N4O4 [M+H]
+
 557.1722, found 557.1738. 
 
 
238 
4
Cl
6,8
(Me)2QuinBAM (92n). A 50 mL round bottom flask was charged with Pd(dba)2 
(25.4 mg, 44.2 μmol), rac-BINAP (27.5 mg, 44.2 μmol), sodium tert-butoxide (637.4 
mg, 6.663 mmol), (R,R)-diaminocyclohexane (252.5 mg, 2.211 mmol), and the quinoline 
(1.000 g, 4.423 mmol). Toluene (15 mL) was added, and the reaction mixture was heated 
at 75 °C and stirred for 2.5 h. The reaction was cooled to room temperature, diluted with 
CH2Cl2, and filtered through celite. The filtrate was concentrated and purified by column 
chromatography (0-2% ethyl acetate in hexanes) to provide a yellow/brown solid (681.0 
mg, 62%). mp 192.0-194.0 °C;  [α] 20D  +530 (c 1.08, CHCl3); Rf = 0.52 (10% 
EtOAc/hexanes); IR (film) 3414, 3279, 2926, 2857, 1604, 1520 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.59 (s, 2H), 7.31 (s, 2H), 6.43 (s, 2H), 5.81 (br s, 2H), 4.12-4.00 (m, 
2H), 2.67 (s, 6H), 2.48-2.40 (m, 2H), 2.44 (s, 6H), 1.93-1.80 (m, 2H), 1.53-1.45 (m, 2H), 
1.45-1.33 (m, 2H); 
13
C NMR (100 MHz, CDCl3) ppm 155.1, 145.6, 142.0, 133.7, 132.8, 
131.4, 121.03, 120.96, 111.5, 56.9, 32.9, 25.1, 21.3, 18.1; HRMS (ESI): Exact mass calcd 
for C28H31Cl2N4 [M+H]
+
 493.1926, found 493.1945. 
  
 
239 
4
Cl
6
CF3QuinBAM (92o). A 25 mL round bottom flask was charged with Pd(dba)2 (14.0 
mg, 24.4 μmol), rac-BINAP (15.2 mg, 24.4 μmol), sodium tert-butoxide (352.3 mg, 
3.666 mmol), (R,R)-diaminocyclohexane (139.5 mg, 1.222 mmol), and the quinoline 
(650.0 g, 2.443 mmol). Toluene (12 mL) was added, and the reaction mixture was heated 
at 60 °C and stirred. The reaction mixture was monitored by TLC; after 2 h, complete 
conversion was observed. The reaction was cooled to room temperature, diluted with 
CH2Cl2, and filtered through celite. The filtrate was concentrated and purified by column 
chromatography (0-10% ethyl acetate in hexanes) to provide a yellow solid (285.7 mg, 
41%). mp 169.0-171.0 °C; [α] 20D  +458 (c 1.17, CHCl3); Rf = 0.16 (10% EtOAc/hexanes); 
IR (film) 3222, 2936, 1605 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 8.21 (s, 2H), 7.75 (s, 
4H), 6.47 (s, 2H), 5.97 (br s, 2H), 4.25-4.00 (m, 2H), 2.45-2.25 (m, 2H), 1.95-1.80 (m, 
2H), 1.60-1.30 (m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 157.5, 150.1, 142.8, 126.8, 
126.5, 124.4 (q, 
2
JCF = 33 Hz), 124.3 (q, 
1
JCF = 270 Hz), 122.2, 120.7, 113.2, 56.1, 32.6, 
24.7; 
19
F NMR (282 MHz, CDCl3) ppm -59.8; HRMS (ESI): Exact mass calcd for 
C26H21Cl2F6N4 [M+H]
+
 573.1047, found 573.1064. 
  
 
240 
4
Cl
6
FQuinBAM (92p). A 25 mL round bottom flask was charged with Pd(dba)2 (14.0 
mg, 24.4 μmol), rac-BINAP (15.2 mg, 24.4 μmol), sodium tert-butoxide (352.3 mg, 
3.666 mmol), (R,R)-diaminocyclohexane (139.5 mg, 1.222 mmol), and the quinoline 
(527.8 mg, 2.443 mmol). Toluene (12 mL) was added, and the reaction mixture was 
heated at 80 °C and stirred. The reaction mixture was monitored by TLC; after 1.5 h, 
complete conversion was observed. The reaction was cooled to room temperature, diluted 
with CH2Cl2, and filtered through celite. The filtrate was concentrated and washed with 
CH2Cl2/hexanes to provide a yellow solid (279.6 mg, 48%). mp 210.0 °C (decomp.); [α]
20
D  +330 (c 0.20, CHCl3); Rf = 0.14 (10% EtOAc/hexanes); IR (film) 3217, 2928, 1607 
cm
-1
;
 1
H NMR (500 MHz, CDCl3) δ 7.67 (s, 2H), 7.57 (br d, J = 7.0 Hz, 2H), 7.34 (ddd, J 
= 8.5, 8.5, 2.5 Hz, 2H), 6.44 (s, 2H), 5.70 (s, 2H), 4.15-3.95 (m, 2H), 2.40-2.25 (m, 2H), 
1.90-1.80 (m, 2H), 1.55-1.35 (m, 4H); 
13
C NMR (125 MHz, CDCl3) ppm 158.3 (d, 
1
JCF = 
239 Hz), 156.1, 145.3, 141.5, 128.1, 121.8, 119.8 (d, 
2
JCF = 25 Hz), 112.9, 108.3 (d, 
2
JCF 
= 25 Hz), 56.1, 32.8, 24.8; HRMS (ESI): Exact mass calcd for C24H21Cl2F2N4 [M+H]
+
 
473.1111, found 473.1126. 
  
 
241 
  
MorphoBAM (94a). A 2-5 mL microwave vial was charged with 
4
ClBAM (94.0 mg, 
214 μmol), morpholine (370 μL, 4.28 mmol), and trifluoromethylbenzene (1.4 mL). This 
suspension was heated at 230 °C and stirred in the microwave for 1 aAlh. The reaction 
was then concentrated and purified by column chromatography (5-10% methanol in 
dichloromethane) to provide a light brown solid. This material was dissolved in 
dichloromethane and then washed with 3 M aq NaOH. The combined organic layers were 
dried over MgSO4 and concentrated to afford a light brown powder (85.6 mg, 74%). mp 
254.0-256.0 °C; [α] 20D  +361 (c 1.08, CHCl3); Rf = 0.29 (10% MeOH/0.5% 
AcOH/CH2Cl2);); IR (film) 3290, 2929, 2855, 1609 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 
7.68 (d, J = 7.6 Hz, 2H), 7.65 (dd, J = 8.0, 0.8 Hz, 2H), 7.45 (ddd, J = 8.0, 6.8, 1.2 Hz, 
2H), 7.09 (ddd, J = 8.4, 6.8, 1.2 Hz, 2H), 5.97 (br s, 2H), 5.46 (s, 2H), 4.24-4.10 (m, 2H), 
3.83-3.70 (m, 8H), 2.92-2.80 (m, 4H), 2.55-2.45 (m, 4H), 2.37-2.27 (m, 2H), 1.92-1.80 
(m, 2H), 1.58-1.40 (m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 158.1, 156.5, 149.2, 
129.0, 126.4, 123.2, 120.7, 119.0, 99.8, 66.8, 56.4, 52.1, 33.1, 25.0; HRMS (ESI): Exact 
mass calcd for C32H39N6O2 [M+H]
+
 539.3134, found 539.3114. 
  
 
242 
PipeBAM (94b). A 2-5 mL microwave vial was charged with 
4
ClBAM (100.0 mg, 227.6 
μmol), piperidine (449 μL, 4.55 mmol), and trifluoromethylbenzene (1.5 mL). This 
suspension was heated at 230 °C and stirred in the microwave for 1h. The reaction was 
then concentrated and purified by column chromatography (3-20% methanol in 
dichloromethane) to provide a light brown solid. This material was dissolved in 
dichloromethane and then washed with 3 M aq NaOH. The combined organic layers were 
dried over MgSO4 and concentrated to afford a light brown powder (90.2 mg, 74%). mp 
225.5-227.5 °C; [α] 20D  +362 (c 1.12, CHCl3); Rf = 0.31 (10% MeOH/0.5% 
AcOH/CH2Cl2); IR (film) 3288, 2933, 2854, 1607 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 
7.70-7.62 (m, 4H), 7.42 (ddd, J = 8.4, 6.8, 1.6 Hz, 2H), 7.08 (ddd, J = 8.0, 7.2, 1.2 Hz, 
2H), 5.80 (br s, 2H), 5.46 (s, 2H), 4.24-4.10 (m, 2H), 2.89-2.70 (m, 4H), 2.58-2.46 (m, 
4H), 2.35-2.25 (m, 2H), 1.90-1.80 (m, 2H), 1.72-1.40 (m, 16 H); 
13
C NMR (100 MHz, 
CDCl3) ppm 158.4, 157.9, 149.2, 128.7, 126.3, 123.6, 120.4, 119.7, 99.6, 56.4, 53.0, 
33.2, 26.0, 25.1, 24.4; HRMS (ESI): Exact mass calcd for C34H43N6 [M+H]
+
 535.3549, 
found 535.3543. 
  
 
243 
MPZBAM (94c). A 2-5 mL microwave vial was charged with 
4
ClBAM (60.0 mg, 137 
μmol), N-methylpiperizine (303 μL, 2.73 mmol), and trifluoromethylbenzene (900 μL). 
This suspension was heated at 230 °C and stirred in the microwave for 1 h. The reaction 
was then concentrated and diluted with CH2Cl2. The solution was washed with 3 M aq 
NaOH. The combined organic layers were dried over MgSO4 and concentrated to afford a 
light brown powder (65.3 mg, 85%). mp 234.0-235.0 °C; [α] 20D  +297 (c 1.07, CHCl3); Rf 
= 0.02 (10% MeOH/0.5% AcOH/CH2Cl2); IR (film) 3284, 2935, 2846, 2800, 1608 cm
-1
;
 
1
H NMR (400 MHz, CDCl3) δ 7.67 (br d, J = 7.6 Hz, 2H), 7.66 (dd, J = 8.0, 1.2 Hz, 2H), 
7.43 (ddd, J = 8.4, 7.2, 1.6 Hz, 2H), 7.08 (ddd, J = 8.0, 7.2, 0.8 Hz, 2H), 5.94 (br s, 2H), 
5.59 (s, 2H), 4.17-4.04 (m, 2H), 3.10-2.85 (m, 4H), 2.73-2.62 (m, 4H), 2.61-2.42 (m, 
8H), 2.38-2.28 (m, 2H), 2.33 (s, 6H), 1.89-1.77 (m, 2H), 1.55-1.35 (m, 4H); 
13
C NMR 
(100 MHz, CDCl3) ppm 158.1, 156.7, 149.2, 128.9, 126.3, 123.3, 120.6, 119.3, 99.8, 
56.5, 55.0, 51.5, 46.0, 33.1, 25.0; HRMS (ESI): Exact mass calcd for C34H45N8 [M+H]
+
 
565.3767, found 565.3746. 
 
MANBAM (94d). A 2-5 mL microwave vial was charged with 
4
ClBAM (150.0 mg, 
341.0 μmol), N-methylaniline (1.48 mL, 13.6 mmol), and trifluoromethylbenzene (2.3 
 
 
244 
mL). This suspension was heated at 240 °C and stirred in the microwave for 3 h. The 
reaction was then concentrated and purified by column chromatography (0-10% methanol 
in dichloromethane) to provide a light brown solid. This material was dissolved in 
dichloromethane and then washed with 3 M aq NaOH. The combined organic layers were 
dried over MgSO4 and concentrated to afford a light brown powder (111.7 mg, 57%).mp 
205.0-207.0 °C; [α] 20D  +349 (c 1.14, CHCl3); Rf = 0.30 (10% MeOH/0.5% 
AcOH/CH2Cl2); IR (film) 3405, 3266, 3059, 2930, 2857, 1611 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.68 (dd, J = 8.4, 0.8 Hz, 2H), 7.43-7.35 (m, 4H), 7.11 (dd, J = 8.4, 7.2 Hz, 
4H), 6.96 (ddd, J = 6.8, 6.8, 1.2 Hz, 2H), 6.84 (dd, J = 7.2, 7.2 Hz, 2H), 6.71 (d, J = 8.0 
Hz, 4H), 6.08 (s, 2H), 5.84 (br s, 2H), 4.23-4.11 (m, 2H), 3.08 (s, 6H), 2.45-2.30 (m, 2H), 
1.90-1.80 (m, 2H), 1.60-1.40 (m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 158.2, 153.8, 
149.54, 149.48, 129.3, 129.0, 126.2, 124.4, 121.2, 120.4, 120.3, 118.1, 106.4, 56.3, 41.0, 
33.1, 25.0; HRMS (ESI): Exact mass calcd for C38H39N6 [M+H]
+
 579.3236, found 
579.3256. 
 
 
HomopipeBAM (94h). A 2-5 mL microwave vial was charged with 
4
ClBAM (60.0 mg, 
137 μmol), homopiperidine (308 μL, 2.73 mmol), and trifluoromethylbenzene (910 μL). 
This suspension was heated at 230 °C and stirred in the microwave for 1 h. The reaction 
was then concentrated and purified by column chromatography (5-10% methanol in 
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dichloromethane w/ 0.5% AcOH) to provide a light brown solid. This material was 
dissolved in dichloromethane and then washed with 3 M aq NaOH. The combined 
organic layers were dried over MgSO4 and concentrated to afford a light brown powder 
(62.0 mg, 81%). mp 186.0-188.0 °C; [α] 20D  +330 (c 0.50, CHCl3); Rf = 0.31 (10% 
MeOH/0.5% AcOH/CH2Cl2); IR (film) 3303, 2928, 2854, 1600 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.74 (br d, J = 8.0 Hz, 2H), 7.66 (br d, J = 8.4 Hz, 2H), 7.42 (ddd, J = 
8.4, 7.2, 1.6 Hz, 2H), 7.07 (ddd, J = 8.4, 6.8, 1.2 Hz, 2H), 5.65 (br s, 2H), 5.54 (s, 2H), 
4.22-4.05 (m, 2H), 3.12-3.02 (m, 4H), 2.95-2.82 (m, 4H), 2.35-2.20 (m, 2H), 1.90-1.78 
(m, 2H), 1.78-1.58 (m, 16 H), 1.55-1.35 (m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 
158.4, 158.3, 149.5, 128.5, 126.3, 124.2, 120.1, 119.9, 98.8, 56.4, 54.2, 33.3, 28.6, 27.3, 
25.1; HRMS (ESI): Exact mass calcd for C36H47N6 [M+H]
+
 563.3862, found 563.3844. 
 
4
(Me2N)BAM (94i). A 0.5-2.0 mL microwave vial was charged with the corresponding 
4
ClBAM (200.0 mg, 457.3 μmol), Me2NH·HCl (372.9 mg, 4.573 mmol), triethylamine 
(1.0 mL, 7.1 mmol) and trifluoromethylbenzene (1 mL). This suspension was heated at 
200 °C and stirred in the microwave for 10 min. The reaction was then concentrated and 
purified by column chromatography (2-5% MeOH/CH2Cl2 w/ 0.5% AcOH). This 
material was dissolved in dichloromethane and then washed with 3 M aq NaOH. The 
combined organic layers were dried over MgSO4 and concentrated to afford an off white 
powder (74.5 mg, 36%). mp 216.0-217.5 °C; [α] 20D  +529 (c 1.01, CHCl3); Rf = 0.40 (10% 
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MeOH/0.5% AcOH/CH2Cl2); IR (film) 3262, 2931, 2855, 1604, 1534 cm
-1
;
 1
H NMR 
(600 MHz, CDCl3) δ 7.74 (dd, J = 8.4, 1.2 Hz, 2H), 7.68 (d, J = 8.4 Hz, 2H), 7.44 (ddd, J 
= 8.4, 7.2, 1.2 Hz, 2H), 7.10 (ddd, J = 8.4, 7.2, 1.2 Hz, 2H), 5.77 (br s, 2H), 5.55 (s, 2H), 
4.20-4.07 (m, 2H), 2.61 (s, 12 H), 2.47-2.37 (m, 2H), 1.89-1.78 (m, 2H), 1.55-1.39 (m, 
4H); 
13
C NMR (125 MHz, CDCl3) ppm 158.2, 157.7, 149.4, 128.7, 126.3, 124.1, 120.4, 
119.3, 98.6, 56.4, 43.5, 33.3, 25.1; HRMS (CI): Exact mass calcd for C28H35N6 [M+H]
+
 
455.2918, found 455.2914. 
 
(
6
(
9
Anth)
2
Pyr)-PBAM (98). A 2-5 mL microwave vial was charged with the 
corresponding 
4
ClBAM (355.0 mg, 672.2 μmol), pyrrolidine (552 μL, 6.72 mmol), and 
trifluoromethylbenzene (3.4 mL). This suspension was heated at 180 °C and stirred in the 
microwave for 2 h. The reaction was then concentrated and purified by column 
chromatography (5-10% methanol in dichloromethane w/ 0.5% AcOH) to provide a 
yellow solid. This material was dissolved in dichloromethane and then washed with 3 M 
aq NaOH. The combined organic layers were dried over MgSO4 and concentrated to 
afford a light brown powder (285 mg, 75%). mp 151.0-153.0 °C; [α] 20D  +257 (c 1.09, 
CHCl3); Rf = 0.33 (10% MeOH/0.5% AcOH/CH2Cl2); IR (film) 3255, 3052, 2928, 2856, 
1590, 1524 cm
-1
;
 1
H NMR (500 MHz, CDCl3) δ 8.47 (s, 1H), 8.02 (d, J = 8.5 Hz, 2H), 
7.98 (d, J = 8.5 Hz, 1H), 7.90-7.80 (m, 2H), 7.69 (d, J = 8.0 Hz, 1H), 7.50-7.38 (m, 4H), 
7.38-7.30 (m, 2H), 7.08 (dd, J = 8.0, 8.0 Hz, 1H), 6.62 (d, J = 7.0 Hz, 1H), 6.45-6.25 (m, 
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2H), 5.58 (s, 1H), 4.75-4.55 (m, 1H), 4.20-4.00 (m, 1H), 3.78-3.68 (m, 1H), 3.52-3.42 
(m, 4H), 2.45-2.35 (m, 1H), 2.20-2.10 (m, 1H), 1.98-1.88 (m, 4H), 1.75-1.65 (m, 2H), 
1.48-1.30 (m, 4H); 
13
C NMR (150 MHz, CDCl3) ppm 158.7, 157.7, 155.4, 153.6, 149.5, 
136.6, 136.5, 131.4, 131.3, 129.9, 129.7, 128.8, 128.2, 128.1, 126.8, 126.6, 125.14, 
125.07, 124.9 (2C), 124.8, 119.6, 118.4, 114.9, 107.1, 91.7, 56.7, 54.2, 51.8, 32.5, 32.3, 
25.6, 24.8, 24.1 (1 carbon overlapping); HRMS (CI): Exact mass calcd for C38H38N5 
[M+H]
+
 564.3122, found 564.3120. 
 
 
(
6
Mes
2
Pyr)-PBAM·HOTf (99·HOTf). A 0.5-2.0 mL microwave vial was charged with 
the corresponding 
4
ClBAM (95.0 mg, 202 μmol), pyrrolidine (166 μL, 2.02 mmol), and 
trifluoromethylbenzene (200 μL). This suspension was heated at 180 °C and stirred in the 
microwave for 2 h. The reaction was then concentrated and purified by column 
chromatography (5-15% methanol in dichloromethane w/ 0.5% AcOH). This material 
was dissolved in dichloromethane and then washed with 3 M aq NaOH. The combined 
organic layers were dried over MgSO4 and concentrated to afford a light brown powder 
(106.5 mg, >99%). mp 108.0-110.0 °C; [α] 20D  +8.3 (c 0.58, CHCl3); Rf = 0.35 (10% 
MeOH/0.5% AcOH/CH2Cl2); IR (film) 3298, 2934, 2866, 1646, 1608 cm
-1
;
 1
H NMR 
(400 MHz, CDCl3,325K) δ 8.03 (d, J = 8.4 Hz, 1H), 7.76 (dd, J = 8.0, 8.0 Hz, 1H), 7.56-
7.46 (m, 2H), 7.25-7.18 (m, 1H), 7.10 (d, J = 8.4 Hz, 1H), 6.82 (s, 2H), 6.37 (d, J = 7.2 
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Hz, 1H), 5.78 (s, 1H), 3.93-3.80 (m, 2H), 3.79-3.64 (m, 4H), 2.26 (s, 3H), 2.15-2.05 (m, 
1H), 2.06 (s, 6H), 1.90-1.40 (11H), 2NH, HOTf not observed; 
13
C NMR (150 MHz, 
CDCl3, 325 K) ppm 176.7, 155.5, 155.3, 151.9, 142.3, 139.1, 138.5, 135.8, 131.9, 128.5, 
125.8, 123.5, 122.9, 120.4 (q, 
1
JCF  = 317 Hz), 118.6, 115.7, 113.7, 108.2, 85.1, 57.2, 
56.6, 53.0, 32.01, 31.97, 25.8, 24.5, 24.3, 21.0, 19.5, 1C broadened/overlapping;
 19
F 
NMR (282 MHz, CDCl3) ppm -76.6; HRMS (ESI): Exact mass calcd for C33H40N5 [M-
CF3SO3]
+
 506.3284, found 506.3267. 
 
3
QuinPBAM·HOTf (100·HOTf). A 0.5-2.0 mL microwave vial was charged with the 
corresponding 
4
ClBAM (71.4 mg, 177 μmol), pyrrolidine (146 μL, 1.77 mmol), and 
trifluoromethylbenzene (830 μL). This suspension was heated at 180 °C and stirred in the 
microwave for 2 h. The reaction was then concentrated and purified by column 
chromatography (5-10% methanol in dichloromethane w/ 0.5% AcOH) to provide a light 
brown solid (50.0 mg, 65%). To a stirring CH2Cl2 solution of this material was added 1 
equivalent of triflic acid. The solution was concentrated to leave a yellow/brown solid. 
Mp 131.0-133.0 °C; [α] 20D  +170 (c 0.55, CHCl3); Rf = 0.34 (10% MeOH/0.5% 
AcOH/CH2Cl2); IR (film) 3309, 2938, 2865, 1643, 1610, 1525 cm
-1
;
 1
H NMR (600 MHz, 
CDCl3) δ 10.78 (br s, 1H), 8.40 (d, J = 1.2 Hz, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.58 (d, J = 
7.8 Hz, 1H), 7.55 (br d, J = 7.2 Hz, 1H), 7.41-7.32 (m, 2H), 7.29 (dd, J = 7.2 Hz, 1H), 
7.27-7.21 (m, 2H), 7.10 (dd, J = 7.8 Hz, 1H), 5.59 (s, 1H), 5.55 (br s, 1H), 4.85 (br s, 
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1H), 3.90-3.70 (m, 1H), 3.70-3.30 (m, 5H), 2.12-2.01 (m, 2H), 1.94-1.80 (m, 4H), 1.80-
1.70 (m, 2H), 1.68-1.54 (m, 2H), 1.48-1.30 (m, 2H); 
13
C NMR (150 MHz, CDCl3) ppm 
154.4, 151.8, 142.0, 139.6, 137.8, 137.2, 131.5, 129.8, 127.6, 126.6, 126.0, 125.7, 124.6, 
122.8, 120.3 (q, 
1
JCF = 318 Hz), 118.1, 115.4, 114.5, 85.8, 57.02, 56.97, 52.6, 32.3, 31.7, 
25.6, 24.6, 24.4; 
19
F NMR (282 MHz, CDCl3) ppm -76.4; HRMS (ESI): Exact mass calcd 
for C28H32N5 [M-CF3SO3]
+
 438.2658, found 438.2649. 
tert-Butyl (1R,2S)-1,2-bis(4-chlorophenyl)-2-nitroethylcarbamate (101). Imine 
(1.5000 g, 6.2580 mmol) and H,
4
Pyrrolidine
6,7
(MeO)2Quin-BAM (196.1 mg, 312.9 
μmol) were dispensed into a 100 mL round bottom flask equipped with stir bar. Toluene 
(63 mL) was added and the mixture was chilled to -78 °C before addition of the 
nitroalkane 9 (1.1810 g, 6.8840 mmol). The reaction was stirred at -78 °C for 24 h. The 
reaction was kept at the reaction temperature and filtered directly through a pad of silica 
gel with CH2Cl2. The filtrate was concentrated to give 2.2772 g of a white solid that was 
6:1 anti:syn. A portion (1.1000 g) of this material was recrystallized from toluene to 
provide colorless crystals. The crystalline material (586.8 mg) was separated from the 
mother liquor and found to be >200:1 dr, 97% ee by chiral HPLC; (Chiralcel AD-H, 12% 
i
PrOH/hexanes, 1 mL/min, tr(anti, major) = 30.5 min, tr(anti, minor) = 12.8 min, tr(syn, 
major) = 14.9 min, tr(syn, minor) = 45.6 min). Mp 172.0-174.0 °C; [α]
20
D
  -150 (c 0.13, 
CHCl3); Rf = 0.24 (20% EtOAc/hexanes); IR (film) 3381, 2982, 1682, 1551, 1521 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 7.35 (d, 
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J = 8.4 Hz, 2H), 7.28 (d, J = 8.8 Hz, 2H), 5.76 (d, J = 9.6 Hz, 1H), 5.58 (dd, J = 9.6, 9.6 
Hz, 1H), 4.78 (d, J = 9.6 Hz, 1H), 1.28 (s, 9H); 
13
C NMR (150 MHz, CDCl3) ppm 154.2, 
136.6, 135.6, 134.9, 130.1, 129.7, 129.3, 129.1, 128.6, 93.2, 80.8, 56.1, 28.0; HRMS 
(CI): Exact mass calcd for C19H21Cl2N2O4 [M+H]
+
 411.0873, found 411.0865. 
tert-butyl (1R,2S)-2-(2-bromophenyl)-1-(4-chlorophenyl)-2-nitroethylcarbamate 
(101b). According to the general procedure, column chromatography (7-25% ethyl 
acetate in hexanes) afforded a white solid (41.4 mg, 91%) that was found to be 76% ee 
and 4:1 dr by chiral HPLC; (Chiralcel AD-H, 10% iPrOH/hexanes, 1 mL/min, tr(anti, 
major) 8.7 min, tr(anti, minor) = 16.8 min, tr(syn, major) = 14.5 min, tr(syn, minor) = 25.1 
min); Mp 143.0-145.0 °C; Rf = 0.46 (20% EtOAc/hexanes); IR (film) 3500-3250 (broad), 
2979, 2930, 1704, 1556 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.78 (dd, J = 8.0, 1.6 Hz, 
1H), 7.57 (dd, J = 8.0, 1.2 Hz, 1H), 7.40 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.38-7.26 (m, 
5H), 6.44 (d, J = 10.4 Hz, 1H), 5.70 (br s, 1H), 4.92 (br s, 1H), 1.23 (s, 9H); 
13
C NMR 
(100 MHz, CDCl3) ppm 153.9, 135.8, 134.8, 133.0, 131.5, 131.0, 129.3, 128.9, 128.6, 
128.2, 125.5, 91.6, 80.5, 56.2, 28.0; HRMS (ESI): Exact mass calcd for 
C19H20BrClN2NaO4 [M+Na]
+
 477.0193, found 477.0169. 
tert-Butyl (1R,2S)-2-(3-bromophenyl)-1-(4-chlorophenyl)-2-nitroethylcarbamate 
(101c). According to the general procedure, column chromatography (7-25% ethyl 
acetate in hexanes) afforded a white solid (41.5 mg, 91%) that was found to be 89% ee 
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and 13:1 dr by chiral HPLC; (Chiralcel AD-H, 15% 
i
PrOH/hexanes, 1 mL/min, tr(anti, 
major) 29.7 min, tr(anti, minor) = 14.6 min, tr(syn, major) = 13.4 min, tr(syn, minor) = 
17.2 min); Mp 178.0-179.0 °C; [α] 20
D
 -39 (c 0.15, CHCl3); Rf = 0.40 (20% 
EtOAc/hexanes); IR (film) 3388, 2982, 1681, 1549, 1519 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.71 (br s, 1H), 7.58 (ddd, J = 8.0, 1.6, 0.8 Hz, 1H), 7.52 (br d, J = 8.0 Hz, 1H), 
7.35 (d, J = 8.8 Hz, 2H), 7.29 (dd, J = 7.6, 7.6 Hz, 1H), 7.29 (d, J = 8.8 Hz, 2H), 5.75 (br 
s, 1H), 5.56 (br m, 1H), 4.87 (br s, 1H), 1.29 (s, 9H); 
13
C NMR (100MHz, CDCl3) ppm 
154.2, 135.6, 134.9, 133.5, 133.3, 131.8, 130.4, 129.3, 128.6, 127.2, 122.8, 93.1, 80.8, 
56.3, 28.0; HRMS (ESI): Exact mass calcd for C19H20BrClN2NaO4 [M+Na]
+
 477.0193, 
found 477.0197. 
tert-Butyl (1R,2S)-1-(4-chlorophenyl)-2-(naphthalen-2-yl)-2-nitroethylcarbamate 
(101d). According to the general procedure, column chromatography (7-25% ethyl 
acetate in hexanes) afforded a white solid (42.1 mg, 99%) that was found to be 80% ee 
and 10:1 dr by chiral HPLC; (Chiralcel AD-H, 15% 
i
PrOH/hexanes, 1 mL/min, tr(anti, 
major) 53.9 min, tr(anti, minor) = 18.0 min, tr(syn, major) = 16.7 min, tr(syn, minor) = 
26.3 min); Mp 185.5-187.0 °C; [α] 20
D
 -27 (c 0.15, CHCl3); Rf = 0.32 (20% 
EtOAc/hexanes); IR (film) 3388, 2980, 1683, 1550, 1520 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 8.01 (br s, 1H), 7.92-7.85 (m, 3H), 7.65 (dd, J = 8.8, 2.0 Hz, 1H), 7.59-7.52 (m, 
2H), 7.38-7.32 (m, 4H), 5.95 (br d, J = 8.8 Hz, 1H), 5.72 (br dd, J = 9.2, 9.2 Hz, 1H), 
4.86 (d, J = 8.8 Hz, 1H), 1.18 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.2, 136.1, 
134.7, 134.0, 132.8, 129.3, 129.2, 129.0, 128.7, 128.6, 128.3, 127.7, 127.4, 126.9, 124.6, 
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94.2, 80.7, 56.0, 28.0; HRMS (ESI): Exact mass calcd for C23H23ClN2NaO4 [M+Na]
+
 
449.1244, found 449.1256. 
tert-Butyl (1R,2S)-1-(4-chlorophenyl)-2-nitro-2-(4-nitrophenyl)ethylcarbamate 
(101e). According to the general procedure, column chromatography (15-30% ethyl 
acetate in hexanes) afforded a white solid (41.5 mg, 99%) that was found to be 76% ee 
and 2:1 dr by chiral HPLC; (Chiralcel IA, 10% EtOH/hexanes, 1 mL/min, tr(d1, major) 
9.8 min, tr(d1, minor) = 12.6 min, tr(d2, major) = 21.5 min, tr(d2, minor) = 52.8 min); Mp 
165.5-166.0 °C; Rf = 0.07 (10% EtOAc/hexanes); IR (film) 3405, 2981, 2926, 1681, 
1551, 1522 cm
-1
;
 1
H NMR (400 MHz, DMSO-d6) d1 δ 8.35 (d, J = 8.8 Hz, 2H), 7.97 (d, J 
= 8.8 Hz, 2H), 7.55 (d, J = 8.4 Hz, 2H), 7.48 (d, J = 8.4 Hz, 2H), 6.16 (d, J = 11.2 Hz, 
1H), 5.57 (dd, J = 10.8, 10.8 Hz, 1H), 1.14 (s, 9H); d2 δ 8.13 (d, J = 8.8 Hz, 2H), 8.13-
8.07 (1H), 7.82 (d, J = 8.8 Hz, 2H), 7.34 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 8.4 Hz, 2H), 
6.20 (d, J = 11.2 Hz, 1H), 5.69 (dd, J = 10.4, 10.4 Hz, 1H), 1.34 (s, 9H); 
13
C NMR (100 
MHz, DMSO-d6) ppm 154.5, 154.2, 148.5, 148.3, 138.3, 137.9, 136.9, 136.1, 133.2, 
132.6, 130.3, 130.2, 129.8, 129.6, 128.8, 128.5, 123.9, 123.7, 92.2, 91.9, 78.9 (2C), 56.3, 
55.6, 28.0, 27.7. HRMS (ESI): Exact mass calcd for C19H20ClN3NaO6 [M+Na]
+
 
444.0938, found 444.0952. 
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tert-Butyl (1R,2S)-1-(4-chlorophenyl)-2-(4-methoxyphenyl)-2-nitroethylcarbamate 
(101f). Product was made according to the general procedure with the exception that 
reaction warmed to -20 °C and stirred for 1h before filtration. Column chromatography 
(7-25% ethyl acetate in hexanes) afforded a white solid (36.5 mg, 90%) that was found to 
be 86% ee and 17:1 dr by chiral HPLC; (Chiralcel AD-H, 15% 
i
PrOH/hexanes, 1 
mL/min, tr(anti, major) 27.6 min, tr(anti, minor) = 14.3 min, tr(syn, major) = 16.7 min, 
tr(syn, minor) = 37.9 min); Mp 165.0-166.0 °C; [α]
20
D
 -9.1 (c 0.11, CHCl3); Rf = 0.27 
(20% EtOAc/hexanes); IR (film) 3385, 2981, 1683, 1552, 1514 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.47 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.4 Hz, 
2H), 6.92 (d, J = 8.4 Hz, 2H), 5.68 (br s, 1H), 5.58 (br s, 1H), 4.85 (br s, 1H), 3.82 (s, 
3H), 1.26 (s, 9H); 
13
C NMR (150 MHz, CDCl3) ppm 161.1, 154.3, 136.2, 134.6, 130.1, 
129.1, 128.6, 123.2, 114.3, 93.6, 80.6, 56.1, 55.4, 28.1. HRMS (ESI): Exact mass calcd 
for C20H23ClN2NaO5 [M+Na]
+
 429.1193, found 429.1211. 
tert-butyl (1R,2S)-1-(4-chlorophenyl)-2-nitro-2-(pyridin-4-yl)ethylcarbamate (101g). 
According to the general procedure, column chromatography (7-25% ethyl acetate in 
hexanes) afforded a yellow solid (21.7 mg, 57%) that was found to be 71% and 67% ee 
(major and minor diastereomer respectively) and 1.4:1 dr by chiral HPLC; (Chiralcel 
AD-H, 10% EtOH/hexanes, 1 mL/min, tr(anti, major) 13.3 min, tr(anti, minor) = 9.0 min, 
tr(syn, major) = 19.1 min, tr(syn, minor) = 39.4 min); Mp 145.0-146.5 °C; Rf = 0.10 (40% 
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EtOAc/hexanes); IR (film) 3300, 2979, 2932, 1710, 1559 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) d1 δ 8.70 (br s, 2H), 7.48 (br s, 2H), 7.35 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 
2H), 5.81 (br s, 1H), 5.58 (br s, 1H), 4.95 (br s, 1H), 1.26 (s, 9H); d2 δ 8.63 (br s, 1H), 
7.32-7.25 (m, 4H), 7.14 (d, J = 8.4 Hz, 2H), 5.89 (br s, 1H), 5.67 (br s, 1H), 5.60-5.50 (m, 
1H), 1.36 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 154.1 (2C), 150.5, 150.4, 139.7, 
139.6, 135.1, 135.0, 134.6 (2C), 129.4, 129.3, 128.6, 128.1, 123.2, 122.2, 92.8, 92.6, 81.0 
(2C), 56.7, 56.3, 28.1, 28.0. 
Benzyl 3-hydroxyazetidine-1-carboxylate (112). 3-Hydroxyazetidine hydrochloride 
(5.000 mg, 45.64 mmol) was dissolved in 50 mL of deionized water. Sodium bicarbonate 
(17.43 g, 207.5 mmol) was added at room temperature. The stirring mixture was chilled 
to 0 °C, then benzylchloroformate (7.078 g, 41.49 mmol) was added. The reaction 
mixture was allowed to warm gradually to room temperature overnight. The reaction 
mixture was diluted with water before extraction with CH2Cl2. The combined organic 
layers were dried with MgSO4 and concentrated to a slightly golden oil (8.208 g, 95%). 
Rf = 0.14 (50% EtOAc/hexanes); IR (film) 3405, 2951, 2881, 1683 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) δ 7.40-7.28 (m, 5H), 5.08 (s, 2H), 4.58 (br s, 1H), 4.20 (dd, J = 10.0, 6.5 
Hz, 2H), 3.87 (dd, J = 10.0, 4.5 Hz, 2H), 3.04 (d, J = 5.5 Hz, 1H); 
13
C NMR (125 MHz, 
CDCl3) ppm 156.5, 136.5, 128.5, 128.1, 127.9, 66.8, 61.7, 59.1; HRMS (EI): Exact mass 
calcd for C11H13NO3 [M]
+
 207.0890, found 207.0884. 
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Benzyl 3-(trifluoromethylsulfonyloxy)azetidine-1-carboxylate (112b). The following 
is modified from the procedure of Watanabe et al., Tetrahedron, 2008, 64, 4072. To a 
stirring solution of benzyl 3-hydroxyazetidine-1-carboxylate (1.000 g, 4.826 mmol), 
pyridine (778 μL, 9.652 mmol), and CH2Cl2 (24 mL) was added trifluoromethanesulfonic 
anhydride (974 μL, 5.791 mmol) dropwise at -20 °C. The reaction was allowed to 
gradually warm to room temperature while stirring. The reaction mixture was 
concentrated then dissolved in ethyl acetate. The organic solution was washed with water, 
then sat aq NaHCO3, then brine before drying with MgSO4. A golden oil was obtained 
(1.539 g, 94%). Rf = 0.30 (20% EtOAc/hexanes); IR (film) 3354, 3262, 2958, 1718 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.40-7.30 (m, 5H), 5.47-5.40 (m, 1H), 5.11 (s, 3H), 4.41 
(ddd, J = 11.2, 6.8, 0.8 Hz, 2H), 4.25 (ddd, J = 10.8, 4.0, 0.8 Hz, 2H); 
13
C NMR (125 
MHz, CDCl3) ppm 155.9, 135.9, 128.5, 128.3, 128.1, 118.3 (q, J = 319.5 Hz), 74.3, 67.3, 
56.5; HRMS (EI): Exact mass calcd for C12H12F3NO5S [M]
+
 339.0383, found 339.0389. 
Benzyl 3-iodoazetidine-1-carboxylate (114). The triflate (142.2 mg, 419 μmol) was 
dissolved in acetone (1 mL) in a vial equipped with a stir bar. Sodium iodide (125.6 mg, 
838 μmol) was then added and the reaction was stirred at room temperature for 2 h. The 
reaction was then filtered through silica with CH2Cl2. The filtrate was filtered to remove 
the precipitated solid. That precipitated solid was washed with CH2Cl2 and the combined 
organic layers were concentrated to a red oil (118.2 mg, 89%); Rf = 0.25 (20% 
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EtOAc/hexanes); IR (film) 2953, 2884, 1710 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.41-
7.29 (m, 5H), 5.10 (s, 2H), 4.73 (dd, J = 9.2, 7.6 Hz, 2H), 4.50 (tt, J = 7.6, 5.2 Hz, 1H), 
4.36 (dd, J = 10.4, 5.2 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) ppm 155.7, 136.2, 128.5, 
128.2, 128.0, 67.0, 61.6; HRMS (ESI): Exact mass calcd for C11H12INNaO2 [M+Na]
+
 
339.9811, found 339.9821. 
Benzyl 3-nitroazetidine-1-carboxylate (116). To a solution of the iodide (457.3 mg, 
1.442 mmol) in DMF (7.2 mL) was added urea (173.3 mg, 2.884 mmol), then 
phloroglucinol (181.8 mg, 1.442 mmol), then sodium nitrite (497.6 mg, 7.211 mmol). 
The reaction was then heated to 50 °C and stirred for 19 h. The reaction was then poured 
onto water and extracted with ethyl acetate, and the combined organic layers were then 
washed with water, dried over MgSO4, and concentrated. The resulting oil was purified 
by column chromatography (10-20% ethyl acetate in hexanes) to provide the nitro 
azetidine as a white solid (136.4 mg, 40%). Mp 90.0-92.0 °C; Rf = 0.35 (40% 
EtOAc/hexanes); IR (film) 2959, 1713, 1557 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.40-
7.30 (m, 5H), 5.19-5.12 (m, 1H), 5.13 (s, 2H), 4.49 (dd, J = 10.4, 4.8 Hz, 2H), 4.42 (dd, J 
= 10.4, 8.0 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) ppm 155.8, 135.9, 128.5, 128.3, 128.1, 
71.6, 67.3, 54.1; HRMS (EI): Exact mass calcd for C11H12N2O4 [M]
+
 236.0792, found 
236.0784. 
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(R)-benzyl 3-((tert-butoxycarbonylamino)(phenyl)methyl)-3-nitroazetidine-1-
carboxylate (117). Imine (20.5 mg, 100 μmol) and 7MeOPBAM·HOTf (7.2 mg, 10 
μmol) were dispensed into a flame dried vial with a stir bar. The two compounds were 
then stirred in toluene (100 μL) at room temperature until homogeneous. The reaction 
mixture was chilled to -20 °C before the nitroazetidine (23.6 mg, 100 μmol) was added. 
The reaction was stirred for 20 h, and then filtered through a pad of silica gel using 
CH2Cl2 and EtOAc and concentrated. Flash column chromatography (SiO2, 12-20% ethyl 
acetate in hexanes) of the residue yielded the addition product as a colorless solid (19.2 
mg, 87%); the major product was determined to be 92% ee by chiral HPLC analysis 
(Chiralcel IA, 10% 
i
PrOH/hexanes, 1 mL/min, tr(major) = 17.8 min, tr(minor) = 15.4 min; 
mp 134.0-136.0 °C; [α] 20D  +6.82 (c 1.10, CHCl3); Rf = 0.24 (20% EtOAc/hexanes); IR 
(film) 3325, 2978, 2932, 1714, 1549 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.40-7.30 (m, 
8H), 7.20-7.10 (m, 2H), 5.76 (br s, 1H), 5.50 (d, J = 9.5 Hz, 1H), 5.11 (s, 2H), 4.57 (d, J 
= 10.5 Hz, 1H), 4.47 (d, J = 10.0 Hz, 1H), 4.42 (d, J = 10.5 Hz, 1H), 4.37 (d, J = 10.5 Hz, 
1H), 1.44 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 155.9, 155.2, 135.8, 134.6, 129.1, 
129.0, 128.5, 128.3, 128.1, 126.4, 85.9, 81.0, 67.4, 57.4, 56.7, 28.2; HRMS (ESI): Exact 
mass calcd for C23H27N3NaO6 [M+Na]
+
 464.1798, found 464.1776. 
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(-)-Nutlin-3 (124).
180
 Tf2O (28.1 μL, 166.8 μmol) was added to a stirred solution of 
Ph3PO (92.8 mg, 333.6 μmol) in CH2Cl2 (500 μL) at 0 °C. The mixture was stirred for 10 
min before urea (50.0 mg, 83.4 μmol) was added as a solution in CH2Cl2 (600 μL), and 
the reaction was stirred for 1 h at 0 °C. The reaction mixture was allowed to warm to 
room temperature before addition of aq. NaHCO3. The organic layer was separated, the 
aqueous layer was extracted with CH2Cl2, and the combined organic layers were then 
dried over MgSO4, filtered, and concentrated. Column chromatography (0-4% methanol 
in dichloromethane) of the residue provided the compound as a white solid (42.5 mg, 
88%). Mp 127.0-129.0 °C; [α] 20
D
 -150 (c 0.13, CHCl3);  Rf = 0.24 (5% MeOH/CH2Cl2); 
IR (film) 3229, 2980, 2935, 2247, 1678, 1608 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.59 
(d, J = 8.8 Hz, 1H), 7.08 (d, J = 8.4 Hz, 2H), 7.02 (d, J = 8.0 Hz, 2H), 6.92 (d, J = 8.4 Hz, 
2H), 6.86 (d, J = 8.4 Hz, 2H), 6.66 (s, 1H), 6.54 (dd, J = 8.4, 1.6 Hz, 1H), 6.47 (br s, 1H), 
5.55 (d, J = 9.6 Hz, 1H), 5.47 (d, J = 9.6 Hz, 1H), 4.60 (qq, J = 6.0, 6.0 Hz, 1H), 3.83 (s, 
3H), 3.75 (d, J = 18.0 Hz, 1H), 3.62 (d, J = 18.0 Hz, 1H), 3.40-3.31 (m, 1H), 3.23-3.13 
(m, 1H), 2.97 (br s, 2H), 1.37 (d, J = 6.0 Hz, 3H), 1.32 (d, J = 6.0 Hz, 3H); 
13
C NMR 
(100 MHz, CDCl3) ppm 166.9, 163.0, 160.2, 157.0, 154.7, 136.0, 135.0, 133.1, 132.8, 
132.1, 129.2, 128.4, 128.1, 127.9, 113.4, 104.6, 100.1, 71.7, 70.9, 69.1, 55.5, 49.4, 41.8, 
                                                 
180
 Adapted from Pemberton, N.; Pinkner, J. S.; Edvinsson, S.; Hultgren, S. J.; Almqvist, F. Tetrahedron 
2008, 64, 9368-9376. 
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40.3, 20.03, 20.01; HRMS (CI): Exact mass calcd for C30H31Cl2N4O4 [M+H]
+
 581.1717, 
found 581.1705. 
 
This enantiomer corresponded to “enantiomer-a” using the HPLC conditions as described 
previously.
181
 The compound was found to be 99% ee; (Chiralcel OD, 30% 
iPrOH/hexanes, 1 mL/min, tr(major) = 8.6 min, tr( minor) = not observed). Additionally, 
the (+)-enantiomer was prepared using an identical procedure with (S,S)-
H,
4
PyrrolidineQuin-BAM to form compound 7 (84% ee), which was converted to (+)-
Nutlin-3. This compound correlated with “enantiomer-b”. and was found to be 85% ee; 
(Chiralcel OD, 30% iPrOH/hexanes, 1 mL/min, tr(major) = 10.5 min, tr( minor) = 8.6  
min). 
 
 
Further evidence supporting the structural assignment 
includes an HMBC (Figure 46), which clearly showed 
the anticipated couplings for Nutlin-3. C26 (155 ppm) 
Showed correlations to H27/H27` and H30/H30‟ and to 
H1 (but not H8). C15 (160 ppm) Showed correlations to 
both of the imidazoline methines (H1 and H8) and also to the H25.  
  
                                                 
181
 Wang, Z.; Jonca, M.; Lambros, T.; Ferguson, S.; Goodnow, R. J. Pharm. Biomed. Anal. 2007, 45, 720-
729. 
Figure 46. Nutlin-3 HMBC Correlations (600 MHz) 
 
260 
 
2-Oxo-piperazine (134)
182
. The resulting orange oil was purified by column 
chromatography (10% MeOH in CH2Cl2 w/ 1% NH4OH). A yellow solid (2.8634 g, 
71%) was obtained that was sufficiently pure by 
1
H NMR. Rf = 0.07 (10% 
MeOH/CH2Cl2 w/ 1% NH4OH); IR (film) 3400, 1650 cm
-1
; 
1
H NMR (500 MHz, CDCl3) 
δ 7.18 (br s, 1H), 3.46 (s, 2H), 3.35-3.28 (m, 2H), 2.98 (t, J = 5.5 Hz, 2H), 1.89 (br s, 
1H); 
13
C NMR (125 MHz, CDCl3) ppm 170.4, 49.6, 42.7, 42.2; HRMS (CI): Exact mass 
calcd for C4H9N2O [M+H]
+
 101.0709, found 101.0714. 
 
N-((1R,2S)-1,2-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxybenzamido)ethyl)-3-
oxopiperazine-1-carbox-amide (135). Amine (100.0 mg, 211.2 μmol) was dissolved in 
CH2Cl2 (1.0 mL) and stirred at room temperature. CDI (41.1 mg, 253.5 μmol) was added 
and the reaction was stirred for 1 h. 2-Oxo-piperazine (42.3 mg, 422.4 μmol) was added, 
and the reaction mixture was stirred for an additional 4 hours. The reaction mixture was 
concentrated and purified by column chromatography (0-2-5% methanol in 
dichloromethane) to provide a white solid (119.6 mg, 94%). [α] 20
D
 +110 (c 0.14, CHCl3); 
                                                 
182
 Elmaleh, D. R.; Choi, S.-W. U.S. Patent 6,835,371, December 28, 2004. 
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Rf = 0.34 (10% MeOH/CH2Cl2); IR (film) 3369, 2978, 2932, 2243, 1634, 1605 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.37 (d, J = 8.0 Hz, 1H), 8.28 (d, J = 8.8 Hz, 1H), 7.80 (d, J = 
4.8 Hz, 1H), 7.29 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 6.95 (d, J = 8.4 Hz, 2H), 
6.88 (d, J = 8.4 Hz, 2H), 6.62 (dd, J = 8.8, 2.0 Hz, 1H), 6.46 (d, J = 2.0 Hz, 1H), 6.15 (br 
s, 1H), 5.77 (dd, J = 7.6, 2.0 Hz, 1H), 5.10 (dd, J = 8.8, 2.4 Hz, 1H), 4.66 (qq, J = 6.0, 6.0 
Hz, 1H), 4.15 (d, J = 2.4 Hz, 2H), 3.86 (s, 3H), 3.73 (ddd, J = 13.2, 5.6, 4.4 Hz, 1H), 3.60 
(ddd, J = 13.2, 6.4, 4.4 Hz, 1H), 3.46-3.35 (m, 2H), 1.20 (d, J = 6.0 Hz, 3H), 1.14 (d, J = 
6.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 168.0, 167.0, 163.0, 157.2, 155.9, 136.7, 
136.6, 134.3, 133.8, 133.2, 129.4, 128.6, 128.4, 128.0, 113.5, 105.4, 100.3, 71.4, 61.6, 
57.5, 55.5, 47.4, 40.9, 39.9, 21.9, 21.5; HRMS (CI): Exact mass calcd for C30H33Cl2N4O5 
[M+H]
+
 599.1823, found 599.1814. 
tert-Butyl (1R,2S)-2-amino-1,2-bis(4-chlorophenyl)ethylcarbamate (136). The 
nitroalkane (411.3 mg, 1.000 mmol) was dissolved in MeOH (4.0 mL) at room 
temperature. CoCl2 (129.8 mg, 1.000 mmol) was added and the reaction mixture was 
chilled to 0 °C before NaBH4 (567.6 mg, 15.00 mmol) was added in three portions over 
40 min. The reaction mixture was stirred at 0 °C for an additional 30 min before the 
mixture was quenched with sat. aq. NH4Cl. The reaction mixture was adjusted to pH 10 
with conc. aq. NH4OH. The mixture was extracted with ethyl acetate, dried over MgSO4, 
and concentrated. Column chromatography (25-45% ethyl acetate in hexanes) of the 
residue afforded the product as a white solid (251.7 mg, 66%). Mp 149.0-150.0 °C; [α] 20
D
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+67 (c 0.12, CHCl3); Rf = 0.12 (50% EtOAc/hexanes); IR (film) 3377, 2981, 1683, 1523 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.24 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 
7.00 (d, J = 8.4 Hz, 2H), 6.93 (d, J = 8.4 Hz, 2H), 5.49 (d, J = 7.6 Hz, 1H), 4.79 (br s, 
1H), 4.23 (br s, 1H), 1.50 (s, 2H), 1.36 (s, 9H); 
13
C NMR (100 MHz, CDCl3) ppm 155.0, 
140.3 (2C), 133.3, 133.2, 128.7, 128.4, 128.2 (2C), 79.8, 59.5, 59.1, 28.2; HRMS (ESI): 
Exact mass calcd for C19H23Cl2N2O2 [M+H]
+
 381.1137, found 381.1147. 
Isopropyl 2-isopropoxy-4-methoxybenzoate (137).
183
 Isopropyl bromide (2.926 g, 
23.79 mmol) was added to a stirred mixture of 4-methoxysalicylic acid (1.000 g, 5.947 
mmol), K2CO3 (3.286 g, 23.79 mmol), and dry DMF (30 mL) at room temperature. The 
mixture was allowed to stir for 20 min before heating to reflux for 31 h. The reaction 
mixture was cooled to room temperature, treated with KI (98.7 mg, 595 μmol) and stirred 
for 17 h. The reaction was quenched with 1 M aq HCl then extracted with diethyl ether. 
The combined organic layers were washed with 1 M aq Na2CO3, water, then brine before 
drying over MgSO4. Concentration of the dried organic layers resulted in a bronze oil 
(1.0549 g, 70%) that was pure by 
1
H NMR. Rf = 0.16 (5% EtOAc/hexanes); IR (film) 
2979, 2936, 1721, 1694, 1608, 1575 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ  7.77 (d, J = 7.2 
Hz, 1H), 6.49-6.43 (m, 2H), 5.20 (heptet, J = 6.4 Hz, 1H), 4.55 (heptet, J = 6.0 Hz, 1H), 
3.81 (s, 3H), 1.36 (d, J = 6.0 Hz, 6H), 1.33 (d, J = 6.0 Hz, 6H); 
13
C NMR (100 MHz, 
CDCl3) ppm 165.8, 163.5, 159.3, 133.4, 114.9, 104.9, 101.8, 71.5, 67.5, 55.4, 22.0 (2C); 
HRMS (CI): Exact mass calcd for C14H21O4 [M+H]
+
 253.1434, found 253.1431. 
                                                 
183
Adapted from: Hattori, T.; Shimazumi, Y.; Goto, H.; Yamabe, O.; Morohashi, N.; Kawai, W.; Miyano, 
S. J. Org. Chem. 2003, 68, 2099-2108. 
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2-Isopropoxy-4-methoxybenzoic acid (138).
135 
Ester (985.0 mg, 3.904 mmol) was 
boiled with KOH (703.8 mg, 12.54 mmol) in a mixture of ethanol (11.7 mL) and water 
(2.3 mL) for 4 h. EtOH was then removed by evaporation. The remaining material was 
diluted with water and treated with 3 M HCl until precipitation occurred. The suspension 
was then extracted with diethyl ether. The combined organic layers were washed with 
brine before drying over MgSO4. The solution was concentrated to a red oil (733.2 mg, 
89%) that was pure by 
1
H NMR. Rf = 0.33 (50% EtOAc/hexanes); IR (film) 3261, 2981, 
1730, 1608 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 10.91 (br s, 1H), 8.12 (d, J = 9.0 Hz, 
1H), 6.62 (dd, J = 9.0, 2.5 Hz, 1H), 6.52 (d, J = 2.0 Hz, 1H), 4.81 (heptet, J = 6.5 Hz, 
1H), 3.86 (s, 3H), 1.47 (d, J = 6.0 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 165.5, 
164.9, 157.8, 135.4, 111.4, 106.8, 100.7, 73.9, 55.7, 21.9; HRMS (ESI): Exact mass calcd 
for C11H14NaO4 [M+Na]
+
 233.0790, found 233.0795. 
tert-Butyl (1R,2S)-1,2-bis(4-chlorophenyl)-2-(2-isopropoxy-4-
methoxybenzamido)ethylcarbamate (139). The amine (170.0 mg, 445.8 μmol) and 
carboxylic acid (93.7 mg, 445.8 μmol) were dissolved in CH2Cl2 (2.2 mL) at room 
temperature. The solution was chilled to 0 °C and EDC (111.1 mg, 579.6 μmol) and 
DMAP (5.4 mg, 44.6 μmol) were added. The reaction mixture was stirred and allowed to 
gradually warm to room temperature. After 16 h, the reaction mixture was diluted with 
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water and extracted with CH2Cl2. The combined organic layers were washed once with 
water, dried over MgSO4, and concentrated. The resulting white solid was washed with 
CH2Cl2 and hexanes, leaving a white solid (224.5 mg, 88%) that was pure by NMR. Mp 
239.0-241.0 °C (decomp.); [α]
20
D  -29 (c 0.13, CHCl3);  Rf = 0.13 (20% EtOAc/hexanes); 
IR (film) 3355, 2976, 1680, 1629, 1607, 1529 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.39 
(d, J = 7.2 Hz, 1H), 8.19 (d, J = 8.8 Hz, 1H), 7.26 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 
2H), 7.02 (d, J = 6.8 Hz, 2H), 6.93 (d, J = 8.4 Hz, 2H), 6.59 (dd, J = 8.8, 2.4 Hz, 1H), 
6.46 (d, J = 1.6 Hz, 1H), 5.91 (br s, 1H), 5.78 (br s, 1H), 5.07 (br s, 1H), 4.75-4.60 (m, 
1H), 3.84 (s, 3H), 1.38 (s, 9H), 1.30-1.21 (m, 6H); 
13
C NMR (100 MHz, CDCl3) ppm 
165.6, 163.6, 157.2, 155.0, 136.9, 136.7, 134.2, 133.6, 133.3, 128.6 (2C), 128.5, 128.3, 
114.1, 105.2, 100.2, 79.9, 71.4, 59.5, 56.6, 55.5, 28.3, 22.0, 21.6; HRMS (ESI): Exact 
mass calcd for C30H34Cl2N2NaO5 [M+Na]
+
 595.1742, found 595.1743. 
 
 
N-((1S,2R)-2-Amino-1,2-bis(4-chlorophenyl)ethyl)-2-isopropoxy-4-
methoxybenzamide (140). Amide (180.0 mg, 313.9 μmol) was dissolved in CH2Cl2 (3.1 
mL). TFA (932 μL, 12.6 mmol) was added and the mixture was stirred at room 
temperature for 16 h. The reaction mixture was poured into satd. aq. NaHCO3 and 
extracted with CH2Cl2. The combined organic layers were dried over MgSO4, filtered, 
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and concentrated to a light brown foam (130.3 mg, 88%). [α] 20
D
 -140 (c 0.11, CHCl3); Rf 
= 0.46 (10% MeOH/CH2Cl2); IR (film) 3376, 2925, 2853, 1644, 1605, 1521 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.88 (d, J = 8.0 Hz, 1H), 8.13 (d, J = 8.8 Hz, 1H), 7.24 (d, J = 
8.4 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 7.03 (d, J = 8.4 Hz, 2H), 7.00 (d, J = 8.8 Hz, 2H), 
6.56 (dd, J = 8.8, 2.4 Hz, 1H), 6.49 (d, J = 2.0 Hz, 1H), 5.43 (dd, J = 8.0, 4.8 Hz, 1H), 
4.75 (qq, J = 6.0, 6.0 Hz, 1H), 4.41 (d, J = 4.8 Hz, 1H), 3.83 (s, 3H), 1.45 (d, J = 5.6 Hz, 
3H), 1.44 (d, J = 5.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 164.7, 163.3, 157.2, 
140.7, 136.8, 134.1, 133.2, 133.1, 129.1, 128.4, 128.3, 128.2, 115.0, 105.1, 100.3, 71.5, 
59.0, 58.6, 55.5, 22.2, 22.0; HRMS (ESI): Exact mass calcd for C25H27Cl2N2O3 [M+H]
+
 
473.1399, found 473.1400. 
 
2,4-Dichloroquinoline (160). See Appendix for large scale Organic Syntheses 
manuscript procedure. 
 
2,4-Dichloro-7-methoxyquinoline (160b). Phosphorus(V) oxychloride (20 mL, 1.3 M) 
was added through a running condenser into a 3-neck round bottom flask equipped with a 
stir bar containing malonic acid (2.710 g, 26.00 mmol) at room temperature. While 
stirring, m-anisidine (4.000 g, 32.48 mmol) was added in small portions over a period of 
15 minutes through an open neck of the round bottom flask. The reaction mixture was 
heated and stirred at reflux for 5 hours. The reaction mixture was allowed to cool to room 
temperature before it was poured over crushed ice (~350 mL). The pH of the resulting 
 
266 
aqueous solution was adjusted to 10 with concentrated ammonium hydroxide. The 
aqueous suspension was extracted with dichloromethane. The combined organic layers 
were dried over MgSO4 and filtered before concentration to provide a 2.2:1 mixture (
1
H 
NMR) of the 7-methoxy and 5-methoxy regioisomers. Purification by column 
chromatography (0-8% ethyl acetate in hexanes) yielded a white solid (3.181 g, 54%) that 
was recrystallized from ethyl acetate and hexanes to provide the 7-methoxy isomer. Mp 
131.5-132.5 °C; Rf = 0.18 (5% EtOAc/hexanes); IR (film) 3092, 2982, 1623, 1572, 1559 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 9.2 Hz, 1H), 7.32 (s, 1H), 7.31 (d, J = 
2.4 Hz, 1H), 7.23 (dd, J = 9.2 ,2.4 Hz, 1H), 3.92 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 
ppm 162.2, 150.2, 150.0, 143.9, 125.2, 120.7, 120.1, 119.5, 107.1, 55.7; HRMS (ESI): 
Exact mass calcd for C10H8Cl2NO [M+H]
+
 227.9977, found 227.9973. 
2,4-Dichloro-6,7-dimethylquinoline (160d). Compound was prepared using 3,4-
dimethylaniline (10.0 g, 82.5 mmol), malonic acid (6.88 g, 66.0 mmol), and POCl3 (50 
mL) according to the general procedure. The reaction time was 4 hours. The crude solid 
was purified by column chromatography (0-2% Et2O/hexanes) to produce a white solid 
(8.104 g, 54%). This material was subjected to column chromatography a second time (0-
2% Et2O/hexanes) and enriched fractions were concentrated to provide 3.095 g of a 2:1 
mixture of regioisomers. This material was recrystallized twice from ethyl acetate and 
hexanes to provide 819 mg of a 44:1 mixture of regioisomers (GC) favoring the desired 
compound. Mp 95.5-96.5 °C; Rf = 0.34 (10% EtOAc/hexanes); IR (film) 2947, 2917, 
1547 cm
-1
; 
1
H NMR
 
(400 MHz, CDCl3) δ 7.82 (s, 1H), 7.72 (s, 1H), 7.35 (s, 1H), 2.44 (s, 
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6H); 
13
C NMR (100 MHz, CDCl3) ppm 148.7, 147.1, 143.1, 142.1, 138.1, 128.3, 123.5, 
123.2, 120.8, 20.3, 20.2; HRMS (CI): Exact mass calcd for C11H10Cl2N [M+H]
+
 
226.0185, found 226.0179. 
2,4-Dichloro-8-methoxyquinoline (160f). Compound was prepared using o-anisidine 
(14.1 mL, 125 mmol), malonic acid (13.0 g, 125 mmol), and POCl3 (50 mL) according to 
the general procedure. The reaction time was 7 hours. Soxhlet extraction of the crude 
solid with hexanes for ~24 h followed by cooling of the obtained extract yielded a yellow 
solid precipitate (2.6135 g, 9%) that was pure by 
1
H NMR. Mp 127.5-128.5 °C; Rf = 0.08 
(10% EtOAc/hexanes); IR (film) 3097, 3008, 1576, 1561 cm
-1
; 
1
H NMR
 
(500 MHz, 
CDCl3) δ 7.76 (d, J = 8.5 Hz, 1H), 7.57 (dd, J = 8.0, 8.0 Hz, 1H), 7.55 (s, 1H), 7.15 (d, J 
= 7.5 Hz, 1H), 4.08 (s, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 154.8, 148.9, 144.3, 
139.9, 128.1, 126.4, 122.7, 115.6, 109.8, 56.3; HRMS (CI): Exact mass calcd for 
C10H7Cl2NO [M+H]
+
 226.9899, found 226.9890. 
 
2,4-Dichloro-6-methoxyquinoline (160g). Phosphorus(V) oxychloride (40 mL, 1.5 M) 
was added through a condenser into a 3-neck round bottom flask containing malonic acid 
(6.244 g, 60.00 mmol) and a stir bar at room temperature. While stirring, p-anisidine 
(9.236 g, 75.00 mmol) was added in small portions over a period of 15 minutes through 
an open neck of the round bottom flask. The reaction mixture was heated and stirred at 
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reflux for 5 hours. The reaction mixture was allowed to cool to room temperature before 
it was poured over crushed ice (~700 mL). The pH of the resulting aqueous solution was 
then adjusted to 10 with concentrated ammonium hydroxide (~85 mL). The aqueous 
suspension was extracted with dichloromethane. The combined organic layers were then 
dried over MgSO4 before concentration. Purification by column chromatography (0-5% 
ethyl acetate in hexanes) yielded the title compound as a slightly yellow solid (4.7812 g, 
35%). Mp 170.5-171.5 °C; Rf = 0.27 (2% EtOAc/hexanes); IR (film) 3084, 3013, 2982, 
1623, 1562, 1499 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 9.0 Hz, 1H), 7.45 (s, 
1H), 7.40 (dd, J = 9.0, 3.0 Hz, 1H), 7.36 (d, J = 3.0 Hz, 1H), 3.96 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) ppm 158.9, 147.0, 144.0, 142.6, 130.4 126.3, 124.1, 122.0, 101.9, 55.7; 
HRMS (CI): Exact mass calcd for C10H8Cl2NO [M+H]
+
 227.9977, found 227.9974. 
 2,4-Dichloro-8-methylquinoline (160i). Compound was prepared using 4-hydroxy-8-
methylquinolinone (3.400 g, 19.19 mmol) and POCl3 (20 mL) according to the general 
procedure. The reaction time was 2 hours. Column chromatography (0-2% 
EtOAc/hexanes) yielded the title compound as a white solid (2.2274 g, 55%). Mp 81.0-
81.5 °C; Rf = 0.52 (5% EtOAc/hexanes); IR (film) 3085, 2960, 2922, 1566 cm
-1
; 
1
H 
NMR
 
(400 MHz, CDCl3) δ 7.99 (d, J = 8.4 Hz, 1H), 7.60 (d, J = 6.8 Hz, 1H), 7.49 (dd, J 
= 8.0, 8.0 Hz, 1H), 7.45 (s, 1H), 2.75 (s, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 148.5, 
147.2, 144.3, 137.2, 131.6, 127.4, 125.1, 121.9, 121.6, 18.1; HRMS (ESI): Exact mass 
calcd for C10H8Cl2N [M+H]
+
 212.0034, found 212.0033. 
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 2,4-Dichloro-8-ethoxyquinoline (160j). Compound was prepared using 2-ethoxyaniline 
(6.5 mL, 50 mmol), malonic acid (5.2 g, 50 mmol), and POCl3 (20 mL) according to the 
general procedure. The reaction was run at 75 °C for 3 days. Column chromatography (0-
10% EtOAc/hexanes) yielded the title compound as a light brown solid (1.8714 g, 15%). 
Mp 59.5-60.5 °C; Rf = 0.16 (5% EtOAc/hexanes); IR (film) 3081, 2982, 2932, 1560 cm
-1
; 
1
H NMR
 
(400 MHz, CDCl3) δ 7.71 (dd, J = 8.4, 1.2 Hz, 1H), 7.55-7.49 (m, 1H), 7.50 (s, 
1H), 7.12 (br d, J = 8.0 Hz, 1H), 4.30 (q, J = 7.2 Hz, 2H), 1.58 (t, J = 6.8 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3) ppm 154.1, 148.7, 144.1, 140.1, 128.0, 126.4, 122.5, 115.4, 
110.8, 64.8, 14.4; HRMS (ESI): Exact mass calcd for C11H10Cl2NO [M+H]
+
 242.0139, 
found 242.0137. 
2,4-Dichloro-8-ethylquinoline (160k). Compound was prepared using 2-ethylaniline 
(6.2 mL, 50 mmol), malonic acid (5.2 g, 50 mmol), and POCl3 (20 mL) according to the 
general procedure. The reaction time was 16 hours. Column chromatography (0-2% 
EtOAc/hexanes) provided the title compound as a white solid (2.626 g, 23%). Mp 40.0-
41.0 °C; Rf = 0.61 (5% EtOAc/hexanes); IR (film) 3096, 3075, 2969, 2919, 1564 cm
-1
; 
1
H NMR
 
(400 MHz, CDCl3) δ 8.00 (dd, J = 8.4, 1.2 Hz, 1H), 7.61 (br d, J = 6.8 Hz, 1H), 
7.53 (dd, J = 8.4, 7.2 Hz, 1H), 7.45 (s, 1H), 3.24 (q, J = 7.6 Hz, 2H), 1.36 (t, J = 7.6 Hz, 
3H); 
13
C NMR (100 MHz, CDCl3) ppm 148.5, 146.7, 144.3, 142.9, 129.9, 127.6, 125.1, 
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121.8, 121.6, 24.5, 14.8; HRMS (ESI): Exact mass calcd for C11H10Cl2N [M+H]
+
 
226.0190, found 226.0196. 
2,4-Dichloro-7,8-dimethylquinoline (160l). Compound was prepared using 2,3-
dimethylaniline (6.1 mL, 50 mmol), malonic acid (5.2 g, 50 mmol), and POCl3 (20 mL) 
according to the general procedure. The reaction time was 15 hours. Purification by 
column chromatography (100% hexanes) yielded the title compound as a white solid 
(4.1165 g, 36%). Mp 68.0-69.0 °C; Rf = 0.56 (5% EtOAc/hexanes); IR (film) 3094, 2952, 
1608, 1578, 1558 cm
-1
; 
1
H NMR
 
(400 MHz, CDCl3) δ 7.82 (d, J = 8.4 Hz, 1H), 7.36 (d, J 
= 8.8 Hz, 1H), 7.33 (s, 1H), 2.64 (s, 3H), 2.46 (s, 3H) ; 
13
C NMR (100 MHz, CDCl3) ppm 
148.3, 147.0 , 144.0, 139.6, 134.4, 130.3, 123.3, 120.7, 120.4, 20.7, 13.5; HRMS (ESI): 
Exact mass calcd for C11H10Cl2N [M+H]
+
 226.0190, found 226.0187. 
2,4-Dichloro-6,8-dimethoxyquinoline (160m). Compound was prepared using 6,8-
dimethoxyaniline (10.0 g, 65.3 mmol), malonic acid (6.79 g, 65.3 mmol), and POCl3 (26 
mL) according to the general procedure. The reaction time was 2 hours. The crude solid 
was soxhlet extracted with hexanes for 3 d to provide the title compound as a greenish-
brown solid (1.376 g, 8%). Mp 183.5-184.5 °C; Rf = 0.09 (10% EtOAc/hexanes); IR 
(film) 3080, 2964, 1615, 1562 cm
-1
; 
1
H NMR
 
(400 MHz, CDCl3) δ 7.50 (s, 1H), 6.98 (d, 
J = 2.4 Hz, 1H), 6.77 (d, J = 2.4 Hz, 1H), 4.03 (s, 1H), 3.95 (s, 1H); 
13
C NMR (100 MHz, 
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CDCl3) ppm 159.4, 155.8, 146.1, 142.7, 136.6, 127.1, 122.9, 103.0, 93.7, 56.3, 55.7; 
HRMS (ESI): Exact mass calcd for C11H10Cl2NO2 [M+H]
+
 258.0089, found 258.0094. 
 
 
2,4-Dichloro-6,8-dimethylquinoline (160n). Compound was prepared using 2,4-
dimethylaniline (6.2 mL, 50 mmol), malonic acid (5.2 g, 50 mmol), and POCl3 (20 mL) 
according to the general procedure. The reaction time was 6 hours. Precipitation from 
acetone yielded the title compound as a yellow solid (3.1786 g, 28%). Mp 101.0-103.0 
°C; Rf = 0.59 (5% EtOAc/hexanes); IR (film) 3091, 2960, 2921, 1566 cm
-1
; 
1
H NMR
 
(400 MHz, CDCl3) δ 7.77 (s, 1H), 7.45 (s, 1H), 7.43 (s, 1H), 2.71 (s, 3H), 2.51 (s, 3H); 
13
C NMR (100 MHz, CDCl3) ppm 147.6, 145.9, 143.5, 137.6, 136.8, 133.8, 125.1, 121.6, 
120.9, 21.7, 18.0; HRMS (ESI): Exact mass calcd for C11H10Cl2N [M+H]
+
 226.0190, 
found 226.0198. 
 2,4-Dichloro-6-fluoroquinoline (160p). Compound was prepared using 4-fluoroaniline 
(5.556 g, 50 mmol), malonic acid (5.203 g, 50 mmol), and POCl3 (20 mL) according to 
the general procedure. The reaction time was 4 hours. The crude solid was soxhlet 
extracted with hexanes for 6 hours to provide a yellow solid (1.9382 g, 18%). Mp 88.0-
90.0 °C; Rf = 0.31 (5% EtOAc/hexanes); IR (film) 3063, 1626, 1559 cm
-1
; 
1
H NMR
 
(400 
MHz, CDCl3) δ 8.02 (dd, J = 9.2, 5.2 Hz, 1H), 7.79 (dd, J = 9.2, 5.2 Hz, 1H), 7.54 (ddd, J 
= 9.2, 8.0, 2.8 Hz, 1H), 7.52 (s, 1H); 
13
C NMR (100 MHz, CDCl3) ppm 161.2 (d, 
1
JCF = 
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250 Hz), 149.2 (d, 
4
JCF = 3.0 Hz), 145.1, 143.5 (
4
JCF = 6.0 Hz), 131.6 (d, 
3
JCF = 9.0 Hz), 
126.2 (d, 
3
JCF = 11 Hz), 122.6,  121.7 (d, 
2
JCF = 25 Hz), 108.2 (d, 
2
JCF = 25 Hz); 
19
F NMR 
(282 MHz, CDCl3) ppm -107.9; HRMS (EI): Exact mass calcd for C9H4Cl2FN [M]
+ 
214.9699, found 214.9708. 
2,4-Dichloro-6-tert-butylquinoline (160q). Compound was prepared using 4-tert-
butylaniline (5.000 g, 33.56 mmol), malonic acid (3.492 g, 33.56 mmol), and POCl3 (20 
mL) according to the general procedure. The reaction time was 9 hours. Soxhlet 
extraction of the crude solid with hexanes for ~48 h yielded the title compound as orange 
solid (2.872 g, 34%). Mp 43.5-44.5 °C; Rf = 0.48 (5% EtOAc/hexanes); IR (film) 2964, 
2869, 1568, 1494 cm
-1
; 
1
H NMR
 
(400 MHz, CDCl3) δ 8.09 (d, J = 2.0 Hz, 1H), 7.96 (d, J 
= 9.2 Hz, 1H), 7.87 (dd, J = 8.8, 2.4Hz, 1H), 7.46 (s, 1H), 1.43 (s, 9H); 
13
C NMR (100 
MHz, CDCl3) ppm 151.1, 149.0, 146.6, 144.2, 130.4, 128.5, 124.7, 121.7, 119.1, 35.3, 
31.1; HRMS (ESI): Exact mass calcd for C13H14Cl2N [M+H]
+
 254.0503, found 254.0501. 
2,4-Dichloro-6,7(methylenedioxy)quinoline (160r). Compound was prepared using 
3,4(methylenedioxy)aniline (7.805 g, 75.00 mmol), malonic acid (10.29 g, 75.00 mmol), 
and POCl3 (30 mL) according to the general procedure. The reaction time was 9 hours. 
The crude solid was soxhlet extracted with hexanes for 17 hours. Upon cooling, solid 
precipitated from the extract. This solid was of exceptional purity. The concentrated 
extract contained product of slightly lower purity. The crude solid was soxhlet extracted 
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with hexanes for three additional days to recover more of the desired compound. The 
material was combined to provide 6.103 g (34%). Mp 170.0-171.0 °C; Rf = 0.18 (5% 
EtOAc/hexanes); IR (film) 3092, 2924, 1614, 1568, 1489 cm
-1
; 
1
H NMR
 
(400 MHz, 
CDCl3) δ 7.39 (s, 1H), 7.33 (s, 1H), 7.27 (s, 1H), 6.14 (s, 2H); 
13
C NMR (100 MHz, 
CDCl3) ppm 152.1, 149.1, 147.7, 146.6, 142.5, 122.2, 120.0, 105.6, 102.4, 99.8; HRMS 
(CI): Exact mass calcd for C10H6Cl2NO2 [M+H]
+
 241.9770, found 241.9769. 
 2,4-Dichloro-6-nitroquinoline (160s). Compound was prepared using 4-nitroaniline 
(6.9 g, 50 mmol), malonic acid (5.2 g, 50 mmol), and POCl3 (20 mL) according to the 
general procedure. The reaction time was 17 hours. The crude solid was soxhlet extracted 
with hexanes for 18 h to provide a yellow solid (761.4 mg, 6%). Mp 187.0-188.0 °C; Rf = 
0.28 (10% EtOAc/hexanes); IR (film) 3092, 3062, 2962, 1578 cm
-1
; 
1
H NMR
 
(400 MHz, 
CDCl3) δ 9.13 (d, J = 2.4 Hz, 1H), 8.56 (d, J = 9.2, 2.4 Hz, 1H), 8.18 (d, J = 9.2 Hz, 1H), 
7.67 (s, 1H); 
13
C NMR (100 MHz, CDCl3) ppm 153.8, 150.1, 146.3, 146.0, 131.0, 125.1, 
124.7, 123.9, 121.2; HRMS (EI): Exact mass calcd for C9H4Cl2N2O2 [M]
+
 241.9644, 
found 241.9654. 
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APPENDIX 
 
PREPARATION H,
4
PYRROLIDINEQUIN-BAM (PBAM) 
 
Submitted by 
Tyler A. Davis, Mark C. Dobish, Ken E. Schwieter, Aspen C. Chun and Jeffrey N. 
Johnston
184
 
 
1. Procedure 
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275 
Caution! Part A of this procedure must be carried out in a well-ventilated hood and the 
apparatus must be equipped with a hydrogen chloride (HCl) trap to avoid exposure to 
HCl gas. 
 
A. 2,4-Dichloroquinoline (160). A 250 mL, 3-neck, round-bottomed flask is equipped 
with a stir bar (38 x 17 mm) and charged with malonic acid (26.0 g, 250 mmol, Note 
1).
185
 A rubber septum is connected to one of the side arms and a condenser is attached to 
the middle neck. That condenser is equipped with a line that runs to an HCl trap (Note 2). 
The flask is lowered into an ice water bath and POCl3 (100 mL, Note 3) is poured into the 
open side arm. That open side arm is sealed with a rubber septum. A slight positive flow 
of nitrogen gas is introduced into the system through a needle inserted into one of the side 
arm septa (Note 4). Aniline (22.8 mL, 250 mmol, Note 5) is added slowly to the stirring 
mixture by syringe through a side arm septum over a period of 20 minutes. The flask is 
then removed from the ice water bath, allowed to stir for 10 minutes, and placed into an 
oil bath (~110 °C). The mixture is stirred at reflux for 6 hours. The flask was removed 
from the oil bath and allowed to cool for 5 minutes. The mixture was slowly and 
carefully poured onto crushed ice (~ 1 L in 2 L beaker) while intermittently stirring with 
a spatula. The residual material in the 3-neck round-bottomed flask was removed by 
carefully adding water (100 mL) to the flask and scraping out with a spatula. The aqueous 
mixture is vigorously stirred by hand with a spatula. The 2 L quench beaker is placed into 
a bucket of ice. 6 M aq NaOH (475 mL) is added slowly (over a period of 25 min, 
keeping the temperature ≤ 50 °C) while intermittently stirring. The pH of the solution 
                                                 
185
 A modification of the procedure reported by Jones: Jones, K.; Roset, X.; Rossiter, S.; Whitfield, P. Org. 
Biomol. Chem. 2003, 1, 4380-4383. 
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was ~7 (Note 6). The beaker was removed from the ice bath and the suspension was 
allowed to cool to rt and age with stirring (stir bar) for 12 h (Note 7). The suspension was 
then vacuum filtered through a Buchner funnel (12 cm diameter). Water (150 mL) was 
used to rinse the residual material from the beaker. The filtered red solid was rinsed with 
water (150 mL) on the filter. After drying on the filter (1 h), the solid was transferred into 
2 cellulose thimbles (33 mm x 94 mm, int. diam. x ext. length). Each thimble was Soxhlet 
extracted with hexanes (300 mL) for 16 h. The hexanes extract was concentrated (Note 8) 
by rotary evaporation (30 °C, 23 mm Hg) and further dried under vacuum (0.1 mm Hg) 
to leave a yellow solid (16.5-18.0 g, 33-36%, Note 9) that was used in step B without 
further purification. 
The crude material can be further purified by recrystallization. The crude solid (5.0 g) 
was dispensed into a 50 mL Erlenmeyer flask and dissolved in 20 mL of a 3:1 mixture of 
hexanes and toluene with heating in a ~70 °C water bath. The solution was allowed to 
slowly cool to room temperature (Note 10) before it was placed in an ice-water bath. 
After 2 hours, the mother liquor was decanted. The recrystallization flask was kept in the 
ice-water bath while the crystals were rinsed with ice-cold hexanes (5 mL). The rinsate 
was decanted. Residual solvent was removed by vacuum (0.1 mm Hg) to leave a yellow 
crystalline solid (2.99-3.17 g, 60-63% recovery, Note 11). 
 
B. H,
4
ClQuin-BAM (92). A 100-mL, round-bottomed flask (24/40 joint) equipped with a 
stir bar (32 x 15 mm), rubber septum and argon inlet needle (Note 12) was first charged 
with (R,R)-diaminocyclohexane (1.63 g, 14.3 mmol, Note 13). Then (Note 14) Pd(dba)2 
(164 mg, 285 μmol), rac-BINAP (356 mg, 572 μmol), sodium tert-butoxide (4.12 g, 42.9 
277 
mmol), and 2,4-dichloroquinoline (160) (5.66 g, 28.6 mmol) were added and the reaction 
vessel was placed under an argon atmosphere.
186
 Toluene (35 mL, Note 15) was 
dispensed into the flask, and the resulting red-brown solution was placed into an oil bath 
heated to 80 °C with stirring (Note 16). The reaction was monitored by TLC (Note 17); 
after 1.5 h, nearly complete conversion was observed. The reaction was cooled to 25 °C, 
and saturated NH4Cl (10 mL) and water (10 mL) were added to the flask. The suspension 
was stirred for 5 min and cooled to 0 °C for 10 m. The reaction mixture was filtered 
through a Buchner funnel (9 cm diameter) and washed with water (50 mL) and hexanes 
(150 mL, Note 18) to afford a light yellow solid. This crude solid was transferred to a 
pre-weighed 100 mL (24/40 joint) round-bottomed flask and dried under vacuum (0.1 
mm Hg) for at least 10 h to leave 4.10-4.68 g of a light yellow solid  (65-75%, Note 19), 
which was used in step C without further purification.  
 
C. H,
4
PyrrolidineQuin-BAM (PBAM) (76). A 10-20 mL microwave vial equipped with a 
stir bar (12 x 8 mm) was charged with H,
4
ClQuin-BAM (92) (4.30 g, 9.83 mmol), 
pyrrolidine (3.23 mL, 39.3 mmol, Note 20), and trifluoromethylbenzene (3.3 mL, Note 
21). The vial was sealed, and this suspension was heated with stirring at 200 °C in the 
microwave for 30 m (Note 22). The reaction mixture was diluted and transferred with 20 
mL of dichloromethane to a 500 mL round-bottomed flask for evaporation (Note 23). The 
reaction was then concentrated by rotary evaporation (80 °C, 23 mm Hg), redissolved in 
dichloromethane (50 mL), transferred to a 125 mL separatory funnel, and washed with 
3M NaOH (50 mL) and water (4 x 50 mL). The resulting organic layer was dispensed 
into a 125 mL Erlenmeyer flask and dried (MgSO4, 2 g). The solution was filtered (flask 
                                                 
186
 Adapted from Wagaw, S.; Rennels, R. A.; Buchwald, S. L. J. Am. Chem. Soc. 1997, 119, 8451-8458. 
278 
and filter were rinsed with an extra 25 mL of dichloromethane) into a 250 mL round-
bottomed flask and concentrated by rotary evaporation (30 °C, 23 mm Hg) and high 
vacuum (0.1 mm Hg, 1h) to provide a light brown powder (Note 24).  
As much of the material as possible was transferred as a solid from the round-
bottomed flask to a pre-weighed 250 mL Erlenmeyer flask. The remaining solid was 
dissolved and transferred into a 25 mL pear-shaped flask with 10 mL of dichloromethane 
and concentrated by rotary evaporation (30 °C, 23 mm Hg) and high vacuum (0.1 mm 
Hg, 1 h). This material was then added to the 250 mL Erlenmeyer flask. The material was 
dissolved in a 90:10 mixture of acetone and toluene (20 mL/g crude product) with heating 
in a water bath (70 °C) (Note 25). The solution was removed from heat and placed on the 
bench for 1 hour to cool to room temperature. The flask was placed in an ice bath for 3 h 
or until no further crystallization was observed. The mother liquor was decanted leaving 
crystals that were washed with ice-cold acetone (2 x 10 mL). Residual solvent was 
removed from the crystals by placing the Erlenmeyer flask under vacuum (0.1 mm Hg) 
for a period of 5-10 m (Note 26). The crystalline material was transferred to a pre-
weighed 20 mL glass scintillation vial and dried for ~14 h in a drying pistol (0.1 mm Hg) 
over refluxing toluene. The vial was temporarily removed from the drying pistol, and the 
material was thoroughly pulverized with a spatula and returned to the drying pistol for 6 
additional h. The dried material was a white powder (3.12-3.35 g, 63-67% yield) (Note 
27).  
 
 
2. Notes 
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1. Malonic acid (99%) was purchased from Sigma-Aldrich and used as received. 
2. The reflux condenser is fitted with an outlet that is connected with Tygon tubing to 
two 250 mL bubblers, the first emply, and the second filled with water to serve as the 
HCl trap. 
3. POCl3 (99%) was purchased from Aldrich and used as received. 
4. The gas flow should be monitored by constantly checking the bubbler during the 
aniline addition to prevent the development of negative pressure in the system. 
5. Aniline (99.9%) was purchased from Fisher Scientific Company and used as 
received. 
6. This workup procedure should fully hydrolyze all P-Cl bonds leaving phosphoric acid 
as the byproduct of POCl3 quenching.
187
 
7. This served to fully quench the suspension and to produce a finer crude solid with 
fewer chunks. This facilitated transfer into the soxhlet thimble and allowed for a more 
efficient extraction due to increased surface area of the solid. 
8. It may be necessary to filter the extract if red solid precipates from the solution. 
9. The crude 2,4-dichloroquinoline (160) exhibited the following: mp 62.0-63.0 
(uncorrected); Rf = 0.43 (10% EtOAc/hexanes); IR (film) 3065, 1570, 1554 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.12 (br d, J = 8.4 Hz, 1H), 7.98 (br d, J = 8.4 Hz, 1H), 7.75 
(ddd, J = 8.4, 7.2, 1.6 Hz, 1H), 7.60 (ddd, J = 8.0, 6.8, 0.8 Hz, 1H), 7.44 (s, 1H); 
13
C 
NMR (100 MHz, CDCl3) ppm 149.7, 148.0, 144.2, 131.4, 128.8, 127.8, 125.0, 124.0, 
121.8. This data matched the values given in the literature.
185
  
                                                 
187
 Achmatowicz, M. M.; Thiel, O. R.; Colyer, J. T.; Hu, J.; Elipe, M. V. S.; Tomaskevitch, J.; Tedrow, J. 
S.; Larsen, R. D. Org. Process Res. Dev. 2010, 14, 1490-1500. 
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10. If a precipitate forms when the solution is cooled to room temperature, the solution 
should be filtered before cooling in an ice-water bath. 
11. The melting point range of the recrystallized 2,4-dichloroquinoline (1) was 63.0-63.5 
°C (uncorrected). Material that was purified by column chromatography (0-4% 
EtOAc/hexanes) exhibited a melting point of 64.0-64.5 °C (uncorrected). 
12. The apparatus was flame-dried under reduced pressure (0.1 mm Hg) and then 
maintained under an atmosphere of argon during the course of reaction.  
13.  (1R,2R)-(−)-1,2-Diaminocyclohexane was resolved from a trans/cis mixture (60/40) 
using the protocol of Jacobsen
188
 with L-(+)-tartaric acid. The salt was then dissolved in 
10 M NaOH and continuously extracted using benzene in a liquid/liquid extractor for 5 
days. Alternatively, the diamine (98%, optical purity ee: 99%) can be purchased from 
Sigma-Aldrich. This diamine is stored in a freezer and weighed directly into the 100 mL 
round-bottomed flask. This diamine is a white solid but becomes a viscous oil as it warms 
to room temperature. To avoid difficulties in transfer, the diamine is weighed in the 
reaction vessel without allowing the diamine to warm to room temperature. 
14. Bis(dibenzylideneacetone)palladium, 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene 
and sodium tert-butoxide were dispensed into a flame-dried vial in a glovebox under an 
argon atmosphere. This vial was removed from the glovebox and its contents were then 
transferred into the round-bottomed flask. Bis(dibenzylideneacetone)palladium was 
prepared according to the procedure of Rettig and Maitlis.
189
 Alternatively, it can be 
purchased from a commercial supplier. (±)-2,2′-Bis(diphenylphosphino)-1,1′-
                                                 
188
 Larrow, J. F.; Jacobsen, E. N.; Gao, Y.; Hong, Y.; Nie, X.; Zepp, C. M. J. Org. Chem. 1994, 59, 1939-
1942. 
189
 Rettig, M. F.; Maitlis, P. M. Inorg. Synth. 1977, 17, 134-137. 
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binaphthalene (97%) and sodium tert-butoxide (97%) were purchased from Aldrich 
Chemical Co and were used as received. 
15. Toluene (ACS grade) was purchased from Fisher and was dried by passage through a 
column of activated alumina as described by Grubbs.
190
 
16. After 5-10 minutes a solid forms and is manually dispersed by vigorously swirling the 
flask by hand. 
17. Thin layer chromatography (TLC) was performed using glass-backed silica gel (250 
μm) plates from Sorbent Technologies. UV light was used to visualize the product. With 
20% ethyl acetate/hexanes, the starting material has Rf = 0.59 and the product has Rf  = 
0.23. Upon reaction completion, there may still be a relatively faint spot visible of the 
same Rf as the starting material. 
18. Hexanes (ACS grade) was purchased from Fisher Scientific Company and used as 
received.  
19. We have found this material to be of sufficient purity for use as a reactant to make 92. 
It can be further purified by column chromatography (10% ethyl acetate in hexanes). This 
crude material exhibited some variation from batch to batch in terms of melting point. A 
range of 235-245 °C is observed, but individual samples exhibit a routinely narrow (≤ 2 
°C) melting point range. The melting point of material purified by column 
chromatography is 236.0-237.0 °C. H,
4
ClQuin-BAM (2) exhibited the following: mp 
236.0-237.0; [α]
20
D  +508 (c 1.0, DMSO); Rf = 0.23 (20% EtOAc/hexanes); IR (film) 
3220, 2930, 1601 cm
-1
; 
1
H NMR (400 MHz, DMSO-d6) δ 7.82 (d, J = 8.0 Hz, 2H), 7.62-
7.53 (m, 4H), 7.29-7.20 (m, 4H), 6.84 (s, 2H), 4.05 (br s, 2H), 2.28-2.16 (m, 2H), 1.83-
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1.67 (m, 2H), 1.50-1.28 (m, 4H); 
13
C NMR (100 MHz, DMSO-d6) ppm 156.5, 148.5, 
140.2, 130.4, 126.0, 123.4, 122.1, 120.3, 112.6, 53.6, 31.7, 24.3; HRMS (CI): Exact mass 
calcd for C24H23Cl2N4 [M+H]
+
 437.1300, found 437.1294. We have found H,
4
ClQuin-
BAM to be a bench stable solid. No decomposition of this compound has been observed 
after years of storage on the benchtop in a screw cap vial. 
20. Pyrrolidine (99%) was purchased from Alfa Aesar and was used as received. 
21. Trifluoromethyl benzene (99+%) was purchased from Acros and was used as 
received.  
22. The reaction was performed in a Biotage Initiator EXP US 355302 microwave reactor 
set at a constant temperature of 200 °C. This reaction takes place in a sealed vial. This 
microwave system monitors the pressure and heat inside the sealed vial and shuts off for 
safety purposes when 20 bar or 250 °C is reached. Usually, the pressure inside the vial 
will exceed 15 bar at the initial stages of heating then stabilize. Due to the heat of 
dissolution in some cases, the pressure may exceed the set safety parameters. When this 
occurs, the heating protocol is restarted and no further temperature or pressure variations 
are observed. Confirmation of consumption of starting material can be made by TLC with 
UV visualization (10% methanol/0.5% acetic acid/89.5% dichloromethane, starting 
material Rf = 0.79, product Rf = 0.38). 
23. Dichloromethane (ACS grade) was purchased from Fisher Scientific Company and 
used as received. The contents of the microwave vial will congeal upon cooling, but the 
use of 20 mL of dichloromethane will sufficiently dissolve and transfer the mixture. It 
might be necessary to stir the contents of the vial with the added dichloromethane for 
several minutes to get this congealed mixture to dissolve for transfer. The use of an 
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abnormally large flask (500 mL for less than 30 mL of solution) is necessary because this 
viscous mixture foams upon concentration by rotavap. The extra headspace is needed to 
prevent the crude product from foaming out of the flask and into the rotavap bump trap. 
24. The material at this stage can be dried by subjecting the material to a drying pistol 
heated by refluxing toluene for 24-48 h. We have found this dried material without 
further purification to give the same performance (stereoselection) as a catalyst as 
material further purified (column chromatography or recrystallization).  
25. Acetone (ACS grade) was purchased from Sigma-Aldrich and used as received. The 
crude material might fully dissolve and crystallize in a matter of seconds upon addition of 
the solvent mixture at room temperature. These crystals may not fully redissolve upon 
heating and swirling, but the recrystallization will still work when the solution is cooled. 
26. Vacuum was applied with a needle through a septum secured to the top of the flask. 
The goal of this manipulation is merely to obtain a free-flowing solid. 
27. The mother liquor and crystal washings were concentrated and subjected to the same 
recrystallization procedure to produce an additional 800 mg of product to raise the yield 
for the last step to 81-85%. During the determination of the melting point, the material 
gradually turns from white to slightly brown between 200 °C and the melting point. 
Despite this appearance change, the melting point observed is consistent at 243-245 °C. 
We have noticed some variation in the melting point range (241-246 °C), but individual 
samples exhibit a routinely narrow (≤ 2 °C) melting point. PBAM (92) exhibited the 
following: mp 243.0-245.0; [α] 20D  +406 (c 1.2, CHCl3); Rf = 0.38 (10% MeOH/CH2Cl2 
with 0.5% acetic acid); IR (film) 3259, 3056, 2927, 2855, 2935, 1591, 1529 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.87 (d, J = 8.4 Hz, 2H), 7.65 (d, J = 8.4 Hz, 2H), 7.40 (dd, J 
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= 7.2, 7.2 Hz, 2H), 7.01 (dd, J = 7.2, 7.2 Hz, 2H), 5.70 (br s, 2H), 5.28 (s, 2H), 4.09 (br s, 
2H), 3.35-3.22 (m, 4H), 3.16-3.05 (m, 4H), 2.37-2.23 (m, 2H), 1.90-1.75 (m, 10H), 1.58-
1.37 (m, 4H); 
13
C NMR (100 MHz, CDCl3) ppm 158.4, 153.2, 149.9, 128.3, 126.4, 124.7, 
119.1, 118.7, 93.0, 56.3, 51.5, 33.4, 25.5, 25.1; HRMS (ESI): Exact mass calcd for 
C32H39N6[M+H]
+
 507.3236, found 507.3250. Anal. calcd for C32H38N6: C, 75.85; H, 
7.56; N, 16.59. Found: C, 75.80; H, 7.72; N, 16.45. PBAM purified by column 
chromatography has been stable upon storage in a screw cap vial on the benchtop for 
several years without sign of decomposition. 
 
